data_1jt8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jt8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.234 0.54 . . . . 1.0 109.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.744 HG12 ' HB2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -109.91 161.46 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.034 -1.099 . . . . 1.0 108.034 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.662 ' HG ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -125.11 120.73 32.25 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 117.957 -1.497 . . . . 1.0 109.356 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.565 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.23 162.06 26.84 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.359 -1.877 . . . . 1.0 112.542 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.602 HG22 HG11 ' A' ' 64' ' ' VAL . 11.3 pt -98.12 139.95 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.664 ' HA ' HG11 ' A' ' 37' ' ' VAL . 9.8 tp -99.46 151.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.22 1.01 . . . . 1.0 111.273 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.366 179.154 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.265 0.555 . . . . 1.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.547 HG21 HG12 ' A' ' 26' ' ' ILE . 7.0 m -141.25 169.6 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.639 0.733 . . . . 1.0 110.428 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.41 127.98 56.3 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 120.11 -0.636 . . . . 1.0 110.733 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.7 148.57 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.705 1.241 . . . . 1.0 112.333 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.66 135.12 55.2 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.227 -2.508 . . . . 1.0 104.227 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -140.16 160.42 39.99 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.591 -1.644 . . . . 1.0 114.462 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 6.0 tp -93.55 179.51 5.36 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.903 -1.888 . . . . 1.0 105.903 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.55 ' HB3' HG13 ' A' ' 22' ' ' ILE . 9.1 t70 75.3 22.66 1.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.05 -2.574 . . . . 1.0 104.05 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.67 55.98 15.11 Favored Glycine 0 N--CA 1.5 2.918 0 CA-C-N 115.028 -0.987 . . . . 1.0 113.961 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -145.75 154.48 42.09 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.467 2.134 . . . . 1.0 113.395 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.59 117.8 10.7 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.559 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.82 164.91 31.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.768 -1.173 . . . . 1.0 113.256 -175.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.475 HD22 ' HG3' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -97.55 125.1 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.794 -2.298 . . . . 1.0 104.794 175.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.92 142.93 16.38 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 120.795 -1.19 . . . . 1.0 112.157 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.6 ptm180 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.329 0.585 . . . . 1.0 109.783 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.602 HG11 HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -105.69 142.86 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.788 -1.195 . . . . 1.0 109.297 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.643 HG11 ' HA ' ' A' ' 82' ' ' TRP . 33.6 m -142.63 155.26 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.753 0.787 . . . . 1.0 111.435 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.509 HD11 HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -99.93 134.54 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -119.22 153.42 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-O 123.051 1.405 . . . . 1.0 113.793 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 ttpp -108.27 146.94 34.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 113.616 -1.629 . . . . 1.0 106.667 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HD2' ' HG2' ' A' ' 68' ' ' LYS . 38.8 Cg_endo -88.36 138.03 3.81 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.307 2.005 . . . . 1.0 112.944 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 77' ' ' LYS . 11.2 m0 . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.983 0.896 . . . . 1.0 111.779 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.475 ' HG3' HD22 ' A' ' 46' ' ' LEU . 2.9 mttm -98.22 152.29 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 18.1 p -143.91 151.67 40.12 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 119.975 -1.703 . . . . 1.0 111.681 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.61 118.51 37.08 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.5 HG22 HG11 ' A' ' 67' ' ' VAL . 2.2 pt -113.5 155.03 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.904 1.335 . . . . 1.0 114.594 -174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -116.61 128.63 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 105.388 -2.079 . . . . 1.0 105.388 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.643 ' HA ' HG11 ' A' ' 65' ' ' VAL . 1.1 t90 -97.24 142.23 29.38 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.923 0.868 . . . . 1.0 111.446 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.575 HG11 HG13 ' A' ' 64' ' ' VAL . 51.4 t . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -61.9 -35.4 78.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 1.0 109.102 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -55.16 19.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.595 . . . . 1.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.662 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 2.3 pp -61.83 -37.98 86.49 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.778 -0.576 . . . . 1.0 110.308 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.468 ' HD3' HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -65.34 -44.6 87.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.407 -0.808 . . . . 1.0 109.24 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.601 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 23.9 mtp85 -57.62 -36.94 72.46 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.33 -33.27 75.46 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.64 -44.93 95.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.02 -39.42 90.2 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.841 -0.8 . . . . 1.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.28 -48.76 80.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.771 -0.581 . . . . 1.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.78 -43.15 99.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.646 -0.659 . . . . 1.0 109.953 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 O-C-N 121.616 -0.678 . . . . 1.0 110.155 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.496 1.825 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.595 HG23 ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -113.46 161.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -123.86 134.01 53.66 Favored 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 117.542 -1.663 . . . . 1.0 109.434 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 39' ' ' CYS . . . -141.47 155.36 25.2 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 118.033 -2.032 . . . . 1.0 112.854 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.504 HG13 ' HG3' ' A' ' 38' ' ' ARG . 1.6 pp -99.33 138.81 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.082 -1.822 . . . . 1.0 106.082 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.562 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 3.1 pt -99.99 145.82 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.428 1.109 . . . . 1.0 111.954 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.488 1.464 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.029 178.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.843 0.83 . . . . 1.0 110.329 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -117.26 161.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 144.75 29.94 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.562 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 t -134.78 144.77 33.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.458 1.123 . . . . 1.0 111.867 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG3' HG13 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -110.77 141.51 43.99 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.332 -2.47 . . . . 1.0 104.332 174.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -139.92 154.72 47.3 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 117.159 -1.816 . . . . 1.0 114.536 -175.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 HD21 ' HE3' ' A' ' 93' ' ' LYS . 10.1 tp -92.71 171.7 8.83 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.299 -1.741 . . . . 1.0 106.299 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 1.1 t70 78.41 23.0 0.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.987 -2.597 . . . . 1.0 103.987 -171.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 53.17 34.37 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-N 114.92 -1.036 . . . . 1.0 115.028 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HD3' HG23 ' A' ' 22' ' ' ILE . 2.8 mptt -146.13 153.11 40.3 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.685 2.242 . . . . 1.0 112.557 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 117.25 16.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.94 164.53 32.63 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.463 -0.895 . . . . 1.0 111.905 -176.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.76 127.53 40.82 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.018 -2.215 . . . . 1.0 105.018 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.49 140.24 14.94 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.892 -1.13 . . . . 1.0 111.871 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 ptm85 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.462 0.648 . . . . 1.0 109.72 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB2' HD11 ' A' ' 26' ' ' ILE . 4.5 m-20 . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.9 p -97.18 138.62 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.839 -1.163 . . . . 1.0 108.168 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -141.75 142.71 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.841 -0.744 . . . . 1.0 111.282 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 HD12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -99.11 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 104.475 -2.417 . . . . 1.0 104.475 176.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.624 HG12 HG21 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -126.52 156.55 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.972 -1.491 . . . . 1.0 113.667 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.14 153.03 41.28 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 106.747 -1.575 . . . . 1.0 106.747 177.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 38.5 Cg_endo -89.03 140.0 3.85 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.412 2.075 . . . . 1.0 113.06 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.556 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.0 m95 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.517 0.675 . . . . 1.0 110.931 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.556 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 1.7 mttm -112.54 152.13 29.18 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 28.9 p -145.72 153.61 41.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 119.908 -1.745 . . . . 1.0 112.289 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 3.1 t0 -98.91 124.37 43.81 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.72 -2.326 . . . . 1.0 104.72 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.624 HG21 HG12 ' A' ' 67' ' ' VAL . 3.7 pt -122.33 149.97 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 117.484 -1.686 . . . . 1.0 114.72 -175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 66' ' ' ILE . 2.5 pt -121.98 119.51 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.633 ' HA ' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.42 159.83 14.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.009 0.909 . . . . 1.0 112.187 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.076 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.19 -41.85 93.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.696 -0.627 . . . . 1.0 109.648 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -60.01 -46.69 88.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.72 -0.613 . . . . 1.0 109.477 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HB3' HD21 ' A' ' 23' ' ' LEU . 60.8 mt -63.68 -38.02 89.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.601 -0.687 . . . . 1.0 110.252 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HE3' HD21 ' A' ' 40' ' ' LEU . 15.0 mmtt -61.94 -50.21 73.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.523 -0.736 . . . . 1.0 109.018 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.641 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -57.59 -35.46 70.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.465 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -62.22 -34.76 77.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.859 -0.526 . . . . 1.0 109.94 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.69 -39.79 90.3 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.847 -1.301 . . . . 1.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.641 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.7 m-85 -65.99 -53.05 43.71 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 1.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 3.2 pp -60.78 -37.65 82.61 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.423 -0.798 . . . . 1.0 109.514 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -65.76 -42.76 90.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.668 -0.645 . . . . 1.0 109.382 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.989 -0.444 . . . . 1.0 110.118 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 121.334 0.588 . . . . 1.0 109.613 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -103.67 161.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.33 -0.857 . . . . 1.0 109.06 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.07 119.93 38.83 Favored 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 117.636 -1.626 . . . . 1.0 109.215 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 67' ' ' VAL . . . -122.55 161.54 16.71 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.971 -1.585 . . . . 1.0 112.937 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.0 137.07 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.443 -1.688 . . . . 1.0 106.443 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.622 ' HA ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -99.15 154.98 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.591 1.186 . . . . 1.0 112.602 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-N 113.455 -1.702 . . . . 1.0 108.154 178.389 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.353 0.597 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.85 169.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 122.057 0.932 . . . . 1.0 110.386 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -97.07 127.98 43.56 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.237 -1.394 . . . . 1.0 107.237 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.622 HG22 ' HA ' ' A' ' 26' ' ' ILE . 1.5 t -131.36 152.32 37.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.426 1.108 . . . . 1.0 111.838 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.8 149.34 48.69 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.43 158.17 43.86 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.134 -176.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -94.62 176.38 6.3 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 78.43 22.35 0.74 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.178 -2.527 . . . . 1.0 104.178 -171.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.84 9.44 Favored Glycine 0 N--CA 1.507 3.386 0 N-CA-C 115.759 1.064 . . . . 1.0 115.759 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mptt -146.85 158.4 43.91 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 121.201 2.5 . . . . 1.0 113.514 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 44' ' ' THR . 0.7 OUTLIER -140.54 118.39 11.76 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 106.148 -1.797 . . . . 1.0 106.148 176.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.636 ' HG3' ' CB ' ' A' ' 76' ' ' GLN . 2.4 mpp_? -147.17 165.26 30.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.081 -1.012 . . . . 1.0 113.392 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.94 129.12 42.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.347 -2.464 . . . . 1.0 104.347 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.1 137.95 13.71 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.709 -1.234 . . . . 1.0 112.053 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB3' HD13 ' A' ' 26' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.402 ' CG1' HG21 ' A' ' 89' ' ' VAL . 19.1 m -100.79 145.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.478 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 82' ' ' TRP . 2.9 m -144.7 157.65 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.655 0.741 . . . . 1.0 111.798 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 81' ' ' ILE . 1.2 pt -99.56 132.36 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.591 -2.744 . . . . 1.0 103.591 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.4 m -122.25 155.36 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 118.106 -1.438 . . . . 1.0 114.257 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.4 mtpp -112.87 150.06 42.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.334 -1.757 . . . . 1.0 107.592 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.8 Cg_endo -89.94 141.07 3.58 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.617 2.212 . . . . 1.0 112.516 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.3 m0 . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.636 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 122.233 1.016 . . . . 1.0 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.593 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -109.35 155.2 21.5 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 25.6 p -144.19 151.74 39.91 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.195 -1.566 . . . . 1.0 111.319 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -98.6 118.7 35.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 103.737 -2.69 . . . . 1.0 103.737 176.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.553 HG12 ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -120.95 138.2 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.377 -1.329 . . . . 1.0 113.49 -174.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.554 HG22 HG12 ' A' ' 66' ' ' ILE . 5.7 tt -115.23 120.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 175.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.618 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 1.8 p90 -97.99 160.13 14.49 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.416 1.103 . . . . 1.0 113.108 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 . . . . . 0 N--CA 1.488 1.428 0 CA-C-N 114.765 -1.107 . . . . 1.0 108.734 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.29 -52.38 63.65 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 1.0 109.284 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -39.52 91.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.646 . . . . 1.0 109.419 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 15.9 mt -58.35 -40.31 81.87 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -64.13 -53.24 52.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.811 -0.555 . . . . 1.0 109.653 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 6.3 mtt-85 -55.45 -35.9 65.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.772 -0.58 . . . . 1.0 109.584 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HA ' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -64.43 -34.9 79.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.833 -0.542 . . . . 1.0 110.24 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.22 -40.5 92.33 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.3 m-85 -66.53 -53.1 38.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.826 -0.808 . . . . 1.0 111.043 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.3 pp -61.96 -40.14 94.56 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.429 -0.794 . . . . 1.0 109.841 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.88 -38.74 89.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.586 -0.696 . . . . 1.0 109.457 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 1.0 109.632 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.265 0.555 . . . . 1.0 109.761 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.554 HG13 HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -114.63 161.77 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' C ' ' HB2' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -126.95 123.07 36.32 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 117.722 -1.591 . . . . 1.0 109.658 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.52 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -140.55 163.63 26.45 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.215 -1.469 . . . . 1.0 112.232 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.58 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.628 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.7 pt -98.65 148.43 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 122.265 1.031 . . . . 1.0 111.595 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 35' ' ' VAL . 34.2 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-N 114.001 -1.454 . . . . 1.0 108.259 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.588 0.709 . . . . 1.0 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -99.96 162.44 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.427 ' N ' HG13 ' A' ' 35' ' ' VAL . 4.9 ptt180 -98.18 131.17 44.77 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.628 ' CG2' ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -134.85 153.09 34.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.986 0.898 . . . . 1.0 111.35 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 147.86 48.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.156 -1.794 . . . . 1.0 106.156 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -144.27 160.47 40.94 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.411 -1.316 . . . . 1.0 114.09 -176.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 6.0 mt -93.93 177.47 5.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 22.5 m-20 77.03 22.66 1.01 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 104.344 -2.465 . . . . 1.0 104.344 -172.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.43 52.25 13.71 Favored Glycine 0 N--CA 1.502 3.077 0 CA-C-O 118.708 -1.051 . . . . 1.0 115.234 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -146.76 151.5 37.27 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.094 2.447 . . . . 1.0 113.153 177.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 44' ' ' THR . 3.3 t -134.73 118.19 16.83 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 105.094 -2.188 . . . . 1.0 105.094 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.63 ' CZ ' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.65 162.74 37.8 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.882 -1.127 . . . . 1.0 113.028 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.27 123.04 42.16 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 103.685 -2.709 . . . . 1.0 103.685 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.77 143.55 16.73 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.469 -1.348 . . . . 1.0 112.237 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 110.156 -0.313 . . . . 1.0 110.156 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.5 p -96.21 136.81 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG22 ' CA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER -140.92 139.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.621 -0.832 . . . . 1.0 110.982 -178.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.556 HG13 ' CG1' ' A' ' 81' ' ' ILE . 1.7 pp -99.21 143.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.043 -2.206 . . . . 1.0 105.043 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' CZ ' ' A' ' 45' ' ' ARG . 1.5 m -140.28 159.31 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.611 -1.636 . . . . 1.0 114.677 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.8 OUTLIER -99.29 151.68 37.5 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 113.265 -1.789 . . . . 1.0 107.056 176.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.5 Cg_endo -90.04 141.25 3.56 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.409 2.073 . . . . 1.0 112.13 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m0 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.5 mp0 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.869 0.843 . . . . 1.0 110.773 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.528 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 4.0 mttm -112.98 154.74 25.98 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 11.3 p -145.1 153.57 41.55 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 119.961 -1.712 . . . . 1.0 111.776 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 1.3 t70 -99.45 119.43 37.98 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.591 HG21 ' CG1' ' A' ' 67' ' ' VAL . 2.7 pt -120.84 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.392 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 ' CG1' HG13 ' A' ' 66' ' ' ILE . 5.0 pt -126.39 118.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.181 -2.155 . . . . 1.0 105.181 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.599 ' CA ' HG22 ' A' ' 65' ' ' VAL . 7.5 p-90 -105.51 160.44 15.16 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.099 0.952 . . . . 1.0 112.792 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 . . . . . 0 N--CA 1.494 1.727 0 CA-C-N 115.337 -0.847 . . . . 1.0 108.717 179.312 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.3 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -44.06 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.636 -0.665 . . . . 1.0 109.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -58.31 -46.47 86.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.617 -0.677 . . . . 1.0 109.357 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.456 HD11 HD12 ' A' ' 23' ' ' LEU . 1.6 mt -63.58 -35.18 79.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.703 -0.623 . . . . 1.0 109.607 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.83 -50.27 67.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.655 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 15.7 mtm180 -54.75 -40.26 69.14 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 98' ' ' LEU . 17.2 ttpp -63.06 -33.44 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.008 -0.433 . . . . 1.0 110.092 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.25 -38.83 94.12 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.261 -1.135 . . . . 1.0 110.261 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.655 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.4 m-85 -66.13 -53.88 32.41 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.756 -0.849 . . . . 1.0 110.735 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 95' ' ' LYS . 2.2 pp -62.52 -38.63 90.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -0.783 . . . . 1.0 110.08 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.9 -45.3 82.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.567 -0.708 . . . . 1.0 109.761 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.787 -0.571 . . . . 1.0 110.168 -179.797 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.564 HG13 HG21 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -113.63 161.24 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.32 -0.862 . . . . 1.0 109.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -118.49 126.21 51.54 Favored 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 118.384 -1.326 . . . . 1.0 109.234 -178.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.588 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -140.28 161.92 26.46 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 118.586 -1.768 . . . . 1.0 112.79 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.64 144.5 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.63 HG12 HG13 ' A' ' 65' ' ' VAL . 3.7 pt -98.83 152.02 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.344 1.069 . . . . 1.0 111.985 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-N 114.204 -1.362 . . . . 1.0 108.617 178.902 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.568 0.699 . . . . 1.0 109.966 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.46 HG13 ' HB ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -110.96 161.9 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.25 131.33 44.68 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.62 ' CG2' ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -129.97 147.25 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.397 1.094 . . . . 1.0 111.701 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -117.99 139.29 51.38 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 105.461 -2.052 . . . . 1.0 105.461 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.588 ' HB2' ' CA ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -141.28 160.38 40.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.883 -1.527 . . . . 1.0 114.195 -175.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 6.1 mt -94.36 176.64 6.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.092 -1.413 . . . . 1.0 107.436 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 3.3 t70 76.74 23.09 1.07 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 103.961 -2.607 . . . . 1.0 103.961 -171.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 54.99 18.16 Favored Glycine 0 N--CA 1.502 3.096 0 CA-C-N 115.001 -1.0 . . . . 1.0 114.247 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.713 ' HB3' ' HD2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -146.38 155.05 42.32 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 120.573 2.187 . . . . 1.0 112.752 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.7 m -140.36 116.39 10.44 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.713 ' HD2' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -146.46 164.95 30.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.21 -0.996 . . . . 1.0 112.408 -175.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -95.3 126.31 40.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 104.464 -2.421 . . . . 1.0 104.464 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.595 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -94.76 131.49 10.73 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.67 -1.253 . . . . 1.0 111.535 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.501 0.667 . . . . 1.0 109.888 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.25 133.53 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 1.0 108.386 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' A' ' 82' ' ' TRP . 35.9 m -139.64 150.16 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.682 0.753 . . . . 1.0 111.249 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.621 HG13 ' CG1' ' A' ' 81' ' ' ILE . 1.6 pp -99.6 142.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.994 -2.224 . . . . 1.0 104.994 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.685 HG22 ' CZ ' ' A' ' 45' ' ' ARG . 2.0 m -140.25 156.4 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 117.38 -1.728 . . . . 1.0 114.367 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 8.8 ptpt -101.1 153.73 37.59 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.941 -1.481 . . . . 1.0 108.168 176.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.443 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.0 Cg_endo -89.83 143.82 4.29 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.605 2.203 . . . . 1.0 112.168 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.513 ' CD2' ' HB3' ' A' ' 77' ' ' LYS . 11.1 m0 . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 107.834 -1.172 . . . . 1.0 107.834 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.684 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 42.0 mm-40 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.553 0.692 . . . . 1.0 110.557 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HB3' ' CD2' ' A' ' 70' ' ' TRP . 16.0 mttm -107.8 152.96 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 106.634 -1.617 . . . . 1.0 106.634 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.662 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 24.9 p -144.79 154.61 42.88 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.94 -1.725 . . . . 1.0 111.805 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 6.7 t70 -99.27 118.44 35.95 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 103.403 -2.814 . . . . 1.0 103.403 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.652 HG13 ' HB ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -118.61 147.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 118.145 -1.422 . . . . 1.0 113.752 -174.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.621 ' CG1' HG13 ' A' ' 66' ' ' ILE . 2.0 pt -125.58 120.31 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.647 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -98.16 158.25 15.67 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.151 0.977 . . . . 1.0 112.993 -175.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-N 115.218 -0.901 . . . . 1.0 109.228 -179.586 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.503 2.215 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.53 -42.34 78.29 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.456 -0.777 . . . . 1.0 109.183 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.407 ' CH2' ' HD2' ' A' ' 95' ' ' LYS . 59.1 t90 -64.99 -42.5 94.45 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.46 ' HB3' HD22 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -60.15 -34.66 73.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.746 -0.596 . . . . 1.0 109.692 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HG3' HD12 ' A' ' 23' ' ' LEU . 1.6 mttt -63.63 -56.0 19.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.597 -0.69 . . . . 1.0 109.508 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.597 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -59.73 -36.46 76.61 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HD2' ' CH2' ' A' ' 91' ' ' TRP . 12.4 tttp -64.72 -33.57 76.27 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.07 -44.25 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.061 -1.215 . . . . 1.0 110.061 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.693 -0.886 . . . . 1.0 109.831 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.42 -56.52 20.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.901 -0.5 . . . . 1.0 109.913 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.44 -34.21 77.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.274 -0.891 . . . . 1.0 109.599 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.497 1.921 0 O-C-N 121.742 -0.599 . . . . 1.0 109.925 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.432 ' HB ' ' NH1' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -114.46 161.35 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -121.26 132.36 54.76 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.195 -1.402 . . . . 1.0 109.153 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 39' ' ' CYS . . . -141.79 155.62 25.48 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 118.18 -1.962 . . . . 1.0 113.086 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 63' ' ' ASP . 9.8 tt -100.37 138.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 105.958 -1.867 . . . . 1.0 105.958 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.708 HG12 HG13 ' A' ' 65' ' ' VAL . 6.6 pt -98.36 149.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 122.589 1.185 . . . . 1.0 112.567 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 113.865 -1.516 . . . . 1.0 108.763 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.561 ' HD3' ' CB ' ' A' ' 46' ' ' LEU . 21.8 ttm-85 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.44 0.638 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.442 ' N ' ' HG2' ' A' ' 34' ' ' ARG . 0.9 OUTLIER -111.05 161.82 9.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HG2' ' N ' ' A' ' 37' ' ' VAL . 10.1 ttp180 -100.0 141.04 33.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.381 -1.34 . . . . 1.0 107.381 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 26' ' ' ILE . 2.3 t -133.87 148.49 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.442 1.115 . . . . 1.0 112.018 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -112.68 141.17 46.78 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 104.657 -2.349 . . . . 1.0 104.657 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -141.25 158.47 43.85 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.17 -1.812 . . . . 1.0 115.015 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 6.5 tp -93.42 172.78 8.07 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.775 -1.557 . . . . 1.0 107.477 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 2.1 t70 77.44 22.8 0.91 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 104.134 -2.543 . . . . 1.0 104.134 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.69 56.08 16.73 Favored Glycine 0 N--CA 1.501 3.018 0 CA-C-N 114.975 -1.011 . . . . 1.0 114.276 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.702 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -145.62 151.12 37.57 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 120.452 2.126 . . . . 1.0 112.661 178.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.535 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -133.93 117.92 17.3 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 176.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 76' ' ' GLN . 0.9 OUTLIER -145.95 162.57 37.51 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.001 -1.08 . . . . 1.0 112.847 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CB ' ' HD3' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -97.89 117.89 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.401 -2.814 . . . . 1.0 103.401 174.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' HA3' ' CD1' ' A' ' 80' ' ' ILE . . . -101.57 153.93 18.87 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.785 -1.198 . . . . 1.0 112.753 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.702 0.763 . . . . 1.0 110.143 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 25' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.56 137.84 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 120.502 -1.374 . . . . 1.0 109.183 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.708 HG13 HG12 ' A' ' 26' ' ' ILE . 3.1 m -141.58 158.62 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.889 -0.724 . . . . 1.0 111.306 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 81' ' ' ILE . 14.4 tt -99.57 149.03 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 105.045 -2.205 . . . . 1.0 105.045 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.702 HG23 ' CZ ' ' A' ' 45' ' ' ARG . 1.3 m -134.22 157.4 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.6 -1.64 . . . . 1.0 114.54 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 41.4 mtmt -103.94 152.82 39.1 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 113.332 -1.758 . . . . 1.0 106.928 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.42 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.3 Cg_endo -89.16 141.39 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.684 2.256 . . . . 1.0 113.033 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.583 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m95 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.737 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 5.9 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.457 0.646 . . . . 1.0 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.583 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 16.4 mttm -114.87 158.87 21.36 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 21.6 p -146.25 155.86 42.97 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.144 -1.597 . . . . 1.0 111.944 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.81 117.54 34.13 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 104.337 -2.468 . . . . 1.0 104.337 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.559 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -120.01 161.35 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.312 1.597 . . . . 1.0 115.312 -174.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' CG1' HG23 ' A' ' 66' ' ' ILE . 1.2 pp -118.94 120.28 63.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 175.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.702 ' HA ' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -97.54 156.3 16.56 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.188 0.994 . . . . 1.0 112.709 -176.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.067 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -63.22 -48.86 76.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.706 -0.621 . . . . 1.0 110.086 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -54.27 -50.54 67.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 1.0 109.395 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.4 mt -61.57 -39.05 89.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.758 -0.589 . . . . 1.0 109.622 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.471 ' HE2' HD21 ' A' ' 40' ' ' LEU . 10.1 mmtm -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.767 -0.583 . . . . 1.0 109.847 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.811 ' HA ' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.32 -55.32 32.83 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -25.17 67.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.94 -59.03 10.83 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.498 -0.858 . . . . 1.0 111.487 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.811 ' CZ ' ' HA ' ' A' ' 94' ' ' ARG . 10.4 p90 -70.58 -39.11 74.05 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.429 1.114 . . . . 1.0 110.308 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.5 -52.88 62.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.873 -0.517 . . . . 1.0 110.268 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.57 -42.15 95.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.591 -0.693 . . . . 1.0 109.778 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.582 -0.699 . . . . 1.0 109.585 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 1.0 110.741 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.645 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 1.2 mp -111.13 158.37 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -130.62 126.97 38.0 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 118.185 -1.406 . . . . 1.0 108.886 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.5 161.68 27.35 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 117.566 -2.254 . . . . 1.0 114.21 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.498 ' HB ' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -98.04 135.07 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 177.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.802 ' HA ' HG22 ' A' ' 37' ' ' VAL . 9.4 tp -104.57 152.72 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.498 1.142 . . . . 1.0 112.629 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 114.21 -1.359 . . . . 1.0 108.15 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 26' ' ' ILE . 6.5 m -137.38 168.51 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.742 0.782 . . . . 1.0 110.188 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.62 122.31 41.25 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.259 -0.577 . . . . 1.0 110.725 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -120.9 148.61 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 122.868 1.318 . . . . 1.0 111.78 -179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -110.03 139.89 44.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.899 -2.63 . . . . 1.0 103.899 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 43' ' ' LYS . 1.8 p -141.32 162.56 35.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.334 -1.746 . . . . 1.0 115.665 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' A' ' 41' ' ' ASP . 38.2 tp -89.84 169.49 11.21 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.91 -1.95 . . . . 1.0 105.926 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.596 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 15.6 m-20 78.83 24.5 0.55 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 104.527 -2.397 . . . . 1.0 104.527 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.44 58.57 13.69 Favored Glycine 0 N--CA 1.498 2.799 0 CA-C-N 114.738 -1.119 . . . . 1.0 113.434 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.659 ' CB ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -144.79 156.35 43.99 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.679 1.739 . . . . 1.0 112.994 178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.91 120.74 12.71 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.218 -1.771 . . . . 1.0 106.218 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.787 ' CZ ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.18 163.23 35.02 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.144 -1.422 . . . . 1.0 114.456 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 124.75 43.33 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' NH2' ' A' ' 45' ' ' ARG . . . -105.62 159.84 15.2 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.545 -1.312 . . . . 1.0 113.48 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 178.436 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.672 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -102.23 128.44 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.12 . . . . 1.0 108.205 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 82' ' ' TRP . 16.5 m -140.59 148.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.521 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.4 tt -98.72 141.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.677 ' HA ' HG21 ' A' ' 80' ' ' ILE . 1.2 m -121.6 148.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.726 -1.234 . . . . 1.0 113.536 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -102.39 141.33 22.3 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 106.568 -1.641 . . . . 1.0 106.568 176.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.539 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 39.9 Cg_endo -88.64 137.25 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.967 1.778 . . . . 1.0 113.253 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.508 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.7 m0 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.757 -1.571 . . . . 1.0 106.757 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.676 ' HG3' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt20 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 122.627 1.204 . . . . 1.0 113.208 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -100.8 160.11 14.63 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.347 -1.723 . . . . 1.0 106.347 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.612 ' HB2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.98 160.22 42.63 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 119.764 -1.835 . . . . 1.0 111.618 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 1.2 p-10 -117.95 117.81 30.27 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.677 HG21 ' HA ' ' A' ' 67' ' ' VAL . 2.4 pt -115.16 160.58 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.34 122.29 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 105.227 -2.138 . . . . 1.0 105.227 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.575 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.36 148.12 23.99 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.325 0.584 . . . . 1.0 111.293 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.508 ' O ' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.393 0.616 . . . . 1.0 110.43 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.672 ' HB ' ' CB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.68 -37.86 59.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -66.2 -55.03 18.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.853 -0.529 . . . . 1.0 109.864 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER -63.98 -51.3 64.96 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.459 -0.775 . . . . 1.0 111.076 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' CG ' ' N ' ' A' ' 94' ' ' ARG . 1.2 pttt -59.02 -43.47 91.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.283 -0.886 . . . . 1.0 110.42 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.63 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -60.49 -39.1 86.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.411 -0.806 . . . . 1.0 108.988 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 5.5 mtpp -59.53 -33.82 71.86 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.22 -42.43 94.24 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.939 -1.264 . . . . 1.0 109.939 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.3 m-85 -66.46 -55.11 17.23 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.716 -0.873 . . . . 1.0 110.661 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 3.9 pp -59.78 -33.91 72.33 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.528 -0.733 . . . . 1.0 110.445 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -51.04 64.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.486 -0.759 . . . . 1.0 109.764 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.636 -0.665 . . . . 1.0 110.194 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 121.196 0.522 . . . . 1.0 110.727 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.625 HG23 HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -104.21 155.1 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 92' ' ' LEU . 1.6 pp -122.64 119.68 31.47 Favored 'General case' 0 N--CA 1.517 2.915 0 C-N-CA 118.045 -1.462 . . . . 1.0 109.172 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.39 160.75 26.02 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 117.7 -2.19 . . . . 1.0 113.705 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.47 HG23 HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -99.09 130.9 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.485 -1.672 . . . . 1.0 106.485 177.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.641 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -99.56 154.55 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.255 1.026 . . . . 1.0 111.991 -177.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.931 -1.031 . . . . 1.0 108.697 179.459 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.361 0.601 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.565 HG23 HG12 ' A' ' 26' ' ' ILE . 10.7 m -129.38 168.68 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.201 1.0 . . . . 1.0 110.883 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -106.14 131.55 53.27 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 115.236 -0.893 . . . . 1.0 109.216 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -140.41 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.226 -0.921 . . . . 1.0 111.035 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.34 141.07 40.7 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -142.09 162.32 35.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.881 -1.528 . . . . 1.0 114.306 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -92.13 178.88 5.73 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 176.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 76.58 23.8 1.07 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 -171.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.94 55.31 27.4 Favored Glycine 0 N--CA 1.5 2.919 0 CA-C-N 114.806 -1.088 . . . . 1.0 113.989 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.729 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 3.2 tptp -145.85 153.99 41.48 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.634 2.217 . . . . 1.0 113.474 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.417 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -135.39 117.49 15.41 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 104.682 -2.34 . . . . 1.0 104.682 175.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.667 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.17 160.83 41.42 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.764 -1.175 . . . . 1.0 112.977 -175.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.18 123.56 43.56 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.551 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.9 146.07 18.13 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.433 -1.365 . . . . 1.0 112.652 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 89' ' ' VAL . 3.8 t -109.33 139.43 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.93 -1.106 . . . . 1.0 108.535 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 82' ' ' TRP . 34.6 m -140.2 152.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.973 0.892 . . . . 1.0 111.894 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.9 pt -99.61 139.68 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 105.501 -2.037 . . . . 1.0 105.501 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.667 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -139.49 158.74 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 117.312 -1.755 . . . . 1.0 114.272 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -100.68 154.88 36.92 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 107.504 -1.295 . . . . 1.0 107.504 176.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.443 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.8 Cg_endo -89.35 141.89 4.19 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.664 2.243 . . . . 1.0 112.549 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.684 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 12.3 m0 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.031 -1.47 . . . . 1.0 107.031 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.553 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 4.5 tt0 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.893 0.854 . . . . 1.0 111.388 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.684 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 37.2 mmtm -112.5 154.76 25.41 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.598 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 14.4 p -144.56 156.16 44.01 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 119.776 -1.828 . . . . 1.0 111.634 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -106.23 119.17 38.54 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 175.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.588 HG22 ' CG1' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -106.65 161.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 115.575 1.694 . . . . 1.0 115.575 -174.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -120.29 123.61 70.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 103.781 -2.674 . . . . 1.0 103.781 175.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.57 ' HA ' HG13 ' A' ' 65' ' ' VAL . 6.6 t90 -96.29 138.0 34.54 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.951 0.881 . . . . 1.0 111.908 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.17 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 25' ' ' ILE . 3.4 t . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -44.24 80.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.495 -0.753 . . . . 1.0 109.51 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.452 ' CE3' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -65.09 -45.13 86.5 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HB3' HD21 ' A' ' 23' ' ' LEU . 1.9 mt -57.69 -40.99 80.72 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.609 -0.682 . . . . 1.0 109.212 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.463 ' HE2' HD22 ' A' ' 40' ' ' LEU . 6.5 mtmt -58.57 -50.09 75.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.597 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -56.38 -36.11 68.48 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 7.4 tptt -62.22 -35.4 78.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.917 -0.489 . . . . 1.0 109.854 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.59 91.34 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.1 m-85 -66.18 -53.04 42.28 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.915 -0.756 . . . . 1.0 110.802 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 3.6 pp -62.17 -34.86 77.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.321 -0.862 . . . . 1.0 109.918 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -38.98 92.45 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.693 . . . . 1.0 109.818 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 1.0 109.769 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -122.49 161.74 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD2' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.96 127.75 43.85 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 117.947 -1.501 . . . . 1.0 109.038 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -142.11 161.74 27.19 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 118.248 -1.929 . . . . 1.0 112.776 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -98.26 130.99 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 HG12 ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -99.03 153.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.198 0.999 . . . . 1.0 111.398 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 N--CA 1.49 1.554 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.729 179.284 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 ' CG2' HG12 ' A' ' 26' ' ' ILE . 16.9 m -137.45 167.6 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.91 0.862 . . . . 1.0 110.79 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.563 ' HA ' HD11 ' A' ' 46' ' ' LEU . 8.6 ptt-85 -109.54 130.64 55.49 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG11 HG13 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -141.03 144.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.899 -1.12 . . . . 1.0 111.018 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 144.48 35.86 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 105.548 -2.019 . . . . 1.0 105.548 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.0 m -139.61 157.24 46.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.233 -1.387 . . . . 1.0 113.125 -176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.487 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -94.25 179.51 5.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.64 ' HB3' HG13 ' A' ' 22' ' ' ILE . 6.9 t70 76.44 23.41 1.15 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 103.561 -2.755 . . . . 1.0 103.561 -171.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.66 52.74 36.28 Favored Glycine 0 N--CA 1.5 2.903 0 CA-C-N 114.878 -1.056 . . . . 1.0 113.99 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.609 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -146.03 154.02 41.39 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 120.818 2.309 . . . . 1.0 112.796 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.71 118.03 13.68 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.576 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -147.65 164.4 33.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.049 -1.06 . . . . 1.0 112.808 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.563 HD11 ' HA ' ' A' ' 36' ' ' ARG . 2.8 mm? -97.42 132.63 42.95 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.084 -2.191 . . . . 1.0 105.084 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.701 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.21 150.62 19.67 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.745 -1.217 . . . . 1.0 111.909 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.1 ptm180 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.481 0.658 . . . . 1.0 109.787 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.517 ' HA ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -102.45 141.74 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.805 -1.184 . . . . 1.0 109.906 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 82' ' ' TRP . 17.8 m -142.0 159.29 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.612 0.72 . . . . 1.0 111.224 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 81' ' ' ILE . 1.1 tt -100.32 144.17 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.508 ' CG2' HG22 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -129.66 152.85 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 118.0 -1.48 . . . . 1.0 113.432 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 19.9 mttt -104.75 148.26 35.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' HA ' HH22 ' A' ' 45' ' ' ARG . 39.5 Cg_endo -88.49 135.52 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.255 1.97 . . . . 1.0 112.875 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.698 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.3 m0 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 107.621 -1.252 . . . . 1.0 107.621 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 122.184 0.993 . . . . 1.0 112.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.698 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 24.1 tptt -102.34 150.68 23.09 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 106.125 -1.805 . . . . 1.0 106.125 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.701 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 17.4 p -143.15 151.44 40.69 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 119.97 -1.706 . . . . 1.0 111.466 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.67 120.33 39.53 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.639 HG12 ' HA3' ' A' ' 47' ' ' GLY . 1.8 pp -119.95 156.64 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.064 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 66' ' ' ILE . 1.4 tp -118.47 128.91 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 105.487 -2.042 . . . . 1.0 105.487 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.678 ' HA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.89 147.58 24.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.748 0.785 . . . . 1.0 111.665 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.485 0.659 . . . . 1.0 109.605 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.585 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 86.1 t . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -63.18 -38.49 91.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.166 -0.959 . . . . 1.0 109.26 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -66.19 -55.57 15.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.775 -0.578 . . . . 1.0 110.251 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.585 ' CD2' ' HA ' ' A' ' 89' ' ' VAL . 1.4 pp -58.28 -33.88 69.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.655 -0.653 . . . . 1.0 109.848 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -58.49 -49.63 76.67 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -58.48 -35.47 72.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.02 -34.19 77.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.795 -0.566 . . . . 1.0 109.966 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.24 -44.81 93.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.055 -1.618 . . . . 1.0 109.055 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -65.93 -37.46 86.1 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 -56.03 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -34.68 73.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.872 -0.518 . . . . 1.0 109.943 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 1.0 110.176 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.117 0.484 . . . . 1.0 109.773 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 43' ' ' LYS . 1.2 mp -110.26 162.13 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -128.12 125.26 38.84 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 117.891 -1.524 . . . . 1.0 109.43 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.65 161.9 27.01 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.11 -1.995 . . . . 1.0 113.051 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.464 HG22 HG11 ' A' ' 64' ' ' VAL . 7.7 pt -98.29 131.67 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -100.5 156.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 122.182 0.992 . . . . 1.0 111.751 -177.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.43 0.633 . . . . 1.0 109.822 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 26' ' ' ILE . 7.0 m -124.1 168.24 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 121.888 0.851 . . . . 1.0 110.384 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.604 ' HA ' HD11 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -108.15 132.01 54.05 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 178.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -140.91 145.38 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 118.939 -1.105 . . . . 1.0 111.274 -178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.09 141.36 44.7 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.654 -1.98 . . . . 1.0 105.654 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.2 m -137.88 157.43 46.42 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.253 -1.379 . . . . 1.0 113.176 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' HB3' HD12 ' A' ' 23' ' ' LEU . 3.7 tp -93.69 177.94 5.84 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.279 -1.748 . . . . 1.0 106.279 176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' HB3' HG13 ' A' ' 22' ' ' ILE . 2.8 t70 76.63 22.87 1.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 104.308 -2.479 . . . . 1.0 104.308 -172.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.61 18.03 Favored Glycine 0 N--CA 1.499 2.874 0 CA-C-N 115.079 -0.964 . . . . 1.0 113.998 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.18 153.46 41.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 120.465 2.133 . . . . 1.0 112.203 178.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.5 116.89 10.71 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.179 -2.156 . . . . 1.0 105.179 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -148.27 164.08 35.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.716 -1.193 . . . . 1.0 113.342 -175.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 36' ' ' ARG . 4.1 mm? -97.31 130.23 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 104.753 -2.314 . . . . 1.0 104.753 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.679 ' HA3' HG12 ' A' ' 80' ' ' ILE . . . -95.18 149.09 19.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.027 -1.082 . . . . 1.0 111.921 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.443 0.64 . . . . 1.0 109.981 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.483 ' CG1' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.36 140.74 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.753 -1.217 . . . . 1.0 109.776 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 82' ' ' TRP . 19.4 m -142.5 158.12 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.514 0.673 . . . . 1.0 111.071 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.467 ' CG2' HG12 ' A' ' 81' ' ' ILE . 1.8 tp -100.87 146.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -131.36 154.7 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 118.291 -1.364 . . . . 1.0 113.444 -177.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.1 mmpp? -107.48 149.32 38.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 106.507 -1.664 . . . . 1.0 106.507 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.466 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.1 Cg_endo -88.48 136.34 3.27 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.417 2.078 . . . . 1.0 112.956 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.649 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.7 m0 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 122.097 0.951 . . . . 1.0 111.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 4.8 tppt? -99.73 151.98 20.62 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.317 -1.735 . . . . 1.0 106.317 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 30.9 p -142.73 152.04 41.91 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.126 -1.609 . . . . 1.0 111.31 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.64 119.62 38.83 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 104.788 -2.301 . . . . 1.0 104.788 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.679 HG12 ' HA3' ' A' ' 47' ' ' GLY . 1.3 pp -120.32 155.79 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 117.761 -1.576 . . . . 1.0 114.994 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.467 HG12 ' CG2' ' A' ' 66' ' ' ILE . 1.8 pp -117.21 132.35 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.72 -1.955 . . . . 1.0 105.72 175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.672 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.86 146.29 25.57 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.879 0.847 . . . . 1.0 111.462 -176.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.409 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.548 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 110.262 -0.273 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 91' ' ' TRP . 10.2 pt-20 -65.19 -34.33 78.12 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.985 -1.072 . . . . 1.0 109.342 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.4 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.3 m95 -65.26 -55.65 17.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.598 -0.689 . . . . 1.0 109.47 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.611 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 1.6 pp -62.02 -34.53 76.38 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.784 -0.573 . . . . 1.0 109.935 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -61.24 -50.03 74.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.0 109.501 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.51 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -56.82 -37.56 71.38 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.776 -0.578 . . . . 1.0 109.531 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.907 -0.496 . . . . 1.0 110.091 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.96 -44.46 94.49 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -65.89 -37.61 86.58 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.896 -0.767 . . . . 1.0 109.647 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.13 -46.62 89.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.3 -34.73 79.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 1.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.5 2.037 0 O-C-N 121.588 -0.695 . . . . 1.0 110.154 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.076 0.465 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.69 118.84 1.15 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.281 -0.887 . . . . 1.0 109.627 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -139.0 78.6 1.68 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.635 -0.666 . . . . 1.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.77 162.5 29.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.652 . . . . 1.0 109.895 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.98 147.75 52.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.587 -0.696 . . . . 1.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 59.67 65.35 1.15 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.543 0.687 . . . . 1.0 109.261 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.15 136.36 53.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 1.0 109.693 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -84.24 111.88 19.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.585 -0.697 . . . . 1.0 109.127 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -89.84 151.09 21.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.634 -0.666 . . . . 1.0 110.203 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.5 pt -67.37 -33.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.79 -0.569 . . . . 1.0 110.348 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.36 17.69 9.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.467 -0.771 . . . . 1.0 110.981 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.54 -179.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 1.0 109.599 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 67.48 67.63 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.528 -0.733 . . . . 1.0 109.289 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.487 HG13 ' HD2' ' A' ' 15' ' ' PRO . 4.6 tp -91.59 135.98 27.18 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.597 -0.689 . . . . 1.0 109.602 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 14' ' ' ILE . 34.6 Cg_endo -76.43 178.74 7.16 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 122.635 2.223 . . . . 1.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 65.44 101.11 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.311 0.577 . . . . 1.0 109.826 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.04 72.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.55 0.69 . . . . 1.0 109.284 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -69.78 -51.76 31.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.52 -0.737 . . . . 1.0 109.826 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.01 25.41 11.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.619 -0.676 . . . . 1.0 110.035 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 64.12 175.13 0.18 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.374 -0.829 . . . . 1.0 110.341 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -126.23 172.94 9.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.513 -0.742 . . . . 1.0 109.741 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.744 HG12 ' HB2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -109.91 161.46 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.034 -1.099 . . . . 1.0 108.034 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.662 ' HG ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -125.11 120.73 32.25 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 117.957 -1.497 . . . . 1.0 109.356 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.565 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.23 162.06 26.84 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.359 -1.877 . . . . 1.0 112.542 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.602 HG22 HG11 ' A' ' 64' ' ' VAL . 11.3 pt -98.12 139.95 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.664 ' HA ' HG11 ' A' ' 37' ' ' VAL . 9.8 tp -99.46 151.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.22 1.01 . . . . 1.0 111.273 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.82 138.42 28.68 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.366 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.677 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER 167.54 123.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.187 0.518 . . . . 1.0 110.118 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.42 ' SD ' ' HG2' ' A' ' 60' ' ' ARG . 10.7 tpt -109.67 -29.72 8.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.813 -0.555 . . . . 1.0 109.64 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.76 -56.48 20.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.573 -0.705 . . . . 1.0 109.765 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.7 75.83 1.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.0 37.47 4.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.693 -0.887 . . . . 1.0 109.444 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.61 1.28 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.628 -0.67 . . . . 1.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.9 155.26 46.33 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.0 109.547 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.677 ' HA ' ' HG3' ' A' ' 28' ' ' GLN . 7.0 m -141.25 169.6 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.639 0.733 . . . . 1.0 110.428 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.41 127.98 56.3 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 120.11 -0.636 . . . . 1.0 110.733 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.664 HG11 ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.7 148.57 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.705 1.241 . . . . 1.0 112.333 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.66 135.12 55.2 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.227 -2.508 . . . . 1.0 104.227 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.565 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -140.16 160.42 39.99 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.591 -1.644 . . . . 1.0 114.462 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 6.0 tp -93.55 179.51 5.36 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.903 -1.888 . . . . 1.0 105.903 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.55 ' HB3' HG13 ' A' ' 22' ' ' ILE . 9.1 t70 75.3 22.66 1.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.05 -2.574 . . . . 1.0 104.05 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.67 55.98 15.11 Favored Glycine 0 N--CA 1.5 2.918 0 CA-C-N 115.028 -0.987 . . . . 1.0 113.961 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.744 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -145.75 154.48 42.09 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.467 2.134 . . . . 1.0 113.395 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.59 117.8 10.7 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.559 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.82 164.91 31.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.768 -1.173 . . . . 1.0 113.256 -175.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.475 HD22 ' HG3' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -97.55 125.1 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.794 -2.298 . . . . 1.0 104.794 175.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.709 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.92 142.93 16.38 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 120.795 -1.19 . . . . 1.0 112.157 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.6 ptm180 -121.39 149.49 42.91 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.329 0.585 . . . . 1.0 109.783 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -126.86 156.49 73.82 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 33.3 Cg_endo -74.43 167.93 25.98 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.619 2.212 . . . . 1.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.52 -45.45 93.08 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -58.25 -55.09 39.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.637 -0.92 . . . . 1.0 109.9 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.508 ' HB3' HG12 ' A' ' 49' ' ' ILE . 1.8 mp -65.58 -33.97 77.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.732 -0.605 . . . . 1.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -52.1 -48.36 64.79 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.445 -0.785 . . . . 1.0 110.782 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 3.63 51.11 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.508 -0.745 . . . . 1.0 110.667 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -116.12 -15.95 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.261 -0.899 . . . . 1.0 110.85 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' A' ' 82' ' ' TRP . 1.1 pp -80.9 -52.43 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.147 -0.971 . . . . 1.0 110.418 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.7 m95 43.84 53.64 6.07 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.443 0.64 . . . . 1.0 110.157 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.443 HG13 HD13 ' A' ' 57' ' ' ILE . 33.0 m -70.65 133.79 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.461 -0.774 . . . . 1.0 109.908 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 8.5 ttt-85 -93.0 -66.92 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -174.49 113.67 0.17 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.566 -0.709 . . . . 1.0 109.854 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.41 66.48 0.85 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.691 -0.964 . . . . 1.0 110.691 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.91 160.49 29.82 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.631 -0.923 . . . . 1.0 108.734 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.602 HG11 HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -105.69 142.86 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.788 -1.195 . . . . 1.0 109.297 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.643 HG11 ' HA ' ' A' ' 82' ' ' TRP . 33.6 m -142.63 155.26 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.753 0.787 . . . . 1.0 111.435 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.509 HD11 HG23 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -99.93 134.54 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -119.22 153.42 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-O 123.051 1.405 . . . . 1.0 113.793 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 ttpp -108.27 146.94 34.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 113.616 -1.629 . . . . 1.0 106.667 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HD2' ' HG2' ' A' ' 68' ' ' LYS . 38.8 Cg_endo -88.36 138.03 3.81 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.307 2.005 . . . . 1.0 112.944 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 77' ' ' LYS . 11.2 m0 -122.61 117.61 26.23 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 47.86 -147.75 0.21 Allowed 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 119.095 0.861 . . . . 1.0 110.343 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.128 -0.983 . . . . 1.0 109.98 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 52.16 -158.71 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.373 -0.829 . . . . 1.0 110.088 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.52 25.68 17.38 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.225 -1.55 . . . . 1.0 109.225 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.56 136.62 0.26 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -111.3 154.19 24.86 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.826 -1.149 . . . . 1.0 111.779 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.475 ' HG3' HD22 ' A' ' 46' ' ' LEU . 2.9 mttm -98.22 152.29 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.709 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 18.1 p -143.91 151.67 40.12 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 119.975 -1.703 . . . . 1.0 111.681 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.61 118.51 37.08 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.5 HG22 HG11 ' A' ' 67' ' ' VAL . 2.2 pt -113.5 155.03 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.904 1.335 . . . . 1.0 114.594 -174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -116.61 128.63 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 105.388 -2.079 . . . . 1.0 105.388 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.643 ' HA ' HG11 ' A' ' 65' ' ' VAL . 1.1 t90 -97.24 142.23 29.38 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.923 0.868 . . . . 1.0 111.446 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HG3' ' CE ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -167.6 142.81 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -105.68 91.24 3.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 1.0 109.864 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 m 59.56 105.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.381 0.61 . . . . 1.0 110.594 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.43 ' CE ' ' HG3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -138.75 -74.67 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.39 -0.819 . . . . 1.0 109.872 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.81 -43.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -59.41 -57.39 13.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 1.0 109.509 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.575 HG11 HG13 ' A' ' 64' ' ' VAL . 51.4 t -65.63 -34.33 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.535 -0.728 . . . . 1.0 109.198 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -61.9 -35.4 78.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 1.0 109.102 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -55.16 19.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.595 . . . . 1.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 2.3 pp -61.83 -37.98 86.49 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.778 -0.576 . . . . 1.0 110.308 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.468 ' HD3' HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -65.34 -44.6 87.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.407 -0.808 . . . . 1.0 109.24 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.601 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 23.9 mtp85 -57.62 -36.94 72.46 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.33 -33.27 75.46 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.64 -44.93 95.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.601 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.02 -39.42 90.2 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.841 -0.8 . . . . 1.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.28 -48.76 80.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.771 -0.581 . . . . 1.0 109.667 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.78 -43.15 99.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.646 -0.659 . . . . 1.0 109.953 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -55.28 18.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.616 -0.678 . . . . 1.0 110.155 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.54 -171.18 3.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.548 -0.72 . . . . 1.0 110.211 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 118.63 -0.7 . . . . 1.0 110.078 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.98 112.51 14.13 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.73 -0.606 . . . . 1.0 109.669 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -128.7 144.98 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.697 -0.627 . . . . 1.0 109.487 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.04 144.65 56.7 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 1.0 109.979 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.05 120.04 17.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.615 -0.678 . . . . 1.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -145.86 -52.28 0.25 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.764 -0.585 . . . . 1.0 109.617 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.35 157.14 36.25 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.685 -0.634 . . . . 1.0 109.869 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.05 126.99 36.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 1.0 109.7 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.52 -171.7 2.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.745 -0.597 . . . . 1.0 109.572 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.44 98.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.48 -0.762 . . . . 1.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.93 -166.92 0.6 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.64 -176.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.309 -0.869 . . . . 1.0 110.013 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -168.88 150.46 4.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.801 -0.562 . . . . 1.0 109.762 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' A' ' 99' ' ' ASP . 2.9 tp -141.95 112.97 6.33 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.461 -0.774 . . . . 1.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.19 -37.32 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.852 2.368 . . . . 1.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -62.07 124.6 21.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.67 . . . . 1.0 109.461 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 16.52 13.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.657 -0.652 . . . . 1.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.25 166.16 17.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.272 -0.892 . . . . 1.0 109.803 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -101.55 58.48 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.526 -0.734 . . . . 1.0 109.257 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.37 45.67 1.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.475 -0.766 . . . . 1.0 109.428 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -108.89 134.06 52.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.286 -0.883 . . . . 1.0 109.77 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.595 HG23 ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -113.46 161.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -123.86 134.01 53.66 Favored 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 117.542 -1.663 . . . . 1.0 109.434 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 39' ' ' CYS . . . -141.47 155.36 25.2 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 118.033 -2.032 . . . . 1.0 112.854 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.504 HG13 ' HG3' ' A' ' 38' ' ' ARG . 1.6 pp -99.33 138.81 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.082 -1.822 . . . . 1.0 106.082 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.562 ' CG2' ' CG2' ' A' ' 37' ' ' VAL . 3.1 pt -99.99 145.82 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.428 1.109 . . . . 1.0 111.954 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -142.03 136.6 30.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.029 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.574 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 40.6 tt0 -143.54 96.61 2.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.655 -0.653 . . . . 1.0 109.584 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -43.04 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.5 mt -137.35 54.64 1.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.41 13.2 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.4 -73.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.59 -0.947 . . . . 1.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -107.07 -33.83 7.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.622 -0.674 . . . . 1.0 110.051 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.67 146.78 26.11 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.843 0.83 . . . . 1.0 110.329 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -117.26 161.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 144.75 29.94 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.562 ' CG2' ' CG2' ' A' ' 26' ' ' ILE . 1.7 t -134.78 144.77 33.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.458 1.123 . . . . 1.0 111.867 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG3' HG13 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -110.77 141.51 43.99 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.332 -2.47 . . . . 1.0 104.332 174.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -139.92 154.72 47.3 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 117.159 -1.816 . . . . 1.0 114.536 -175.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 HD21 ' HE3' ' A' ' 93' ' ' LYS . 10.1 tp -92.71 171.7 8.83 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.299 -1.741 . . . . 1.0 106.299 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 1.1 t70 78.41 23.0 0.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.987 -2.597 . . . . 1.0 103.987 -171.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 53.17 34.37 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-N 114.92 -1.036 . . . . 1.0 115.028 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HD3' HG23 ' A' ' 22' ' ' ILE . 2.8 mptt -146.13 153.11 40.3 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.685 2.242 . . . . 1.0 112.557 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 117.25 16.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.94 164.53 32.63 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.463 -0.895 . . . . 1.0 111.905 -176.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.76 127.53 40.82 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.018 -2.215 . . . . 1.0 105.018 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.629 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.49 140.24 14.94 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.892 -1.13 . . . . 1.0 111.871 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 ptm85 -100.11 139.07 36.31 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.462 0.648 . . . . 1.0 109.72 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.603 HG12 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -128.67 161.89 54.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.603 ' HD2' HG12 ' A' ' 49' ' ' ILE . 33.1 Cg_endo -74.57 -44.86 0.35 Allowed 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 122.444 2.096 . . . . 1.0 111.386 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.66 -9.1 2.59 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.119 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HB3' ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -59.39 -34.24 72.19 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.277 -1.131 . . . . 1.0 110.472 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -51.0 -39.93 56.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.67 . . . . 1.0 110.662 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -61.78 -50.45 72.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.573 -0.704 . . . . 1.0 110.215 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -71.06 -21.83 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.617 -0.677 . . . . 1.0 110.734 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -65.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.318 -0.864 . . . . 1.0 110.165 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.37 150.74 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.378 -0.826 . . . . 1.0 110.159 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -156.54 33.49 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 1.0 109.902 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.7 -3.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.179 -0.951 . . . . 1.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.05 164.54 34.34 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.047 -1.033 . . . . 1.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 142.16 51.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 1.0 109.633 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.26 86.9 0.67 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.774 -1.331 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB2' HD11 ' A' ' 26' ' ' ILE . 4.5 m-20 -127.7 162.19 27.15 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.749 -0.854 . . . . 1.0 109.28 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 84' ' ' TYR . 5.9 p -97.18 138.62 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.839 -1.163 . . . . 1.0 108.168 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -141.75 142.71 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.841 -0.744 . . . . 1.0 111.282 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 HD12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -99.11 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 104.475 -2.417 . . . . 1.0 104.475 176.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.624 HG12 HG21 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -126.52 156.55 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.972 -1.491 . . . . 1.0 113.667 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.14 153.03 41.28 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 106.747 -1.575 . . . . 1.0 106.747 177.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.478 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 38.5 Cg_endo -89.03 140.0 3.85 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.412 2.075 . . . . 1.0 113.06 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.556 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.0 m95 -123.8 119.02 28.5 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 134.2 47.82 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 119.064 0.847 . . . . 1.0 109.935 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p 177.02 104.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 121.51 0.671 . . . . 1.0 109.32 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.26 142.32 17.12 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 1.0 110.359 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.3 -46.41 1.17 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.93 177.58 7.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.63 -0.924 . . . . 1.0 108.844 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 -109.29 150.15 28.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.593 -1.317 . . . . 1.0 110.931 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.556 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 1.7 mttm -112.54 152.13 29.18 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.629 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 28.9 p -145.72 153.61 41.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 119.908 -1.745 . . . . 1.0 112.289 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 3.1 t0 -98.91 124.37 43.81 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.72 -2.326 . . . . 1.0 104.72 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.624 HG21 HG12 ' A' ' 67' ' ' VAL . 3.7 pt -122.33 149.97 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 117.484 -1.686 . . . . 1.0 114.72 -175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 66' ' ' ILE . 2.5 pt -121.98 119.51 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.633 ' HA ' HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.42 159.83 14.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.009 0.909 . . . . 1.0 112.187 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 84' ' ' TYR . 0.1 OUTLIER 179.26 -179.57 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' LYS . 52.0 m-85 31.3 78.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 120.553 0.216 . . . . 1.0 110.912 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.5 p -58.57 72.09 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.63 0.729 . . . . 1.0 110.394 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -167.03 -163.46 0.54 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.0 t -98.95 112.69 24.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.916 -1.115 . . . . 1.0 109.57 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.11 32.67 1.23 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.387 -0.82 . . . . 1.0 110.014 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -65.24 -37.69 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.328 -0.858 . . . . 1.0 109.568 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.19 -41.85 93.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.696 -0.627 . . . . 1.0 109.648 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -60.01 -46.69 88.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.72 -0.613 . . . . 1.0 109.477 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HB3' HD21 ' A' ' 23' ' ' LEU . 60.8 mt -63.68 -38.02 89.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.601 -0.687 . . . . 1.0 110.252 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HE3' HD21 ' A' ' 40' ' ' LEU . 15.0 mmtt -61.94 -50.21 73.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.523 -0.736 . . . . 1.0 109.018 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.641 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -57.59 -35.46 70.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.465 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -62.22 -34.76 77.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.859 -0.526 . . . . 1.0 109.94 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.69 -39.79 90.3 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.847 -1.301 . . . . 1.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.641 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.7 m-85 -65.99 -53.05 43.71 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 1.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 3.2 pp -60.78 -37.65 82.61 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.423 -0.798 . . . . 1.0 109.514 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.43 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . 1.7 t70 -65.76 -42.76 90.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.668 -0.645 . . . . 1.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.36 -49.24 54.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.989 -0.444 . . . . 1.0 110.118 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 111.86 13.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.708 . . . . 1.0 109.401 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.686 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpp . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.627 -0.509 . . . . 1.0 109.627 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.68 82.19 0.19 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.464 0.649 . . . . 1.0 109.557 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.5 83.06 2.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 1.0 109.531 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.22 84.35 1.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.534 -0.729 . . . . 1.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.27 131.14 46.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.547 -0.72 . . . . 1.0 109.608 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -84.29 105.53 15.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 1.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.88 -31.54 14.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.743 -0.598 . . . . 1.0 109.807 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -114.47 142.87 45.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.533 -0.73 . . . . 1.0 109.772 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -118.28 18.89 13.63 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.417 0.627 . . . . 1.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.5 tt -106.3 100.06 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 1.0 109.7 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.34 -14.53 12.78 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.985 0.898 . . . . 1.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 3.5 p -88.81 -149.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 12.6 mmm180 79.82 12.6 1.09 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.39 -0.818 . . . . 1.0 110.59 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 tp -64.85 132.5 95.47 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.367 -0.833 . . . . 1.0 109.013 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.46 -82.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.568 2.179 . . . . 1.0 111.147 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.27 60.05 3.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 1.0 109.289 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -96.93 34.83 1.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.599 -0.688 . . . . 1.0 110.621 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.17 -141.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.057 -1.027 . . . . 1.0 109.434 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -139.74 33.6 2.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.806 -1.184 . . . . 1.0 110.388 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.08 -81.74 0.05 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 1.0 110.087 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.12 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.695 -0.628 . . . . 1.0 109.613 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -103.67 161.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.33 -0.857 . . . . 1.0 109.06 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -114.07 119.93 38.83 Favored 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 117.636 -1.626 . . . . 1.0 109.215 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 67' ' ' VAL . . . -122.55 161.54 16.71 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.971 -1.585 . . . . 1.0 112.937 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -124.0 137.07 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.443 -1.688 . . . . 1.0 106.443 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.622 ' HA ' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -99.15 154.98 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.591 1.186 . . . . 1.0 112.602 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -141.11 127.68 20.12 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.455 -1.702 . . . . 1.0 108.154 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -98.76 150.99 21.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.511 -0.743 . . . . 1.0 109.97 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 ttm -95.22 -65.03 1.0 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.551 -0.718 . . . . 1.0 109.289 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.21 50.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.642 -0.662 . . . . 1.0 109.743 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 110.06 1.6 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 154.96 6.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.853 -0.792 . . . . 1.0 109.805 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -68.08 -49.09 63.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.62 -0.675 . . . . 1.0 109.308 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -100.35 158.83 15.6 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.353 0.597 . . . . 1.0 109.642 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.85 169.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 122.057 0.932 . . . . 1.0 110.386 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -97.07 127.98 43.56 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.237 -1.394 . . . . 1.0 107.237 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.622 HG22 ' HA ' ' A' ' 26' ' ' ILE . 1.5 t -131.36 152.32 37.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.426 1.108 . . . . 1.0 111.838 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.8 149.34 48.69 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.43 158.17 43.86 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.134 -176.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -94.62 176.38 6.3 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 78.43 22.35 0.74 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.178 -2.527 . . . . 1.0 104.178 -171.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.84 9.44 Favored Glycine 0 N--CA 1.507 3.386 0 N-CA-C 115.759 1.064 . . . . 1.0 115.759 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mptt -146.85 158.4 43.91 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 121.201 2.5 . . . . 1.0 113.514 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 44' ' ' THR . 0.7 OUTLIER -140.54 118.39 11.76 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 106.148 -1.797 . . . . 1.0 106.148 176.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.636 ' HG3' ' CB ' ' A' ' 76' ' ' GLN . 2.4 mpp_? -147.17 165.26 30.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.081 -1.012 . . . . 1.0 113.392 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.94 129.12 42.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.347 -2.464 . . . . 1.0 104.347 174.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.1 137.95 13.71 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.709 -1.234 . . . . 1.0 112.053 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -111.67 151.48 28.81 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.628 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 1.2 pp -133.36 164.42 44.1 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.684 -0.635 . . . . 1.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 34.4 Cg_endo -76.0 -51.44 0.1 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.745 2.297 . . . . 1.0 111.173 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.6 2.1 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -41.96 84.39 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.723 -0.869 . . . . 1.0 109.874 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.06 -38.32 82.45 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.795 -0.566 . . . . 1.0 110.135 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.61 79.03 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.652 -0.655 . . . . 1.0 110.155 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -23.03 38.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.725 . . . . 1.0 110.415 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.5 24.84 11.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.336 -0.852 . . . . 1.0 110.634 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 tp -132.39 151.48 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 1.0 110.006 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -139.75 45.53 1.91 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -112.97 170.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 1.0 110.278 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -113.39 -161.43 0.76 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 150.36 25.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 1.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.56 76.54 1.27 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.634 -1.386 . . . . 1.0 109.634 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER -132.76 161.88 32.91 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.627 -0.925 . . . . 1.0 109.906 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG22 ' CB ' ' A' ' 88' ' ' GLN . 19.1 m -100.79 145.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.478 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.618 ' CG1' ' HA ' ' A' ' 82' ' ' TRP . 2.9 m -144.7 157.65 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.655 0.741 . . . . 1.0 111.798 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 81' ' ' ILE . 1.2 pt -99.56 132.36 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.591 -2.744 . . . . 1.0 103.591 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 22' ' ' ILE . 1.4 m -122.25 155.36 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 118.106 -1.438 . . . . 1.0 114.257 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.4 mtpp -112.87 150.06 42.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.334 -1.757 . . . . 1.0 107.592 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.8 Cg_endo -89.94 141.07 3.58 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.617 2.212 . . . . 1.0 112.516 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.593 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.3 m0 -124.93 119.91 30.11 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 134.23 49.47 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.646 1.112 . . . . 1.0 110.366 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 p 177.01 108.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-O 121.689 0.756 . . . . 1.0 109.579 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.02 142.18 31.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.399 -0.813 . . . . 1.0 110.693 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.79 -43.06 1.74 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.145 -1.182 . . . . 1.0 110.145 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.46 163.43 5.49 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.636 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 mt-30 -103.63 157.63 16.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.897 -1.521 . . . . 1.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.593 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -109.35 155.2 21.5 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 25.6 p -144.19 151.74 39.91 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.195 -1.566 . . . . 1.0 111.319 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -98.6 118.7 35.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 103.737 -2.69 . . . . 1.0 103.737 176.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.553 HG12 ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -120.95 138.2 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.377 -1.329 . . . . 1.0 113.49 -174.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.554 HG22 HG12 ' A' ' 66' ' ' ILE . 5.7 tt -115.23 120.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 175.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.618 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 1.8 p90 -97.99 160.13 14.49 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.416 1.103 . . . . 1.0 113.108 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -173.13 163.53 4.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.765 -1.107 . . . . 1.0 108.734 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.497 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -171.73 108.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.856 -0.794 . . . . 1.0 108.856 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.9 t -155.35 -41.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.604 -0.685 . . . . 1.0 110.413 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.55 -65.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 1.0 110.098 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -137.9 149.31 46.12 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.479 -0.763 . . . . 1.0 110.045 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.482 ' CB ' HG22 ' A' ' 64' ' ' VAL . 2.4 tp60 -163.83 -64.02 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.645 -0.66 . . . . 1.0 109.547 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.427 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 92.5 t -60.67 -34.06 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.69 -0.631 . . . . 1.0 109.665 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.29 -52.38 63.65 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 1.0 109.284 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -39.52 91.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.646 . . . . 1.0 109.419 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 15.9 mt -58.35 -40.31 81.87 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -64.13 -53.24 52.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.811 -0.555 . . . . 1.0 109.653 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 6.3 mtt-85 -55.45 -35.9 65.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.772 -0.58 . . . . 1.0 109.584 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HA ' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -64.43 -34.9 79.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.833 -0.542 . . . . 1.0 110.24 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.22 -40.5 92.33 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.3 m-85 -66.53 -53.1 38.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.826 -0.808 . . . . 1.0 111.043 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.3 pp -61.96 -40.14 94.56 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.429 -0.794 . . . . 1.0 109.841 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.88 -38.74 89.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.586 -0.696 . . . . 1.0 109.457 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -55.15 20.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 1.0 109.632 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.8 100.25 11.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.621 -0.674 . . . . 1.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptm . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.412 0.625 . . . . 1.0 109.676 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.69 35.54 4.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.435 -0.791 . . . . 1.0 109.817 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.07 110.38 18.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 1.0 109.275 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -167.49 -42.11 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.673 -0.642 . . . . 1.0 110.238 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.5 117.76 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.64 . . . . 1.0 110.026 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.37 33.6 3.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.741 -0.6 . . . . 1.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -125.21 112.04 15.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.387 -0.821 . . . . 1.0 109.438 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.16 116.38 28.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.561 -0.712 . . . . 1.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.13 168.06 10.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.638 -0.664 . . . . 1.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.03 72.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.798 0.809 . . . . 1.0 109.185 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 145.96 37.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.824 . . . . 1.0 109.854 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' HB ' ' CZ3' ' A' ' 91' ' ' TRP . 16.2 m 40.21 -151.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 CA-C-O 120.886 0.374 . . . . 1.0 111.038 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 61.06 -174.89 0.12 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.442 -0.786 . . . . 1.0 110.256 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.483 HG13 ' HD2' ' A' ' 15' ' ' PRO . 2.8 tt -157.21 127.16 3.3 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.356 -0.84 . . . . 1.0 109.735 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' HG13 ' A' ' 14' ' ' ILE . 35.5 Cg_endo -76.82 -25.41 9.15 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.732 2.288 . . . . 1.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -62.15 117.37 5.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.609 -0.682 . . . . 1.0 109.361 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -121.11 50.71 1.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.464 0.649 . . . . 1.0 109.362 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.59 -60.01 2.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.479 -0.763 . . . . 1.0 109.137 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -165.53 -56.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.13 132.4 3.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.797 -0.565 . . . . 1.0 109.637 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.27 167.41 9.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.554 HG13 HG22 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -114.63 161.77 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' C ' ' HB2' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -126.95 123.07 36.32 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 117.722 -1.591 . . . . 1.0 109.658 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.52 ' O ' HG13 ' A' ' 65' ' ' VAL . . . -140.55 163.63 26.45 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.215 -1.469 . . . . 1.0 112.232 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.58 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.628 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 1.7 pt -98.65 148.43 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 122.265 1.031 . . . . 1.0 111.595 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 35' ' ' VAL . 34.2 tt0 -140.87 130.19 23.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.001 -1.454 . . . . 1.0 108.259 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.58 ' HA ' HG23 ' A' ' 35' ' ' VAL . 12.9 pt20 -58.68 141.2 53.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.526 -0.734 . . . . 1.0 110.529 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 ttp -100.02 -138.6 0.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.37 -35.68 81.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.082 -1.011 . . . . 1.0 109.603 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.72 82.29 1.16 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.52 -65.18 0.32 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.789 -0.83 . . . . 1.0 109.793 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -46.04 0.05 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.585 -0.697 . . . . 1.0 110.098 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -99.12 141.66 31.6 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.588 0.709 . . . . 1.0 110.09 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -99.96 162.44 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' N ' HG13 ' A' ' 35' ' ' VAL . 4.9 ptt180 -98.18 131.17 44.77 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.628 ' CG2' ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -134.85 153.09 34.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.986 0.898 . . . . 1.0 111.35 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 147.86 48.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.156 -1.794 . . . . 1.0 106.156 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -144.27 160.47 40.94 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.411 -1.316 . . . . 1.0 114.09 -176.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 6.0 mt -93.93 177.47 5.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 22.5 m-20 77.03 22.66 1.01 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 104.344 -2.465 . . . . 1.0 104.344 -172.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.43 52.25 13.71 Favored Glycine 0 N--CA 1.502 3.077 0 CA-C-O 118.708 -1.051 . . . . 1.0 115.234 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -146.76 151.5 37.27 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.094 2.447 . . . . 1.0 113.153 177.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 44' ' ' THR . 3.3 t -134.73 118.19 16.83 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 105.094 -2.188 . . . . 1.0 105.094 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.63 ' CZ ' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.65 162.74 37.8 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.882 -1.127 . . . . 1.0 113.028 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.27 123.04 42.16 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 103.685 -2.709 . . . . 1.0 103.685 174.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.77 143.55 16.73 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.469 -1.348 . . . . 1.0 112.237 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -99.43 140.76 33.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.713 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 3.1 pt -129.13 169.53 12.89 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.776 -0.578 . . . . 1.0 109.837 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.713 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 33.7 Cg_endo -75.11 -20.67 16.42 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.598 2.199 . . . . 1.0 111.535 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.34 -0.75 20.65 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.758 -0.937 . . . . 1.0 110.758 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -65.3 -33.85 76.95 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.325 -1.103 . . . . 1.0 110.33 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD23 ' HB ' ' A' ' 57' ' ' ILE . 1.3 mt -53.58 -34.97 60.26 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.573 -0.704 . . . . 1.0 110.596 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -46.44 62.66 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.554 -0.716 . . . . 1.0 110.295 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -93.73 -33.53 13.58 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.58 -0.7 . . . . 1.0 110.334 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -64.18 0.97 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.591 -0.693 . . . . 1.0 110.227 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HB ' HD23 ' A' ' 53' ' ' LEU . 0.6 OUTLIER -80.02 164.28 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.465 -0.772 . . . . 1.0 109.75 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -173.36 -44.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.564 -0.71 . . . . 1.0 111.214 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -50.7 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.289 -0.882 . . . . 1.0 111.384 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.63 151.64 25.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.166 -0.959 . . . . 1.0 110.746 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 28' ' ' GLN . 1.1 mp0 -123.18 -168.51 1.77 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.732 -0.605 . . . . 1.0 109.652 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 84.76 1.48 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.12 -1.592 . . . . 1.0 109.12 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.1 163.85 22.89 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.735 -0.862 . . . . 1.0 110.156 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.589 HG11 ' HB3' ' A' ' 88' ' ' GLN . 1.5 p -96.21 136.81 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG22 ' CA ' ' A' ' 82' ' ' TRP . 0.3 OUTLIER -140.92 139.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.621 -0.832 . . . . 1.0 110.982 -178.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.556 HG13 ' CG1' ' A' ' 81' ' ' ILE . 1.7 pp -99.21 143.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.043 -2.206 . . . . 1.0 105.043 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG23 ' CZ ' ' A' ' 45' ' ' ARG . 1.5 m -140.28 159.31 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.611 -1.636 . . . . 1.0 114.677 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.8 OUTLIER -99.29 151.68 37.5 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 113.265 -1.789 . . . . 1.0 107.056 176.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.5 Cg_endo -90.04 141.25 3.56 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.409 2.073 . . . . 1.0 112.13 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m0 -121.93 118.35 28.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.02 133.31 50.53 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.767 0.712 . . . . 1.0 110.246 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.3 p 174.57 104.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 109.152 -0.684 . . . . 1.0 109.152 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.05 144.16 35.52 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.434 -0.791 . . . . 1.0 110.464 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.78 -40.11 2.53 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.102 -1.199 . . . . 1.0 110.102 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -169.93 151.16 4.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.546 -0.973 . . . . 1.0 108.458 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.5 mp0 -97.97 155.74 16.95 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.62 -1.232 . . . . 1.0 110.773 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.528 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 4.0 mttm -112.98 154.74 25.98 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 11.3 p -145.1 153.57 41.55 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 119.961 -1.712 . . . . 1.0 111.776 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 1.3 t70 -99.45 119.43 37.98 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.591 HG21 ' CG1' ' A' ' 67' ' ' VAL . 2.7 pt -120.84 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.392 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' CG1' HG13 ' A' ' 66' ' ' ILE . 5.0 pt -126.39 118.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.181 -2.155 . . . . 1.0 105.181 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.599 ' CA ' HG22 ' A' ' 65' ' ' VAL . 7.5 p-90 -105.51 160.44 15.16 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.099 0.952 . . . . 1.0 112.792 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 179.39 -175.63 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.337 -0.847 . . . . 1.0 108.717 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' O ' HG13 ' A' ' 64' ' ' VAL . 9.8 m-85 44.11 84.36 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.351 0.596 . . . . 1.0 110.753 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -60.98 -22.52 64.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.372 -0.83 . . . . 1.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -80.36 -79.59 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.367 -0.833 . . . . 1.0 110.147 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -156.27 166.28 33.89 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.388 -0.82 . . . . 1.0 110.774 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.589 ' HB3' HG11 ' A' ' 64' ' ' VAL . 12.2 tp60 178.14 -29.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.909 -0.495 . . . . 1.0 110.333 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.3 t -49.98 -38.4 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.512 -0.742 . . . . 1.0 110.004 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -44.06 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.636 -0.665 . . . . 1.0 109.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.406 ' CZ3' ' HB ' ' A' ' 12' ' ' VAL . 83.6 t90 -58.31 -46.47 86.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.617 -0.677 . . . . 1.0 109.357 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.456 HD11 HD12 ' A' ' 23' ' ' LEU . 1.6 mt -63.58 -35.18 79.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.703 -0.623 . . . . 1.0 109.607 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -64.83 -50.27 67.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.655 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 15.7 mtm180 -54.75 -40.26 69.14 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.529 ' HA ' HD21 ' A' ' 98' ' ' LEU . 17.2 ttpp -63.06 -33.44 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.008 -0.433 . . . . 1.0 110.092 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.25 -38.83 94.12 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.261 -1.135 . . . . 1.0 110.261 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.655 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.4 m-85 -66.13 -53.88 32.41 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.756 -0.849 . . . . 1.0 110.735 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 95' ' ' LYS . 2.2 pp -62.52 -38.63 90.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -0.783 . . . . 1.0 110.08 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.9 -45.3 82.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.567 -0.708 . . . . 1.0 109.761 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -65.18 -34.95 79.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.787 -0.571 . . . . 1.0 110.168 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -58.24 9.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 1.0 109.865 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 117.661 -1.162 . . . . 1.0 110.276 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.78 37.66 4.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.693 -0.629 . . . . 1.0 109.702 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -134.87 39.71 2.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.413 -0.804 . . . . 1.0 109.526 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.57 145.11 17.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.415 -0.803 . . . . 1.0 109.863 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -82.48 166.56 19.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.682 -0.636 . . . . 1.0 109.906 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.17 118.4 6.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.571 -0.705 . . . . 1.0 109.725 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.44 -164.78 1.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.804 -0.56 . . . . 1.0 109.742 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 158.29 16.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.408 -0.807 . . . . 1.0 110.278 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -108.28 144.59 35.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.526 -0.734 . . . . 1.0 109.642 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.78 74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.742 0.782 . . . . 1.0 109.303 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -107.87 17.32 22.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.438 -0.789 . . . . 1.0 110.289 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 p -93.31 172.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.742 -0.599 . . . . 1.0 109.717 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 70.33 96.08 0.07 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.368 0.604 . . . . 1.0 109.488 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.404 HG13 ' HD2' ' A' ' 15' ' ' PRO . 4.4 tp -118.6 134.9 23.46 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.607 -0.683 . . . . 1.0 109.659 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.404 ' HD2' HG13 ' A' ' 14' ' ' ILE . 35.5 Cg_endo -77.08 -163.75 0.23 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.679 2.252 . . . . 1.0 110.675 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 67.6 90.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.6 -0.688 . . . . 1.0 109.506 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -163.86 72.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.609 -0.682 . . . . 1.0 109.36 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.0 -58.74 7.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.725 . . . . 1.0 109.58 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -69.63 0.85 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.684 . . . . 1.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -156.73 117.51 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.71 -0.619 . . . . 1.0 109.681 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 156.87 37.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.605 -0.684 . . . . 1.0 109.275 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.564 HG13 HG21 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -113.63 161.24 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.32 -0.862 . . . . 1.0 109.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -118.49 126.21 51.54 Favored 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 118.384 -1.326 . . . . 1.0 109.234 -178.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.588 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -140.28 161.92 26.46 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 118.586 -1.768 . . . . 1.0 112.79 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.64 144.5 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.63 HG12 HG13 ' A' ' 65' ' ' VAL . 3.7 pt -98.83 152.02 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.344 1.069 . . . . 1.0 111.985 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.75 121.66 14.53 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.204 -1.362 . . . . 1.0 108.617 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.17 105.69 13.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.742 -0.599 . . . . 1.0 109.564 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -33.11 71.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.646 -0.659 . . . . 1.0 109.913 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.7 -58.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 1.0 109.16 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.33 -119.93 0.74 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.706 -1.358 . . . . 1.0 109.706 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.13 -169.54 0.18 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.808 -0.819 . . . . 1.0 110.219 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.91 9.36 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.386 -0.821 . . . . 1.0 110.288 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 134.99 42.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.273 -0.892 . . . . 1.0 109.966 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.46 HG13 ' HB ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -110.96 161.9 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.25 131.33 44.68 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.62 ' CG2' ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -129.97 147.25 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.397 1.094 . . . . 1.0 111.701 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -117.99 139.29 51.38 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 105.461 -2.052 . . . . 1.0 105.461 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.588 ' HB2' ' CA ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -141.28 160.38 40.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.883 -1.527 . . . . 1.0 114.195 -175.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 41' ' ' ASP . 6.1 mt -94.36 176.64 6.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.092 -1.413 . . . . 1.0 107.436 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 3.3 t70 76.74 23.09 1.07 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 103.961 -2.607 . . . . 1.0 103.961 -171.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 54.99 18.16 Favored Glycine 0 N--CA 1.502 3.096 0 CA-C-N 115.001 -1.0 . . . . 1.0 114.247 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.713 ' HB3' ' HD2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -146.38 155.05 42.32 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 120.573 2.187 . . . . 1.0 112.752 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.7 m -140.36 116.39 10.44 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.713 ' HD2' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -146.46 164.95 30.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.21 -0.996 . . . . 1.0 112.408 -175.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -95.3 126.31 40.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 104.464 -2.421 . . . . 1.0 104.464 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.595 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -94.76 131.49 10.73 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.67 -1.253 . . . . 1.0 111.535 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -104.33 133.85 48.53 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.501 0.667 . . . . 1.0 109.888 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -122.17 151.19 58.34 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.02 -86.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.471 2.114 . . . . 1.0 110.115 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.68 7.93 3.63 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -66.19 -52.78 44.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -1.139 . . . . 1.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 49' ' ' ILE . 2.9 tp -65.44 -41.95 92.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 1.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -26.2 68.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 1.0 111.09 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -99.74 -37.56 9.05 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.246 -0.909 . . . . 1.0 110.776 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.44 -9.77 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.443 -0.785 . . . . 1.0 111.323 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 53' ' ' LEU . 3.5 tp -48.39 135.05 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.44 -0.788 . . . . 1.0 110.451 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.44 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.18 174.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.698 -0.626 . . . . 1.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 -71.82 -75.92 0.12 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.493 -0.754 . . . . 1.0 109.714 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.73 174.02 5.96 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 1.0 109.935 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.23 75.03 1.29 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.221 -1.552 . . . . 1.0 109.221 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.22 161.21 20.26 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.658 -0.907 . . . . 1.0 109.707 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' A' ' 88' ' ' GLN . 2.6 p -99.25 133.53 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 1.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' A' ' 82' ' ' TRP . 35.9 m -139.64 150.16 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.682 0.753 . . . . 1.0 111.249 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.621 HG13 ' CG1' ' A' ' 81' ' ' ILE . 1.6 pp -99.6 142.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.994 -2.224 . . . . 1.0 104.994 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.685 HG22 ' CZ ' ' A' ' 45' ' ' ARG . 2.0 m -140.25 156.4 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 117.38 -1.728 . . . . 1.0 114.367 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 8.8 ptpt -101.1 153.73 37.59 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.941 -1.481 . . . . 1.0 108.168 176.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.443 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.0 Cg_endo -89.83 143.82 4.29 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.605 2.203 . . . . 1.0 112.168 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.513 ' CD2' ' HB3' ' A' ' 77' ' ' LYS . 11.1 m0 -123.82 119.14 28.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.834 -1.172 . . . . 1.0 107.834 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 131.41 44.24 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 119.43 1.014 . . . . 1.0 109.648 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.9 p 178.84 103.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 121.507 0.67 . . . . 1.0 109.336 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -51.42 141.41 15.61 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.56 -0.712 . . . . 1.0 110.783 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.45 -47.06 1.08 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.634 -1.386 . . . . 1.0 109.634 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.84 156.91 11.45 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.684 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 42.0 mm-40 -94.09 149.04 21.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.88 -1.137 . . . . 1.0 110.557 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.513 ' HB3' ' CD2' ' A' ' 70' ' ' TRP . 16.0 mttm -107.8 152.96 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 106.634 -1.617 . . . . 1.0 106.634 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.662 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 24.9 p -144.79 154.61 42.88 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.94 -1.725 . . . . 1.0 111.805 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 6.7 t70 -99.27 118.44 35.95 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 103.403 -2.814 . . . . 1.0 103.403 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.652 HG13 ' HB ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -118.61 147.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 118.145 -1.422 . . . . 1.0 113.752 -174.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.621 ' CG1' HG13 ' A' ' 66' ' ' ILE . 2.0 pt -125.58 120.31 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.647 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -98.16 158.25 15.67 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.151 0.977 . . . . 1.0 112.993 -175.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -176.26 163.4 2.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.218 -0.901 . . . . 1.0 109.228 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 48.21 -149.23 0.18 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.938 -0.476 . . . . 1.0 110.537 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 p -147.21 103.81 3.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.363 -0.836 . . . . 1.0 108.848 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.8 pttm 38.84 46.33 1.05 Allowed 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.339 0.59 . . . . 1.0 110.774 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -140.97 77.5 1.6 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.453 -0.779 . . . . 1.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.46 ' HB2' HG12 ' A' ' 64' ' ' VAL . 0.3 OUTLIER 177.41 -35.4 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.636 -0.665 . . . . 1.0 110.188 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.0 m -54.27 -34.79 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.538 -0.726 . . . . 1.0 110.254 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.53 -42.34 78.29 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.456 -0.777 . . . . 1.0 109.183 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.407 ' CH2' ' HD2' ' A' ' 95' ' ' LYS . 59.1 t90 -64.99 -42.5 94.45 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' HB3' HD22 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -60.15 -34.66 73.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.746 -0.596 . . . . 1.0 109.692 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HG3' HD12 ' A' ' 23' ' ' LEU . 1.6 mttt -63.63 -56.0 19.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.597 -0.69 . . . . 1.0 109.508 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.597 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -59.73 -36.46 76.61 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.407 ' HD2' ' CH2' ' A' ' 91' ' ' TRP . 12.4 tttp -64.72 -33.57 76.27 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.07 -44.25 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.061 -1.215 . . . . 1.0 110.061 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.693 -0.886 . . . . 1.0 109.831 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -57.42 -56.52 20.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.901 -0.5 . . . . 1.0 109.913 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.44 -34.21 77.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.274 -0.891 . . . . 1.0 109.599 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.44 -37.05 74.62 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.742 -0.599 . . . . 1.0 109.925 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.514 ' C ' ' HG ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -69.89 -40.16 75.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 1.0 109.944 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HG ' ' C ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.509 2.486 0 CA-C-O 119.159 -0.448 . . . . 1.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 -42.56 9.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.747 -0.595 . . . . 1.0 109.678 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 62.33 33.07 16.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.806 -0.559 . . . . 1.0 109.969 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -142.44 121.63 13.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.42 -0.8 . . . . 1.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.85 145.74 28.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.691 . . . . 1.0 109.889 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -125.1 -57.29 1.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.667 -0.645 . . . . 1.0 109.429 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -140.64 -56.44 0.52 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.632 -0.667 . . . . 1.0 109.373 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.28 125.38 14.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.743 -0.598 . . . . 1.0 109.473 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.43 -160.37 1.03 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 1.0 109.774 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 pt -70.06 -163.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.413 -0.804 . . . . 1.0 109.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.36 176.81 0.27 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.478 -0.764 . . . . 1.0 109.486 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.65 152.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.184 -0.948 . . . . 1.0 110.128 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -132.85 -65.57 0.7 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.498 ' C ' ' O ' ' A' ' 13' ' ' ARG . 5.8 tp 0.52 87.46 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 C-N-CA 123.554 0.742 . . . . 1.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.15 145.17 17.1 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.918 2.412 . . . . 1.0 110.395 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -112.6 141.27 46.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.512 -0.743 . . . . 1.0 109.688 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 22.05 16.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.605 -0.685 . . . . 1.0 110.197 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -112.97 125.98 54.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.361 -0.837 . . . . 1.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.5 -36.74 26.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.754 -0.591 . . . . 1.0 109.973 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.72 96.16 3.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.587 -0.696 . . . . 1.0 109.562 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -153.9 134.54 13.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.653 -0.654 . . . . 1.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.432 ' HB ' ' NH1' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -114.46 161.35 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -121.26 132.36 54.76 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.195 -1.402 . . . . 1.0 109.153 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 39' ' ' CYS . . . -141.79 155.62 25.48 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 118.18 -1.962 . . . . 1.0 113.086 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 63' ' ' ASP . 9.8 tt -100.37 138.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 105.958 -1.867 . . . . 1.0 105.958 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.708 HG12 HG13 ' A' ' 65' ' ' VAL . 6.6 pt -98.36 149.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 122.589 1.185 . . . . 1.0 112.567 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.44 119.4 11.94 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.865 -1.516 . . . . 1.0 108.763 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.584 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -99.33 66.75 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.478 0.656 . . . . 1.0 109.905 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.3 mtt -101.21 114.02 27.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.325 -0.859 . . . . 1.0 108.792 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.59 42.44 8.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.46 0.648 . . . . 1.0 109.488 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.36 167.5 20.55 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.04 -67.84 0.58 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.491 -1.005 . . . . 1.0 109.787 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -94.12 -51.09 4.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.539 -0.725 . . . . 1.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.561 ' HD3' ' CB ' ' A' ' 46' ' ' LEU . 21.8 ttm-85 -99.27 146.55 26.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.67 -0.644 . . . . 1.0 109.381 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -111.05 161.82 9.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HG2' ' N ' ' A' ' 37' ' ' VAL . 10.1 ttp180 -100.0 141.04 33.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.381 -1.34 . . . . 1.0 107.381 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 26' ' ' ILE . 2.3 t -133.87 148.49 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.442 1.115 . . . . 1.0 112.018 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -112.68 141.17 46.78 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 104.657 -2.349 . . . . 1.0 104.657 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -141.25 158.47 43.85 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.17 -1.812 . . . . 1.0 115.015 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 6.5 tp -93.42 172.78 8.07 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.775 -1.557 . . . . 1.0 107.477 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 2.1 t70 77.44 22.8 0.91 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 104.134 -2.543 . . . . 1.0 104.134 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.69 56.08 16.73 Favored Glycine 0 N--CA 1.501 3.018 0 CA-C-N 114.975 -1.011 . . . . 1.0 114.276 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.702 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -145.62 151.12 37.57 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 120.452 2.126 . . . . 1.0 112.661 178.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.535 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -133.93 117.92 17.3 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 176.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 76' ' ' GLN . 0.9 OUTLIER -145.95 162.57 37.51 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.001 -1.08 . . . . 1.0 112.847 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CB ' ' HD3' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -97.89 117.89 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.401 -2.814 . . . . 1.0 103.401 174.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' HA3' ' CD1' ' A' ' 80' ' ' ILE . . . -101.57 153.93 18.87 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.785 -1.198 . . . . 1.0 112.753 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.75 156.86 22.09 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.702 0.763 . . . . 1.0 110.143 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 3.5 pt -140.64 163.43 43.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 32.9 Cg_endo -74.79 -34.06 4.39 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.575 2.183 . . . . 1.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 10.39 80.12 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -65.49 -50.96 63.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -1.133 . . . . 1.0 109.39 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -65.49 -34.23 77.79 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.739 -0.6 . . . . 1.0 109.967 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -54.78 -43.82 73.14 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.53 -0.732 . . . . 1.0 109.991 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.05 -33.94 61.78 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 1.0 110.06 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -61.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.439 -0.788 . . . . 1.0 109.782 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -120.48 157.52 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.68 -0.637 . . . . 1.0 109.923 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -121.95 127.82 50.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.0 109.553 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.32 161.14 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.598 . . . . 1.0 109.751 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.34 168.84 18.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.552 -0.717 . . . . 1.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.02 132.19 47.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 1.0 109.879 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.53 76.97 0.25 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.064 -1.214 . . . . 1.0 110.064 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -129.61 160.68 32.53 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.56 137.84 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 120.502 -1.374 . . . . 1.0 109.183 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.708 HG13 HG12 ' A' ' 26' ' ' ILE . 3.1 m -141.58 158.62 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.889 -0.724 . . . . 1.0 111.306 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.436 HG23 ' CG1' ' A' ' 81' ' ' ILE . 14.4 tt -99.57 149.03 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 105.045 -2.205 . . . . 1.0 105.045 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.702 HG23 ' CZ ' ' A' ' 45' ' ' ARG . 1.3 m -134.22 157.4 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.6 -1.64 . . . . 1.0 114.54 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 41.4 mtmt -103.94 152.82 39.1 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 113.332 -1.758 . . . . 1.0 106.928 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.42 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.3 Cg_endo -89.16 141.39 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.684 2.256 . . . . 1.0 113.033 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.583 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m95 -123.27 119.04 28.98 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 130.28 40.99 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.336 0.971 . . . . 1.0 110.187 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 p -177.56 111.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-O 121.462 0.649 . . . . 1.0 109.737 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.52 143.79 44.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.073 -1.017 . . . . 1.0 109.867 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.47 -42.05 1.99 Allowed Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.73 169.76 4.86 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.737 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 5.9 tt0 -108.29 157.5 18.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.44 -1.412 . . . . 1.0 110.471 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.583 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 16.4 mttm -114.87 158.87 21.36 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 21.6 p -146.25 155.86 42.97 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.144 -1.597 . . . . 1.0 111.944 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.81 117.54 34.13 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 104.337 -2.468 . . . . 1.0 104.337 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.559 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -120.01 161.35 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.312 1.597 . . . . 1.0 115.312 -174.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' CG1' HG23 ' A' ' 66' ' ' ILE . 1.2 pp -118.94 120.28 63.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 175.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.702 ' HA ' HG11 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -97.54 156.3 16.56 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.188 0.994 . . . . 1.0 112.709 -176.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.5 -176.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.067 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.65 99.07 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.17 0.51 . . . . 1.0 110.381 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -63.49 -33.87 76.53 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 1.0 109.008 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.98 174.49 7.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.5 p -63.91 132.27 50.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.443 -0.786 . . . . 1.0 110.217 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 8.65 3.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.15 -34.31 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.247 -0.908 . . . . 1.0 108.933 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -63.22 -48.86 76.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.706 -0.621 . . . . 1.0 110.086 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -54.27 -50.54 67.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 1.0 109.395 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.4 mt -61.57 -39.05 89.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.758 -0.589 . . . . 1.0 109.622 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.471 ' HE2' HD21 ' A' ' 40' ' ' LEU . 10.1 mmtm -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.767 -0.583 . . . . 1.0 109.847 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.811 ' HA ' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.32 -55.32 32.83 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -25.17 67.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.94 -59.03 10.83 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.498 -0.858 . . . . 1.0 111.487 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.811 ' CZ ' ' HA ' ' A' ' 94' ' ' ARG . 10.4 p90 -70.58 -39.11 74.05 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.429 1.114 . . . . 1.0 110.308 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.5 -52.88 62.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.873 -0.517 . . . . 1.0 110.268 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.57 -42.15 95.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.591 -0.693 . . . . 1.0 109.778 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -46.36 89.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.582 -0.699 . . . . 1.0 109.585 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.29 84.86 6.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.439 0.638 . . . . 1.0 109.292 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.82 -1.086 . . . . 1.0 109.697 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.83 55.56 6.13 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.678 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -92.27 167.98 11.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.483 -0.761 . . . . 1.0 110.093 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 63.56 81.85 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.443 0.64 . . . . 1.0 109.732 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.3 -45.19 1.97 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.634 -0.666 . . . . 1.0 109.625 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.34 153.8 29.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.621 -0.674 . . . . 1.0 109.792 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.85 127.26 31.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.793 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.458 ' HB3' HD11 ' A' ' 10' ' ' ILE . 7.3 mt-30 -142.27 140.61 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.576 -0.702 . . . . 1.0 109.877 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -113.32 22.22 14.46 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.513 0.673 . . . . 1.0 110.294 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -51.72 -24.31 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.043 -0.41 . . . . 1.0 110.965 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -71.58 -146.32 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.483 -0.761 . . . . 1.0 109.524 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -60.48 -178.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.123 -0.985 . . . . 1.0 110.633 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -46.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.665 -0.647 . . . . 1.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 pt -53.89 129.27 56.5 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.727 -0.608 . . . . 1.0 110.039 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.11 157.16 30.26 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.782 2.321 . . . . 1.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.3 ttp-105 -82.23 76.74 9.09 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.75 13.35 9.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 1.0 110.259 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.25 67.23 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.549 -0.719 . . . . 1.0 109.245 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.34 -64.82 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 1.0 109.708 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -172.22 -47.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.645 -0.659 . . . . 1.0 110.038 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.52 148.84 38.62 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 1.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.645 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 1.2 mp -111.13 158.37 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -130.62 126.97 38.0 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 118.185 -1.406 . . . . 1.0 108.886 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.5 161.68 27.35 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 117.566 -2.254 . . . . 1.0 114.21 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.498 ' HB ' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -98.04 135.07 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 177.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.802 ' HA ' HG22 ' A' ' 37' ' ' VAL . 9.4 tp -104.57 152.72 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.498 1.142 . . . . 1.0 112.629 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.21 -1.359 . . . . 1.0 108.15 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -130.65 105.99 8.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.607 -0.683 . . . . 1.0 109.549 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -47.6 6.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.609 -0.682 . . . . 1.0 109.719 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -88.05 -53.79 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.596 -0.69 . . . . 1.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.04 79.87 1.06 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.76 52.63 2.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.799 -0.824 . . . . 1.0 109.187 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.34 5.56 4.81 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.726 -0.609 . . . . 1.0 110.869 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 160.28 40.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.273 -0.892 . . . . 1.0 109.52 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 26' ' ' ILE . 6.5 m -137.38 168.51 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.742 0.782 . . . . 1.0 110.188 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.62 122.31 41.25 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.259 -0.577 . . . . 1.0 110.725 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -120.9 148.61 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 122.868 1.318 . . . . 1.0 111.78 -179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -110.03 139.89 44.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.899 -2.63 . . . . 1.0 103.899 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.659 ' SG ' ' CB ' ' A' ' 43' ' ' LYS . 1.8 p -141.32 162.56 35.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.334 -1.746 . . . . 1.0 115.665 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' A' ' 41' ' ' ASP . 38.2 tp -89.84 169.49 11.21 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.91 -1.95 . . . . 1.0 105.926 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.596 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 15.6 m-20 78.83 24.5 0.55 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 104.527 -2.397 . . . . 1.0 104.527 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.44 58.57 13.69 Favored Glycine 0 N--CA 1.498 2.799 0 CA-C-N 114.738 -1.119 . . . . 1.0 113.434 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.659 ' CB ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -144.79 156.35 43.99 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.679 1.739 . . . . 1.0 112.994 178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.91 120.74 12.71 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.218 -1.771 . . . . 1.0 106.218 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.787 ' CZ ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.18 163.23 35.02 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.144 -1.422 . . . . 1.0 114.456 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 124.75 43.33 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' NH2' ' A' ' 45' ' ' ARG . . . -105.62 159.84 15.2 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.545 -1.312 . . . . 1.0 113.48 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -124.09 144.0 50.13 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.81 149.54 73.94 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 33.2 Cg_endo -74.71 153.57 43.42 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.721 2.281 . . . . 1.0 110.896 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.42 -26.81 64.77 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -54.07 -41.68 68.45 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.916 . . . . 1.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 49' ' ' ILE . 10.5 mt -65.07 -43.96 90.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.632 -0.668 . . . . 1.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -65.25 -35.65 81.69 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.746 -0.596 . . . . 1.0 109.649 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -61.19 -40.79 95.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.689 -0.632 . . . . 1.0 109.659 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -65.0 0.73 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tt -168.35 151.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -119.69 132.86 55.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.626 -0.671 . . . . 1.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.18 158.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.651 -0.655 . . . . 1.0 109.331 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -76.54 -57.59 3.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.38 -0.825 . . . . 1.0 109.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.9 150.88 5.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.62 -0.675 . . . . 1.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.42 66.0 1.06 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -128.95 160.42 32.76 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.592 -0.946 . . . . 1.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.672 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -102.23 128.44 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.12 . . . . 1.0 108.205 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 82' ' ' TRP . 16.5 m -140.59 148.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.521 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.4 tt -98.72 141.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.677 ' HA ' HG21 ' A' ' 80' ' ' ILE . 1.2 m -121.6 148.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.726 -1.234 . . . . 1.0 113.536 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -102.39 141.33 22.3 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 106.568 -1.641 . . . . 1.0 106.568 176.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.539 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 39.9 Cg_endo -88.64 137.25 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.967 1.778 . . . . 1.0 113.253 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.508 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.7 m0 -117.73 117.35 29.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.757 -1.571 . . . . 1.0 106.757 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 0.6 OUTLIER 51.15 -161.85 0.07 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 120.822 1.646 . . . . 1.0 109.326 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 71' ' ' GLU . 91.2 t -156.77 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.515 -1.366 . . . . 1.0 111.773 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -31.1 134.6 0.06 Allowed 'General case' 0 N--CA 1.513 2.718 0 CA-C-O 121.808 0.813 . . . . 1.0 113.179 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.15 -58.41 4.24 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.416 -1.074 . . . . 1.0 110.416 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.92 168.35 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.676 ' HG3' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt20 -131.93 159.75 37.76 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 116.875 -1.93 . . . . 1.0 113.208 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -100.8 160.11 14.63 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.347 -1.723 . . . . 1.0 106.347 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.612 ' HB2' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.98 160.22 42.63 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 119.764 -1.835 . . . . 1.0 111.618 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 1.2 p-10 -117.95 117.81 30.27 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.677 HG21 ' HA ' ' A' ' 67' ' ' VAL . 2.4 pt -115.16 160.58 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.34 122.29 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 105.227 -2.138 . . . . 1.0 105.227 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.575 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.36 148.12 23.99 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.325 0.584 . . . . 1.0 111.293 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.508 ' O ' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER 176.02 172.13 0.37 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.393 0.616 . . . . 1.0 110.43 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.664 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . 99.9 m-85 47.01 -175.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.686 0.755 . . . . 1.0 112.483 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 84' ' ' TYR . 6.3 t 175.45 51.44 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -152.48 -68.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.013 -1.054 . . . . 1.0 110.589 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.7 m -137.05 109.83 7.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.362 -0.836 . . . . 1.0 110.365 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.552 ' HB3' HG22 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 174.96 -77.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.672 ' HB ' ' CB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -66.52 -33.74 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -52.68 -37.86 59.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -66.2 -55.03 18.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.853 -0.529 . . . . 1.0 109.864 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' CG ' ' HA ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER -63.98 -51.3 64.96 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.459 -0.775 . . . . 1.0 111.076 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' CG ' ' N ' ' A' ' 94' ' ' ARG . 1.2 pttt -59.02 -43.47 91.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.283 -0.886 . . . . 1.0 110.42 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.63 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -60.49 -39.1 86.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.411 -0.806 . . . . 1.0 108.988 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 5.5 mtpp -59.53 -33.82 71.86 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.22 -42.43 94.24 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.939 -1.264 . . . . 1.0 109.939 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.63 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.3 m-85 -66.46 -55.11 17.23 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.716 -0.873 . . . . 1.0 110.661 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 3.9 pp -59.78 -33.91 72.33 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.528 -0.733 . . . . 1.0 110.445 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -51.04 64.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.486 -0.759 . . . . 1.0 109.764 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -56.29 12.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.636 -0.665 . . . . 1.0 110.194 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HA ' HD11 ' A' ' 101' ' ' LEU . 0.4 OUTLIER -137.86 -172.4 3.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.61 -0.681 . . . . 1.0 109.725 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 117.711 -1.138 . . . . 1.0 110.25 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HG2' ' HB2' ' A' ' 8' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.02 99.18 2.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.609 -0.682 . . . . 1.0 109.584 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.07 119.42 21.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 1.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.56 87.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.728 . . . . 1.0 109.7 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 38.92 42.25 0.63 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.157 0.503 . . . . 1.0 111.1 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -168.3 -74.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.883 . . . . 1.0 109.554 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.36 172.98 2.18 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.73 -0.606 . . . . 1.0 109.68 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.441 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.1 pt20 -89.41 11.05 20.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.421 -0.8 . . . . 1.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -101.1 20.12 16.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 1.0 110.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 tp -54.42 142.67 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.228 0.537 . . . . 1.0 110.089 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -71.35 178.61 3.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.678 -0.639 . . . . 1.0 110.174 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.13 159.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.566 -0.709 . . . . 1.0 110.071 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.31 88.82 1.6 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.83 116.92 5.35 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.541 -0.724 . . . . 1.0 109.413 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.5 -178.4 4.56 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 122.758 2.306 . . . . 1.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 66.7 98.73 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.305 0.574 . . . . 1.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -154.88 -55.59 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.616 -0.678 . . . . 1.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -15.3 32.33 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.642 -0.661 . . . . 1.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.44 -22.36 18.33 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 1.0 111.196 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -147.29 -62.62 0.28 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.031 -1.043 . . . . 1.0 111.246 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.75 119.06 6.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.504 -0.747 . . . . 1.0 110.727 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.625 HG23 HG23 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -104.21 155.1 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 92' ' ' LEU . 1.6 pp -122.64 119.68 31.47 Favored 'General case' 0 N--CA 1.517 2.915 0 C-N-CA 118.045 -1.462 . . . . 1.0 109.172 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.39 160.75 26.02 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 117.7 -2.19 . . . . 1.0 113.705 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.47 HG23 HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -99.09 130.9 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.485 -1.672 . . . . 1.0 106.485 177.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.641 ' HA ' ' HB ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -99.56 154.55 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.255 1.026 . . . . 1.0 111.991 -177.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -140.04 128.75 23.12 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.931 -1.031 . . . . 1.0 108.697 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -117.68 83.79 2.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.728 -0.608 . . . . 1.0 109.569 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -40.6 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.433 -0.792 . . . . 1.0 109.033 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.08 124.12 51.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 89.88 1.28 Allowed Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 -71.38 0.73 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.871 . . . . 1.0 109.663 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.44 -54.22 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.609 -0.682 . . . . 1.0 109.709 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.61 160.71 14.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.661 -0.649 . . . . 1.0 109.86 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.565 HG23 HG12 ' A' ' 26' ' ' ILE . 10.7 m -129.38 168.68 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.201 1.0 . . . . 1.0 110.883 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -106.14 131.55 53.27 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 115.236 -0.893 . . . . 1.0 109.216 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -140.41 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.226 -0.921 . . . . 1.0 111.035 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.34 141.07 40.7 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -142.09 162.32 35.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.881 -1.528 . . . . 1.0 114.306 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.637 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -92.13 178.88 5.73 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 176.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 76.58 23.8 1.07 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 -171.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.94 55.31 27.4 Favored Glycine 0 N--CA 1.5 2.919 0 CA-C-N 114.806 -1.088 . . . . 1.0 113.989 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.729 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 3.2 tptp -145.85 153.99 41.48 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.634 2.217 . . . . 1.0 113.474 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.417 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -135.39 117.49 15.41 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 104.682 -2.34 . . . . 1.0 104.682 175.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.667 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.17 160.83 41.42 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.764 -1.175 . . . . 1.0 112.977 -175.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.18 123.56 43.56 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.551 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.9 146.07 18.13 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.433 -1.365 . . . . 1.0 112.652 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -106.67 140.45 39.51 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.624 HG12 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -135.17 157.19 77.34 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' HG12 ' A' ' 49' ' ' ILE . 33.5 Cg_endo -75.9 -44.23 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.444 2.096 . . . . 1.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.45 33.51 0.1 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -66.76 -43.47 83.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.383 -1.069 . . . . 1.0 109.767 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.93 -49.96 75.34 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.798 -0.564 . . . . 1.0 109.981 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -24.65 61.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.513 -0.742 . . . . 1.0 110.556 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.49 5.09 31.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.35 -0.844 . . . . 1.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -129.0 -70.64 0.66 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.008 -1.058 . . . . 1.0 110.36 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.84 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.416 -0.802 . . . . 1.0 110.593 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 68.16 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.32 144.99 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.591 -0.693 . . . . 1.0 109.222 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -61.36 -63.43 1.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.638 -0.664 . . . . 1.0 109.439 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.47 121.17 0.5 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.714 -0.616 . . . . 1.0 109.595 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.14 73.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.43 160.55 38.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.646 -0.914 . . . . 1.0 108.945 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 84' ' ' TYR . 3.8 t -109.33 139.43 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.93 -1.106 . . . . 1.0 108.535 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 ' HA ' ' A' ' 82' ' ' TRP . 34.6 m -140.2 152.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.973 0.892 . . . . 1.0 111.894 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.9 pt -99.61 139.68 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 105.501 -2.037 . . . . 1.0 105.501 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.667 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -139.49 158.74 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 117.312 -1.755 . . . . 1.0 114.272 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -100.68 154.88 36.92 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 107.504 -1.295 . . . . 1.0 107.504 176.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.443 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.8 Cg_endo -89.35 141.89 4.19 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.664 2.243 . . . . 1.0 112.549 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.684 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 12.3 m0 -121.42 117.35 26.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.031 -1.47 . . . . 1.0 107.031 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 47.91 -158.27 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 120.244 1.384 . . . . 1.0 109.525 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 73.5 t -155.91 -81.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.821 -1.174 . . . . 1.0 110.793 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -42.32 143.61 0.6 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.667 0.746 . . . . 1.0 112.002 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.79 -54.46 3.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 p30 174.1 160.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.553 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 4.5 tt0 -111.37 149.72 30.78 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.277 -1.369 . . . . 1.0 111.388 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.684 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 37.2 mmtm -112.5 154.76 25.41 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.598 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 14.4 p -144.56 156.16 44.01 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 119.776 -1.828 . . . . 1.0 111.634 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -106.23 119.17 38.54 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 175.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.588 HG22 ' CG1' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -106.65 161.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 115.575 1.694 . . . . 1.0 115.575 -174.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -120.29 123.61 70.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 103.781 -2.674 . . . . 1.0 103.781 175.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.57 ' HA ' HG13 ' A' ' 65' ' ' VAL . 6.6 t90 -96.29 138.0 34.54 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.951 0.881 . . . . 1.0 111.908 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.98 -167.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.17 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 6.0 m-85 59.44 89.02 0.07 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.474 0.654 . . . . 1.0 110.288 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -74.26 -29.16 61.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.485 -0.759 . . . . 1.0 109.547 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.11 -159.74 0.75 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 1.0 109.777 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 p -62.33 148.57 44.73 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.825 . . . . 1.0 110.234 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.512 ' HG2' ' CG ' ' A' ' 84' ' ' TYR . 8.7 tp60 -161.76 -40.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.695 -0.628 . . . . 1.0 110.044 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 25' ' ' ILE . 3.4 t -53.96 -34.94 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.64 -0.662 . . . . 1.0 109.771 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -44.24 80.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.495 -0.753 . . . . 1.0 109.51 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.452 ' CE3' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -65.09 -45.13 86.5 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HB3' HD21 ' A' ' 23' ' ' LEU . 1.9 mt -57.69 -40.99 80.72 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.609 -0.682 . . . . 1.0 109.212 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.463 ' HE2' HD22 ' A' ' 40' ' ' LEU . 6.5 mtmt -58.57 -50.09 75.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.597 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -56.38 -36.11 68.48 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HA ' ' CD2' ' A' ' 98' ' ' LEU . 7.4 tptt -62.22 -35.4 78.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.917 -0.489 . . . . 1.0 109.854 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.59 91.34 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.1 m-85 -66.18 -53.04 42.28 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.915 -0.756 . . . . 1.0 110.802 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 95' ' ' LYS . 3.6 pp -62.17 -34.86 77.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.321 -0.862 . . . . 1.0 109.918 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.66 -38.98 92.45 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.693 . . . . 1.0 109.818 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -61.35 -53.54 55.37 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 1.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.92 97.98 9.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 1.0 109.358 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 118.455 -0.783 . . . . 1.0 109.907 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.15 146.83 31.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.636 -0.665 . . . . 1.0 109.696 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -123.58 108.15 12.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.564 -0.71 . . . . 1.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -113.03 -58.28 2.18 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -111.54 -54.74 2.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.0 109.72 1.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.728 -0.608 . . . . 1.0 109.457 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.61 -86.16 0.57 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.584 -0.698 . . . . 1.0 109.2 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -179.5 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.501 -0.75 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -70.1 167.95 16.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.627 . . . . 1.0 110.128 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -108.78 62.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.678 0.751 . . . . 1.0 109.2 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.0 -16.98 59.87 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.943 0.878 . . . . 1.0 110.982 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 87' ' ' THR . 5.4 p -162.93 160.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.716 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' C ' ' A' ' 14' ' ' ILE . 1.5 ttm-85 -154.53 -69.43 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.465 ' C ' ' O ' ' A' ' 13' ' ' ARG . 1.6 pt 23.54 81.15 0.18 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 122.693 0.397 . . . . 1.0 111.862 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.41 85.72 1.66 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.645 2.23 . . . . 1.0 110.044 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.87 109.1 19.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.663 -0.648 . . . . 1.0 109.74 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.67 37.3 4.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.17 148.71 42.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.52 -0.738 . . . . 1.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.77 44.24 1.06 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.669 -0.644 . . . . 1.0 109.374 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -163.6 99.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 1.0 109.257 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.06 142.67 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.597 -0.689 . . . . 1.0 109.76 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.64 HG13 ' HB3' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -122.49 161.74 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD2' ' C ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -127.96 127.75 43.85 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 117.947 -1.501 . . . . 1.0 109.038 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -142.11 161.74 27.19 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 118.248 -1.929 . . . . 1.0 112.776 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -98.26 130.99 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 HG12 ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -99.03 153.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.198 0.999 . . . . 1.0 111.398 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -142.73 119.71 11.33 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.729 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.672 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 6.6 tp-100 -134.95 130.52 35.94 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.48 ' HA ' ' HE1' ' A' ' 29' ' ' MET . 5.3 tpt -162.02 39.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.421 -0.799 . . . . 1.0 110.015 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.86 15.58 3.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.851 . . . . 1.0 110.245 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.26 66.81 2.31 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 144.27 30.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.609 -0.936 . . . . 1.0 110.12 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -68.87 -20.53 64.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.81 -0.556 . . . . 1.0 109.931 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.88 161.07 13.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 28' ' ' GLN . 16.9 m -137.45 167.6 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.91 0.862 . . . . 1.0 110.79 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.563 ' HA ' HD11 ' A' ' 46' ' ' LEU . 8.6 ptt-85 -109.54 130.64 55.49 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG11 HG13 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -141.03 144.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.899 -1.12 . . . . 1.0 111.018 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 144.48 35.86 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 105.548 -2.019 . . . . 1.0 105.548 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.0 m -139.61 157.24 46.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.233 -1.387 . . . . 1.0 113.125 -176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.487 ' HA ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -94.25 179.51 5.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.64 ' HB3' HG13 ' A' ' 22' ' ' ILE . 6.9 t70 76.44 23.41 1.15 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 103.561 -2.755 . . . . 1.0 103.561 -171.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.66 52.74 36.28 Favored Glycine 0 N--CA 1.5 2.903 0 CA-C-N 114.878 -1.056 . . . . 1.0 113.99 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.609 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -146.03 154.02 41.39 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 120.818 2.309 . . . . 1.0 112.796 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.71 118.03 13.68 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.576 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -147.65 164.4 33.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.049 -1.06 . . . . 1.0 112.808 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.563 HD11 ' HA ' ' A' ' 36' ' ' ARG . 2.8 mm? -97.42 132.63 42.95 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.084 -2.191 . . . . 1.0 105.084 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.701 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.21 150.62 19.67 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.745 -1.217 . . . . 1.0 111.909 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.1 ptm180 -123.66 141.89 51.58 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.481 0.658 . . . . 1.0 109.787 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 HG23 ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -100.24 158.93 31.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.6 -58.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.483 2.122 . . . . 1.0 111.089 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.37 -63.07 0.16 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -39.03 89.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.784 -0.833 . . . . 1.0 109.369 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.08 -34.61 78.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.762 -0.587 . . . . 1.0 109.688 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -49.71 -36.4 25.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.507 -0.746 . . . . 1.0 110.542 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -85.81 -34.9 20.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.409 -0.807 . . . . 1.0 110.147 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -35.97 58.62 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.51 -0.744 . . . . 1.0 110.728 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.585 HG23 ' HB3' ' A' ' 82' ' ' TRP . 1.3 pp -59.84 142.28 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 1.0 110.46 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -144.06 51.58 1.31 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.461 0.648 . . . . 1.0 109.366 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG2' ' HB3' ' A' ' 28' ' ' GLN . 26.5 m -68.47 134.91 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.411 -0.806 . . . . 1.0 109.089 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -137.37 -54.04 0.68 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.406 -0.809 . . . . 1.0 110.408 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -105.97 -14.86 15.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.0 111.201 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.42 92.62 0.12 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' HB2' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -97.19 160.68 14.2 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.517 ' HA ' HG23 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -102.45 141.74 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.805 -1.184 . . . . 1.0 109.906 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 82' ' ' TRP . 17.8 m -142.0 159.29 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.612 0.72 . . . . 1.0 111.224 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 81' ' ' ILE . 1.1 tt -100.32 144.17 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.508 ' CG2' HG22 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -129.66 152.85 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 118.0 -1.48 . . . . 1.0 113.432 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 19.9 mttt -104.75 148.26 35.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' HA ' HH22 ' A' ' 45' ' ' ARG . 39.5 Cg_endo -88.49 135.52 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.255 1.97 . . . . 1.0 112.875 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.698 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.3 m0 -120.74 117.11 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.621 -1.252 . . . . 1.0 107.621 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 47.5 -147.18 0.21 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 119.131 0.878 . . . . 1.0 110.203 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.409 ' CG1' ' H ' ' A' ' 73' ' ' GLN . 1.3 p -155.82 -84.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.091 -1.005 . . . . 1.0 109.567 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.409 ' H ' ' CG1' ' A' ' 72' ' ' VAL . 5.1 mt-30 49.31 -152.54 0.13 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.159 -0.963 . . . . 1.0 110.168 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.57 18.14 57.07 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.886 -1.286 . . . . 1.0 109.886 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.01 135.5 1.75 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -113.54 154.76 26.57 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.583 -1.247 . . . . 1.0 112.139 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.698 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 24.1 tptt -102.34 150.68 23.09 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 106.125 -1.805 . . . . 1.0 106.125 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.701 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 17.4 p -143.15 151.44 40.69 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 119.97 -1.706 . . . . 1.0 111.466 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.67 120.33 39.53 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.639 HG12 ' HA3' ' A' ' 47' ' ' GLY . 1.8 pp -119.95 156.64 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.064 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 66' ' ' ILE . 1.4 tp -118.47 128.91 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 105.487 -2.042 . . . . 1.0 105.487 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.678 ' HA ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.89 147.58 24.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.748 0.785 . . . . 1.0 111.665 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' HG2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -178.23 162.81 1.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.485 0.659 . . . . 1.0 109.605 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -101.75 -50.69 3.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.553 -0.717 . . . . 1.0 109.126 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -126.19 70.67 1.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.448 ' HG2' ' HG2' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -87.75 161.8 17.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.441 -0.787 . . . . 1.0 109.793 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.552 ' HB ' HG22 ' A' ' 12' ' ' VAL . 5.6 p -79.99 -1.96 41.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.591 -0.693 . . . . 1.0 110.702 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG2' ' HD2' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -104.35 -52.77 2.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.26 -0.9 . . . . 1.0 109.834 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.585 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 86.1 t -65.39 -34.65 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.45 -0.781 . . . . 1.0 109.843 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -63.18 -38.49 91.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.166 -0.959 . . . . 1.0 109.26 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -66.19 -55.57 15.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.775 -0.578 . . . . 1.0 110.251 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.585 ' CD2' ' HA ' ' A' ' 89' ' ' VAL . 1.4 pp -58.28 -33.88 69.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.655 -0.653 . . . . 1.0 109.848 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.9 mtpp -58.49 -49.63 76.67 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -58.48 -35.47 72.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.02 -34.19 77.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.795 -0.566 . . . . 1.0 109.966 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.24 -44.81 93.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.055 -1.618 . . . . 1.0 109.055 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.58 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -65.93 -37.46 86.1 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 -56.03 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -34.68 73.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.872 -0.518 . . . . 1.0 109.943 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -59.28 -55.09 39.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 1.0 110.176 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -139.34 156.91 46.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.411 -0.806 . . . . 1.0 110.293 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.503 2.212 0 CA-C-O 117.719 -1.134 . . . . 1.0 110.013 -179.598 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptp . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.174 0.511 . . . . 1.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.34 -51.78 7.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.608 -0.682 . . . . 1.0 109.627 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.24 165.36 29.44 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.686 . . . . 1.0 110.093 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.66 0.02 24.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.679 -0.638 . . . . 1.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.26 179.12 4.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 1.0 110.033 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 69.06 106.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.262 0.554 . . . . 1.0 109.976 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -72.68 0.71 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 1.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.95 29.72 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.536 -0.728 . . . . 1.0 110.232 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -131.1 167.8 18.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.226 -0.922 . . . . 1.0 110.129 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -98.13 154.8 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.621 -0.675 . . . . 1.0 109.329 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -177.88 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.833 0.825 . . . . 1.0 111.684 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -87.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-O 122.031 0.92 . . . . 1.0 110.456 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.06 135.47 50.86 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.315 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.4 pt -78.05 162.48 67.03 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.846 -0.534 . . . . 1.0 109.685 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 34.3 Cg_endo -75.9 -49.98 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.687 2.258 . . . . 1.0 111.238 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.57 156.78 27.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.428 -0.795 . . . . 1.0 109.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 56.12 1.85 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 1.0 109.527 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -147.82 176.19 10.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.36 -0.838 . . . . 1.0 110.248 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.14 -7.59 59.59 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.569 -0.707 . . . . 1.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 18.2 m120 -54.3 -38.03 65.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.395 -0.816 . . . . 1.0 109.887 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 121.26 17.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.691 -0.63 . . . . 1.0 109.773 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 43' ' ' LYS . 1.2 mp -110.26 162.13 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -128.12 125.26 38.84 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 117.891 -1.524 . . . . 1.0 109.43 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.65 161.9 27.01 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.11 -1.995 . . . . 1.0 113.051 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.464 HG22 HG11 ' A' ' 64' ' ' VAL . 7.7 pt -98.29 131.67 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -100.5 156.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 122.182 0.992 . . . . 1.0 111.751 -177.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.99 126.05 18.33 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.708 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.634 ' HG2' HG11 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -131.19 104.86 7.31 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.423 ' HA ' ' HE1' ' A' ' 29' ' ' MET . 1.3 tpt -139.58 49.14 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.401 -0.812 . . . . 1.0 109.272 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.8 mt -140.45 -54.98 0.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 1.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.89 73.09 0.98 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.41 -77.64 0.34 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.887 . . . . 1.0 109.937 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.61 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.577 -0.702 . . . . 1.0 109.956 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.32 160.66 14.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.627 -0.671 . . . . 1.0 109.822 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.634 HG11 ' HG2' ' A' ' 28' ' ' GLN . 7.0 m -124.1 168.24 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 121.888 0.851 . . . . 1.0 110.384 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.604 ' HA ' HD11 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -108.15 132.01 54.05 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 178.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -140.91 145.38 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 118.939 -1.105 . . . . 1.0 111.274 -178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.09 141.36 44.7 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.654 -1.98 . . . . 1.0 105.654 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.2 m -137.88 157.43 46.42 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.253 -1.379 . . . . 1.0 113.176 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' HB3' HD12 ' A' ' 23' ' ' LEU . 3.7 tp -93.69 177.94 5.84 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.279 -1.748 . . . . 1.0 106.279 176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' HB3' HG13 ' A' ' 22' ' ' ILE . 2.8 t70 76.63 22.87 1.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 104.308 -2.479 . . . . 1.0 104.308 -172.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.61 18.03 Favored Glycine 0 N--CA 1.499 2.874 0 CA-C-N 115.079 -0.964 . . . . 1.0 113.998 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.598 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.18 153.46 41.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 120.465 2.133 . . . . 1.0 112.203 178.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.5 116.89 10.71 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.179 -2.156 . . . . 1.0 105.179 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -148.27 164.08 35.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.716 -1.193 . . . . 1.0 113.342 -175.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 36' ' ' ARG . 4.1 mm? -97.31 130.23 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 104.753 -2.314 . . . . 1.0 104.753 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.679 ' HA3' HG12 ' A' ' 80' ' ' ILE . . . -95.18 149.09 19.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.027 -1.082 . . . . 1.0 111.921 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -126.06 143.86 50.95 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.443 0.64 . . . . 1.0 109.981 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 HD12 HD12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -101.75 157.7 33.18 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.511 ' HD2' HG13 ' A' ' 49' ' ' ILE . 34.8 Cg_endo -76.28 -50.64 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.546 2.164 . . . . 1.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.66 -64.23 0.18 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -36.0 80.41 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.657 -0.908 . . . . 1.0 109.796 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 4.5 mp -65.02 -34.78 79.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.7 -0.625 . . . . 1.0 109.882 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.497 ' CB ' HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.62 -32.8 65.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.483 -0.76 . . . . 1.0 110.34 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -84.04 -28.66 27.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.479 -0.763 . . . . 1.0 110.355 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.59 -34.81 19.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 1.0 110.83 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 54' ' ' LYS . 1.3 pp -54.2 132.51 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.473 -0.767 . . . . 1.0 110.454 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.87 60.71 1.37 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 63' ' ' ASP . 11.5 m -74.29 153.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.522 -0.736 . . . . 1.0 109.349 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -141.35 -49.72 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.391 -0.818 . . . . 1.0 110.649 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.78 18.2 5.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.375 -0.828 . . . . 1.0 111.251 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.45 92.33 0.72 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.7 -1.238 . . . . 1.0 110.521 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' HB2' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -99.25 161.33 13.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.483 ' CG1' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.36 140.74 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.753 -1.217 . . . . 1.0 109.776 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 82' ' ' TRP . 19.4 m -142.5 158.12 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.514 0.673 . . . . 1.0 111.071 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.467 ' CG2' HG12 ' A' ' 81' ' ' ILE . 1.8 tp -100.87 146.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -131.36 154.7 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 118.291 -1.364 . . . . 1.0 113.444 -177.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.1 mmpp? -107.48 149.32 38.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 106.507 -1.664 . . . . 1.0 106.507 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.466 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.1 Cg_endo -88.48 136.34 3.27 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.417 2.078 . . . . 1.0 112.956 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.649 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.7 m0 -121.08 116.15 24.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 45.09 -154.43 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 CA-C-N 118.999 0.818 . . . . 1.0 110.964 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -142.61 -79.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.211 -0.931 . . . . 1.0 109.225 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.37 -152.29 0.11 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.456 -0.777 . . . . 1.0 110.508 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.9 13.12 66.9 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.113 -1.195 . . . . 1.0 110.113 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.77 145.56 1.96 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -113.37 151.76 30.86 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.724 -1.19 . . . . 1.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 4.8 tppt? -99.73 151.98 20.62 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.317 -1.735 . . . . 1.0 106.317 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.652 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 30.9 p -142.73 152.04 41.91 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.126 -1.609 . . . . 1.0 111.31 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.64 119.62 38.83 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 104.788 -2.301 . . . . 1.0 104.788 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.679 HG12 ' HA3' ' A' ' 47' ' ' GLY . 1.3 pp -120.32 155.79 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 117.761 -1.576 . . . . 1.0 114.994 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.467 HG12 ' CG2' ' A' ' 66' ' ' ILE . 1.8 pp -117.21 132.35 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.72 -1.955 . . . . 1.0 105.72 175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.672 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.86 146.29 25.57 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.879 0.847 . . . . 1.0 111.462 -176.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -173.49 154.42 2.56 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.409 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.42 -45.7 6.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.745 . . . . 1.0 109.132 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -122.13 56.14 1.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 83' ' ' ARG . 2.2 tmtm? -73.74 144.24 45.76 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.52 -0.737 . . . . 1.0 109.79 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -73.62 -20.24 60.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.664 -0.647 . . . . 1.0 109.624 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -47.93 14.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 1.0 109.675 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.548 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 59.5 t -65.26 -36.32 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.705 -0.622 . . . . 1.0 110.262 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 91' ' ' TRP . 10.2 pt-20 -65.19 -34.33 78.12 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.985 -1.072 . . . . 1.0 109.342 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.4 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.3 m95 -65.26 -55.65 17.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.598 -0.689 . . . . 1.0 109.47 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.611 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 1.6 pp -62.02 -34.53 76.38 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.784 -0.573 . . . . 1.0 109.935 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -61.24 -50.03 74.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.0 109.501 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.51 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -56.82 -37.56 71.38 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.776 -0.578 . . . . 1.0 109.531 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.907 -0.496 . . . . 1.0 110.091 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.96 -44.46 94.49 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.51 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -65.89 -37.61 86.58 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.896 -0.767 . . . . 1.0 109.647 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.13 -46.62 89.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.3 -34.73 79.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 1.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.25 -55.2 36.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.588 -0.695 . . . . 1.0 110.154 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -140.13 162.72 34.56 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.522 -0.736 . . . . 1.0 110.247 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.164 0 CA-C-O 117.725 -1.131 . . . . 1.0 110.137 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.234 0.54 . . . . 1.0 109.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.768 ' C ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -109.91 161.46 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.034 -1.099 . . . . 1.0 108.034 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.953 ' CB ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -125.11 120.73 32.25 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 117.957 -1.497 . . . . 1.0 109.356 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.23 162.06 26.84 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.359 -1.877 . . . . 1.0 112.542 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.651 HG22 HG13 ' A' ' 64' ' ' VAL . 11.3 pt -98.12 139.95 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.015 ' CD1' HG13 ' A' ' 37' ' ' VAL . 9.8 tp -99.46 151.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.22 1.01 . . . . 1.0 111.273 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.366 179.154 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.265 0.555 . . . . 1.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.664 HG23 HD11 ' A' ' 26' ' ' ILE . 7.0 m -141.25 169.6 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.639 0.733 . . . . 1.0 110.428 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.41 127.98 56.3 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 120.11 -0.636 . . . . 1.0 110.733 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.015 HG13 ' CD1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.7 148.57 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.705 1.241 . . . . 1.0 112.333 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.66 135.12 55.2 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.227 -2.508 . . . . 1.0 104.227 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -140.16 160.42 39.99 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.591 -1.644 . . . . 1.0 114.462 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.0 tp -93.55 179.51 5.36 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.903 -1.888 . . . . 1.0 105.903 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.573 ' HB3' HG13 ' A' ' 22' ' ' ILE . 9.1 t70 75.3 22.66 1.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.05 -2.574 . . . . 1.0 104.05 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.67 55.98 15.11 Favored Glycine 0 N--CA 1.5 2.918 0 CA-C-N 115.028 -0.987 . . . . 1.0 113.961 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.764 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -145.75 154.48 42.09 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.467 2.134 . . . . 1.0 113.395 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.59 117.8 10.7 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.82 164.91 31.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.768 -1.173 . . . . 1.0 113.256 -175.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.533 HD11 ' HG2' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -97.55 125.1 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.794 -2.298 . . . . 1.0 104.794 175.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.728 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.92 142.93 16.38 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 120.795 -1.19 . . . . 1.0 112.157 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.6 ptm180 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.329 0.585 . . . . 1.0 109.783 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.931 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.69 142.86 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.788 -1.195 . . . . 1.0 109.297 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.885 HG12 ' HA ' ' A' ' 82' ' ' TRP . 33.6 m -142.63 155.26 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.753 0.787 . . . . 1.0 111.435 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.535 HG22 ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -99.93 134.54 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.832 HG12 HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -119.22 153.42 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-O 123.051 1.405 . . . . 1.0 113.793 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 ttpp -108.27 146.94 34.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 113.616 -1.629 . . . . 1.0 106.667 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.578 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.8 Cg_endo -88.36 138.03 3.81 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.307 2.005 . . . . 1.0 112.944 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.497 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.2 m0 . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.983 0.896 . . . . 1.0 111.779 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' HD11 ' A' ' 46' ' ' LEU . 2.9 mttm -98.22 152.29 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.728 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 18.1 p -143.91 151.67 40.12 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 119.975 -1.703 . . . . 1.0 111.681 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.61 118.51 37.08 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.832 HG22 HG12 ' A' ' 67' ' ' VAL . 2.2 pt -113.5 155.03 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.904 1.335 . . . . 1.0 114.594 -174.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -116.61 128.63 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 105.388 -2.079 . . . . 1.0 105.388 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.1 t90 -97.24 142.23 29.38 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.923 0.868 . . . . 1.0 111.446 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.931 HG11 ' CG1' ' A' ' 64' ' ' VAL . 51.4 t . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -61.9 -35.4 78.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 1.0 109.102 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -55.16 19.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.595 . . . . 1.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.953 HD13 ' CB ' ' A' ' 23' ' ' LEU . 2.3 pp -61.83 -37.98 86.49 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.778 -0.576 . . . . 1.0 110.308 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.632 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -65.34 -44.6 87.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.407 -0.808 . . . . 1.0 109.24 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 23.9 mtp85 -57.62 -36.94 72.46 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.33 -33.27 75.46 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.64 -44.93 95.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.606 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.02 -39.42 90.2 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.841 -0.8 . . . . 1.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.654 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.2 tm? -59.28 -48.76 80.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.771 -0.581 . . . . 1.0 109.667 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.78 -43.15 99.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.646 -0.659 . . . . 1.0 109.953 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 O-C-N 121.616 -0.678 . . . . 1.0 110.155 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.496 1.825 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.689 HG21 ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -113.46 161.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.85 HD11 ' CD1' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -123.86 134.01 53.66 Favored 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 117.542 -1.663 . . . . 1.0 109.434 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -141.47 155.36 25.2 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 118.033 -2.032 . . . . 1.0 112.854 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 38' ' ' ARG . 1.6 pp -99.33 138.81 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.082 -1.822 . . . . 1.0 106.082 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 82' ' ' TRP . 3.1 pt -99.99 145.82 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.428 1.109 . . . . 1.0 111.954 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.488 1.464 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.029 178.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.843 0.83 . . . . 1.0 110.329 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG11 ' HB ' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -117.26 161.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 144.75 29.94 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.74 ' CG2' HG22 ' A' ' 26' ' ' ILE . 1.7 t -134.78 144.77 33.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.458 1.123 . . . . 1.0 111.867 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -110.77 141.51 43.99 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.332 -2.47 . . . . 1.0 104.332 174.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -139.92 154.72 47.3 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 117.159 -1.816 . . . . 1.0 114.536 -175.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD23 ' HE3' ' A' ' 93' ' ' LYS . 10.1 tp -92.71 171.7 8.83 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.299 -1.741 . . . . 1.0 106.299 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.677 ' HB3' HG22 ' A' ' 22' ' ' ILE . 1.1 t70 78.41 23.0 0.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.987 -2.597 . . . . 1.0 103.987 -171.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 53.17 34.37 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-N 114.92 -1.036 . . . . 1.0 115.028 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.689 ' HD3' HG21 ' A' ' 22' ' ' ILE . 2.8 mptt -146.13 153.11 40.3 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.685 2.242 . . . . 1.0 112.557 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 117.25 16.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.622 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.94 164.53 32.63 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.463 -0.895 . . . . 1.0 111.905 -176.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.76 127.53 40.82 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.018 -2.215 . . . . 1.0 105.018 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.644 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.49 140.24 14.94 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.892 -1.13 . . . . 1.0 111.871 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 ptm85 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.462 0.648 . . . . 1.0 109.72 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' HD11 ' A' ' 26' ' ' ILE . 4.5 m-20 . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' ARG . 5.9 p -97.18 138.62 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.839 -1.163 . . . . 1.0 108.168 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -141.75 142.71 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.841 -0.744 . . . . 1.0 111.282 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.739 HG12 HD11 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -99.11 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 104.475 -2.417 . . . . 1.0 104.475 176.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -126.52 156.55 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.972 -1.491 . . . . 1.0 113.667 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.14 153.03 41.28 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 106.747 -1.575 . . . . 1.0 106.747 177.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 38.5 Cg_endo -89.03 140.0 3.85 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.412 2.075 . . . . 1.0 113.06 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.0 m95 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.517 0.675 . . . . 1.0 110.931 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 1.7 mttm -112.54 152.13 29.18 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.644 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 28.9 p -145.72 153.61 41.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 119.908 -1.745 . . . . 1.0 112.289 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 3.1 t0 -98.91 124.37 43.81 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.72 -2.326 . . . . 1.0 104.72 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.874 HG22 HG12 ' A' ' 67' ' ' VAL . 3.7 pt -122.33 149.97 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 117.484 -1.686 . . . . 1.0 114.72 -175.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.739 HD11 HG12 ' A' ' 66' ' ' ILE . 2.5 pt -121.98 119.51 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.838 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.42 159.83 14.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.009 0.909 . . . . 1.0 112.187 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.076 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 23' ' ' LEU . 44.4 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.19 -41.85 93.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.696 -0.627 . . . . 1.0 109.648 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -60.01 -46.69 88.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.72 -0.613 . . . . 1.0 109.477 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.85 ' CD1' HD11 ' A' ' 23' ' ' LEU . 60.8 mt -63.68 -38.02 89.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.601 -0.687 . . . . 1.0 110.252 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.538 ' HE3' HD23 ' A' ' 40' ' ' LEU . 15.0 mmtt -61.94 -50.21 73.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.523 -0.736 . . . . 1.0 109.018 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.651 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -57.59 -35.46 70.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.675 ' HA ' HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -62.22 -34.76 77.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.859 -0.526 . . . . 1.0 109.94 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.69 -39.79 90.3 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.847 -1.301 . . . . 1.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.7 m-85 -65.99 -53.05 43.71 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 1.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.2 pp -60.78 -37.65 82.61 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.423 -0.798 . . . . 1.0 109.514 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.447 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.7 t70 -65.76 -42.76 90.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.668 -0.645 . . . . 1.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.989 -0.444 . . . . 1.0 110.118 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 121.334 0.588 . . . . 1.0 109.613 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -103.67 161.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.33 -0.857 . . . . 1.0 109.06 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' HB2' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -114.07 119.93 38.83 Favored 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 117.636 -1.626 . . . . 1.0 109.215 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 67' ' ' VAL . . . -122.55 161.54 16.71 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.971 -1.585 . . . . 1.0 112.937 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 37' ' ' VAL . 1.1 pp -124.0 137.07 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.443 -1.688 . . . . 1.0 106.443 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -99.15 154.98 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.591 1.186 . . . . 1.0 112.602 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-N 113.455 -1.702 . . . . 1.0 108.154 178.389 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.353 0.597 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.85 169.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 122.057 0.932 . . . . 1.0 110.386 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -97.07 127.98 43.56 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.237 -1.394 . . . . 1.0 107.237 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 80' ' ' ILE . 1.5 t -131.36 152.32 37.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.426 1.108 . . . . 1.0 111.838 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.8 149.34 48.69 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.43 158.17 43.86 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.134 -176.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.712 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -94.62 176.38 6.3 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.756 ' HB3' HG22 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 78.43 22.35 0.74 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.178 -2.527 . . . . 1.0 104.178 -171.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.84 9.44 Favored Glycine 0 N--CA 1.507 3.386 0 N-CA-C 115.759 1.064 . . . . 1.0 115.759 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mptt -146.85 158.4 43.91 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 121.201 2.5 . . . . 1.0 113.514 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 44' ' ' THR . 0.7 OUTLIER -140.54 118.39 11.76 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 106.148 -1.797 . . . . 1.0 106.148 176.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' HG3' ' CB ' ' A' ' 76' ' ' GLN . 2.4 mpp_? -147.17 165.26 30.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.081 -1.012 . . . . 1.0 113.392 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' HG ' ' A' ' 78' ' ' CYS . 4.8 mp -94.94 129.12 42.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.347 -2.464 . . . . 1.0 104.347 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.1 137.95 13.71 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.709 -1.234 . . . . 1.0 112.053 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.479 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.835 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 89' ' ' VAL . 19.1 m -100.79 145.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.478 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 82' ' ' TRP . 2.9 m -144.7 157.65 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.655 0.741 . . . . 1.0 111.798 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.852 HG12 HG22 ' A' ' 81' ' ' ILE . 1.2 pt -99.56 132.36 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.591 -2.744 . . . . 1.0 103.591 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.864 HG12 ' CG1' ' A' ' 80' ' ' ILE . 1.4 m -122.25 155.36 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 118.106 -1.438 . . . . 1.0 114.257 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.4 mtpp -112.87 150.06 42.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.334 -1.757 . . . . 1.0 107.592 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.8 Cg_endo -89.94 141.07 3.58 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.617 2.212 . . . . 1.0 112.516 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.3 m0 . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.661 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 122.233 1.016 . . . . 1.0 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.611 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -109.35 155.2 21.5 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.554 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 25.6 p -144.19 151.74 39.91 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.195 -1.566 . . . . 1.0 111.319 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -98.6 118.7 35.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 103.737 -2.69 . . . . 1.0 103.737 176.069 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.882 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -120.95 138.2 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.377 -1.329 . . . . 1.0 113.49 -174.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.852 HG22 HG12 ' A' ' 66' ' ' ILE . 5.7 tt -115.23 120.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.871 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.8 p90 -97.99 160.13 14.49 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.416 1.103 . . . . 1.0 113.108 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 2.1 tpt180 . . . . . 0 N--CA 1.488 1.428 0 CA-C-N 114.765 -1.107 . . . . 1.0 108.734 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.843 ' HA ' HD12 ' A' ' 92' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.29 -52.38 63.65 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 1.0 109.284 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -39.52 91.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.646 . . . . 1.0 109.419 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 89' ' ' VAL . 15.9 mt -58.35 -40.31 81.87 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HG3' HD13 ' A' ' 23' ' ' LEU . 15.3 mttm -64.13 -53.24 52.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.811 -0.555 . . . . 1.0 109.653 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 6.3 mtt-85 -55.45 -35.9 65.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.772 -0.58 . . . . 1.0 109.584 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HE2' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -64.43 -34.9 79.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.833 -0.542 . . . . 1.0 110.24 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.22 -40.5 92.33 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.3 m-85 -66.53 -53.1 38.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.826 -0.808 . . . . 1.0 111.043 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.691 HD11 ' HE2' ' A' ' 95' ' ' LYS . 3.3 pp -61.96 -40.14 94.56 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.429 -0.794 . . . . 1.0 109.841 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 t70 -65.88 -38.74 89.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.586 -0.696 . . . . 1.0 109.457 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 1.0 109.632 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.265 0.555 . . . . 1.0 109.761 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -114.63 161.77 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -126.95 123.07 36.32 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 117.722 -1.591 . . . . 1.0 109.658 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -140.55 163.63 26.45 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.215 -1.469 . . . . 1.0 112.232 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.58 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.027 ' HA ' HG22 ' A' ' 37' ' ' VAL . 1.7 pt -98.65 148.43 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 122.265 1.031 . . . . 1.0 111.595 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 35' ' ' VAL . 34.2 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-N 114.001 -1.454 . . . . 1.0 108.259 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.588 0.709 . . . . 1.0 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -99.96 162.44 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -98.18 131.17 44.77 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.027 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -134.85 153.09 34.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.986 0.898 . . . . 1.0 111.35 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 147.86 48.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.156 -1.794 . . . . 1.0 106.156 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -144.27 160.47 40.94 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.411 -1.316 . . . . 1.0 114.09 -176.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 40' ' ' LEU . 6.0 mt -93.93 177.47 5.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 22' ' ' ILE . 22.5 m-20 77.03 22.66 1.01 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 104.344 -2.465 . . . . 1.0 104.344 -172.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.43 52.25 13.71 Favored Glycine 0 N--CA 1.502 3.077 0 CA-C-O 118.708 -1.051 . . . . 1.0 115.234 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -146.76 151.5 37.27 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.094 2.447 . . . . 1.0 113.153 177.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 44' ' ' THR . 3.3 t -134.73 118.19 16.83 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 105.094 -2.188 . . . . 1.0 105.094 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.77 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.65 162.74 37.8 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.882 -1.127 . . . . 1.0 113.028 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -98.27 123.04 42.16 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 103.685 -2.709 . . . . 1.0 103.685 174.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.77 143.55 16.73 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.469 -1.348 . . . . 1.0 112.237 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' CB ' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 110.156 -0.313 . . . . 1.0 110.156 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.648 HG23 ' CG2' ' A' ' 89' ' ' VAL . 1.5 p -96.21 136.81 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -140.92 139.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.621 -0.832 . . . . 1.0 110.982 -178.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 81' ' ' ILE . 1.7 pp -99.21 143.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.043 -2.206 . . . . 1.0 105.043 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 80' ' ' ILE . 1.5 m -140.28 159.31 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.611 -1.636 . . . . 1.0 114.677 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.8 OUTLIER -99.29 151.68 37.5 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 113.265 -1.789 . . . . 1.0 107.056 176.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.5 Cg_endo -90.04 141.25 3.56 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.409 2.073 . . . . 1.0 112.13 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m0 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . 1.5 mp0 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.869 0.843 . . . . 1.0 110.773 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 4.0 mttm -112.98 154.74 25.98 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 11.3 p -145.1 153.57 41.55 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 119.961 -1.712 . . . . 1.0 111.776 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.574 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 1.3 t70 -99.45 119.43 37.98 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 HG12 ' A' ' 67' ' ' VAL . 2.7 pt -120.84 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.392 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.673 HD11 HG12 ' A' ' 66' ' ' ILE . 5.0 pt -126.39 118.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.181 -2.155 . . . . 1.0 105.181 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.613 ' CA ' HG23 ' A' ' 65' ' ' VAL . 7.5 p-90 -105.51 160.44 15.16 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.099 0.952 . . . . 1.0 112.792 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 . . . . . 0 N--CA 1.494 1.727 0 CA-C-N 115.337 -0.847 . . . . 1.0 108.717 179.312 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 64' ' ' VAL . 87.3 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -44.06 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.636 -0.665 . . . . 1.0 109.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -58.31 -46.47 86.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.617 -0.677 . . . . 1.0 109.357 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.565 HD13 HD11 ' A' ' 23' ' ' LEU . 1.6 mt -63.58 -35.18 79.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.703 -0.623 . . . . 1.0 109.607 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HD2' HG12 ' A' ' 89' ' ' VAL . 1.1 mptp? -64.83 -50.27 67.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.666 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 15.7 mtm180 -54.75 -40.26 69.14 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' A' ' 98' ' ' LEU . 17.2 ttpp -63.06 -33.44 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.008 -0.433 . . . . 1.0 110.092 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.25 -38.83 94.12 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.261 -1.135 . . . . 1.0 110.261 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.4 m-85 -66.13 -53.88 32.41 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.756 -0.849 . . . . 1.0 110.735 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 95' ' ' LYS . 2.2 pp -62.52 -38.63 90.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -0.783 . . . . 1.0 110.08 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.9 -45.3 82.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.567 -0.708 . . . . 1.0 109.761 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.787 -0.571 . . . . 1.0 110.168 -179.797 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.826 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -113.63 161.24 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.32 -0.862 . . . . 1.0 109.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -118.49 126.21 51.54 Favored 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 118.384 -1.326 . . . . 1.0 109.234 -178.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -140.28 161.92 26.46 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 118.586 -1.768 . . . . 1.0 112.79 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.64 144.5 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 37' ' ' VAL . 3.7 pt -98.83 152.02 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.344 1.069 . . . . 1.0 111.985 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-N 114.204 -1.362 . . . . 1.0 108.617 178.902 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.568 0.699 . . . . 1.0 109.966 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 ' HB ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -110.96 161.9 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.25 131.33 44.68 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -129.97 147.25 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.397 1.094 . . . . 1.0 111.701 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -117.99 139.29 51.38 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 105.461 -2.052 . . . . 1.0 105.461 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -141.28 160.38 40.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.883 -1.527 . . . . 1.0 114.195 -175.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HD2' ' A' ' 93' ' ' LYS . 6.1 mt -94.36 176.64 6.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.092 -1.413 . . . . 1.0 107.436 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.826 ' HB3' HG22 ' A' ' 22' ' ' ILE . 3.3 t70 76.74 23.09 1.07 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 103.961 -2.607 . . . . 1.0 103.961 -171.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 54.99 18.16 Favored Glycine 0 N--CA 1.502 3.096 0 CA-C-N 115.001 -1.0 . . . . 1.0 114.247 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.721 ' HB3' ' HD2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -146.38 155.05 42.32 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 120.573 2.187 . . . . 1.0 112.752 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.7 m -140.36 116.39 10.44 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.803 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.46 164.95 30.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.21 -0.996 . . . . 1.0 112.408 -175.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -95.3 126.31 40.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 104.464 -2.421 . . . . 1.0 104.464 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -94.76 131.49 10.73 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.67 -1.253 . . . . 1.0 111.535 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.501 0.667 . . . . 1.0 109.888 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.642 HG23 HG13 ' A' ' 89' ' ' VAL . 2.6 p -99.25 133.53 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 1.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.129 HG12 ' HA ' ' A' ' 82' ' ' TRP . 35.9 m -139.64 150.16 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.682 0.753 . . . . 1.0 111.249 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.804 HG12 HD11 ' A' ' 81' ' ' ILE . 1.6 pp -99.6 142.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.994 -2.224 . . . . 1.0 104.994 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 2.0 m -140.25 156.4 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 117.38 -1.728 . . . . 1.0 114.367 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 8.8 ptpt -101.1 153.73 37.59 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.941 -1.481 . . . . 1.0 108.168 176.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.449 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.0 Cg_endo -89.83 143.82 4.29 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.605 2.203 . . . . 1.0 112.168 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.54 ' CD2' ' HB3' ' A' ' 77' ' ' LYS . 11.1 m0 . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 107.834 -1.172 . . . . 1.0 107.834 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 42.0 mm-40 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.553 0.692 . . . . 1.0 110.557 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HB3' ' CD2' ' A' ' 70' ' ' TRP . 16.0 mttm -107.8 152.96 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 106.634 -1.617 . . . . 1.0 106.634 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.69 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 24.9 p -144.79 154.61 42.88 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.94 -1.725 . . . . 1.0 111.805 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 6.7 t70 -99.27 118.44 35.95 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 103.403 -2.814 . . . . 1.0 103.403 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.725 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -118.61 147.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 118.145 -1.422 . . . . 1.0 113.752 -174.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.804 HD11 HG12 ' A' ' 66' ' ' ILE . 2.0 pt -125.58 120.31 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 1.129 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -98.16 158.25 15.67 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.151 0.977 . . . . 1.0 112.993 -175.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-N 115.218 -0.901 . . . . 1.0 109.228 -179.586 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HG23 ' A' ' 64' ' ' VAL . 10.0 m . . . . . 0 N--CA 1.503 2.215 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.53 -42.34 78.29 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.456 -0.777 . . . . 1.0 109.183 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.41 ' CH2' ' HD2' ' A' ' 95' ' ' LYS . 59.1 t90 -64.99 -42.5 94.45 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -60.15 -34.66 73.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.746 -0.596 . . . . 1.0 109.692 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HD2' HD13 ' A' ' 40' ' ' LEU . 1.6 mttt -63.63 -56.0 19.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.597 -0.69 . . . . 1.0 109.508 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -59.73 -36.46 76.61 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HD2' ' CH2' ' A' ' 91' ' ' TRP . 12.4 tttp -64.72 -33.57 76.27 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.07 -44.25 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.061 -1.215 . . . . 1.0 110.061 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.604 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.693 -0.886 . . . . 1.0 109.831 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.4 tm? -57.42 -56.52 20.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.901 -0.5 . . . . 1.0 109.913 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.44 -34.21 77.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.274 -0.891 . . . . 1.0 109.599 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.497 1.921 0 O-C-N 121.742 -0.599 . . . . 1.0 109.925 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.46 161.35 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -121.26 132.36 54.76 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.195 -1.402 . . . . 1.0 109.153 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -141.79 155.62 25.48 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 118.18 -1.962 . . . . 1.0 113.086 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 38' ' ' ARG . 9.8 tt -100.37 138.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 105.958 -1.867 . . . . 1.0 105.958 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.898 ' HA ' HG22 ' A' ' 37' ' ' VAL . 6.6 pt -98.36 149.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 122.589 1.185 . . . . 1.0 112.567 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 113.865 -1.516 . . . . 1.0 108.763 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.581 ' HD3' ' CB ' ' A' ' 46' ' ' LEU . 21.8 ttm-85 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.44 0.638 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -111.05 161.82 9.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' HG2' ' N ' ' A' ' 37' ' ' VAL . 10.1 ttp180 -100.0 141.04 33.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.381 -1.34 . . . . 1.0 107.381 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.3 t -133.87 148.49 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.442 1.115 . . . . 1.0 112.018 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HG3' HG22 ' A' ' 25' ' ' ILE . 1.1 ptm180 -112.68 141.17 46.78 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 104.657 -2.349 . . . . 1.0 104.657 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -141.25 158.47 43.85 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.17 -1.812 . . . . 1.0 115.015 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.5 tp -93.42 172.78 8.07 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.775 -1.557 . . . . 1.0 107.477 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.528 ' HB3' HG22 ' A' ' 22' ' ' ILE . 2.1 t70 77.44 22.8 0.91 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 104.134 -2.543 . . . . 1.0 104.134 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.69 56.08 16.73 Favored Glycine 0 N--CA 1.501 3.018 0 CA-C-N 114.975 -1.011 . . . . 1.0 114.276 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -145.62 151.12 37.57 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 120.452 2.126 . . . . 1.0 112.661 178.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.557 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -133.93 117.92 17.3 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 176.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.997 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -145.95 162.57 37.51 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.001 -1.08 . . . . 1.0 112.847 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -97.89 117.89 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.401 -2.814 . . . . 1.0 103.401 174.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 80' ' ' ILE . . . -101.57 153.93 18.87 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.785 -1.198 . . . . 1.0 112.753 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.702 0.763 . . . . 1.0 110.143 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.56 137.84 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 120.502 -1.374 . . . . 1.0 109.183 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 82' ' ' TRP . 3.1 m -141.58 158.62 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.889 -0.724 . . . . 1.0 111.306 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.786 HG22 ' CG1' ' A' ' 81' ' ' ILE . 14.4 tt -99.57 149.03 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 105.045 -2.205 . . . . 1.0 105.045 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 1.3 m -134.22 157.4 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.6 -1.64 . . . . 1.0 114.54 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 41.4 mtmt -103.94 152.82 39.1 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 113.332 -1.758 . . . . 1.0 106.928 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 40.3 Cg_endo -89.16 141.39 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.684 2.256 . . . . 1.0 113.033 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.601 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m95 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 5.9 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.457 0.646 . . . . 1.0 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 16.4 mttm -114.87 158.87 21.36 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 21.6 p -146.25 155.86 42.97 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.144 -1.597 . . . . 1.0 111.944 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.81 117.54 34.13 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 104.337 -2.468 . . . . 1.0 104.337 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.589 HG22 ' CB ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -120.01 161.35 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.312 1.597 . . . . 1.0 115.312 -174.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.786 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.2 pp -118.94 120.28 63.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 175.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.961 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -97.54 156.3 16.56 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.188 0.994 . . . . 1.0 112.709 -176.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.067 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 23' ' ' LEU . 48.9 t . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -63.22 -48.86 76.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.706 -0.621 . . . . 1.0 110.086 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -54.27 -50.54 67.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 1.0 109.395 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.4 mt -61.57 -39.05 89.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.758 -0.589 . . . . 1.0 109.622 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' A' ' 40' ' ' LEU . 10.1 mmtm -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.767 -0.583 . . . . 1.0 109.847 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.823 ' HA ' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.32 -55.32 32.83 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -25.17 67.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.94 -59.03 10.83 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.498 -0.858 . . . . 1.0 111.487 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.823 ' CZ ' ' HA ' ' A' ' 94' ' ' ARG . 10.4 p90 -70.58 -39.11 74.05 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.429 1.114 . . . . 1.0 110.308 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.5 -52.88 62.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.873 -0.517 . . . . 1.0 110.268 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.57 -42.15 95.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.591 -0.693 . . . . 1.0 109.778 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.582 -0.699 . . . . 1.0 109.585 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 1.0 110.741 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.711 HG23 ' SG ' ' A' ' 39' ' ' CYS . 1.2 mp -111.13 158.37 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.929 ' HB3' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -130.62 126.97 38.0 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 118.185 -1.406 . . . . 1.0 108.886 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -142.5 161.68 27.35 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 117.566 -2.254 . . . . 1.0 114.21 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -98.04 135.07 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 177.362 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.034 ' CD1' HG23 ' A' ' 37' ' ' VAL . 9.4 tp -104.57 152.72 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.498 1.142 . . . . 1.0 112.629 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 114.21 -1.359 . . . . 1.0 108.15 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 26' ' ' ILE . 6.5 m -137.38 168.51 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.742 0.782 . . . . 1.0 110.188 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.62 122.31 41.25 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.259 -0.577 . . . . 1.0 110.725 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -120.9 148.61 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 122.868 1.318 . . . . 1.0 111.78 -179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -110.03 139.89 44.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.899 -2.63 . . . . 1.0 103.899 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.711 ' SG ' HG23 ' A' ' 22' ' ' ILE . 1.8 p -141.32 162.56 35.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.334 -1.746 . . . . 1.0 115.665 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 41' ' ' ASP . 38.2 tp -89.84 169.49 11.21 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.91 -1.95 . . . . 1.0 105.926 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.608 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 15.6 m-20 78.83 24.5 0.55 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 104.527 -2.397 . . . . 1.0 104.527 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.44 58.57 13.69 Favored Glycine 0 N--CA 1.498 2.799 0 CA-C-N 114.738 -1.119 . . . . 1.0 113.434 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.659 ' CB ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -144.79 156.35 43.99 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.679 1.739 . . . . 1.0 112.994 178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.91 120.74 12.71 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.218 -1.771 . . . . 1.0 106.218 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.814 ' CZ ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.18 163.23 35.02 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.144 -1.422 . . . . 1.0 114.456 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 124.75 43.33 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' NH2' ' A' ' 45' ' ' ARG . . . -105.62 159.84 15.2 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.545 -1.312 . . . . 1.0 113.48 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 178.436 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 26' ' ' ILE . 9.3 t70 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.23 128.44 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.12 . . . . 1.0 108.205 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 82' ' ' TRP . 16.5 m -140.59 148.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.521 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 tt -98.72 141.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 22' ' ' ILE . 1.2 m -121.6 148.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.726 -1.234 . . . . 1.0 113.536 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -102.39 141.33 22.3 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 106.568 -1.641 . . . . 1.0 106.568 176.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 39.9 Cg_endo -88.64 137.25 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.967 1.778 . . . . 1.0 113.253 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.7 m0 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.757 -1.571 . . . . 1.0 106.757 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.668 ' HG3' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt20 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 122.627 1.204 . . . . 1.0 113.208 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -100.8 160.11 14.63 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.347 -1.723 . . . . 1.0 106.347 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.954 ' SG ' HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -146.98 160.22 42.63 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 119.764 -1.835 . . . . 1.0 111.618 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 1.2 p-10 -117.95 117.81 30.27 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.954 HG23 ' SG ' ' A' ' 78' ' ' CYS . 2.4 pt -115.16 160.58 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.34 122.29 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 105.227 -2.138 . . . . 1.0 105.227 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 1.002 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.36 148.12 23.99 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.325 0.584 . . . . 1.0 111.293 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.696 ' O ' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.393 0.616 . . . . 1.0 110.43 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 3.1 mt-10 -52.68 -37.86 59.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -66.2 -55.03 18.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.853 -0.529 . . . . 1.0 109.864 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.042 HD11 HG22 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -63.98 -51.3 64.96 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.459 -0.775 . . . . 1.0 111.076 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 1.2 pttt -59.02 -43.47 91.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.283 -0.886 . . . . 1.0 110.42 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.639 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -60.49 -39.1 86.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.411 -0.806 . . . . 1.0 108.988 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.637 ' HA ' HD21 ' A' ' 98' ' ' LEU . 5.5 mtpp -59.53 -33.82 71.86 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -66.22 -42.43 94.24 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.939 -1.264 . . . . 1.0 109.939 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.639 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.3 m-85 -66.46 -55.11 17.23 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.716 -0.873 . . . . 1.0 110.661 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.9 pp -59.78 -33.91 72.33 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.528 -0.733 . . . . 1.0 110.445 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.76 -51.04 64.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.486 -0.759 . . . . 1.0 109.764 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.636 -0.665 . . . . 1.0 110.194 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 121.196 0.522 . . . . 1.0 110.727 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.21 155.1 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 92' ' ' LEU . 1.6 pp -122.64 119.68 31.47 Favored 'General case' 0 N--CA 1.517 2.915 0 C-N-CA 118.045 -1.462 . . . . 1.0 109.172 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -139.39 160.75 26.02 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 117.7 -2.19 . . . . 1.0 113.705 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.703 HG23 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -99.09 130.9 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.485 -1.672 . . . . 1.0 106.485 177.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -99.56 154.55 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.255 1.026 . . . . 1.0 111.991 -177.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.931 -1.031 . . . . 1.0 108.697 179.459 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.361 0.601 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' ILE . 10.7 m -129.38 168.68 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.201 1.0 . . . . 1.0 110.883 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -106.14 131.55 53.27 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 115.236 -0.893 . . . . 1.0 109.216 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -140.41 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.226 -0.921 . . . . 1.0 111.035 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.34 141.07 40.7 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -142.09 162.32 35.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.881 -1.528 . . . . 1.0 114.306 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -92.13 178.88 5.73 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 176.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 76.58 23.8 1.07 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 -171.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 43' ' ' LYS . . . 62.94 55.31 27.4 Favored Glycine 0 N--CA 1.5 2.919 0 CA-C-N 114.806 -1.088 . . . . 1.0 113.989 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 3.2 tptp -145.85 153.99 41.48 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.634 2.217 . . . . 1.0 113.474 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -135.39 117.49 15.41 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 104.682 -2.34 . . . . 1.0 104.682 175.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.733 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.17 160.83 41.42 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.764 -1.175 . . . . 1.0 112.977 -175.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.18 123.56 43.56 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 80' ' ' ILE . . . -96.9 146.07 18.13 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.433 -1.365 . . . . 1.0 112.652 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 89' ' ' VAL . 3.8 t -109.33 139.43 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.93 -1.106 . . . . 1.0 108.535 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 82' ' ' TRP . 34.6 m -140.2 152.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.973 0.892 . . . . 1.0 111.894 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.581 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.9 pt -99.61 139.68 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 105.501 -2.037 . . . . 1.0 105.501 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -139.49 158.74 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 117.312 -1.755 . . . . 1.0 114.272 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -100.68 154.88 36.92 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 107.504 -1.295 . . . . 1.0 107.504 176.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.8 Cg_endo -89.35 141.89 4.19 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.664 2.243 . . . . 1.0 112.549 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 12.3 m0 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.031 -1.47 . . . . 1.0 107.031 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 2.2 tt0 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.893 0.854 . . . . 1.0 111.388 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 37.2 mmtm -112.5 154.76 25.41 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 14.4 p -144.56 156.16 44.01 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 119.776 -1.828 . . . . 1.0 111.634 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -106.23 119.17 38.54 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 175.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.997 HG22 HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -106.65 161.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 115.575 1.694 . . . . 1.0 115.575 -174.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -120.29 123.61 70.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 103.781 -2.674 . . . . 1.0 103.781 175.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.937 ' HA ' HG12 ' A' ' 65' ' ' VAL . 6.6 t90 -96.29 138.0 34.54 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.951 0.881 . . . . 1.0 111.908 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.17 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 23' ' ' LEU . 3.4 t . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -44.24 80.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.495 -0.753 . . . . 1.0 109.51 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.461 ' CE3' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -65.09 -45.13 86.5 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.791 ' HB3' HD22 ' A' ' 23' ' ' LEU . 1.9 mt -57.69 -40.99 80.72 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.609 -0.682 . . . . 1.0 109.212 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CE ' HG12 ' A' ' 89' ' ' VAL . 6.5 mtmt -58.57 -50.09 75.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.609 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -56.38 -36.11 68.48 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 98' ' ' LEU . 7.4 tptt -62.22 -35.4 78.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.917 -0.489 . . . . 1.0 109.854 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.59 91.34 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.1 m-85 -66.18 -53.04 42.28 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.915 -0.756 . . . . 1.0 110.802 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.6 pp -62.17 -34.86 77.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.321 -0.862 . . . . 1.0 109.918 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -62.66 -38.98 92.45 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.693 . . . . 1.0 109.818 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 1.0 109.769 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -122.49 161.74 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.96 127.75 43.85 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 117.947 -1.501 . . . . 1.0 109.038 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -142.11 161.74 27.19 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 118.248 -1.929 . . . . 1.0 112.776 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -98.26 130.99 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -99.03 153.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.198 0.999 . . . . 1.0 111.398 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 N--CA 1.49 1.554 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.729 179.284 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.635 HG21 HG12 ' A' ' 26' ' ' ILE . 16.9 m -137.45 167.6 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.91 0.862 . . . . 1.0 110.79 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.537 ' HA ' HD12 ' A' ' 46' ' ' LEU . 8.6 ptt-85 -109.54 130.64 55.49 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -141.03 144.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.899 -1.12 . . . . 1.0 111.018 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.641 ' HG3' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -108.37 144.48 35.86 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 105.548 -2.019 . . . . 1.0 105.548 176.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.0 m -139.61 157.24 46.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.233 -1.387 . . . . 1.0 113.125 -176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.53 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.25 179.51 5.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.673 ' HB3' HG13 ' A' ' 22' ' ' ILE . 6.9 t70 76.44 23.41 1.15 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 103.561 -2.755 . . . . 1.0 103.561 -171.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.66 52.74 36.28 Favored Glycine 0 N--CA 1.5 2.903 0 CA-C-N 114.878 -1.056 . . . . 1.0 113.99 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -146.03 154.02 41.39 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 120.818 2.309 . . . . 1.0 112.796 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.71 118.03 13.68 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -147.65 164.4 33.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.049 -1.06 . . . . 1.0 112.808 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.8 mm? -97.42 132.63 42.95 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.084 -2.191 . . . . 1.0 105.084 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.21 150.62 19.67 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.745 -1.217 . . . . 1.0 111.909 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.1 ptm180 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.481 0.658 . . . . 1.0 109.787 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -102.45 141.74 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.805 -1.184 . . . . 1.0 109.906 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.959 HG12 ' HA ' ' A' ' 82' ' ' TRP . 17.8 m -142.0 159.29 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.612 0.72 . . . . 1.0 111.224 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 81' ' ' ILE . 1.1 tt -100.32 144.17 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.76 HG22 HG22 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -129.66 152.85 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 118.0 -1.48 . . . . 1.0 113.432 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 19.9 mttt -104.75 148.26 35.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 45' ' ' ARG . 39.5 Cg_endo -88.49 135.52 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.255 1.97 . . . . 1.0 112.875 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.714 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.3 m0 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 107.621 -1.252 . . . . 1.0 107.621 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 122.184 0.993 . . . . 1.0 112.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.714 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 24.1 tptt -102.34 150.68 23.09 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 106.125 -1.805 . . . . 1.0 106.125 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 17.4 p -143.15 151.44 40.69 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 119.97 -1.706 . . . . 1.0 111.466 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.67 120.33 39.53 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 67' ' ' VAL . 1.8 pp -119.95 156.64 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.064 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 66' ' ' ILE . 1.4 tp -118.47 128.91 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 105.487 -2.042 . . . . 1.0 105.487 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.959 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.89 147.58 24.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.748 0.785 . . . . 1.0 111.665 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.485 0.659 . . . . 1.0 109.605 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.783 ' HA ' HD21 ' A' ' 92' ' ' LEU . 86.1 t . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -63.18 -38.49 91.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.166 -0.959 . . . . 1.0 109.26 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -66.19 -55.57 15.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.775 -0.578 . . . . 1.0 110.251 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.93 HD13 ' HG ' ' A' ' 23' ' ' LEU . 1.4 pp -58.28 -33.88 69.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.655 -0.653 . . . . 1.0 109.848 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 92' ' ' LEU . 10.9 mtpp -58.49 -49.63 76.67 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.589 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -58.48 -35.47 72.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.02 -34.19 77.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.795 -0.566 . . . . 1.0 109.966 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.24 -44.81 93.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.055 -1.618 . . . . 1.0 109.055 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -65.93 -37.46 86.1 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 -56.03 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -34.68 73.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.872 -0.518 . . . . 1.0 109.943 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 1.0 110.176 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.117 0.484 . . . . 1.0 109.773 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 mp -110.26 162.13 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.893 ' O ' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.12 125.26 38.84 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 117.891 -1.524 . . . . 1.0 109.43 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.65 161.9 27.01 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.11 -1.995 . . . . 1.0 113.051 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.553 HG22 HG13 ' A' ' 64' ' ' VAL . 7.7 pt -98.29 131.67 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -100.5 156.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 122.182 0.992 . . . . 1.0 111.751 -177.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.43 0.633 . . . . 1.0 109.822 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.71 HG21 HG12 ' A' ' 26' ' ' ILE . 7.0 m -124.1 168.24 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 121.888 0.851 . . . . 1.0 110.384 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.778 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -108.15 132.01 54.05 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 178.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.453 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -140.91 145.38 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 118.939 -1.105 . . . . 1.0 111.274 -178.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -111.09 141.36 44.7 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.654 -1.98 . . . . 1.0 105.654 176.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 2.2 m -137.88 157.43 46.42 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.253 -1.379 . . . . 1.0 113.176 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.82 ' HB3' HD11 ' A' ' 23' ' ' LEU . 3.7 tp -93.69 177.94 5.84 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.279 -1.748 . . . . 1.0 106.279 176.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG13 ' A' ' 22' ' ' ILE . 2.8 t70 76.63 22.87 1.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 104.308 -2.479 . . . . 1.0 104.308 -172.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.61 18.03 Favored Glycine 0 N--CA 1.499 2.874 0 CA-C-N 115.079 -0.964 . . . . 1.0 113.998 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.18 153.46 41.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 120.465 2.133 . . . . 1.0 112.203 178.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.5 116.89 10.71 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.179 -2.156 . . . . 1.0 105.179 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -148.27 164.08 35.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.716 -1.193 . . . . 1.0 113.342 -175.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 36' ' ' ARG . 4.1 mm? -97.31 130.23 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 104.753 -2.314 . . . . 1.0 104.753 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.715 ' HA3' HG12 ' A' ' 80' ' ' ILE . . . -95.18 149.09 19.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.027 -1.082 . . . . 1.0 111.921 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.443 0.64 . . . . 1.0 109.981 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.846 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.36 140.74 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.753 -1.217 . . . . 1.0 109.776 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 82' ' ' TRP . 19.4 m -142.5 158.12 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.514 0.673 . . . . 1.0 111.071 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.822 HG22 ' CG1' ' A' ' 81' ' ' ILE . 1.8 tp -100.87 146.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.836 HG22 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -131.36 154.7 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 118.291 -1.364 . . . . 1.0 113.444 -177.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.1 mmpp? -107.48 149.32 38.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 106.507 -1.664 . . . . 1.0 106.507 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.1 Cg_endo -88.48 136.34 3.27 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.417 2.078 . . . . 1.0 112.956 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.7 m0 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 122.097 0.951 . . . . 1.0 111.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.667 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 4.8 tppt? -99.73 151.98 20.62 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.317 -1.735 . . . . 1.0 106.317 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.666 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 30.9 p -142.73 152.04 41.91 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.126 -1.609 . . . . 1.0 111.31 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.64 119.62 38.83 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 104.788 -2.301 . . . . 1.0 104.788 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 26' ' ' ILE . 1.3 pp -120.32 155.79 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 117.761 -1.576 . . . . 1.0 114.994 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.822 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.8 pp -117.21 132.35 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.72 -1.955 . . . . 1.0 105.72 175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.921 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.86 146.29 25.57 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.879 0.847 . . . . 1.0 111.462 -176.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.409 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.846 HG11 ' CG1' ' A' ' 64' ' ' VAL . 59.5 t . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 110.262 -0.273 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 91' ' ' TRP . 10.2 pt-20 -65.19 -34.33 78.12 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.985 -1.072 . . . . 1.0 109.342 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.412 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.3 m95 -65.26 -55.65 17.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.598 -0.689 . . . . 1.0 109.47 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.798 HD13 ' CG ' ' A' ' 23' ' ' LEU . 1.6 pp -62.02 -34.53 76.38 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.784 -0.573 . . . . 1.0 109.935 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HD2' HG12 ' A' ' 89' ' ' VAL . 2.4 mtpp -61.24 -50.03 74.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.0 109.501 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -56.82 -37.56 71.38 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.776 -0.578 . . . . 1.0 109.531 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.907 -0.496 . . . . 1.0 110.091 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.96 -44.46 94.49 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -65.89 -37.61 86.58 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.896 -0.767 . . . . 1.0 109.647 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.1 tm? -61.13 -46.62 89.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.3 -34.73 79.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 1.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.5 2.037 0 O-C-N 121.588 -0.695 . . . . 1.0 110.154 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.076 0.465 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.69 118.84 1.15 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.281 -0.887 . . . . 1.0 109.627 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -139.0 78.6 1.68 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.635 -0.666 . . . . 1.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.77 162.5 29.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.652 . . . . 1.0 109.895 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.98 147.75 52.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.587 -0.696 . . . . 1.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 59.67 65.35 1.15 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.543 0.687 . . . . 1.0 109.261 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.15 136.36 53.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 1.0 109.693 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -84.24 111.88 19.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.585 -0.697 . . . . 1.0 109.127 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -89.84 151.09 21.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.634 -0.666 . . . . 1.0 110.203 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.711 HG22 HG21 ' A' ' 87' ' ' THR . 32.5 pt -67.37 -33.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.79 -0.569 . . . . 1.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.36 17.69 9.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.467 -0.771 . . . . 1.0 110.981 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.605 HG12 HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -83.54 -179.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 1.0 109.599 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' H ' HG22 ' A' ' 12' ' ' VAL . 9.3 ttt180 67.48 67.63 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.528 -0.733 . . . . 1.0 109.289 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG13 ' HD2' ' A' ' 15' ' ' PRO . 4.6 tp -91.59 135.98 27.18 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.597 -0.689 . . . . 1.0 109.602 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 14' ' ' ILE . 34.6 Cg_endo -76.43 178.74 7.16 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 122.635 2.223 . . . . 1.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 65.44 101.11 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.311 0.577 . . . . 1.0 109.826 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.04 72.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.55 0.69 . . . . 1.0 109.284 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -69.78 -51.76 31.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.52 -0.737 . . . . 1.0 109.826 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.01 25.41 11.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.619 -0.676 . . . . 1.0 110.035 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 64.12 175.13 0.18 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.374 -0.829 . . . . 1.0 110.341 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -126.23 172.94 9.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.513 -0.742 . . . . 1.0 109.741 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.768 ' C ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -109.91 161.46 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.034 -1.099 . . . . 1.0 108.034 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.953 ' CB ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -125.11 120.73 32.25 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 117.957 -1.497 . . . . 1.0 109.356 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.23 162.06 26.84 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.359 -1.877 . . . . 1.0 112.542 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.651 HG22 HG13 ' A' ' 64' ' ' VAL . 11.3 pt -98.12 139.95 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.015 ' CD1' HG13 ' A' ' 37' ' ' VAL . 9.8 tp -99.46 151.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.22 1.01 . . . . 1.0 111.273 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.82 138.42 28.68 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.366 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.687 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER 167.54 123.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.187 0.518 . . . . 1.0 110.118 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.441 ' SD ' ' HG2' ' A' ' 60' ' ' ARG . 10.7 tpt -109.67 -29.72 8.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.813 -0.555 . . . . 1.0 109.64 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.76 -56.48 20.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.573 -0.705 . . . . 1.0 109.765 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.7 75.83 1.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.0 37.47 4.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.693 -0.887 . . . . 1.0 109.444 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.61 1.28 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.628 -0.67 . . . . 1.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.9 155.26 46.33 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.0 109.547 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.687 ' HA ' ' HG3' ' A' ' 28' ' ' GLN . 7.0 m -141.25 169.6 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.639 0.733 . . . . 1.0 110.428 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.41 127.98 56.3 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 120.11 -0.636 . . . . 1.0 110.733 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.015 HG13 ' CD1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.7 148.57 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.705 1.241 . . . . 1.0 112.333 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.66 135.12 55.2 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.227 -2.508 . . . . 1.0 104.227 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -140.16 160.42 39.99 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.591 -1.644 . . . . 1.0 114.462 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.0 tp -93.55 179.51 5.36 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.903 -1.888 . . . . 1.0 105.903 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' HB3' HG13 ' A' ' 22' ' ' ILE . 9.1 t70 75.3 22.66 1.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.05 -2.574 . . . . 1.0 104.05 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.67 55.98 15.11 Favored Glycine 0 N--CA 1.5 2.918 0 CA-C-N 115.028 -0.987 . . . . 1.0 113.961 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.764 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -145.75 154.48 42.09 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.467 2.134 . . . . 1.0 113.395 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.59 117.8 10.7 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.82 164.91 31.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.768 -1.173 . . . . 1.0 113.256 -175.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.533 HD11 ' HG2' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -97.55 125.1 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.794 -2.298 . . . . 1.0 104.794 175.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.728 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.92 142.93 16.38 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 120.795 -1.19 . . . . 1.0 112.157 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.6 ptm180 -121.39 149.49 42.91 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.329 0.585 . . . . 1.0 109.783 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -126.86 156.49 73.82 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 33.3 Cg_endo -74.43 167.93 25.98 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.619 2.212 . . . . 1.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.52 -45.45 93.08 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -58.25 -55.09 39.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.637 -0.92 . . . . 1.0 109.9 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HB3' HG12 ' A' ' 49' ' ' ILE . 1.8 mp -65.58 -33.97 77.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.732 -0.605 . . . . 1.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -52.1 -48.36 64.79 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.445 -0.785 . . . . 1.0 110.782 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 3.63 51.11 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.508 -0.745 . . . . 1.0 110.667 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -116.12 -15.95 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.261 -0.899 . . . . 1.0 110.85 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.573 HG22 ' CE3' ' A' ' 82' ' ' TRP . 1.1 pp -80.9 -52.43 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.147 -0.971 . . . . 1.0 110.418 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.7 m95 43.84 53.64 6.07 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.443 0.64 . . . . 1.0 110.157 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG12 ' CD1' ' A' ' 82' ' ' TRP . 33.0 m -70.65 133.79 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.461 -0.774 . . . . 1.0 109.908 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 8.5 ttt-85 -93.0 -66.92 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -174.49 113.67 0.17 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.566 -0.709 . . . . 1.0 109.854 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.41 66.48 0.85 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.691 -0.964 . . . . 1.0 110.691 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.91 160.49 29.82 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.631 -0.923 . . . . 1.0 108.734 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.931 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.69 142.86 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.788 -1.195 . . . . 1.0 109.297 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.885 HG12 ' HA ' ' A' ' 82' ' ' TRP . 33.6 m -142.63 155.26 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.753 0.787 . . . . 1.0 111.435 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.535 HG22 ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -99.93 134.54 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.832 HG12 HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -119.22 153.42 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-O 123.051 1.405 . . . . 1.0 113.793 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 ttpp -108.27 146.94 34.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 113.616 -1.629 . . . . 1.0 106.667 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.578 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.8 Cg_endo -88.36 138.03 3.81 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.307 2.005 . . . . 1.0 112.944 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.497 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.2 m0 -122.61 117.61 26.23 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 47.86 -147.75 0.21 Allowed 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 119.095 0.861 . . . . 1.0 110.343 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.128 -0.983 . . . . 1.0 109.98 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 52.16 -158.71 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.373 -0.829 . . . . 1.0 110.088 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.52 25.68 17.38 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.225 -1.55 . . . . 1.0 109.225 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.56 136.62 0.26 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -111.3 154.19 24.86 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.826 -1.149 . . . . 1.0 111.779 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' HD11 ' A' ' 46' ' ' LEU . 2.9 mttm -98.22 152.29 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.728 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 18.1 p -143.91 151.67 40.12 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 119.975 -1.703 . . . . 1.0 111.681 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.61 118.51 37.08 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.832 HG22 HG12 ' A' ' 67' ' ' VAL . 2.2 pt -113.5 155.03 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.904 1.335 . . . . 1.0 114.594 -174.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -116.61 128.63 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 105.388 -2.079 . . . . 1.0 105.388 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.1 t90 -97.24 142.23 29.38 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.923 0.868 . . . . 1.0 111.446 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -167.6 142.81 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -105.68 91.24 3.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 1.0 109.864 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 m 59.56 105.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.381 0.61 . . . . 1.0 110.594 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.444 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -138.75 -74.67 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.39 -0.819 . . . . 1.0 109.872 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.711 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -175.81 -43.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -59.41 -57.39 13.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 1.0 109.509 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.931 HG11 ' CG1' ' A' ' 64' ' ' VAL . 51.4 t -65.63 -34.33 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.535 -0.728 . . . . 1.0 109.198 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -61.9 -35.4 78.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 1.0 109.102 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -55.16 19.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.595 . . . . 1.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.953 HD13 ' CB ' ' A' ' 23' ' ' LEU . 2.3 pp -61.83 -37.98 86.49 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.778 -0.576 . . . . 1.0 110.308 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.632 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -65.34 -44.6 87.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.407 -0.808 . . . . 1.0 109.24 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 23.9 mtp85 -57.62 -36.94 72.46 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.33 -33.27 75.46 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.64 -44.93 95.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.606 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.02 -39.42 90.2 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.841 -0.8 . . . . 1.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.654 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.2 tm? -59.28 -48.76 80.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.771 -0.581 . . . . 1.0 109.667 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.78 -43.15 99.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.646 -0.659 . . . . 1.0 109.953 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -55.28 18.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.616 -0.678 . . . . 1.0 110.155 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.54 -171.18 3.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.548 -0.72 . . . . 1.0 110.211 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 118.63 -0.7 . . . . 1.0 110.078 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.98 112.51 14.13 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.73 -0.606 . . . . 1.0 109.669 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -128.7 144.98 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.697 -0.627 . . . . 1.0 109.487 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.04 144.65 56.7 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 1.0 109.979 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.05 120.04 17.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.615 -0.678 . . . . 1.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -145.86 -52.28 0.25 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.764 -0.585 . . . . 1.0 109.617 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.35 157.14 36.25 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.685 -0.634 . . . . 1.0 109.869 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.05 126.99 36.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 1.0 109.7 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.52 -171.7 2.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.745 -0.597 . . . . 1.0 109.572 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.44 98.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.48 -0.762 . . . . 1.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.93 -166.92 0.6 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.64 -176.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.309 -0.869 . . . . 1.0 110.013 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -168.88 150.46 4.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.801 -0.562 . . . . 1.0 109.762 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 HG21 ' HB2' ' A' ' 99' ' ' ASP . 2.9 tp -141.95 112.97 6.33 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.461 -0.774 . . . . 1.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.19 -37.32 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.852 2.368 . . . . 1.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -62.07 124.6 21.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.67 . . . . 1.0 109.461 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 16.52 13.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.657 -0.652 . . . . 1.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.25 166.16 17.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.272 -0.892 . . . . 1.0 109.803 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -101.55 58.48 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.526 -0.734 . . . . 1.0 109.257 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.37 45.67 1.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.475 -0.766 . . . . 1.0 109.428 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -108.89 134.06 52.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.286 -0.883 . . . . 1.0 109.77 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.689 HG21 ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -113.46 161.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.85 HD11 ' CD1' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -123.86 134.01 53.66 Favored 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 117.542 -1.663 . . . . 1.0 109.434 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -141.47 155.36 25.2 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 118.033 -2.032 . . . . 1.0 112.854 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 38' ' ' ARG . 1.6 pp -99.33 138.81 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.082 -1.822 . . . . 1.0 106.082 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 82' ' ' TRP . 3.1 pt -99.99 145.82 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.428 1.109 . . . . 1.0 111.954 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -142.03 136.6 30.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.029 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.867 ' HB2' HG22 ' A' ' 35' ' ' VAL . 10.6 tt0 -143.54 96.61 2.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.655 -0.653 . . . . 1.0 109.584 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -43.04 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.5 mt -137.35 54.64 1.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.41 13.2 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.4 -73.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.59 -0.947 . . . . 1.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -107.07 -33.83 7.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.622 -0.674 . . . . 1.0 110.051 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.67 146.78 26.11 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.843 0.83 . . . . 1.0 110.329 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -117.26 161.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 144.75 29.94 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.74 ' CG2' HG22 ' A' ' 26' ' ' ILE . 1.7 t -134.78 144.77 33.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.458 1.123 . . . . 1.0 111.867 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -110.77 141.51 43.99 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.332 -2.47 . . . . 1.0 104.332 174.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -139.92 154.72 47.3 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 117.159 -1.816 . . . . 1.0 114.536 -175.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD23 ' HE3' ' A' ' 93' ' ' LYS . 10.1 tp -92.71 171.7 8.83 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.299 -1.741 . . . . 1.0 106.299 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.677 ' HB3' HG22 ' A' ' 22' ' ' ILE . 1.1 t70 78.41 23.0 0.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.987 -2.597 . . . . 1.0 103.987 -171.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 53.17 34.37 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-N 114.92 -1.036 . . . . 1.0 115.028 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.689 ' HD3' HG21 ' A' ' 22' ' ' ILE . 2.8 mptt -146.13 153.11 40.3 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.685 2.242 . . . . 1.0 112.557 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 117.25 16.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.622 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.94 164.53 32.63 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.463 -0.895 . . . . 1.0 111.905 -176.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.76 127.53 40.82 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.018 -2.215 . . . . 1.0 105.018 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.644 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.49 140.24 14.94 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.892 -1.13 . . . . 1.0 111.871 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 ptm85 -100.11 139.07 36.31 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.462 0.648 . . . . 1.0 109.72 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -128.67 161.89 54.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.638 ' HD2' HG12 ' A' ' 49' ' ' ILE . 33.1 Cg_endo -74.57 -44.86 0.35 Allowed 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 122.444 2.096 . . . . 1.0 111.386 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.66 -9.1 2.59 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.119 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' HB3' ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -59.39 -34.24 72.19 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.277 -1.131 . . . . 1.0 110.472 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.529 ' HG ' ' CD2' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -51.0 -39.93 56.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.67 . . . . 1.0 110.662 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -61.78 -50.45 72.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.573 -0.704 . . . . 1.0 110.215 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -71.06 -21.83 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.617 -0.677 . . . . 1.0 110.734 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -65.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.318 -0.864 . . . . 1.0 110.165 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.37 150.74 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.378 -0.826 . . . . 1.0 110.159 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -156.54 33.49 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 1.0 109.902 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.7 -3.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.179 -0.951 . . . . 1.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.05 164.54 34.34 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.047 -1.033 . . . . 1.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 142.16 51.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 1.0 109.633 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.26 86.9 0.67 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.774 -1.331 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' HD11 ' A' ' 26' ' ' ILE . 4.5 m-20 -127.7 162.19 27.15 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.749 -0.854 . . . . 1.0 109.28 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' ARG . 5.9 p -97.18 138.62 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.839 -1.163 . . . . 1.0 108.168 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -141.75 142.71 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.841 -0.744 . . . . 1.0 111.282 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.739 HG12 HD11 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -99.11 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 104.475 -2.417 . . . . 1.0 104.475 176.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -126.52 156.55 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.972 -1.491 . . . . 1.0 113.667 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.14 153.03 41.28 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 106.747 -1.575 . . . . 1.0 106.747 177.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 38.5 Cg_endo -89.03 140.0 3.85 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.412 2.075 . . . . 1.0 113.06 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.0 m95 -123.8 119.02 28.5 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 134.2 47.82 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 119.064 0.847 . . . . 1.0 109.935 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 75' ' ' ASP . 2.1 p 177.02 104.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 121.51 0.671 . . . . 1.0 109.32 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.26 142.32 17.12 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 1.0 110.359 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.3 -46.41 1.17 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.616 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -165.93 177.58 7.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.63 -0.924 . . . . 1.0 108.844 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 -109.29 150.15 28.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.593 -1.317 . . . . 1.0 110.931 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 1.7 mttm -112.54 152.13 29.18 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.644 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 28.9 p -145.72 153.61 41.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 119.908 -1.745 . . . . 1.0 112.289 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 3.1 t0 -98.91 124.37 43.81 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.72 -2.326 . . . . 1.0 104.72 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.874 HG22 HG12 ' A' ' 67' ' ' VAL . 3.7 pt -122.33 149.97 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 117.484 -1.686 . . . . 1.0 114.72 -175.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.739 HD11 HG12 ' A' ' 66' ' ' ILE . 2.5 pt -121.98 119.51 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.838 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.42 159.83 14.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.009 0.909 . . . . 1.0 112.187 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.26 -179.57 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LYS . 52.0 m-85 31.3 78.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 120.553 0.216 . . . . 1.0 110.912 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.5 p -58.57 72.09 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.63 0.729 . . . . 1.0 110.394 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -167.03 -163.46 0.54 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 87' ' ' THR . 9.0 t -98.95 112.69 24.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.916 -1.115 . . . . 1.0 109.57 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.11 32.67 1.23 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.387 -0.82 . . . . 1.0 110.014 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 23' ' ' LEU . 44.4 t -65.24 -37.69 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.328 -0.858 . . . . 1.0 109.568 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.19 -41.85 93.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.696 -0.627 . . . . 1.0 109.648 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -60.01 -46.69 88.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.72 -0.613 . . . . 1.0 109.477 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.85 ' CD1' HD11 ' A' ' 23' ' ' LEU . 60.8 mt -63.68 -38.02 89.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.601 -0.687 . . . . 1.0 110.252 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.538 ' HE3' HD23 ' A' ' 40' ' ' LEU . 15.0 mmtt -61.94 -50.21 73.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.523 -0.736 . . . . 1.0 109.018 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.651 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -57.59 -35.46 70.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.675 ' HA ' HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -62.22 -34.76 77.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.859 -0.526 . . . . 1.0 109.94 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.69 -39.79 90.3 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.847 -1.301 . . . . 1.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.7 m-85 -65.99 -53.05 43.71 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 1.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.2 pp -60.78 -37.65 82.61 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.423 -0.798 . . . . 1.0 109.514 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB2' HG21 ' A' ' 14' ' ' ILE . 1.7 t70 -65.76 -42.76 90.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.668 -0.645 . . . . 1.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.36 -49.24 54.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.989 -0.444 . . . . 1.0 110.118 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 111.86 13.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.708 . . . . 1.0 109.401 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.686 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpp . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.627 -0.509 . . . . 1.0 109.627 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.68 82.19 0.19 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.464 0.649 . . . . 1.0 109.557 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.5 83.06 2.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 1.0 109.531 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.22 84.35 1.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.534 -0.729 . . . . 1.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.27 131.14 46.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.547 -0.72 . . . . 1.0 109.608 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -84.29 105.53 15.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 1.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.88 -31.54 14.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.743 -0.598 . . . . 1.0 109.807 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -114.47 142.87 45.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.533 -0.73 . . . . 1.0 109.772 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -118.28 18.89 13.63 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.417 0.627 . . . . 1.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.5 tt -106.3 100.06 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 1.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.34 -14.53 12.78 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.985 0.898 . . . . 1.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.672 HG22 ' H ' ' A' ' 13' ' ' ARG . 3.5 p -88.81 -149.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.672 ' H ' HG22 ' A' ' 12' ' ' VAL . 12.6 mmm180 79.82 12.6 1.09 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.39 -0.818 . . . . 1.0 110.59 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 tp -64.85 132.5 95.47 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.367 -0.833 . . . . 1.0 109.013 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.46 -82.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.568 2.179 . . . . 1.0 111.147 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.27 60.05 3.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 1.0 109.289 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -96.93 34.83 1.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.599 -0.688 . . . . 1.0 110.621 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.17 -141.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.057 -1.027 . . . . 1.0 109.434 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -139.74 33.6 2.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.806 -1.184 . . . . 1.0 110.388 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.08 -81.74 0.05 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 1.0 110.087 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.12 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.695 -0.628 . . . . 1.0 109.613 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -103.67 161.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.33 -0.857 . . . . 1.0 109.06 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' HB2' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -114.07 119.93 38.83 Favored 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 117.636 -1.626 . . . . 1.0 109.215 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 67' ' ' VAL . . . -122.55 161.54 16.71 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.971 -1.585 . . . . 1.0 112.937 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 37' ' ' VAL . 1.1 pp -124.0 137.07 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.443 -1.688 . . . . 1.0 106.443 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -99.15 154.98 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.591 1.186 . . . . 1.0 112.602 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -141.11 127.68 20.12 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.455 -1.702 . . . . 1.0 108.154 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -98.76 150.99 21.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.511 -0.743 . . . . 1.0 109.97 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 ttm -95.22 -65.03 1.0 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.551 -0.718 . . . . 1.0 109.289 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.21 50.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.642 -0.662 . . . . 1.0 109.743 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 110.06 1.6 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 154.96 6.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.853 -0.792 . . . . 1.0 109.805 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -68.08 -49.09 63.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.62 -0.675 . . . . 1.0 109.308 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -100.35 158.83 15.6 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.353 0.597 . . . . 1.0 109.642 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.85 169.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 122.057 0.932 . . . . 1.0 110.386 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -97.07 127.98 43.56 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.237 -1.394 . . . . 1.0 107.237 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 80' ' ' ILE . 1.5 t -131.36 152.32 37.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.426 1.108 . . . . 1.0 111.838 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.8 149.34 48.69 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.43 158.17 43.86 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.134 -176.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.712 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -94.62 176.38 6.3 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.756 ' HB3' HG22 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 78.43 22.35 0.74 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.178 -2.527 . . . . 1.0 104.178 -171.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.84 9.44 Favored Glycine 0 N--CA 1.507 3.386 0 N-CA-C 115.759 1.064 . . . . 1.0 115.759 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mptt -146.85 158.4 43.91 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 121.201 2.5 . . . . 1.0 113.514 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 44' ' ' THR . 0.7 OUTLIER -140.54 118.39 11.76 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 106.148 -1.797 . . . . 1.0 106.148 176.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.661 ' HG3' ' CB ' ' A' ' 76' ' ' GLN . 2.4 mpp_? -147.17 165.26 30.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.081 -1.012 . . . . 1.0 113.392 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' HG ' ' A' ' 78' ' ' CYS . 4.8 mp -94.94 129.12 42.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.347 -2.464 . . . . 1.0 104.347 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.1 137.95 13.71 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.709 -1.234 . . . . 1.0 112.053 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.479 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -111.67 151.48 28.81 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.791 HG21 ' CZ3' ' A' ' 82' ' ' TRP . 1.2 pp -133.36 164.42 44.1 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.684 -0.635 . . . . 1.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 34.4 Cg_endo -76.0 -51.44 0.1 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.745 2.297 . . . . 1.0 111.173 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.6 2.1 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -41.96 84.39 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.723 -0.869 . . . . 1.0 109.874 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.06 -38.32 82.45 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.795 -0.566 . . . . 1.0 110.135 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.61 79.03 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.652 -0.655 . . . . 1.0 110.155 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -23.03 38.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.725 . . . . 1.0 110.415 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.5 24.84 11.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.336 -0.852 . . . . 1.0 110.634 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.463 ' CG1' HG22 ' A' ' 59' ' ' VAL . 9.2 tp -132.39 151.48 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 1.0 110.006 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -139.75 45.53 1.91 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 57' ' ' ILE . 29.2 m -112.97 170.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 1.0 110.278 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -113.39 -161.43 0.76 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 150.36 25.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 1.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.56 76.54 1.27 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.634 -1.386 . . . . 1.0 109.634 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.835 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -132.76 161.88 32.91 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.627 -0.925 . . . . 1.0 109.906 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 89' ' ' VAL . 19.1 m -100.79 145.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.478 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 82' ' ' TRP . 2.9 m -144.7 157.65 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.655 0.741 . . . . 1.0 111.798 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.852 HG12 HG22 ' A' ' 81' ' ' ILE . 1.2 pt -99.56 132.36 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.591 -2.744 . . . . 1.0 103.591 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.864 HG12 ' CG1' ' A' ' 80' ' ' ILE . 1.4 m -122.25 155.36 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 118.106 -1.438 . . . . 1.0 114.257 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.4 mtpp -112.87 150.06 42.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.334 -1.757 . . . . 1.0 107.592 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.8 Cg_endo -89.94 141.07 3.58 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.617 2.212 . . . . 1.0 112.516 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.3 m0 -124.93 119.91 30.11 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 134.23 49.47 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.646 1.112 . . . . 1.0 110.366 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.833 HG11 ' HD3' ' A' ' 77' ' ' LYS . 1.5 p 177.01 108.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-O 121.689 0.756 . . . . 1.0 109.579 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.02 142.18 31.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.399 -0.813 . . . . 1.0 110.693 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.79 -43.06 1.74 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.145 -1.182 . . . . 1.0 110.145 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.823 ' O ' HG13 ' A' ' 72' ' ' VAL . 4.5 p-10 -172.46 163.43 5.49 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.661 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 mt-30 -103.63 157.63 16.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.897 -1.521 . . . . 1.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.833 ' HD3' HG11 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -109.35 155.2 21.5 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.554 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 25.6 p -144.19 151.74 39.91 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.195 -1.566 . . . . 1.0 111.319 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -98.6 118.7 35.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 103.737 -2.69 . . . . 1.0 103.737 176.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.882 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -120.95 138.2 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.377 -1.329 . . . . 1.0 113.49 -174.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.852 HG22 HG12 ' A' ' 66' ' ' ILE . 5.7 tt -115.23 120.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 175.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.871 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.8 p90 -97.99 160.13 14.49 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.416 1.103 . . . . 1.0 113.108 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 2.1 tpt180 -173.13 163.53 4.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.765 -1.107 . . . . 1.0 108.734 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -171.73 108.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.856 -0.794 . . . . 1.0 108.856 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 86' ' ' LYS . 8.9 t -155.35 -41.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.604 -0.685 . . . . 1.0 110.413 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.418 ' N ' HG23 ' A' ' 85' ' ' THR . 4.0 ttpm? -152.55 -65.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 1.0 110.098 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -137.9 149.31 46.12 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.479 -0.763 . . . . 1.0 110.045 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.49 ' CB ' HG21 ' A' ' 64' ' ' VAL . 2.4 tp60 -163.83 -64.02 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.645 -0.66 . . . . 1.0 109.547 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.843 ' HA ' HD12 ' A' ' 92' ' ' LEU . 92.5 t -60.67 -34.06 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.69 -0.631 . . . . 1.0 109.665 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.29 -52.38 63.65 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 1.0 109.284 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -39.52 91.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.646 . . . . 1.0 109.419 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 89' ' ' VAL . 15.9 mt -58.35 -40.31 81.87 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HG3' HD13 ' A' ' 23' ' ' LEU . 15.3 mttm -64.13 -53.24 52.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.811 -0.555 . . . . 1.0 109.653 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 6.3 mtt-85 -55.45 -35.9 65.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.772 -0.58 . . . . 1.0 109.584 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HE2' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -64.43 -34.9 79.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.833 -0.542 . . . . 1.0 110.24 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.22 -40.5 92.33 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.3 m-85 -66.53 -53.1 38.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.826 -0.808 . . . . 1.0 111.043 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.691 HD11 ' HE2' ' A' ' 95' ' ' LYS . 3.3 pp -61.96 -40.14 94.56 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.429 -0.794 . . . . 1.0 109.841 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 t70 -65.88 -38.74 89.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.586 -0.696 . . . . 1.0 109.457 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -55.15 20.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 1.0 109.632 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.8 100.25 11.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.621 -0.674 . . . . 1.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptm . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.412 0.625 . . . . 1.0 109.676 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.69 35.54 4.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.435 -0.791 . . . . 1.0 109.817 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.07 110.38 18.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 1.0 109.275 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -167.49 -42.11 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.673 -0.642 . . . . 1.0 110.238 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.5 117.76 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.64 . . . . 1.0 110.026 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.37 33.6 3.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.741 -0.6 . . . . 1.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -125.21 112.04 15.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.387 -0.821 . . . . 1.0 109.438 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.16 116.38 28.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.561 -0.712 . . . . 1.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.13 168.06 10.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.638 -0.664 . . . . 1.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -85.03 72.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.798 0.809 . . . . 1.0 109.185 179.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 145.96 37.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.824 . . . . 1.0 109.854 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' HG2' ' A' ' 13' ' ' ARG . 16.2 m 40.21 -151.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 CA-C-O 120.886 0.374 . . . . 1.0 111.038 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 12' ' ' VAL . 12.9 mmt85 61.06 -174.89 0.12 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.442 -0.786 . . . . 1.0 110.256 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.49 HD12 HD13 ' A' ' 66' ' ' ILE . 2.8 tt -157.21 127.16 3.3 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.356 -0.84 . . . . 1.0 109.735 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' HG13 ' A' ' 14' ' ' ILE . 35.5 Cg_endo -76.82 -25.41 9.15 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.732 2.288 . . . . 1.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -62.15 117.37 5.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.609 -0.682 . . . . 1.0 109.361 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -121.11 50.71 1.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.464 0.649 . . . . 1.0 109.362 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.59 -60.01 2.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.479 -0.763 . . . . 1.0 109.137 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -165.53 -56.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.13 132.4 3.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.797 -0.565 . . . . 1.0 109.637 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.27 167.41 9.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -114.63 161.77 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -126.95 123.07 36.32 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 117.722 -1.591 . . . . 1.0 109.658 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -140.55 163.63 26.45 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.215 -1.469 . . . . 1.0 112.232 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.58 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.027 ' HA ' HG22 ' A' ' 37' ' ' VAL . 1.7 pt -98.65 148.43 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 122.265 1.031 . . . . 1.0 111.595 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 35' ' ' VAL . 34.2 tt0 -140.87 130.19 23.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.001 -1.454 . . . . 1.0 108.259 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.596 ' HA ' HG22 ' A' ' 35' ' ' VAL . 12.9 pt20 -58.68 141.2 53.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.526 -0.734 . . . . 1.0 110.529 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 ttp -100.02 -138.6 0.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.37 -35.68 81.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.082 -1.011 . . . . 1.0 109.603 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.72 82.29 1.16 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.52 -65.18 0.32 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.789 -0.83 . . . . 1.0 109.793 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -46.04 0.05 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.585 -0.697 . . . . 1.0 110.098 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -99.12 141.66 31.6 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.588 0.709 . . . . 1.0 110.09 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -99.96 162.44 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -98.18 131.17 44.77 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.027 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -134.85 153.09 34.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.986 0.898 . . . . 1.0 111.35 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 147.86 48.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.156 -1.794 . . . . 1.0 106.156 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -144.27 160.47 40.94 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.411 -1.316 . . . . 1.0 114.09 -176.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 40' ' ' LEU . 6.0 mt -93.93 177.47 5.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 22' ' ' ILE . 22.5 m-20 77.03 22.66 1.01 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 104.344 -2.465 . . . . 1.0 104.344 -172.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.43 52.25 13.71 Favored Glycine 0 N--CA 1.502 3.077 0 CA-C-O 118.708 -1.051 . . . . 1.0 115.234 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -146.76 151.5 37.27 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.094 2.447 . . . . 1.0 113.153 177.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 44' ' ' THR . 3.3 t -134.73 118.19 16.83 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 105.094 -2.188 . . . . 1.0 105.094 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.77 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.65 162.74 37.8 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.882 -1.127 . . . . 1.0 113.028 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -98.27 123.04 42.16 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 103.685 -2.709 . . . . 1.0 103.685 174.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.77 143.55 16.73 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.469 -1.348 . . . . 1.0 112.237 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -99.43 140.76 33.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.74 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 3.1 pt -129.13 169.53 12.89 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.776 -0.578 . . . . 1.0 109.837 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.74 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 33.7 Cg_endo -75.11 -20.67 16.42 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.598 2.199 . . . . 1.0 111.535 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.34 -0.75 20.65 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.758 -0.937 . . . . 1.0 110.758 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -65.3 -33.85 76.95 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.325 -1.103 . . . . 1.0 110.33 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HB ' ' A' ' 57' ' ' ILE . 1.3 mt -53.58 -34.97 60.26 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.573 -0.704 . . . . 1.0 110.596 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -46.44 62.66 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.554 -0.716 . . . . 1.0 110.295 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -93.73 -33.53 13.58 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.58 -0.7 . . . . 1.0 110.334 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -64.18 0.97 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.591 -0.693 . . . . 1.0 110.227 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.718 HD11 ' HA ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -80.02 164.28 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.465 -0.772 . . . . 1.0 109.75 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -173.36 -44.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.564 -0.71 . . . . 1.0 111.214 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -50.7 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.289 -0.882 . . . . 1.0 111.384 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.63 151.64 25.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.166 -0.959 . . . . 1.0 110.746 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.718 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.1 mp0 -123.18 -168.51 1.77 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.732 -0.605 . . . . 1.0 109.652 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 84.76 1.48 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.12 -1.592 . . . . 1.0 109.12 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' CB ' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -127.1 163.85 22.89 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.735 -0.862 . . . . 1.0 110.156 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.764 HG21 ' HB3' ' A' ' 88' ' ' GLN . 1.5 p -96.21 136.81 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -140.92 139.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.621 -0.832 . . . . 1.0 110.982 -178.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 81' ' ' ILE . 1.7 pp -99.21 143.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.043 -2.206 . . . . 1.0 105.043 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 80' ' ' ILE . 1.5 m -140.28 159.31 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.611 -1.636 . . . . 1.0 114.677 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.8 OUTLIER -99.29 151.68 37.5 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 113.265 -1.789 . . . . 1.0 107.056 176.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.5 Cg_endo -90.04 141.25 3.56 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.409 2.073 . . . . 1.0 112.13 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m0 -121.93 118.35 28.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.02 133.31 50.53 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.767 0.712 . . . . 1.0 110.246 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 75' ' ' ASP . 1.3 p 174.57 104.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 109.152 -0.684 . . . . 1.0 109.152 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.05 144.16 35.52 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.434 -0.791 . . . . 1.0 110.464 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.78 -40.11 2.53 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.102 -1.199 . . . . 1.0 110.102 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.776 ' O ' HG13 ' A' ' 72' ' ' VAL . 3.8 p-10 -169.93 151.16 4.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.546 -0.973 . . . . 1.0 108.458 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . 1.5 mp0 -97.97 155.74 16.95 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.62 -1.232 . . . . 1.0 110.773 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 4.0 mttm -112.98 154.74 25.98 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 11.3 p -145.1 153.57 41.55 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 119.961 -1.712 . . . . 1.0 111.776 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.574 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 1.3 t70 -99.45 119.43 37.98 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 HG12 ' A' ' 67' ' ' VAL . 2.7 pt -120.84 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.392 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.673 HD11 HG12 ' A' ' 66' ' ' ILE . 5.0 pt -126.39 118.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.181 -2.155 . . . . 1.0 105.181 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.613 ' CA ' HG23 ' A' ' 65' ' ' VAL . 7.5 p-90 -105.51 160.44 15.16 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.099 0.952 . . . . 1.0 112.792 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 179.39 -175.63 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.337 -0.847 . . . . 1.0 108.717 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 64' ' ' VAL . 9.8 m-85 44.11 84.36 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.351 0.596 . . . . 1.0 110.753 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -60.98 -22.52 64.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.372 -0.83 . . . . 1.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 87' ' ' THR . 3.9 tttt -80.36 -79.59 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.367 -0.833 . . . . 1.0 110.147 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 86' ' ' LYS . 1.3 p -156.27 166.28 33.89 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.388 -0.82 . . . . 1.0 110.774 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.764 ' HB3' HG21 ' A' ' 64' ' ' VAL . 12.2 tp60 178.14 -29.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.909 -0.495 . . . . 1.0 110.333 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 64' ' ' VAL . 87.3 t -49.98 -38.4 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.512 -0.742 . . . . 1.0 110.004 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -44.06 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.636 -0.665 . . . . 1.0 109.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.411 ' CZ3' ' HB ' ' A' ' 12' ' ' VAL . 83.6 t90 -58.31 -46.47 86.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.617 -0.677 . . . . 1.0 109.357 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.565 HD13 HD11 ' A' ' 23' ' ' LEU . 1.6 mt -63.58 -35.18 79.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.703 -0.623 . . . . 1.0 109.607 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HD2' HG12 ' A' ' 89' ' ' VAL . 1.1 mptp? -64.83 -50.27 67.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.666 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 15.7 mtm180 -54.75 -40.26 69.14 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' A' ' 98' ' ' LEU . 17.2 ttpp -63.06 -33.44 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.008 -0.433 . . . . 1.0 110.092 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.25 -38.83 94.12 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.261 -1.135 . . . . 1.0 110.261 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.4 m-85 -66.13 -53.88 32.41 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.756 -0.849 . . . . 1.0 110.735 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 95' ' ' LYS . 2.2 pp -62.52 -38.63 90.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -0.783 . . . . 1.0 110.08 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.9 -45.3 82.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.567 -0.708 . . . . 1.0 109.761 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -65.18 -34.95 79.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.787 -0.571 . . . . 1.0 110.168 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -58.24 9.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 1.0 109.865 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 117.661 -1.162 . . . . 1.0 110.276 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.78 37.66 4.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.693 -0.629 . . . . 1.0 109.702 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -134.87 39.71 2.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.413 -0.804 . . . . 1.0 109.526 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.57 145.11 17.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.415 -0.803 . . . . 1.0 109.863 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -82.48 166.56 19.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.682 -0.636 . . . . 1.0 109.906 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.17 118.4 6.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.571 -0.705 . . . . 1.0 109.725 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.44 -164.78 1.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.804 -0.56 . . . . 1.0 109.742 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 158.29 16.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.408 -0.807 . . . . 1.0 110.278 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -108.28 144.59 35.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.526 -0.734 . . . . 1.0 109.642 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -136.78 74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.742 0.782 . . . . 1.0 109.303 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -107.87 17.32 22.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.438 -0.789 . . . . 1.0 110.289 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 13' ' ' ARG . 2.1 p -93.31 172.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.742 -0.599 . . . . 1.0 109.717 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' H ' HG22 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 70.33 96.08 0.07 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.368 0.604 . . . . 1.0 109.488 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 4.4 tp -118.6 134.9 23.46 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.607 -0.683 . . . . 1.0 109.659 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 35.5 Cg_endo -77.08 -163.75 0.23 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.679 2.252 . . . . 1.0 110.675 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 67.6 90.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.6 -0.688 . . . . 1.0 109.506 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -163.86 72.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.609 -0.682 . . . . 1.0 109.36 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.0 -58.74 7.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.725 . . . . 1.0 109.58 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -69.63 0.85 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.684 . . . . 1.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -156.73 117.51 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.71 -0.619 . . . . 1.0 109.681 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 156.87 37.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.605 -0.684 . . . . 1.0 109.275 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.826 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -113.63 161.24 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.32 -0.862 . . . . 1.0 109.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -118.49 126.21 51.54 Favored 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 118.384 -1.326 . . . . 1.0 109.234 -178.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -140.28 161.92 26.46 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 118.586 -1.768 . . . . 1.0 112.79 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.64 144.5 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 37' ' ' VAL . 3.7 pt -98.83 152.02 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.344 1.069 . . . . 1.0 111.985 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.75 121.66 14.53 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.204 -1.362 . . . . 1.0 108.617 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.538 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -82.17 105.69 13.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.742 -0.599 . . . . 1.0 109.564 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -33.11 71.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.646 -0.659 . . . . 1.0 109.913 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -162.7 -58.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 1.0 109.16 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.33 -119.93 0.74 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.706 -1.358 . . . . 1.0 109.706 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.13 -169.54 0.18 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.808 -0.819 . . . . 1.0 110.219 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.91 9.36 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.386 -0.821 . . . . 1.0 110.288 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 134.99 42.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.273 -0.892 . . . . 1.0 109.966 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -110.96 161.9 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.25 131.33 44.68 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -129.97 147.25 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.397 1.094 . . . . 1.0 111.701 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -117.99 139.29 51.38 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 105.461 -2.052 . . . . 1.0 105.461 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -141.28 160.38 40.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.883 -1.527 . . . . 1.0 114.195 -175.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HD2' ' A' ' 93' ' ' LYS . 6.1 mt -94.36 176.64 6.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.092 -1.413 . . . . 1.0 107.436 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.826 ' HB3' HG22 ' A' ' 22' ' ' ILE . 3.3 t70 76.74 23.09 1.07 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 103.961 -2.607 . . . . 1.0 103.961 -171.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 54.99 18.16 Favored Glycine 0 N--CA 1.502 3.096 0 CA-C-N 115.001 -1.0 . . . . 1.0 114.247 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.721 ' HB3' ' HD2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -146.38 155.05 42.32 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 120.573 2.187 . . . . 1.0 112.752 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.7 m -140.36 116.39 10.44 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.803 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.46 164.95 30.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.21 -0.996 . . . . 1.0 112.408 -175.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -95.3 126.31 40.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 104.464 -2.421 . . . . 1.0 104.464 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -94.76 131.49 10.73 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.67 -1.253 . . . . 1.0 111.535 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -104.33 133.85 48.53 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.501 0.667 . . . . 1.0 109.888 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -122.17 151.19 58.34 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' HG12 ' A' ' 49' ' ' ILE . 34.2 Cg_endo -76.02 -86.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.471 2.114 . . . . 1.0 110.115 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.68 7.93 3.63 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -66.19 -52.78 44.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -1.139 . . . . 1.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' HB2' HD13 ' A' ' 49' ' ' ILE . 2.9 tp -65.44 -41.95 92.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 1.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -26.2 68.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 1.0 111.09 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -99.74 -37.56 9.05 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.246 -0.909 . . . . 1.0 110.776 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.44 -9.77 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.443 -0.785 . . . . 1.0 111.323 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 53' ' ' LEU . 3.5 tp -48.39 135.05 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.44 -0.788 . . . . 1.0 110.451 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.44 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.18 174.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.698 -0.626 . . . . 1.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 -71.82 -75.92 0.12 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.493 -0.754 . . . . 1.0 109.714 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.73 174.02 5.96 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 1.0 109.935 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.23 75.03 1.29 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.221 -1.552 . . . . 1.0 109.221 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.22 161.21 20.26 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.658 -0.907 . . . . 1.0 109.707 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.82 HG21 ' CB ' ' A' ' 88' ' ' GLN . 2.6 p -99.25 133.53 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 1.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.129 HG12 ' HA ' ' A' ' 82' ' ' TRP . 35.9 m -139.64 150.16 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.682 0.753 . . . . 1.0 111.249 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.804 HG12 HD11 ' A' ' 81' ' ' ILE . 1.6 pp -99.6 142.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.994 -2.224 . . . . 1.0 104.994 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 2.0 m -140.25 156.4 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 117.38 -1.728 . . . . 1.0 114.367 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 8.8 ptpt -101.1 153.73 37.59 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.941 -1.481 . . . . 1.0 108.168 176.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.449 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.0 Cg_endo -89.83 143.82 4.29 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.605 2.203 . . . . 1.0 112.168 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.54 ' CD2' ' HB3' ' A' ' 77' ' ' LYS . 11.1 m0 -123.82 119.14 28.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.834 -1.172 . . . . 1.0 107.834 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 131.41 44.24 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 119.43 1.014 . . . . 1.0 109.648 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 75' ' ' ASP . 1.9 p 178.84 103.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 121.507 0.67 . . . . 1.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -51.42 141.41 15.61 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.56 -0.712 . . . . 1.0 110.783 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.45 -47.06 1.08 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.634 -1.386 . . . . 1.0 109.634 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.797 ' O ' HG13 ' A' ' 72' ' ' VAL . 30.7 t70 -166.84 156.91 11.45 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 42.0 mm-40 -94.09 149.04 21.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.88 -1.137 . . . . 1.0 110.557 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HB3' ' CD2' ' A' ' 70' ' ' TRP . 16.0 mttm -107.8 152.96 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 106.634 -1.617 . . . . 1.0 106.634 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.69 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 24.9 p -144.79 154.61 42.88 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.94 -1.725 . . . . 1.0 111.805 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 6.7 t70 -99.27 118.44 35.95 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 103.403 -2.814 . . . . 1.0 103.403 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.725 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -118.61 147.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 118.145 -1.422 . . . . 1.0 113.752 -174.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.804 HD11 HG12 ' A' ' 66' ' ' ILE . 2.0 pt -125.58 120.31 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 1.129 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -98.16 158.25 15.67 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.151 0.977 . . . . 1.0 112.993 -175.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -176.26 163.4 2.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.218 -0.901 . . . . 1.0 109.228 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 48.21 -149.23 0.18 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.938 -0.476 . . . . 1.0 110.537 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 p -147.21 103.81 3.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.363 -0.836 . . . . 1.0 108.848 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.8 pttm 38.84 46.33 1.05 Allowed 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.339 0.59 . . . . 1.0 110.774 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -140.97 77.5 1.6 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.453 -0.779 . . . . 1.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.82 ' CB ' HG21 ' A' ' 64' ' ' VAL . 0.3 OUTLIER 177.41 -35.4 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.636 -0.665 . . . . 1.0 110.188 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HG23 ' A' ' 64' ' ' VAL . 10.0 m -54.27 -34.79 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.538 -0.726 . . . . 1.0 110.254 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.53 -42.34 78.29 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.456 -0.777 . . . . 1.0 109.183 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.41 ' CH2' ' HD2' ' A' ' 95' ' ' LYS . 59.1 t90 -64.99 -42.5 94.45 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -60.15 -34.66 73.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.746 -0.596 . . . . 1.0 109.692 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HD2' HD13 ' A' ' 40' ' ' LEU . 1.6 mttt -63.63 -56.0 19.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.597 -0.69 . . . . 1.0 109.508 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -59.73 -36.46 76.61 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HD2' ' CH2' ' A' ' 91' ' ' TRP . 12.4 tttp -64.72 -33.57 76.27 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.07 -44.25 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.061 -1.215 . . . . 1.0 110.061 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.604 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.693 -0.886 . . . . 1.0 109.831 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.4 tm? -57.42 -56.52 20.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.901 -0.5 . . . . 1.0 109.913 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.44 -34.21 77.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.274 -0.891 . . . . 1.0 109.599 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.44 -37.05 74.62 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.742 -0.599 . . . . 1.0 109.925 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.531 ' C ' ' HG ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -69.89 -40.16 75.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 1.0 109.944 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' C ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.509 2.486 0 CA-C-O 119.159 -0.448 . . . . 1.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 -42.56 9.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.747 -0.595 . . . . 1.0 109.678 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 62.33 33.07 16.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.806 -0.559 . . . . 1.0 109.969 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -142.44 121.63 13.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.42 -0.8 . . . . 1.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.85 145.74 28.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.691 . . . . 1.0 109.889 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -125.1 -57.29 1.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.667 -0.645 . . . . 1.0 109.429 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -140.64 -56.44 0.52 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.632 -0.667 . . . . 1.0 109.373 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.28 125.38 14.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.743 -0.598 . . . . 1.0 109.473 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.43 -160.37 1.03 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 1.0 109.774 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 pt -70.06 -163.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.413 -0.804 . . . . 1.0 109.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.36 176.81 0.27 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.478 -0.764 . . . . 1.0 109.486 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.65 152.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.184 -0.948 . . . . 1.0 110.128 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -132.85 -65.57 0.7 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 14' ' ' ILE . 5.8 tp 0.52 87.46 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 C-N-CA 123.554 0.742 . . . . 1.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.15 145.17 17.1 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.918 2.412 . . . . 1.0 110.395 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -112.6 141.27 46.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.512 -0.743 . . . . 1.0 109.688 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 22.05 16.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.605 -0.685 . . . . 1.0 110.197 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -112.97 125.98 54.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.361 -0.837 . . . . 1.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.5 -36.74 26.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.754 -0.591 . . . . 1.0 109.973 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.72 96.16 3.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.587 -0.696 . . . . 1.0 109.562 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -153.9 134.54 13.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.653 -0.654 . . . . 1.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.46 161.35 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -121.26 132.36 54.76 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.195 -1.402 . . . . 1.0 109.153 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -141.79 155.62 25.48 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 118.18 -1.962 . . . . 1.0 113.086 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 38' ' ' ARG . 9.8 tt -100.37 138.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 105.958 -1.867 . . . . 1.0 105.958 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.898 ' HA ' HG22 ' A' ' 37' ' ' VAL . 6.6 pt -98.36 149.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 122.589 1.185 . . . . 1.0 112.567 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -141.44 119.4 11.94 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.865 -1.516 . . . . 1.0 108.763 178.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.587 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -99.33 66.75 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.478 0.656 . . . . 1.0 109.905 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.3 mtt -101.21 114.02 27.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.325 -0.859 . . . . 1.0 108.792 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.59 42.44 8.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.46 0.648 . . . . 1.0 109.488 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.36 167.5 20.55 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.04 -67.84 0.58 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.491 -1.005 . . . . 1.0 109.787 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -94.12 -51.09 4.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.539 -0.725 . . . . 1.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.581 ' HD3' ' CB ' ' A' ' 46' ' ' LEU . 21.8 ttm-85 -99.27 146.55 26.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.67 -0.644 . . . . 1.0 109.381 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -111.05 161.82 9.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' HG2' ' N ' ' A' ' 37' ' ' VAL . 10.1 ttp180 -100.0 141.04 33.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.381 -1.34 . . . . 1.0 107.381 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.3 t -133.87 148.49 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.442 1.115 . . . . 1.0 112.018 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HG3' HG22 ' A' ' 25' ' ' ILE . 1.1 ptm180 -112.68 141.17 46.78 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 104.657 -2.349 . . . . 1.0 104.657 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -141.25 158.47 43.85 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.17 -1.812 . . . . 1.0 115.015 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.5 tp -93.42 172.78 8.07 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.775 -1.557 . . . . 1.0 107.477 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.528 ' HB3' HG22 ' A' ' 22' ' ' ILE . 2.1 t70 77.44 22.8 0.91 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 104.134 -2.543 . . . . 1.0 104.134 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.69 56.08 16.73 Favored Glycine 0 N--CA 1.501 3.018 0 CA-C-N 114.975 -1.011 . . . . 1.0 114.276 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -145.62 151.12 37.57 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 120.452 2.126 . . . . 1.0 112.661 178.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.557 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -133.93 117.92 17.3 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 176.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.997 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -145.95 162.57 37.51 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.001 -1.08 . . . . 1.0 112.847 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -97.89 117.89 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.401 -2.814 . . . . 1.0 103.401 174.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 80' ' ' ILE . . . -101.57 153.93 18.87 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.785 -1.198 . . . . 1.0 112.753 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.75 156.86 22.09 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.702 0.763 . . . . 1.0 110.143 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.588 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 3.5 pt -140.64 163.43 43.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 32.9 Cg_endo -74.79 -34.06 4.39 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.575 2.183 . . . . 1.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 10.39 80.12 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -65.49 -50.96 63.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -1.133 . . . . 1.0 109.39 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HA ' HD13 ' A' ' 53' ' ' LEU . 3.3 mm? -65.49 -34.23 77.79 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.739 -0.6 . . . . 1.0 109.967 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -54.78 -43.82 73.14 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.53 -0.732 . . . . 1.0 109.991 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.05 -33.94 61.78 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 1.0 110.06 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -61.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.439 -0.788 . . . . 1.0 109.782 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -120.48 157.52 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.68 -0.637 . . . . 1.0 109.923 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -121.95 127.82 50.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.0 109.553 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.32 161.14 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.598 . . . . 1.0 109.751 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.34 168.84 18.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.552 -0.717 . . . . 1.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.02 132.19 47.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 1.0 109.879 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.53 76.97 0.25 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.064 -1.214 . . . . 1.0 110.064 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -129.61 160.68 32.53 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.56 137.84 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 120.502 -1.374 . . . . 1.0 109.183 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 82' ' ' TRP . 3.1 m -141.58 158.62 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.889 -0.724 . . . . 1.0 111.306 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.786 HG22 ' CG1' ' A' ' 81' ' ' ILE . 14.4 tt -99.57 149.03 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 105.045 -2.205 . . . . 1.0 105.045 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 1.3 m -134.22 157.4 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.6 -1.64 . . . . 1.0 114.54 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 41.4 mtmt -103.94 152.82 39.1 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 113.332 -1.758 . . . . 1.0 106.928 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 40.3 Cg_endo -89.16 141.39 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.684 2.256 . . . . 1.0 113.033 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.601 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m95 -123.27 119.04 28.98 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 130.28 40.99 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.336 0.971 . . . . 1.0 110.187 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 75' ' ' ASP . 1.4 p -177.56 111.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-O 121.462 0.649 . . . . 1.0 109.737 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.52 143.79 44.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.073 -1.017 . . . . 1.0 109.867 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.47 -42.05 1.99 Allowed Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.849 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -172.73 169.76 4.86 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 5.9 tt0 -108.29 157.5 18.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.44 -1.412 . . . . 1.0 110.471 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 16.4 mttm -114.87 158.87 21.36 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 21.6 p -146.25 155.86 42.97 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.144 -1.597 . . . . 1.0 111.944 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.81 117.54 34.13 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 104.337 -2.468 . . . . 1.0 104.337 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.589 HG22 ' CB ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -120.01 161.35 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.312 1.597 . . . . 1.0 115.312 -174.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.786 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.2 pp -118.94 120.28 63.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 175.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.961 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -97.54 156.3 16.56 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.188 0.994 . . . . 1.0 112.709 -176.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.5 -176.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.067 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.65 99.07 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.17 0.51 . . . . 1.0 110.381 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -63.49 -33.87 76.53 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 1.0 109.008 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.98 174.49 7.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.5 p -63.91 132.27 50.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.443 -0.786 . . . . 1.0 110.217 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 8.65 3.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 23' ' ' LEU . 48.9 t -62.15 -34.31 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.247 -0.908 . . . . 1.0 108.933 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -63.22 -48.86 76.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.706 -0.621 . . . . 1.0 110.086 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -54.27 -50.54 67.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 1.0 109.395 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.4 mt -61.57 -39.05 89.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.758 -0.589 . . . . 1.0 109.622 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' A' ' 40' ' ' LEU . 10.1 mmtm -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.767 -0.583 . . . . 1.0 109.847 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.823 ' HA ' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.32 -55.32 32.83 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -25.17 67.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.94 -59.03 10.83 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.498 -0.858 . . . . 1.0 111.487 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.823 ' CZ ' ' HA ' ' A' ' 94' ' ' ARG . 10.4 p90 -70.58 -39.11 74.05 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.429 1.114 . . . . 1.0 110.308 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.5 -52.88 62.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.873 -0.517 . . . . 1.0 110.268 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.57 -42.15 95.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.591 -0.693 . . . . 1.0 109.778 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -46.36 89.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.582 -0.699 . . . . 1.0 109.585 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.29 84.86 6.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.439 0.638 . . . . 1.0 109.292 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.82 -1.086 . . . . 1.0 109.697 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.83 55.56 6.13 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.678 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -92.27 167.98 11.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.483 -0.761 . . . . 1.0 110.093 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 63.56 81.85 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.443 0.64 . . . . 1.0 109.732 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.3 -45.19 1.97 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.634 -0.666 . . . . 1.0 109.625 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.34 153.8 29.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.621 -0.674 . . . . 1.0 109.792 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.85 127.26 31.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.793 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -142.27 140.61 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.576 -0.702 . . . . 1.0 109.877 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -113.32 22.22 14.46 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.513 0.673 . . . . 1.0 110.294 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -51.72 -24.31 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.043 -0.41 . . . . 1.0 110.965 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -71.58 -146.32 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.483 -0.761 . . . . 1.0 109.524 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -60.48 -178.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.123 -0.985 . . . . 1.0 110.633 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -46.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.665 -0.647 . . . . 1.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 pt -53.89 129.27 56.5 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.727 -0.608 . . . . 1.0 110.039 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.11 157.16 30.26 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.782 2.321 . . . . 1.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.3 ttp-105 -82.23 76.74 9.09 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.75 13.35 9.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 1.0 110.259 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.25 67.23 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.549 -0.719 . . . . 1.0 109.245 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.34 -64.82 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 1.0 109.708 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -172.22 -47.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.645 -0.659 . . . . 1.0 110.038 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.52 148.84 38.62 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 1.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.711 HG23 ' SG ' ' A' ' 39' ' ' CYS . 1.2 mp -111.13 158.37 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.929 ' HB3' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -130.62 126.97 38.0 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 118.185 -1.406 . . . . 1.0 108.886 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -142.5 161.68 27.35 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 117.566 -2.254 . . . . 1.0 114.21 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -98.04 135.07 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 177.362 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.034 ' CD1' HG23 ' A' ' 37' ' ' VAL . 9.4 tp -104.57 152.72 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.498 1.142 . . . . 1.0 112.629 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.21 -1.359 . . . . 1.0 108.15 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -130.65 105.99 8.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.607 -0.683 . . . . 1.0 109.549 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -47.6 6.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.609 -0.682 . . . . 1.0 109.719 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -88.05 -53.79 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.596 -0.69 . . . . 1.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.04 79.87 1.06 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.76 52.63 2.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.799 -0.824 . . . . 1.0 109.187 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.34 5.56 4.81 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.726 -0.609 . . . . 1.0 110.869 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 160.28 40.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.273 -0.892 . . . . 1.0 109.52 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 26' ' ' ILE . 6.5 m -137.38 168.51 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.742 0.782 . . . . 1.0 110.188 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.62 122.31 41.25 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.259 -0.577 . . . . 1.0 110.725 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -120.9 148.61 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 122.868 1.318 . . . . 1.0 111.78 -179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -110.03 139.89 44.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.899 -2.63 . . . . 1.0 103.899 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.711 ' SG ' HG23 ' A' ' 22' ' ' ILE . 1.8 p -141.32 162.56 35.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.334 -1.746 . . . . 1.0 115.665 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 41' ' ' ASP . 38.2 tp -89.84 169.49 11.21 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.91 -1.95 . . . . 1.0 105.926 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.608 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 15.6 m-20 78.83 24.5 0.55 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 104.527 -2.397 . . . . 1.0 104.527 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.44 58.57 13.69 Favored Glycine 0 N--CA 1.498 2.799 0 CA-C-N 114.738 -1.119 . . . . 1.0 113.434 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.659 ' CB ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -144.79 156.35 43.99 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.679 1.739 . . . . 1.0 112.994 178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.91 120.74 12.71 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.218 -1.771 . . . . 1.0 106.218 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.814 ' CZ ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.18 163.23 35.02 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.144 -1.422 . . . . 1.0 114.456 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 124.75 43.33 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' NH2' ' A' ' 45' ' ' ARG . . . -105.62 159.84 15.2 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.545 -1.312 . . . . 1.0 113.48 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -124.09 144.0 50.13 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.863 HG12 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.81 149.54 73.94 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 33.2 Cg_endo -74.71 153.57 43.42 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.721 2.281 . . . . 1.0 110.896 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.42 -26.81 64.77 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -54.07 -41.68 68.45 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.916 . . . . 1.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.863 HD12 HG12 ' A' ' 49' ' ' ILE . 10.5 mt -65.07 -43.96 90.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.632 -0.668 . . . . 1.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -65.25 -35.65 81.69 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.746 -0.596 . . . . 1.0 109.649 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -61.19 -40.79 95.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.689 -0.632 . . . . 1.0 109.659 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -65.0 0.73 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tt -168.35 151.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -119.69 132.86 55.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.626 -0.671 . . . . 1.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.18 158.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.651 -0.655 . . . . 1.0 109.331 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -76.54 -57.59 3.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.38 -0.825 . . . . 1.0 109.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.9 150.88 5.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.62 -0.675 . . . . 1.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.42 66.0 1.06 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 26' ' ' ILE . 9.3 t70 -128.95 160.42 32.76 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.592 -0.946 . . . . 1.0 109.361 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.23 128.44 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.12 . . . . 1.0 108.205 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 82' ' ' TRP . 16.5 m -140.59 148.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.521 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 tt -98.72 141.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 22' ' ' ILE . 1.2 m -121.6 148.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.726 -1.234 . . . . 1.0 113.536 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -102.39 141.33 22.3 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 106.568 -1.641 . . . . 1.0 106.568 176.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 39.9 Cg_endo -88.64 137.25 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.967 1.778 . . . . 1.0 113.253 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.7 m0 -117.73 117.35 29.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.757 -1.571 . . . . 1.0 106.757 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER 51.15 -161.85 0.07 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 120.822 1.646 . . . . 1.0 109.326 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 71' ' ' GLU . 91.2 t -156.77 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.515 -1.366 . . . . 1.0 111.773 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -31.1 134.6 0.06 Allowed 'General case' 0 N--CA 1.513 2.718 0 CA-C-O 121.808 0.813 . . . . 1.0 113.179 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.15 -58.41 4.24 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.416 -1.074 . . . . 1.0 110.416 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.92 168.35 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.668 ' HG3' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt20 -131.93 159.75 37.76 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 116.875 -1.93 . . . . 1.0 113.208 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -100.8 160.11 14.63 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.347 -1.723 . . . . 1.0 106.347 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.954 ' SG ' HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -146.98 160.22 42.63 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 119.764 -1.835 . . . . 1.0 111.618 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 1.2 p-10 -117.95 117.81 30.27 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.954 HG23 ' SG ' ' A' ' 78' ' ' CYS . 2.4 pt -115.16 160.58 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.34 122.29 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 105.227 -2.138 . . . . 1.0 105.227 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 1.002 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.36 148.12 23.99 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.325 0.584 . . . . 1.0 111.293 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.696 ' O ' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER 176.02 172.13 0.37 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.393 0.616 . . . . 1.0 110.43 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.686 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . 99.9 m-85 47.01 -175.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.686 0.755 . . . . 1.0 112.483 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 84' ' ' TYR . 6.3 t 175.45 51.44 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -152.48 -68.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.013 -1.054 . . . . 1.0 110.589 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.7 m -137.05 109.83 7.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.362 -0.836 . . . . 1.0 110.365 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.592 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 174.96 -77.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -66.52 -33.74 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 3.1 mt-10 -52.68 -37.86 59.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -66.2 -55.03 18.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.853 -0.529 . . . . 1.0 109.864 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.042 HD11 HG22 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -63.98 -51.3 64.96 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.459 -0.775 . . . . 1.0 111.076 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 1.2 pttt -59.02 -43.47 91.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.283 -0.886 . . . . 1.0 110.42 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.639 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -60.49 -39.1 86.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.411 -0.806 . . . . 1.0 108.988 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.637 ' HA ' HD21 ' A' ' 98' ' ' LEU . 5.5 mtpp -59.53 -33.82 71.86 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -66.22 -42.43 94.24 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.939 -1.264 . . . . 1.0 109.939 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.639 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.3 m-85 -66.46 -55.11 17.23 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.716 -0.873 . . . . 1.0 110.661 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.9 pp -59.78 -33.91 72.33 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.528 -0.733 . . . . 1.0 110.445 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.76 -51.04 64.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.486 -0.759 . . . . 1.0 109.764 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.644 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -66.03 -56.29 12.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.636 -0.665 . . . . 1.0 110.194 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -137.86 -172.4 3.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.61 -0.681 . . . . 1.0 109.725 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 117.711 -1.138 . . . . 1.0 110.25 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG2' ' HB2' ' A' ' 8' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.02 99.18 2.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.609 -0.682 . . . . 1.0 109.584 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.07 119.42 21.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 1.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.56 87.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.728 . . . . 1.0 109.7 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 38.92 42.25 0.63 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.157 0.503 . . . . 1.0 111.1 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -168.3 -74.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.883 . . . . 1.0 109.554 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.36 172.98 2.18 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.73 -0.606 . . . . 1.0 109.68 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.452 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.1 pt20 -89.41 11.05 20.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.421 -0.8 . . . . 1.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -101.1 20.12 16.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 1.0 110.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 tp -54.42 142.67 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.228 0.537 . . . . 1.0 110.089 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -71.35 178.61 3.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.678 -0.639 . . . . 1.0 110.174 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.13 159.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.566 -0.709 . . . . 1.0 110.071 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.31 88.82 1.6 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -144.83 116.92 5.35 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.541 -0.724 . . . . 1.0 109.413 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.5 -178.4 4.56 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 122.758 2.306 . . . . 1.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 66.7 98.73 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.305 0.574 . . . . 1.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -154.88 -55.59 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.616 -0.678 . . . . 1.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -15.3 32.33 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.642 -0.661 . . . . 1.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.44 -22.36 18.33 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 1.0 111.196 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -147.29 -62.62 0.28 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.031 -1.043 . . . . 1.0 111.246 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.75 119.06 6.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.504 -0.747 . . . . 1.0 110.727 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.21 155.1 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 92' ' ' LEU . 1.6 pp -122.64 119.68 31.47 Favored 'General case' 0 N--CA 1.517 2.915 0 C-N-CA 118.045 -1.462 . . . . 1.0 109.172 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -139.39 160.75 26.02 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 117.7 -2.19 . . . . 1.0 113.705 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.703 HG23 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -99.09 130.9 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.485 -1.672 . . . . 1.0 106.485 177.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -99.56 154.55 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.255 1.026 . . . . 1.0 111.991 -177.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -140.04 128.75 23.12 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.931 -1.031 . . . . 1.0 108.697 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -117.68 83.79 2.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.728 -0.608 . . . . 1.0 109.569 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -40.6 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.433 -0.792 . . . . 1.0 109.033 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.08 124.12 51.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 89.88 1.28 Allowed Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 -71.38 0.73 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.871 . . . . 1.0 109.663 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.44 -54.22 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.609 -0.682 . . . . 1.0 109.709 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.61 160.71 14.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.661 -0.649 . . . . 1.0 109.86 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' ILE . 10.7 m -129.38 168.68 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.201 1.0 . . . . 1.0 110.883 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -106.14 131.55 53.27 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 115.236 -0.893 . . . . 1.0 109.216 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -140.41 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.226 -0.921 . . . . 1.0 111.035 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.34 141.07 40.7 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -142.09 162.32 35.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.881 -1.528 . . . . 1.0 114.306 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -92.13 178.88 5.73 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 176.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 76.58 23.8 1.07 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 -171.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 43' ' ' LYS . . . 62.94 55.31 27.4 Favored Glycine 0 N--CA 1.5 2.919 0 CA-C-N 114.806 -1.088 . . . . 1.0 113.989 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 3.2 tptp -145.85 153.99 41.48 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.634 2.217 . . . . 1.0 113.474 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -135.39 117.49 15.41 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 104.682 -2.34 . . . . 1.0 104.682 175.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.733 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.17 160.83 41.42 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.764 -1.175 . . . . 1.0 112.977 -175.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.18 123.56 43.56 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 80' ' ' ILE . . . -96.9 146.07 18.13 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.433 -1.365 . . . . 1.0 112.652 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -106.67 140.45 39.51 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.659 HG12 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -135.17 157.19 77.34 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' HD2' HG12 ' A' ' 49' ' ' ILE . 33.5 Cg_endo -75.9 -44.23 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.444 2.096 . . . . 1.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.45 33.51 0.1 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -66.76 -43.47 83.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.383 -1.069 . . . . 1.0 109.767 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.93 -49.96 75.34 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.798 -0.564 . . . . 1.0 109.981 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -24.65 61.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.513 -0.742 . . . . 1.0 110.556 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.49 5.09 31.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.35 -0.844 . . . . 1.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -129.0 -70.64 0.66 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.008 -1.058 . . . . 1.0 110.36 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.84 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.416 -0.802 . . . . 1.0 110.593 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 68.16 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.32 144.99 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.591 -0.693 . . . . 1.0 109.222 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -61.36 -63.43 1.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.638 -0.664 . . . . 1.0 109.439 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.47 121.17 0.5 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.714 -0.616 . . . . 1.0 109.595 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.14 73.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.43 160.55 38.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.646 -0.914 . . . . 1.0 108.945 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 89' ' ' VAL . 3.8 t -109.33 139.43 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.93 -1.106 . . . . 1.0 108.535 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 82' ' ' TRP . 34.6 m -140.2 152.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.973 0.892 . . . . 1.0 111.894 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.9 pt -99.61 139.68 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 105.501 -2.037 . . . . 1.0 105.501 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -139.49 158.74 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 117.312 -1.755 . . . . 1.0 114.272 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -100.68 154.88 36.92 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 107.504 -1.295 . . . . 1.0 107.504 176.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.8 Cg_endo -89.35 141.89 4.19 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.664 2.243 . . . . 1.0 112.549 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 12.3 m0 -121.42 117.35 26.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.031 -1.47 . . . . 1.0 107.031 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 72' ' ' VAL . 37.1 mt-10 47.91 -158.27 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 120.244 1.384 . . . . 1.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 71' ' ' GLU . 73.5 t -155.91 -81.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.821 -1.174 . . . . 1.0 110.793 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -42.32 143.61 0.6 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.667 0.746 . . . . 1.0 112.002 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.79 -54.46 3.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 p30 174.1 160.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 2.2 tt0 -111.37 149.72 30.78 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.277 -1.369 . . . . 1.0 111.388 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 37.2 mmtm -112.5 154.76 25.41 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 14.4 p -144.56 156.16 44.01 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 119.776 -1.828 . . . . 1.0 111.634 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -106.23 119.17 38.54 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 175.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.997 HG22 HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -106.65 161.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 115.575 1.694 . . . . 1.0 115.575 -174.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -120.29 123.61 70.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 103.781 -2.674 . . . . 1.0 103.781 175.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.937 ' HA ' HG12 ' A' ' 65' ' ' VAL . 6.6 t90 -96.29 138.0 34.54 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.951 0.881 . . . . 1.0 111.908 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.98 -167.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.17 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 6.0 m-85 59.44 89.02 0.07 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.474 0.654 . . . . 1.0 110.288 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -74.26 -29.16 61.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.485 -0.759 . . . . 1.0 109.547 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.11 -159.74 0.75 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 1.0 109.777 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 p -62.33 148.57 44.73 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.825 . . . . 1.0 110.234 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.568 ' HB3' HG11 ' A' ' 64' ' ' VAL . 8.7 tp60 -161.76 -40.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.695 -0.628 . . . . 1.0 110.044 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 23' ' ' LEU . 3.4 t -53.96 -34.94 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.64 -0.662 . . . . 1.0 109.771 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -44.24 80.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.495 -0.753 . . . . 1.0 109.51 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.461 ' CE3' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -65.09 -45.13 86.5 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.791 ' HB3' HD22 ' A' ' 23' ' ' LEU . 1.9 mt -57.69 -40.99 80.72 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.609 -0.682 . . . . 1.0 109.212 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CE ' HG12 ' A' ' 89' ' ' VAL . 6.5 mtmt -58.57 -50.09 75.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.609 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -56.38 -36.11 68.48 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 98' ' ' LEU . 7.4 tptt -62.22 -35.4 78.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.917 -0.489 . . . . 1.0 109.854 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.59 91.34 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.1 m-85 -66.18 -53.04 42.28 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.915 -0.756 . . . . 1.0 110.802 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.6 pp -62.17 -34.86 77.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.321 -0.862 . . . . 1.0 109.918 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -62.66 -38.98 92.45 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.693 . . . . 1.0 109.818 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -61.35 -53.54 55.37 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 1.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 101' ' ' LEU . 2.5 mm? -96.92 97.98 9.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 1.0 109.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 118.455 -0.783 . . . . 1.0 109.907 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.15 146.83 31.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.636 -0.665 . . . . 1.0 109.696 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -123.58 108.15 12.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.564 -0.71 . . . . 1.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -113.03 -58.28 2.18 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -111.54 -54.74 2.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.0 109.72 1.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.728 -0.608 . . . . 1.0 109.457 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.61 -86.16 0.57 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.584 -0.698 . . . . 1.0 109.2 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -179.5 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.501 -0.75 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -70.1 167.95 16.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.627 . . . . 1.0 110.128 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -108.78 62.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.678 0.751 . . . . 1.0 109.2 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.0 -16.98 59.87 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.943 0.878 . . . . 1.0 110.982 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.61 HG21 ' NE1' ' A' ' 91' ' ' TRP . 5.4 p -162.93 160.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.716 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' C ' ' A' ' 14' ' ' ILE . 1.5 ttm-85 -154.53 -69.43 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 88' ' ' GLN . 1.6 pt 23.54 81.15 0.18 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 122.693 0.397 . . . . 1.0 111.862 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.41 85.72 1.66 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.645 2.23 . . . . 1.0 110.044 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.87 109.1 19.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.663 -0.648 . . . . 1.0 109.74 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.67 37.3 4.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.17 148.71 42.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.52 -0.738 . . . . 1.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.77 44.24 1.06 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.669 -0.644 . . . . 1.0 109.374 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -163.6 99.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 1.0 109.257 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.06 142.67 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.597 -0.689 . . . . 1.0 109.76 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -122.49 161.74 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.96 127.75 43.85 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 117.947 -1.501 . . . . 1.0 109.038 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -142.11 161.74 27.19 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 118.248 -1.929 . . . . 1.0 112.776 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -98.26 130.99 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -99.03 153.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.198 0.999 . . . . 1.0 111.398 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -142.73 119.71 11.33 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.729 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.998 ' HB2' HG12 ' A' ' 35' ' ' VAL . 44.8 tp60 -134.95 130.52 35.94 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.467 ' HA ' ' HE3' ' A' ' 29' ' ' MET . 5.3 tpt -162.02 39.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.421 -0.799 . . . . 1.0 110.015 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.421 ' H ' ' NE2' ' A' ' 28' ' ' GLN . 64.6 mt -136.86 15.58 3.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.851 . . . . 1.0 110.245 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.26 66.81 2.31 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 144.27 30.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.609 -0.936 . . . . 1.0 110.12 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -68.87 -20.53 64.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.81 -0.556 . . . . 1.0 109.931 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.88 161.07 13.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.998 HG12 ' HB2' ' A' ' 28' ' ' GLN . 16.9 m -137.45 167.6 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.91 0.862 . . . . 1.0 110.79 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.537 ' HA ' HD12 ' A' ' 46' ' ' LEU . 8.6 ptt-85 -109.54 130.64 55.49 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -141.03 144.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.899 -1.12 . . . . 1.0 111.018 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.641 ' HG3' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -108.37 144.48 35.86 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 105.548 -2.019 . . . . 1.0 105.548 176.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.0 m -139.61 157.24 46.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.233 -1.387 . . . . 1.0 113.125 -176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.53 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.25 179.51 5.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.673 ' HB3' HG13 ' A' ' 22' ' ' ILE . 6.9 t70 76.44 23.41 1.15 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 103.561 -2.755 . . . . 1.0 103.561 -171.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.66 52.74 36.28 Favored Glycine 0 N--CA 1.5 2.903 0 CA-C-N 114.878 -1.056 . . . . 1.0 113.99 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -146.03 154.02 41.39 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 120.818 2.309 . . . . 1.0 112.796 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.71 118.03 13.68 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -147.65 164.4 33.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.049 -1.06 . . . . 1.0 112.808 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.8 mm? -97.42 132.63 42.95 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.084 -2.191 . . . . 1.0 105.084 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.21 150.62 19.67 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.745 -1.217 . . . . 1.0 111.909 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.1 ptm180 -123.66 141.89 51.58 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.481 0.658 . . . . 1.0 109.787 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.449 HG21 ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -100.24 158.93 31.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.6 -58.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.483 2.122 . . . . 1.0 111.089 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.37 -63.07 0.16 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -39.03 89.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.784 -0.833 . . . . 1.0 109.369 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.662 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.4 mp -65.08 -34.61 78.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.762 -0.587 . . . . 1.0 109.688 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' CB ' HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -49.71 -36.4 25.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.507 -0.746 . . . . 1.0 110.542 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -85.81 -34.9 20.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.409 -0.807 . . . . 1.0 110.147 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -35.97 58.62 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.51 -0.744 . . . . 1.0 110.728 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 53' ' ' LEU . 1.3 pp -59.84 142.28 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 1.0 110.46 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -144.06 51.58 1.31 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.461 0.648 . . . . 1.0 109.366 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.805 HG12 ' HB2' ' A' ' 63' ' ' ASP . 26.5 m -68.47 134.91 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.411 -0.806 . . . . 1.0 109.089 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -137.37 -54.04 0.68 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.406 -0.809 . . . . 1.0 110.408 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -105.97 -14.86 15.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.0 111.201 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.42 92.62 0.12 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -97.19 160.68 14.2 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -102.45 141.74 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.805 -1.184 . . . . 1.0 109.906 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.959 HG12 ' HA ' ' A' ' 82' ' ' TRP . 17.8 m -142.0 159.29 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.612 0.72 . . . . 1.0 111.224 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 81' ' ' ILE . 1.1 tt -100.32 144.17 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.76 HG22 HG22 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -129.66 152.85 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 118.0 -1.48 . . . . 1.0 113.432 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 19.9 mttt -104.75 148.26 35.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 45' ' ' ARG . 39.5 Cg_endo -88.49 135.52 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.255 1.97 . . . . 1.0 112.875 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.714 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.3 m0 -120.74 117.11 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.621 -1.252 . . . . 1.0 107.621 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 47.5 -147.18 0.21 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 119.131 0.878 . . . . 1.0 110.203 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 73' ' ' GLN . 1.3 p -155.82 -84.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.091 -1.005 . . . . 1.0 109.567 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.739 ' H ' HG13 ' A' ' 72' ' ' VAL . 5.1 mt-30 49.31 -152.54 0.13 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.159 -0.963 . . . . 1.0 110.168 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.57 18.14 57.07 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.886 -1.286 . . . . 1.0 109.886 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.01 135.5 1.75 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -113.54 154.76 26.57 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.583 -1.247 . . . . 1.0 112.139 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.714 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 24.1 tptt -102.34 150.68 23.09 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 106.125 -1.805 . . . . 1.0 106.125 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 17.4 p -143.15 151.44 40.69 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 119.97 -1.706 . . . . 1.0 111.466 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.67 120.33 39.53 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 67' ' ' VAL . 1.8 pp -119.95 156.64 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.064 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 66' ' ' ILE . 1.4 tp -118.47 128.91 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 105.487 -2.042 . . . . 1.0 105.487 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.959 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.89 147.58 24.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.748 0.785 . . . . 1.0 111.665 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HG2' ' HG2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -178.23 162.81 1.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.485 0.659 . . . . 1.0 109.605 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -101.75 -50.69 3.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.553 -0.717 . . . . 1.0 109.126 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -126.19 70.67 1.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -87.75 161.8 17.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.441 -0.787 . . . . 1.0 109.793 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.591 ' HB ' HG23 ' A' ' 12' ' ' VAL . 5.6 p -79.99 -1.96 41.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.591 -0.693 . . . . 1.0 110.702 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.544 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -104.35 -52.77 2.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.26 -0.9 . . . . 1.0 109.834 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.783 ' HA ' HD21 ' A' ' 92' ' ' LEU . 86.1 t -65.39 -34.65 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.45 -0.781 . . . . 1.0 109.843 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -63.18 -38.49 91.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.166 -0.959 . . . . 1.0 109.26 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.61 ' NE1' HG21 ' A' ' 12' ' ' VAL . 1.7 m0 -66.19 -55.57 15.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.775 -0.578 . . . . 1.0 110.251 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.93 HD13 ' HG ' ' A' ' 23' ' ' LEU . 1.4 pp -58.28 -33.88 69.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.655 -0.653 . . . . 1.0 109.848 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 92' ' ' LEU . 10.9 mtpp -58.49 -49.63 76.67 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.589 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -58.48 -35.47 72.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.02 -34.19 77.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.795 -0.566 . . . . 1.0 109.966 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.24 -44.81 93.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.055 -1.618 . . . . 1.0 109.055 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -65.93 -37.46 86.1 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 -56.03 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -34.68 73.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.872 -0.518 . . . . 1.0 109.943 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.566 ' CB ' HD13 ' A' ' 101' ' ' LEU . 10.9 mt-10 -59.28 -55.09 39.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 1.0 110.176 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.781 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -139.34 156.91 46.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.411 -0.806 . . . . 1.0 110.293 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.503 2.212 0 CA-C-O 117.719 -1.134 . . . . 1.0 110.013 -179.598 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptp . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.174 0.511 . . . . 1.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.34 -51.78 7.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.608 -0.682 . . . . 1.0 109.627 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.24 165.36 29.44 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.686 . . . . 1.0 110.093 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.66 0.02 24.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.679 -0.638 . . . . 1.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.26 179.12 4.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 1.0 110.033 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 69.06 106.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.262 0.554 . . . . 1.0 109.976 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -72.68 0.71 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 1.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.95 29.72 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.536 -0.728 . . . . 1.0 110.232 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -131.1 167.8 18.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.226 -0.922 . . . . 1.0 110.129 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -98.13 154.8 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.621 -0.675 . . . . 1.0 109.329 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -177.88 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.833 0.825 . . . . 1.0 111.684 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -87.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-O 122.031 0.92 . . . . 1.0 110.456 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.06 135.47 50.86 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.315 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.582 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.4 pt -78.05 162.48 67.03 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.846 -0.534 . . . . 1.0 109.685 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 34.3 Cg_endo -75.9 -49.98 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.687 2.258 . . . . 1.0 111.238 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.57 156.78 27.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.428 -0.795 . . . . 1.0 109.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 56.12 1.85 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 1.0 109.527 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -147.82 176.19 10.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.36 -0.838 . . . . 1.0 110.248 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.14 -7.59 59.59 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.569 -0.707 . . . . 1.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 18.2 m120 -54.3 -38.03 65.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.395 -0.816 . . . . 1.0 109.887 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 121.26 17.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.691 -0.63 . . . . 1.0 109.773 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 mp -110.26 162.13 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.893 ' O ' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.12 125.26 38.84 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 117.891 -1.524 . . . . 1.0 109.43 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.65 161.9 27.01 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.11 -1.995 . . . . 1.0 113.051 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.553 HG22 HG13 ' A' ' 64' ' ' VAL . 7.7 pt -98.29 131.67 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -100.5 156.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 122.182 0.992 . . . . 1.0 111.751 -177.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.99 126.05 18.33 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.708 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.891 ' HG2' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -131.19 104.86 7.31 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 tpt -139.58 49.14 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.401 -0.812 . . . . 1.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.8 mt -140.45 -54.98 0.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 1.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.89 73.09 0.98 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.41 -77.64 0.34 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.887 . . . . 1.0 109.937 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.61 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.577 -0.702 . . . . 1.0 109.956 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.32 160.66 14.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.627 -0.671 . . . . 1.0 109.822 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.891 HG12 ' HG2' ' A' ' 28' ' ' GLN . 7.0 m -124.1 168.24 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 121.888 0.851 . . . . 1.0 110.384 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.778 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -108.15 132.01 54.05 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 178.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.453 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -140.91 145.38 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 118.939 -1.105 . . . . 1.0 111.274 -178.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -111.09 141.36 44.7 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.654 -1.98 . . . . 1.0 105.654 176.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 2.2 m -137.88 157.43 46.42 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.253 -1.379 . . . . 1.0 113.176 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.82 ' HB3' HD11 ' A' ' 23' ' ' LEU . 3.7 tp -93.69 177.94 5.84 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.279 -1.748 . . . . 1.0 106.279 176.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG13 ' A' ' 22' ' ' ILE . 2.8 t70 76.63 22.87 1.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 104.308 -2.479 . . . . 1.0 104.308 -172.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.61 18.03 Favored Glycine 0 N--CA 1.499 2.874 0 CA-C-N 115.079 -0.964 . . . . 1.0 113.998 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.18 153.46 41.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 120.465 2.133 . . . . 1.0 112.203 178.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.5 116.89 10.71 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.179 -2.156 . . . . 1.0 105.179 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -148.27 164.08 35.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.716 -1.193 . . . . 1.0 113.342 -175.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 36' ' ' ARG . 4.1 mm? -97.31 130.23 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 104.753 -2.314 . . . . 1.0 104.753 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.715 ' HA3' HG12 ' A' ' 80' ' ' ILE . . . -95.18 149.09 19.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.027 -1.082 . . . . 1.0 111.921 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -126.06 143.86 50.95 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.443 0.64 . . . . 1.0 109.981 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -101.75 157.7 33.18 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 49' ' ' ILE . 34.8 Cg_endo -76.28 -50.64 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.546 2.164 . . . . 1.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.66 -64.23 0.18 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -36.0 80.41 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.657 -0.908 . . . . 1.0 109.796 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 57' ' ' ILE . 4.5 mp -65.02 -34.78 79.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.7 -0.625 . . . . 1.0 109.882 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' CB ' HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.62 -32.8 65.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.483 -0.76 . . . . 1.0 110.34 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -84.04 -28.66 27.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.479 -0.763 . . . . 1.0 110.355 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.59 -34.81 19.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 1.0 110.83 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.626 HG22 ' HB3' ' A' ' 82' ' ' TRP . 1.3 pp -54.2 132.51 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.473 -0.767 . . . . 1.0 110.454 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.87 60.71 1.37 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 63' ' ' ASP . 11.5 m -74.29 153.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.522 -0.736 . . . . 1.0 109.349 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -141.35 -49.72 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.391 -0.818 . . . . 1.0 110.649 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.78 18.2 5.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.375 -0.828 . . . . 1.0 111.251 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.45 92.33 0.72 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.7 -1.238 . . . . 1.0 110.521 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -99.25 161.33 13.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.846 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.36 140.74 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.753 -1.217 . . . . 1.0 109.776 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 82' ' ' TRP . 19.4 m -142.5 158.12 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.514 0.673 . . . . 1.0 111.071 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.822 HG22 ' CG1' ' A' ' 81' ' ' ILE . 1.8 tp -100.87 146.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.836 HG22 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -131.36 154.7 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 118.291 -1.364 . . . . 1.0 113.444 -177.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.1 mmpp? -107.48 149.32 38.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 106.507 -1.664 . . . . 1.0 106.507 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.1 Cg_endo -88.48 136.34 3.27 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.417 2.078 . . . . 1.0 112.956 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.7 m0 -121.08 116.15 24.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 45.09 -154.43 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 CA-C-N 118.999 0.818 . . . . 1.0 110.964 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -142.61 -79.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.211 -0.931 . . . . 1.0 109.225 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 48.37 -152.29 0.11 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.456 -0.777 . . . . 1.0 110.508 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.9 13.12 66.9 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.113 -1.195 . . . . 1.0 110.113 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.77 145.56 1.96 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -113.37 151.76 30.86 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.724 -1.19 . . . . 1.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.667 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 4.8 tppt? -99.73 151.98 20.62 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.317 -1.735 . . . . 1.0 106.317 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.666 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 30.9 p -142.73 152.04 41.91 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.126 -1.609 . . . . 1.0 111.31 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.64 119.62 38.83 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 104.788 -2.301 . . . . 1.0 104.788 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 26' ' ' ILE . 1.3 pp -120.32 155.79 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 117.761 -1.576 . . . . 1.0 114.994 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.822 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.8 pp -117.21 132.35 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.72 -1.955 . . . . 1.0 105.72 175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.921 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.86 146.29 25.57 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.879 0.847 . . . . 1.0 111.462 -176.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -173.49 154.42 2.56 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.409 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.42 -45.7 6.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.745 . . . . 1.0 109.132 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -122.13 56.14 1.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 83' ' ' ARG . 2.2 tmtm? -73.74 144.24 45.76 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.52 -0.737 . . . . 1.0 109.79 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -73.62 -20.24 60.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.664 -0.647 . . . . 1.0 109.624 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -47.93 14.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 1.0 109.675 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.846 HG11 ' CG1' ' A' ' 64' ' ' VAL . 59.5 t -65.26 -36.32 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.705 -0.622 . . . . 1.0 110.262 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 91' ' ' TRP . 10.2 pt-20 -65.19 -34.33 78.12 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.985 -1.072 . . . . 1.0 109.342 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.412 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.3 m95 -65.26 -55.65 17.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.598 -0.689 . . . . 1.0 109.47 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.798 HD13 ' CG ' ' A' ' 23' ' ' LEU . 1.6 pp -62.02 -34.53 76.38 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.784 -0.573 . . . . 1.0 109.935 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HD2' HG12 ' A' ' 89' ' ' VAL . 2.4 mtpp -61.24 -50.03 74.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.0 109.501 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -56.82 -37.56 71.38 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.776 -0.578 . . . . 1.0 109.531 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.907 -0.496 . . . . 1.0 110.091 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.96 -44.46 94.49 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -65.89 -37.61 86.58 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.896 -0.767 . . . . 1.0 109.647 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.1 tm? -61.13 -46.62 89.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.3 -34.73 79.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 1.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' CB ' HD13 ' A' ' 101' ' ' LEU . 12.2 mt-10 -60.25 -55.2 36.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.588 -0.695 . . . . 1.0 110.154 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -140.13 162.72 34.56 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.522 -0.736 . . . . 1.0 110.247 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.164 0 CA-C-O 117.725 -1.131 . . . . 1.0 110.137 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.234 0.54 . . . . 1.0 109.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.768 ' C ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -109.91 161.46 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.034 -1.099 . . . . 1.0 108.034 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.953 ' CB ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -125.11 120.73 32.25 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 117.957 -1.497 . . . . 1.0 109.356 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.23 162.06 26.84 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.359 -1.877 . . . . 1.0 112.542 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.651 HG22 HG13 ' A' ' 64' ' ' VAL . 11.3 pt -98.12 139.95 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.015 ' CD1' HG13 ' A' ' 37' ' ' VAL . 9.8 tp -99.46 151.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.22 1.01 . . . . 1.0 111.273 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 N--CA 1.49 1.574 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.366 179.154 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.265 0.555 . . . . 1.0 109.547 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.664 HG23 HD11 ' A' ' 26' ' ' ILE . 7.0 m -141.25 169.6 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.639 0.733 . . . . 1.0 110.428 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.41 127.98 56.3 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 120.11 -0.636 . . . . 1.0 110.733 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.015 HG13 ' CD1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.7 148.57 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.705 1.241 . . . . 1.0 112.333 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.66 135.12 55.2 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.227 -2.508 . . . . 1.0 104.227 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -140.16 160.42 39.99 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.591 -1.644 . . . . 1.0 114.462 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.0 tp -93.55 179.51 5.36 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.903 -1.888 . . . . 1.0 105.903 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.573 ' HB3' HG13 ' A' ' 22' ' ' ILE . 9.1 t70 75.3 22.66 1.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.05 -2.574 . . . . 1.0 104.05 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.67 55.98 15.11 Favored Glycine 0 N--CA 1.5 2.918 0 CA-C-N 115.028 -0.987 . . . . 1.0 113.961 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.764 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -145.75 154.48 42.09 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.467 2.134 . . . . 1.0 113.395 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.59 117.8 10.7 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.82 164.91 31.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.768 -1.173 . . . . 1.0 113.256 -175.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.533 HD11 ' HG2' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -97.55 125.1 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.794 -2.298 . . . . 1.0 104.794 175.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.728 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.92 142.93 16.38 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 120.795 -1.19 . . . . 1.0 112.157 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.6 ptm180 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.329 0.585 . . . . 1.0 109.783 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 108.734 -0.839 . . . . 1.0 108.734 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.931 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.69 142.86 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.788 -1.195 . . . . 1.0 109.297 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.885 HG12 ' HA ' ' A' ' 82' ' ' TRP . 33.6 m -142.63 155.26 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.753 0.787 . . . . 1.0 111.435 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.535 HG22 ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -99.93 134.54 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.832 HG12 HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -119.22 153.42 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-O 123.051 1.405 . . . . 1.0 113.793 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 ttpp -108.27 146.94 34.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 113.616 -1.629 . . . . 1.0 106.667 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.578 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.8 Cg_endo -88.36 138.03 3.81 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.307 2.005 . . . . 1.0 112.944 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.497 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.2 m0 . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.983 0.896 . . . . 1.0 111.779 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' HD11 ' A' ' 46' ' ' LEU . 2.9 mttm -98.22 152.29 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.728 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 18.1 p -143.91 151.67 40.12 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 119.975 -1.703 . . . . 1.0 111.681 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.61 118.51 37.08 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.832 HG22 HG12 ' A' ' 67' ' ' VAL . 2.2 pt -113.5 155.03 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.904 1.335 . . . . 1.0 114.594 -174.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -116.61 128.63 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 105.388 -2.079 . . . . 1.0 105.388 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.1 t90 -97.24 142.23 29.38 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.923 0.868 . . . . 1.0 111.446 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.931 HG11 ' CG1' ' A' ' 64' ' ' VAL . 51.4 t . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.198 -0.667 . . . . 1.0 109.198 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -61.9 -35.4 78.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 1.0 109.102 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -55.16 19.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.595 . . . . 1.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.953 HD13 ' CB ' ' A' ' 23' ' ' LEU . 2.3 pp -61.83 -37.98 86.49 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.778 -0.576 . . . . 1.0 110.308 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.632 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -65.34 -44.6 87.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.407 -0.808 . . . . 1.0 109.24 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 23.9 mtp85 -57.62 -36.94 72.46 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.33 -33.27 75.46 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.64 -44.93 95.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.606 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.02 -39.42 90.2 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.841 -0.8 . . . . 1.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.654 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.2 tm? -59.28 -48.76 80.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.771 -0.581 . . . . 1.0 109.667 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.78 -43.15 99.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.646 -0.659 . . . . 1.0 109.953 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.931 0 O-C-N 121.616 -0.678 . . . . 1.0 110.155 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.496 1.825 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.689 HG21 ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -113.46 161.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.85 HD11 ' CD1' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -123.86 134.01 53.66 Favored 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 117.542 -1.663 . . . . 1.0 109.434 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -141.47 155.36 25.2 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 118.033 -2.032 . . . . 1.0 112.854 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 38' ' ' ARG . 1.6 pp -99.33 138.81 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.082 -1.822 . . . . 1.0 106.082 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 82' ' ' TRP . 3.1 pt -99.99 145.82 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.428 1.109 . . . . 1.0 111.954 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.488 1.464 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.029 178.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.843 0.83 . . . . 1.0 110.329 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG11 ' HB ' ' A' ' 26' ' ' ILE . 1.0 OUTLIER -117.26 161.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 144.75 29.94 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.74 ' CG2' HG22 ' A' ' 26' ' ' ILE . 1.7 t -134.78 144.77 33.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.458 1.123 . . . . 1.0 111.867 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -110.77 141.51 43.99 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.332 -2.47 . . . . 1.0 104.332 174.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -139.92 154.72 47.3 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 117.159 -1.816 . . . . 1.0 114.536 -175.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD23 ' HE3' ' A' ' 93' ' ' LYS . 10.1 tp -92.71 171.7 8.83 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.299 -1.741 . . . . 1.0 106.299 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.677 ' HB3' HG22 ' A' ' 22' ' ' ILE . 1.1 t70 78.41 23.0 0.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.987 -2.597 . . . . 1.0 103.987 -171.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 53.17 34.37 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-N 114.92 -1.036 . . . . 1.0 115.028 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.689 ' HD3' HG21 ' A' ' 22' ' ' ILE . 2.8 mptt -146.13 153.11 40.3 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.685 2.242 . . . . 1.0 112.557 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 117.25 16.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.622 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.94 164.53 32.63 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.463 -0.895 . . . . 1.0 111.905 -176.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.76 127.53 40.82 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.018 -2.215 . . . . 1.0 105.018 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.644 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.49 140.24 14.94 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.892 -1.13 . . . . 1.0 111.871 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 ptm85 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.462 0.648 . . . . 1.0 109.72 179.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' HD11 ' A' ' 26' ' ' ILE . 4.5 m-20 . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' ARG . 5.9 p -97.18 138.62 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.839 -1.163 . . . . 1.0 108.168 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -141.75 142.71 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.841 -0.744 . . . . 1.0 111.282 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.739 HG12 HD11 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -99.11 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 104.475 -2.417 . . . . 1.0 104.475 176.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -126.52 156.55 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.972 -1.491 . . . . 1.0 113.667 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.14 153.03 41.28 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 106.747 -1.575 . . . . 1.0 106.747 177.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 38.5 Cg_endo -89.03 140.0 3.85 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.412 2.075 . . . . 1.0 113.06 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.0 m95 . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.517 0.675 . . . . 1.0 110.931 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 1.7 mttm -112.54 152.13 29.18 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.644 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 28.9 p -145.72 153.61 41.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 119.908 -1.745 . . . . 1.0 112.289 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 3.1 t0 -98.91 124.37 43.81 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.72 -2.326 . . . . 1.0 104.72 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.874 HG22 HG12 ' A' ' 67' ' ' VAL . 3.7 pt -122.33 149.97 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 117.484 -1.686 . . . . 1.0 114.72 -175.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.739 HD11 HG12 ' A' ' 66' ' ' ILE . 2.5 pt -121.98 119.51 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.838 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.42 159.83 14.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.009 0.909 . . . . 1.0 112.187 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.076 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 23' ' ' LEU . 44.4 t . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 109.568 -0.53 . . . . 1.0 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.19 -41.85 93.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.696 -0.627 . . . . 1.0 109.648 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -60.01 -46.69 88.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.72 -0.613 . . . . 1.0 109.477 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.85 ' CD1' HD11 ' A' ' 23' ' ' LEU . 60.8 mt -63.68 -38.02 89.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.601 -0.687 . . . . 1.0 110.252 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.538 ' HE3' HD23 ' A' ' 40' ' ' LEU . 15.0 mmtt -61.94 -50.21 73.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.523 -0.736 . . . . 1.0 109.018 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.651 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -57.59 -35.46 70.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.675 ' HA ' HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -62.22 -34.76 77.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.859 -0.526 . . . . 1.0 109.94 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.69 -39.79 90.3 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.847 -1.301 . . . . 1.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.7 m-85 -65.99 -53.05 43.71 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 1.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.2 pp -60.78 -37.65 82.61 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.423 -0.798 . . . . 1.0 109.514 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.447 ' N ' HD12 ' A' ' 98' ' ' LEU . 1.7 t70 -65.76 -42.76 90.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.668 -0.645 . . . . 1.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.982 0 O-C-N 121.989 -0.444 . . . . 1.0 110.118 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 121.334 0.588 . . . . 1.0 109.613 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -103.67 161.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.33 -0.857 . . . . 1.0 109.06 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' HB2' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -114.07 119.93 38.83 Favored 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 117.636 -1.626 . . . . 1.0 109.215 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 67' ' ' VAL . . . -122.55 161.54 16.71 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.971 -1.585 . . . . 1.0 112.937 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 37' ' ' VAL . 1.1 pp -124.0 137.07 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.443 -1.688 . . . . 1.0 106.443 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -99.15 154.98 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.591 1.186 . . . . 1.0 112.602 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 N--CA 1.49 1.538 0 CA-C-N 113.455 -1.702 . . . . 1.0 108.154 178.389 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.353 0.597 . . . . 1.0 109.642 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.85 169.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 122.057 0.932 . . . . 1.0 110.386 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -97.07 127.98 43.56 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.237 -1.394 . . . . 1.0 107.237 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 80' ' ' ILE . 1.5 t -131.36 152.32 37.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.426 1.108 . . . . 1.0 111.838 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.8 149.34 48.69 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.43 158.17 43.86 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.134 -176.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.712 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -94.62 176.38 6.3 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.756 ' HB3' HG22 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 78.43 22.35 0.74 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.178 -2.527 . . . . 1.0 104.178 -171.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.84 9.44 Favored Glycine 0 N--CA 1.507 3.386 0 N-CA-C 115.759 1.064 . . . . 1.0 115.759 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mptt -146.85 158.4 43.91 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 121.201 2.5 . . . . 1.0 113.514 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 44' ' ' THR . 0.7 OUTLIER -140.54 118.39 11.76 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 106.148 -1.797 . . . . 1.0 106.148 176.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' HG3' ' CB ' ' A' ' 76' ' ' GLN . 2.4 mpp_? -147.17 165.26 30.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.081 -1.012 . . . . 1.0 113.392 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' HG ' ' A' ' 78' ' ' CYS . 4.8 mp -94.94 129.12 42.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.347 -2.464 . . . . 1.0 104.347 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.1 137.95 13.71 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.709 -1.234 . . . . 1.0 112.053 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.479 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.835 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 89' ' ' VAL . 19.1 m -100.79 145.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.478 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 82' ' ' TRP . 2.9 m -144.7 157.65 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.655 0.741 . . . . 1.0 111.798 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.852 HG12 HG22 ' A' ' 81' ' ' ILE . 1.2 pt -99.56 132.36 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.591 -2.744 . . . . 1.0 103.591 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.864 HG12 ' CG1' ' A' ' 80' ' ' ILE . 1.4 m -122.25 155.36 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 118.106 -1.438 . . . . 1.0 114.257 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.4 mtpp -112.87 150.06 42.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.334 -1.757 . . . . 1.0 107.592 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.8 Cg_endo -89.94 141.07 3.58 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.617 2.212 . . . . 1.0 112.516 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.3 m0 . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.661 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 mt-30 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 122.233 1.016 . . . . 1.0 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.611 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 0.6 OUTLIER -109.35 155.2 21.5 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.554 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 25.6 p -144.19 151.74 39.91 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.195 -1.566 . . . . 1.0 111.319 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -98.6 118.7 35.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 103.737 -2.69 . . . . 1.0 103.737 176.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.882 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -120.95 138.2 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.377 -1.329 . . . . 1.0 113.49 -174.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.852 HG22 HG12 ' A' ' 66' ' ' ILE . 5.7 tt -115.23 120.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.871 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.8 p90 -97.99 160.13 14.49 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.416 1.103 . . . . 1.0 113.108 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 2.1 tpt180 . . . . . 0 N--CA 1.488 1.428 0 CA-C-N 114.765 -1.107 . . . . 1.0 108.734 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.843 ' HA ' HD12 ' A' ' 92' ' ' LEU . 92.5 t . . . . . 0 N--CA 1.499 1.993 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.29 -52.38 63.65 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 1.0 109.284 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -39.52 91.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.646 . . . . 1.0 109.419 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 89' ' ' VAL . 15.9 mt -58.35 -40.31 81.87 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HG3' HD13 ' A' ' 23' ' ' LEU . 15.3 mttm -64.13 -53.24 52.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.811 -0.555 . . . . 1.0 109.653 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 6.3 mtt-85 -55.45 -35.9 65.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.772 -0.58 . . . . 1.0 109.584 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HE2' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -64.43 -34.9 79.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.833 -0.542 . . . . 1.0 110.24 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.22 -40.5 92.33 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.3 m-85 -66.53 -53.1 38.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.826 -0.808 . . . . 1.0 111.043 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.691 HD11 ' HE2' ' A' ' 95' ' ' LYS . 3.3 pp -61.96 -40.14 94.56 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.429 -0.794 . . . . 1.0 109.841 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 t70 -65.88 -38.74 89.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.586 -0.696 . . . . 1.0 109.457 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 1.0 109.632 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.265 0.555 . . . . 1.0 109.761 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -114.63 161.77 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -126.95 123.07 36.32 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 117.722 -1.591 . . . . 1.0 109.658 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -140.55 163.63 26.45 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.215 -1.469 . . . . 1.0 112.232 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.58 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.027 ' HA ' HG22 ' A' ' 37' ' ' VAL . 1.7 pt -98.65 148.43 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 122.265 1.031 . . . . 1.0 111.595 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 35' ' ' VAL . 34.2 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-N 114.001 -1.454 . . . . 1.0 108.259 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.588 0.709 . . . . 1.0 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -99.96 162.44 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -98.18 131.17 44.77 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.027 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -134.85 153.09 34.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.986 0.898 . . . . 1.0 111.35 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 147.86 48.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.156 -1.794 . . . . 1.0 106.156 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -144.27 160.47 40.94 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.411 -1.316 . . . . 1.0 114.09 -176.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 40' ' ' LEU . 6.0 mt -93.93 177.47 5.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 22' ' ' ILE . 22.5 m-20 77.03 22.66 1.01 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 104.344 -2.465 . . . . 1.0 104.344 -172.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.43 52.25 13.71 Favored Glycine 0 N--CA 1.502 3.077 0 CA-C-O 118.708 -1.051 . . . . 1.0 115.234 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -146.76 151.5 37.27 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.094 2.447 . . . . 1.0 113.153 177.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 44' ' ' THR . 3.3 t -134.73 118.19 16.83 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 105.094 -2.188 . . . . 1.0 105.094 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.77 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.65 162.74 37.8 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.882 -1.127 . . . . 1.0 113.028 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -98.27 123.04 42.16 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 103.685 -2.709 . . . . 1.0 103.685 174.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.77 143.55 16.73 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.469 -1.348 . . . . 1.0 112.237 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' CB ' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.236 0 N-CA-C 110.156 -0.313 . . . . 1.0 110.156 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.648 HG23 ' CG2' ' A' ' 89' ' ' VAL . 1.5 p -96.21 136.81 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -140.92 139.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.621 -0.832 . . . . 1.0 110.982 -178.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 81' ' ' ILE . 1.7 pp -99.21 143.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.043 -2.206 . . . . 1.0 105.043 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 80' ' ' ILE . 1.5 m -140.28 159.31 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.611 -1.636 . . . . 1.0 114.677 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.8 OUTLIER -99.29 151.68 37.5 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 113.265 -1.789 . . . . 1.0 107.056 176.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.5 Cg_endo -90.04 141.25 3.56 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.409 2.073 . . . . 1.0 112.13 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m0 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . 1.5 mp0 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.869 0.843 . . . . 1.0 110.773 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 4.0 mttm -112.98 154.74 25.98 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 11.3 p -145.1 153.57 41.55 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 119.961 -1.712 . . . . 1.0 111.776 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.574 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 1.3 t70 -99.45 119.43 37.98 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 HG12 ' A' ' 67' ' ' VAL . 2.7 pt -120.84 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.392 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.673 HD11 HG12 ' A' ' 66' ' ' ILE . 5.0 pt -126.39 118.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.181 -2.155 . . . . 1.0 105.181 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.613 ' CA ' HG23 ' A' ' 65' ' ' VAL . 7.5 p-90 -105.51 160.44 15.16 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.099 0.952 . . . . 1.0 112.792 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 . . . . . 0 N--CA 1.494 1.727 0 CA-C-N 115.337 -0.847 . . . . 1.0 108.717 179.312 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 64' ' ' VAL . 87.3 t . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -44.06 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.636 -0.665 . . . . 1.0 109.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -58.31 -46.47 86.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.617 -0.677 . . . . 1.0 109.357 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.565 HD13 HD11 ' A' ' 23' ' ' LEU . 1.6 mt -63.58 -35.18 79.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.703 -0.623 . . . . 1.0 109.607 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HD2' HG12 ' A' ' 89' ' ' VAL . 1.1 mptp? -64.83 -50.27 67.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.666 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 15.7 mtm180 -54.75 -40.26 69.14 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' A' ' 98' ' ' LEU . 17.2 ttpp -63.06 -33.44 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.008 -0.433 . . . . 1.0 110.092 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.25 -38.83 94.12 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.261 -1.135 . . . . 1.0 110.261 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.4 m-85 -66.13 -53.88 32.41 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.756 -0.849 . . . . 1.0 110.735 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 95' ' ' LYS . 2.2 pp -62.52 -38.63 90.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -0.783 . . . . 1.0 110.08 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.9 -45.3 82.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.567 -0.708 . . . . 1.0 109.761 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.787 -0.571 . . . . 1.0 110.168 -179.797 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 109.275 -0.639 . . . . 1.0 109.275 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.826 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -113.63 161.24 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.32 -0.862 . . . . 1.0 109.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -118.49 126.21 51.54 Favored 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 118.384 -1.326 . . . . 1.0 109.234 -178.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -140.28 161.92 26.46 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 118.586 -1.768 . . . . 1.0 112.79 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.64 144.5 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 37' ' ' VAL . 3.7 pt -98.83 152.02 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.344 1.069 . . . . 1.0 111.985 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-N 114.204 -1.362 . . . . 1.0 108.617 178.902 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.568 0.699 . . . . 1.0 109.966 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 ' HB ' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -110.96 161.9 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.25 131.33 44.68 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -129.97 147.25 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.397 1.094 . . . . 1.0 111.701 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -117.99 139.29 51.38 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 105.461 -2.052 . . . . 1.0 105.461 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -141.28 160.38 40.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.883 -1.527 . . . . 1.0 114.195 -175.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HD2' ' A' ' 93' ' ' LYS . 6.1 mt -94.36 176.64 6.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.092 -1.413 . . . . 1.0 107.436 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.826 ' HB3' HG22 ' A' ' 22' ' ' ILE . 3.3 t70 76.74 23.09 1.07 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 103.961 -2.607 . . . . 1.0 103.961 -171.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 54.99 18.16 Favored Glycine 0 N--CA 1.502 3.096 0 CA-C-N 115.001 -1.0 . . . . 1.0 114.247 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.721 ' HB3' ' HD2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -146.38 155.05 42.32 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 120.573 2.187 . . . . 1.0 112.752 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.7 m -140.36 116.39 10.44 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.803 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.46 164.95 30.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.21 -0.996 . . . . 1.0 112.408 -175.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -95.3 126.31 40.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 104.464 -2.421 . . . . 1.0 104.464 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -94.76 131.49 10.73 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.67 -1.253 . . . . 1.0 111.535 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.501 0.667 . . . . 1.0 109.888 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.642 HG23 HG13 ' A' ' 89' ' ' VAL . 2.6 p -99.25 133.53 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 1.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.129 HG12 ' HA ' ' A' ' 82' ' ' TRP . 35.9 m -139.64 150.16 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.682 0.753 . . . . 1.0 111.249 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.804 HG12 HD11 ' A' ' 81' ' ' ILE . 1.6 pp -99.6 142.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.994 -2.224 . . . . 1.0 104.994 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 2.0 m -140.25 156.4 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 117.38 -1.728 . . . . 1.0 114.367 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 8.8 ptpt -101.1 153.73 37.59 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.941 -1.481 . . . . 1.0 108.168 176.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.449 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.0 Cg_endo -89.83 143.82 4.29 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.605 2.203 . . . . 1.0 112.168 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.54 ' CD2' ' HB3' ' A' ' 77' ' ' LYS . 11.1 m0 . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 107.834 -1.172 . . . . 1.0 107.834 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 42.0 mm-40 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.553 0.692 . . . . 1.0 110.557 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HB3' ' CD2' ' A' ' 70' ' ' TRP . 16.0 mttm -107.8 152.96 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 106.634 -1.617 . . . . 1.0 106.634 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.69 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 24.9 p -144.79 154.61 42.88 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.94 -1.725 . . . . 1.0 111.805 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 6.7 t70 -99.27 118.44 35.95 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 103.403 -2.814 . . . . 1.0 103.403 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.725 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -118.61 147.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 118.145 -1.422 . . . . 1.0 113.752 -174.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.804 HD11 HG12 ' A' ' 66' ' ' ILE . 2.0 pt -125.58 120.31 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 1.129 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -98.16 158.25 15.67 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.151 0.977 . . . . 1.0 112.993 -175.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 . . . . . 0 N--CA 1.491 1.599 0 CA-C-N 115.218 -0.901 . . . . 1.0 109.228 -179.586 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HG23 ' A' ' 64' ' ' VAL . 10.0 m . . . . . 0 N--CA 1.503 2.215 0 N-CA-C 110.254 -0.276 . . . . 1.0 110.254 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.53 -42.34 78.29 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.456 -0.777 . . . . 1.0 109.183 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.41 ' CH2' ' HD2' ' A' ' 95' ' ' LYS . 59.1 t90 -64.99 -42.5 94.45 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -60.15 -34.66 73.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.746 -0.596 . . . . 1.0 109.692 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HD2' HD13 ' A' ' 40' ' ' LEU . 1.6 mttt -63.63 -56.0 19.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.597 -0.69 . . . . 1.0 109.508 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -59.73 -36.46 76.61 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HD2' ' CH2' ' A' ' 91' ' ' TRP . 12.4 tttp -64.72 -33.57 76.27 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.07 -44.25 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.061 -1.215 . . . . 1.0 110.061 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.604 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.693 -0.886 . . . . 1.0 109.831 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.4 tm? -57.42 -56.52 20.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.901 -0.5 . . . . 1.0 109.913 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.44 -34.21 77.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.274 -0.891 . . . . 1.0 109.599 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.497 1.921 0 O-C-N 121.742 -0.599 . . . . 1.0 109.925 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.46 161.35 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -121.26 132.36 54.76 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.195 -1.402 . . . . 1.0 109.153 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -141.79 155.62 25.48 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 118.18 -1.962 . . . . 1.0 113.086 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 38' ' ' ARG . 9.8 tt -100.37 138.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 105.958 -1.867 . . . . 1.0 105.958 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.898 ' HA ' HG22 ' A' ' 37' ' ' VAL . 6.6 pt -98.36 149.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 122.589 1.185 . . . . 1.0 112.567 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 113.865 -1.516 . . . . 1.0 108.763 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.581 ' HD3' ' CB ' ' A' ' 46' ' ' LEU . 21.8 ttm-85 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.44 0.638 . . . . 1.0 109.381 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -111.05 161.82 9.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.445 ' HG2' ' N ' ' A' ' 37' ' ' VAL . 10.1 ttp180 -100.0 141.04 33.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.381 -1.34 . . . . 1.0 107.381 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.3 t -133.87 148.49 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.442 1.115 . . . . 1.0 112.018 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HG3' HG22 ' A' ' 25' ' ' ILE . 1.1 ptm180 -112.68 141.17 46.78 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 104.657 -2.349 . . . . 1.0 104.657 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -141.25 158.47 43.85 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.17 -1.812 . . . . 1.0 115.015 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.5 tp -93.42 172.78 8.07 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.775 -1.557 . . . . 1.0 107.477 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.528 ' HB3' HG22 ' A' ' 22' ' ' ILE . 2.1 t70 77.44 22.8 0.91 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 104.134 -2.543 . . . . 1.0 104.134 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.69 56.08 16.73 Favored Glycine 0 N--CA 1.501 3.018 0 CA-C-N 114.975 -1.011 . . . . 1.0 114.276 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -145.62 151.12 37.57 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 120.452 2.126 . . . . 1.0 112.661 178.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.557 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -133.93 117.92 17.3 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 176.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.997 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -145.95 162.57 37.51 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.001 -1.08 . . . . 1.0 112.847 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -97.89 117.89 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.401 -2.814 . . . . 1.0 103.401 174.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 80' ' ' ILE . . . -101.57 153.93 18.87 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.785 -1.198 . . . . 1.0 112.753 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.702 0.763 . . . . 1.0 110.143 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.56 137.84 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 120.502 -1.374 . . . . 1.0 109.183 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 82' ' ' TRP . 3.1 m -141.58 158.62 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.889 -0.724 . . . . 1.0 111.306 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.786 HG22 ' CG1' ' A' ' 81' ' ' ILE . 14.4 tt -99.57 149.03 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 105.045 -2.205 . . . . 1.0 105.045 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 1.3 m -134.22 157.4 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.6 -1.64 . . . . 1.0 114.54 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 41.4 mtmt -103.94 152.82 39.1 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 113.332 -1.758 . . . . 1.0 106.928 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 40.3 Cg_endo -89.16 141.39 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.684 2.256 . . . . 1.0 113.033 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.601 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m95 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 5.9 tt0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.457 0.646 . . . . 1.0 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 16.4 mttm -114.87 158.87 21.36 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 21.6 p -146.25 155.86 42.97 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.144 -1.597 . . . . 1.0 111.944 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.81 117.54 34.13 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 104.337 -2.468 . . . . 1.0 104.337 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.589 HG22 ' CB ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -120.01 161.35 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.312 1.597 . . . . 1.0 115.312 -174.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.786 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.2 pp -118.94 120.28 63.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 175.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.961 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -97.54 156.3 16.56 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.188 0.994 . . . . 1.0 112.709 -176.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.067 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 23' ' ' LEU . 48.9 t . . . . . 0 N--CA 1.499 1.982 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -63.22 -48.86 76.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.706 -0.621 . . . . 1.0 110.086 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -54.27 -50.54 67.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 1.0 109.395 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.4 mt -61.57 -39.05 89.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.758 -0.589 . . . . 1.0 109.622 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' A' ' 40' ' ' LEU . 10.1 mmtm -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.767 -0.583 . . . . 1.0 109.847 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.823 ' HA ' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.32 -55.32 32.83 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -25.17 67.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.94 -59.03 10.83 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.498 -0.858 . . . . 1.0 111.487 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.823 ' CZ ' ' HA ' ' A' ' 94' ' ' ARG . 10.4 p90 -70.58 -39.11 74.05 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.429 1.114 . . . . 1.0 110.308 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.5 -52.88 62.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.873 -0.517 . . . . 1.0 110.268 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.57 -42.15 95.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.591 -0.693 . . . . 1.0 109.778 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.582 -0.699 . . . . 1.0 109.585 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 1.0 110.741 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.711 HG23 ' SG ' ' A' ' 39' ' ' CYS . 1.2 mp -111.13 158.37 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.929 ' HB3' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -130.62 126.97 38.0 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 118.185 -1.406 . . . . 1.0 108.886 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -142.5 161.68 27.35 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 117.566 -2.254 . . . . 1.0 114.21 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -98.04 135.07 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 177.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.034 ' CD1' HG23 ' A' ' 37' ' ' VAL . 9.4 tp -104.57 152.72 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.498 1.142 . . . . 1.0 112.629 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 114.21 -1.359 . . . . 1.0 108.15 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 26' ' ' ILE . 6.5 m -137.38 168.51 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.742 0.782 . . . . 1.0 110.188 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.62 122.31 41.25 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.259 -0.577 . . . . 1.0 110.725 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -120.9 148.61 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 122.868 1.318 . . . . 1.0 111.78 -179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -110.03 139.89 44.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.899 -2.63 . . . . 1.0 103.899 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.711 ' SG ' HG23 ' A' ' 22' ' ' ILE . 1.8 p -141.32 162.56 35.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.334 -1.746 . . . . 1.0 115.665 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 41' ' ' ASP . 38.2 tp -89.84 169.49 11.21 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.91 -1.95 . . . . 1.0 105.926 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.608 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 15.6 m-20 78.83 24.5 0.55 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 104.527 -2.397 . . . . 1.0 104.527 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.44 58.57 13.69 Favored Glycine 0 N--CA 1.498 2.799 0 CA-C-N 114.738 -1.119 . . . . 1.0 113.434 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.659 ' CB ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -144.79 156.35 43.99 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.679 1.739 . . . . 1.0 112.994 178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.91 120.74 12.71 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.218 -1.771 . . . . 1.0 106.218 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.814 ' CZ ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.18 163.23 35.02 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.144 -1.422 . . . . 1.0 114.456 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 124.75 43.33 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' NH2' ' A' ' 45' ' ' ARG . . . -105.62 159.84 15.2 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.545 -1.312 . . . . 1.0 113.48 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 178.436 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 26' ' ' ILE . 9.3 t70 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.23 128.44 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.12 . . . . 1.0 108.205 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 82' ' ' TRP . 16.5 m -140.59 148.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.521 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 tt -98.72 141.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 22' ' ' ILE . 1.2 m -121.6 148.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.726 -1.234 . . . . 1.0 113.536 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -102.39 141.33 22.3 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 106.568 -1.641 . . . . 1.0 106.568 176.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 39.9 Cg_endo -88.64 137.25 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.967 1.778 . . . . 1.0 113.253 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.7 m0 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 106.757 -1.571 . . . . 1.0 106.757 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.668 ' HG3' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt20 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 122.627 1.204 . . . . 1.0 113.208 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -100.8 160.11 14.63 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.347 -1.723 . . . . 1.0 106.347 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.954 ' SG ' HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -146.98 160.22 42.63 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 119.764 -1.835 . . . . 1.0 111.618 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 1.2 p-10 -117.95 117.81 30.27 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.954 HG23 ' SG ' ' A' ' 78' ' ' CYS . 2.4 pt -115.16 160.58 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.34 122.29 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 105.227 -2.138 . . . . 1.0 105.227 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 1.002 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.36 148.12 23.99 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.325 0.584 . . . . 1.0 111.293 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.696 ' O ' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 121.393 0.616 . . . . 1.0 110.43 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 3.1 mt-10 -52.68 -37.86 59.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -66.2 -55.03 18.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.853 -0.529 . . . . 1.0 109.864 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.042 HD11 HG22 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -63.98 -51.3 64.96 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.459 -0.775 . . . . 1.0 111.076 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 1.2 pttt -59.02 -43.47 91.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.283 -0.886 . . . . 1.0 110.42 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.639 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -60.49 -39.1 86.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.411 -0.806 . . . . 1.0 108.988 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.637 ' HA ' HD21 ' A' ' 98' ' ' LEU . 5.5 mtpp -59.53 -33.82 71.86 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -66.22 -42.43 94.24 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.939 -1.264 . . . . 1.0 109.939 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.639 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.3 m-85 -66.46 -55.11 17.23 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.716 -0.873 . . . . 1.0 110.661 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.9 pp -59.78 -33.91 72.33 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.528 -0.733 . . . . 1.0 110.445 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.76 -51.04 64.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.486 -0.759 . . . . 1.0 109.764 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.636 -0.665 . . . . 1.0 110.194 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 121.196 0.522 . . . . 1.0 110.727 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.21 155.1 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 92' ' ' LEU . 1.6 pp -122.64 119.68 31.47 Favored 'General case' 0 N--CA 1.517 2.915 0 C-N-CA 118.045 -1.462 . . . . 1.0 109.172 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -139.39 160.75 26.02 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 117.7 -2.19 . . . . 1.0 113.705 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.703 HG23 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -99.09 130.9 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.485 -1.672 . . . . 1.0 106.485 177.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -99.56 154.55 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.255 1.026 . . . . 1.0 111.991 -177.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 N--CA 1.493 1.721 0 CA-C-N 114.931 -1.031 . . . . 1.0 108.697 179.459 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.361 0.601 . . . . 1.0 109.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' ILE . 10.7 m -129.38 168.68 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.201 1.0 . . . . 1.0 110.883 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -106.14 131.55 53.27 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 115.236 -0.893 . . . . 1.0 109.216 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -140.41 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.226 -0.921 . . . . 1.0 111.035 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.34 141.07 40.7 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -142.09 162.32 35.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.881 -1.528 . . . . 1.0 114.306 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -92.13 178.88 5.73 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 176.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 76.58 23.8 1.07 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 -171.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 43' ' ' LYS . . . 62.94 55.31 27.4 Favored Glycine 0 N--CA 1.5 2.919 0 CA-C-N 114.806 -1.088 . . . . 1.0 113.989 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 3.2 tptp -145.85 153.99 41.48 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.634 2.217 . . . . 1.0 113.474 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -135.39 117.49 15.41 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 104.682 -2.34 . . . . 1.0 104.682 175.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.733 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.17 160.83 41.42 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.764 -1.175 . . . . 1.0 112.977 -175.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.18 123.56 43.56 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 80' ' ' ILE . . . -96.9 146.07 18.13 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.433 -1.365 . . . . 1.0 112.652 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 108.945 -0.761 . . . . 1.0 108.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 89' ' ' VAL . 3.8 t -109.33 139.43 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.93 -1.106 . . . . 1.0 108.535 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 82' ' ' TRP . 34.6 m -140.2 152.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.973 0.892 . . . . 1.0 111.894 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.581 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.9 pt -99.61 139.68 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 105.501 -2.037 . . . . 1.0 105.501 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -139.49 158.74 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 117.312 -1.755 . . . . 1.0 114.272 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -100.68 154.88 36.92 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 107.504 -1.295 . . . . 1.0 107.504 176.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.8 Cg_endo -89.35 141.89 4.19 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.664 2.243 . . . . 1.0 112.549 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 12.3 m0 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.031 -1.47 . . . . 1.0 107.031 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 4.5 tt0 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.893 0.854 . . . . 1.0 111.388 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 37.2 mmtm -112.5 154.76 25.41 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 14.4 p -144.56 156.16 44.01 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 119.776 -1.828 . . . . 1.0 111.634 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -106.23 119.17 38.54 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 175.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.997 HG22 HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -106.65 161.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 115.575 1.694 . . . . 1.0 115.575 -174.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -120.29 123.61 70.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 103.781 -2.674 . . . . 1.0 103.781 175.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.937 ' HA ' HG12 ' A' ' 65' ' ' VAL . 6.6 t90 -96.29 138.0 34.54 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.951 0.881 . . . . 1.0 111.908 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.17 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 23' ' ' LEU . 3.4 t . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -44.24 80.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.495 -0.753 . . . . 1.0 109.51 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.461 ' CE3' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -65.09 -45.13 86.5 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.791 ' HB3' HD22 ' A' ' 23' ' ' LEU . 1.9 mt -57.69 -40.99 80.72 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.609 -0.682 . . . . 1.0 109.212 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CE ' HG12 ' A' ' 89' ' ' VAL . 6.5 mtmt -58.57 -50.09 75.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.609 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -56.38 -36.11 68.48 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 98' ' ' LEU . 7.4 tptt -62.22 -35.4 78.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.917 -0.489 . . . . 1.0 109.854 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.59 91.34 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.1 m-85 -66.18 -53.04 42.28 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.915 -0.756 . . . . 1.0 110.802 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.6 pp -62.17 -34.86 77.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.321 -0.862 . . . . 1.0 109.918 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -62.66 -38.98 92.45 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.693 . . . . 1.0 109.818 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 1.0 109.769 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 109.76 -0.459 . . . . 1.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -122.49 161.74 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.96 127.75 43.85 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 117.947 -1.501 . . . . 1.0 109.038 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -142.11 161.74 27.19 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 118.248 -1.929 . . . . 1.0 112.776 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -98.26 130.99 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -99.03 153.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.198 0.999 . . . . 1.0 111.398 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 N--CA 1.49 1.554 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.729 179.284 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.635 HG21 HG12 ' A' ' 26' ' ' ILE . 16.9 m -137.45 167.6 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.91 0.862 . . . . 1.0 110.79 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.537 ' HA ' HD12 ' A' ' 46' ' ' LEU . 8.6 ptt-85 -109.54 130.64 55.49 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -141.03 144.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.899 -1.12 . . . . 1.0 111.018 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.641 ' HG3' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -108.37 144.48 35.86 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 105.548 -2.019 . . . . 1.0 105.548 176.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.0 m -139.61 157.24 46.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.233 -1.387 . . . . 1.0 113.125 -176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.53 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.25 179.51 5.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.673 ' HB3' HG13 ' A' ' 22' ' ' ILE . 6.9 t70 76.44 23.41 1.15 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 103.561 -2.755 . . . . 1.0 103.561 -171.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.66 52.74 36.28 Favored Glycine 0 N--CA 1.5 2.903 0 CA-C-N 114.878 -1.056 . . . . 1.0 113.99 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -146.03 154.02 41.39 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 120.818 2.309 . . . . 1.0 112.796 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.71 118.03 13.68 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -147.65 164.4 33.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.049 -1.06 . . . . 1.0 112.808 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.8 mm? -97.42 132.63 42.95 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.084 -2.191 . . . . 1.0 105.084 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.21 150.62 19.67 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.745 -1.217 . . . . 1.0 111.909 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.1 ptm180 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.481 0.658 . . . . 1.0 109.787 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.618 ' O ' HG22 ' A' ' 25' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -102.45 141.74 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.805 -1.184 . . . . 1.0 109.906 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.959 HG12 ' HA ' ' A' ' 82' ' ' TRP . 17.8 m -142.0 159.29 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.612 0.72 . . . . 1.0 111.224 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 81' ' ' ILE . 1.1 tt -100.32 144.17 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.76 HG22 HG22 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -129.66 152.85 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 118.0 -1.48 . . . . 1.0 113.432 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 19.9 mttt -104.75 148.26 35.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 45' ' ' ARG . 39.5 Cg_endo -88.49 135.52 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.255 1.97 . . . . 1.0 112.875 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.714 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.3 m0 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 107.621 -1.252 . . . . 1.0 107.621 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 122.184 0.993 . . . . 1.0 112.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.714 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 24.1 tptt -102.34 150.68 23.09 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 106.125 -1.805 . . . . 1.0 106.125 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 17.4 p -143.15 151.44 40.69 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 119.97 -1.706 . . . . 1.0 111.466 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.67 120.33 39.53 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 67' ' ' VAL . 1.8 pp -119.95 156.64 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.064 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 66' ' ' ILE . 1.4 tp -118.47 128.91 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 105.487 -2.042 . . . . 1.0 105.487 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.959 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.89 147.58 24.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.748 0.785 . . . . 1.0 111.665 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.485 0.659 . . . . 1.0 109.605 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.783 ' HA ' HD21 ' A' ' 92' ' ' LEU . 86.1 t . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -63.18 -38.49 91.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.166 -0.959 . . . . 1.0 109.26 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -66.19 -55.57 15.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.775 -0.578 . . . . 1.0 110.251 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.93 HD13 ' HG ' ' A' ' 23' ' ' LEU . 1.4 pp -58.28 -33.88 69.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.655 -0.653 . . . . 1.0 109.848 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 92' ' ' LEU . 10.9 mtpp -58.49 -49.63 76.67 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.589 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -58.48 -35.47 72.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.02 -34.19 77.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.795 -0.566 . . . . 1.0 109.966 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.24 -44.81 93.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.055 -1.618 . . . . 1.0 109.055 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -65.93 -37.46 86.1 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 -56.03 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -34.68 73.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.872 -0.518 . . . . 1.0 109.943 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 1.0 110.176 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.117 0.484 . . . . 1.0 109.773 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 mp -110.26 162.13 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.893 ' O ' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.12 125.26 38.84 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 117.891 -1.524 . . . . 1.0 109.43 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.65 161.9 27.01 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.11 -1.995 . . . . 1.0 113.051 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.553 HG22 HG13 ' A' ' 64' ' ' VAL . 7.7 pt -98.29 131.67 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -100.5 156.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 122.182 0.992 . . . . 1.0 111.751 -177.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 121.43 0.633 . . . . 1.0 109.822 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.71 HG21 HG12 ' A' ' 26' ' ' ILE . 7.0 m -124.1 168.24 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 121.888 0.851 . . . . 1.0 110.384 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.778 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -108.15 132.01 54.05 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 178.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.453 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -140.91 145.38 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 118.939 -1.105 . . . . 1.0 111.274 -178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -111.09 141.36 44.7 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.654 -1.98 . . . . 1.0 105.654 176.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 2.2 m -137.88 157.43 46.42 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.253 -1.379 . . . . 1.0 113.176 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.82 ' HB3' HD11 ' A' ' 23' ' ' LEU . 3.7 tp -93.69 177.94 5.84 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.279 -1.748 . . . . 1.0 106.279 176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG13 ' A' ' 22' ' ' ILE . 2.8 t70 76.63 22.87 1.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 104.308 -2.479 . . . . 1.0 104.308 -172.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.61 18.03 Favored Glycine 0 N--CA 1.499 2.874 0 CA-C-N 115.079 -0.964 . . . . 1.0 113.998 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.18 153.46 41.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 120.465 2.133 . . . . 1.0 112.203 178.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.5 116.89 10.71 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.179 -2.156 . . . . 1.0 105.179 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -148.27 164.08 35.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.716 -1.193 . . . . 1.0 113.342 -175.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 36' ' ' ARG . 4.1 mm? -97.31 130.23 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 104.753 -2.314 . . . . 1.0 104.753 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.715 ' HA3' HG12 ' A' ' 80' ' ' ILE . . . -95.18 149.09 19.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.027 -1.082 . . . . 1.0 111.921 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.443 0.64 . . . . 1.0 109.981 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.846 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.36 140.74 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.753 -1.217 . . . . 1.0 109.776 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 82' ' ' TRP . 19.4 m -142.5 158.12 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.514 0.673 . . . . 1.0 111.071 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.822 HG22 ' CG1' ' A' ' 81' ' ' ILE . 1.8 tp -100.87 146.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.836 HG22 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -131.36 154.7 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 118.291 -1.364 . . . . 1.0 113.444 -177.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.1 mmpp? -107.48 149.32 38.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 106.507 -1.664 . . . . 1.0 106.507 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.1 Cg_endo -88.48 136.34 3.27 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.417 2.078 . . . . 1.0 112.956 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.7 m0 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 122.097 0.951 . . . . 1.0 111.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.667 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 4.8 tppt? -99.73 151.98 20.62 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.317 -1.735 . . . . 1.0 106.317 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.666 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 30.9 p -142.73 152.04 41.91 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.126 -1.609 . . . . 1.0 111.31 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.64 119.62 38.83 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 104.788 -2.301 . . . . 1.0 104.788 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 26' ' ' ILE . 1.3 pp -120.32 155.79 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 117.761 -1.576 . . . . 1.0 114.994 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.822 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.8 pp -117.21 132.35 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.72 -1.955 . . . . 1.0 105.72 175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.921 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.86 146.29 25.57 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.879 0.847 . . . . 1.0 111.462 -176.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.409 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.846 HG11 ' CG1' ' A' ' 64' ' ' VAL . 59.5 t . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 110.262 -0.273 . . . . 1.0 110.262 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 91' ' ' TRP . 10.2 pt-20 -65.19 -34.33 78.12 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.985 -1.072 . . . . 1.0 109.342 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.412 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.3 m95 -65.26 -55.65 17.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.598 -0.689 . . . . 1.0 109.47 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.798 HD13 ' CG ' ' A' ' 23' ' ' LEU . 1.6 pp -62.02 -34.53 76.38 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.784 -0.573 . . . . 1.0 109.935 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HD2' HG12 ' A' ' 89' ' ' VAL . 2.4 mtpp -61.24 -50.03 74.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.0 109.501 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -56.82 -37.56 71.38 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.776 -0.578 . . . . 1.0 109.531 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.907 -0.496 . . . . 1.0 110.091 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.96 -44.46 94.49 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -65.89 -37.61 86.58 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.896 -0.767 . . . . 1.0 109.647 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.1 tm? -61.13 -46.62 89.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.3 -34.73 79.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 1.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.5 2.037 0 O-C-N 121.588 -0.695 . . . . 1.0 110.154 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.076 0.465 . . . . 1.0 109.982 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.69 118.84 1.15 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.281 -0.887 . . . . 1.0 109.627 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -139.0 78.6 1.68 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.635 -0.666 . . . . 1.0 109.27 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.77 162.5 29.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.657 -0.652 . . . . 1.0 109.895 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.98 147.75 52.83 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.587 -0.696 . . . . 1.0 109.747 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 59.67 65.35 1.15 Allowed 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.543 0.687 . . . . 1.0 109.261 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -125.15 136.36 53.53 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 1.0 109.693 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -84.24 111.88 19.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.585 -0.697 . . . . 1.0 109.127 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -89.84 151.09 21.94 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.634 -0.666 . . . . 1.0 110.203 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.711 HG22 HG21 ' A' ' 87' ' ' THR . 32.5 pt -67.37 -33.8 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.79 -0.569 . . . . 1.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.36 17.69 9.62 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.467 -0.771 . . . . 1.0 110.981 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.605 HG12 HD12 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -83.54 -179.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.69 -0.631 . . . . 1.0 109.599 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.489 ' H ' HG22 ' A' ' 12' ' ' VAL . 9.3 ttt180 67.48 67.63 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.528 -0.733 . . . . 1.0 109.289 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG13 ' HD2' ' A' ' 15' ' ' PRO . 4.6 tp -91.59 135.98 27.18 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.597 -0.689 . . . . 1.0 109.602 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' HG13 ' A' ' 14' ' ' ILE . 34.6 Cg_endo -76.43 178.74 7.16 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 122.635 2.223 . . . . 1.0 110.9 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 65.44 101.11 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.311 0.577 . . . . 1.0 109.826 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.04 72.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.55 0.69 . . . . 1.0 109.284 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -69.78 -51.76 31.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.52 -0.737 . . . . 1.0 109.826 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.01 25.41 11.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.619 -0.676 . . . . 1.0 110.035 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 64.12 175.13 0.18 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.374 -0.829 . . . . 1.0 110.341 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -126.23 172.94 9.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.513 -0.742 . . . . 1.0 109.741 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.768 ' C ' HD13 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -109.91 161.46 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 108.034 -1.099 . . . . 1.0 108.034 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.953 ' CB ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -125.11 120.73 32.25 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 117.957 -1.497 . . . . 1.0 109.356 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.23 162.06 26.84 Favored Glycine 0 N--CA 1.497 2.753 0 C-N-CA 118.359 -1.877 . . . . 1.0 112.542 -177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.651 HG22 HG13 ' A' ' 64' ' ' VAL . 11.3 pt -98.12 139.95 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.995 -1.113 . . . . 1.0 107.995 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.015 ' CD1' HG13 ' A' ' 37' ' ' VAL . 9.8 tp -99.46 151.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.22 1.01 . . . . 1.0 111.273 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -143.82 138.42 28.68 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.884 -1.053 . . . . 1.0 109.366 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.687 ' HG3' ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER 167.54 123.61 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.187 0.518 . . . . 1.0 110.118 178.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.441 ' SD ' ' HG2' ' A' ' 60' ' ' ARG . 10.7 tpt -109.67 -29.72 8.22 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.813 -0.555 . . . . 1.0 109.64 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.76 -56.48 20.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.573 -0.705 . . . . 1.0 109.765 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.7 75.83 1.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.0 37.47 4.21 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.693 -0.887 . . . . 1.0 109.444 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.61 1.28 3.3 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.628 -0.67 . . . . 1.0 110.9 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.9 155.26 46.33 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.0 109.547 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.687 ' HA ' ' HG3' ' A' ' 28' ' ' GLN . 7.0 m -141.25 169.6 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-O 121.639 0.733 . . . . 1.0 110.428 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.41 127.98 56.3 Favored 'General case' 0 N--CA 1.51 2.565 0 C-N-CA 120.11 -0.636 . . . . 1.0 110.733 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.015 HG13 ' CD1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.7 148.57 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 122.705 1.241 . . . . 1.0 112.333 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.66 135.12 55.2 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 104.227 -2.508 . . . . 1.0 104.227 175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 1.7 m -140.16 160.42 39.99 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 117.591 -1.644 . . . . 1.0 114.462 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.0 tp -93.55 179.51 5.36 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 105.903 -1.888 . . . . 1.0 105.903 175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' HB3' HG13 ' A' ' 22' ' ' ILE . 9.1 t70 75.3 22.66 1.66 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 104.05 -2.574 . . . . 1.0 104.05 -172.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.67 55.98 15.11 Favored Glycine 0 N--CA 1.5 2.918 0 CA-C-N 115.028 -0.987 . . . . 1.0 113.961 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.764 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -145.75 154.48 42.09 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 120.467 2.134 . . . . 1.0 113.395 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.59 117.8 10.7 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 105.042 -2.207 . . . . 1.0 105.042 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.707 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -146.82 164.91 31.32 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.768 -1.173 . . . . 1.0 113.256 -175.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.533 HD11 ' HG2' ' A' ' 77' ' ' LYS . 0.5 OUTLIER -97.55 125.1 42.06 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.794 -2.298 . . . . 1.0 104.794 175.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.728 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.92 142.93 16.38 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 120.795 -1.19 . . . . 1.0 112.157 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.6 ptm180 -121.39 149.49 42.91 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.329 0.585 . . . . 1.0 109.783 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -126.86 156.49 73.82 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 -179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 53' ' ' LEU . 33.3 Cg_endo -74.43 167.93 25.98 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 C-N-CA 122.619 2.212 . . . . 1.0 111.118 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.52 -45.45 93.08 Favored Glycine 0 N--CA 1.5 2.96 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -58.25 -55.09 39.43 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.637 -0.92 . . . . 1.0 109.9 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HB3' HG12 ' A' ' 49' ' ' ILE . 1.8 mp -65.58 -33.97 77.14 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.732 -0.605 . . . . 1.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -52.1 -48.36 64.79 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.445 -0.785 . . . . 1.0 110.782 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.07 3.63 51.11 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.508 -0.745 . . . . 1.0 110.667 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttm-85 -116.12 -15.95 11.06 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.261 -0.899 . . . . 1.0 110.85 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.573 HG22 ' CE3' ' A' ' 82' ' ' TRP . 1.1 pp -80.9 -52.43 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.147 -0.971 . . . . 1.0 110.418 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.7 m95 43.84 53.64 6.07 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.443 0.64 . . . . 1.0 110.157 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG12 ' CD1' ' A' ' 82' ' ' TRP . 33.0 m -70.65 133.79 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.461 -0.774 . . . . 1.0 109.908 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HG2' ' SD ' ' A' ' 29' ' ' MET . 8.5 ttt-85 -93.0 -66.92 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -174.49 113.67 0.17 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.566 -0.709 . . . . 1.0 109.854 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.41 66.48 0.85 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.691 -0.964 . . . . 1.0 110.691 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -125.91 160.49 29.82 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.631 -0.923 . . . . 1.0 108.734 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.931 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.69 142.86 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.788 -1.195 . . . . 1.0 109.297 179.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.885 HG12 ' HA ' ' A' ' 82' ' ' TRP . 33.6 m -142.63 155.26 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 121.753 0.787 . . . . 1.0 111.435 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.535 HG22 ' HB ' ' A' ' 81' ' ' ILE . 0.0 OUTLIER -99.93 134.54 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 106.166 -1.79 . . . . 1.0 106.166 176.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.832 HG12 HG22 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -119.22 153.42 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-O 123.051 1.405 . . . . 1.0 113.793 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 3.4 ttpp -108.27 146.94 34.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 CA-C-N 113.616 -1.629 . . . . 1.0 106.667 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.578 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.8 Cg_endo -88.36 138.03 3.81 Favored 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 122.307 2.005 . . . . 1.0 112.944 -177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.497 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.2 m0 -122.61 117.61 26.23 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 47.86 -147.75 0.21 Allowed 'General case' 0 N--CA 1.505 2.292 0 CA-C-N 119.095 0.861 . . . . 1.0 110.343 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.128 -0.983 . . . . 1.0 109.98 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 52.16 -158.71 0.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.373 -0.829 . . . . 1.0 110.088 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.52 25.68 17.38 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 109.225 -1.55 . . . . 1.0 109.225 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.56 136.62 0.26 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -111.3 154.19 24.86 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.826 -1.149 . . . . 1.0 111.779 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.533 ' HG2' HD11 ' A' ' 46' ' ' LEU . 2.9 mttm -98.22 152.29 19.54 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 105.556 -2.016 . . . . 1.0 105.556 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.728 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 18.1 p -143.91 151.67 40.12 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 119.975 -1.703 . . . . 1.0 111.681 -178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.61 118.51 37.08 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 104.567 -2.383 . . . . 1.0 104.567 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.832 HG22 HG12 ' A' ' 67' ' ' VAL . 2.2 pt -113.5 155.03 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 122.904 1.335 . . . . 1.0 114.594 -174.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' A' ' 66' ' ' ILE . 0.8 OUTLIER -116.61 128.63 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 105.388 -2.079 . . . . 1.0 105.388 176.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.885 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.1 t90 -97.24 142.23 29.38 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.923 0.868 . . . . 1.0 111.446 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -167.6 142.81 3.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -105.68 91.24 3.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 1.0 109.864 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 m 59.56 105.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.381 0.61 . . . . 1.0 110.594 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.444 ' HB3' ' HD2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -138.75 -74.67 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.39 -0.819 . . . . 1.0 109.872 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.711 HG21 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -175.81 -43.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -59.41 -57.39 13.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.682 -0.636 . . . . 1.0 109.509 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.931 HG11 ' CG1' ' A' ' 64' ' ' VAL . 51.4 t -65.63 -34.33 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.535 -0.728 . . . . 1.0 109.198 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -61.9 -35.4 78.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.338 -0.851 . . . . 1.0 109.102 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -55.16 19.52 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.749 -0.595 . . . . 1.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.953 HD13 ' CB ' ' A' ' 23' ' ' LEU . 2.3 pp -61.83 -37.98 86.49 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.778 -0.576 . . . . 1.0 110.308 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.632 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -65.34 -44.6 87.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.407 -0.808 . . . . 1.0 109.24 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 23.9 mtp85 -57.62 -36.94 72.46 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.709 -0.848 . . . . 1.0 108.709 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.33 -33.27 75.46 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.64 -44.93 95.72 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.606 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.02 -39.42 90.2 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.841 -0.8 . . . . 1.0 109.43 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.654 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.2 tm? -59.28 -48.76 80.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.771 -0.581 . . . . 1.0 109.667 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.78 -43.15 99.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.646 -0.659 . . . . 1.0 109.953 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -55.28 18.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.616 -0.678 . . . . 1.0 110.155 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.54 -171.18 3.83 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.548 -0.72 . . . . 1.0 110.211 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.503 2.199 0 CA-C-O 118.63 -0.7 . . . . 1.0 110.078 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.597 -0.519 . . . . 1.0 109.597 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.98 112.51 14.13 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.73 -0.606 . . . . 1.0 109.669 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -128.7 144.98 51.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.697 -0.627 . . . . 1.0 109.487 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.04 144.65 56.7 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.649 -0.657 . . . . 1.0 109.979 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.05 120.04 17.1 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.615 -0.678 . . . . 1.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -145.86 -52.28 0.25 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.764 -0.585 . . . . 1.0 109.617 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.35 157.14 36.25 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.685 -0.634 . . . . 1.0 109.869 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.05 126.99 36.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 1.0 109.7 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.52 -171.7 2.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.745 -0.597 . . . . 1.0 109.572 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.44 98.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.48 -0.762 . . . . 1.0 109.826 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.93 -166.92 0.6 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -101.64 -176.32 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.309 -0.869 . . . . 1.0 110.013 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -168.88 150.46 4.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.801 -0.562 . . . . 1.0 109.762 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 HG21 ' HB2' ' A' ' 99' ' ' ASP . 2.9 tp -141.95 112.97 6.33 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.461 -0.774 . . . . 1.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.19 -37.32 0.8 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.852 2.368 . . . . 1.0 110.769 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -62.07 124.6 21.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.67 . . . . 1.0 109.461 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.4 16.52 13.02 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.657 -0.652 . . . . 1.0 110.585 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.25 166.16 17.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.272 -0.892 . . . . 1.0 109.803 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -101.55 58.48 0.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.526 -0.734 . . . . 1.0 109.257 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.37 45.67 1.14 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.475 -0.766 . . . . 1.0 109.428 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -108.89 134.06 52.08 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.286 -0.883 . . . . 1.0 109.77 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.689 HG21 ' HD3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -113.46 161.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 108.426 -0.953 . . . . 1.0 108.426 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.85 HD11 ' CD1' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -123.86 134.01 53.66 Favored 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 117.542 -1.663 . . . . 1.0 109.434 -179.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -141.47 155.36 25.2 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 118.033 -2.032 . . . . 1.0 112.854 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 38' ' ' ARG . 1.6 pp -99.33 138.81 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 106.082 -1.822 . . . . 1.0 106.082 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 82' ' ' TRP . 3.1 pt -99.99 145.82 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.428 1.109 . . . . 1.0 111.954 -177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -142.03 136.6 30.4 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.029 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.867 ' HB2' HG22 ' A' ' 35' ' ' VAL . 40.6 tt0 -143.54 96.61 2.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.655 -0.653 . . . . 1.0 109.584 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -43.04 9.59 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.5 mt -137.35 54.64 1.83 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -114.44 160.41 13.2 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -108.4 -73.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.59 -0.947 . . . . 1.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -107.07 -33.83 7.35 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.622 -0.674 . . . . 1.0 110.051 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.67 146.78 26.11 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.843 0.83 . . . . 1.0 110.329 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -117.26 161.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 144.75 29.94 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.018 -1.104 . . . . 1.0 108.018 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.74 ' CG2' HG22 ' A' ' 26' ' ' ILE . 1.7 t -134.78 144.77 33.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.458 1.123 . . . . 1.0 111.867 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HG3' HG13 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -110.77 141.51 43.99 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 104.332 -2.47 . . . . 1.0 104.332 174.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -139.92 154.72 47.3 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 117.159 -1.816 . . . . 1.0 114.536 -175.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD23 ' HE3' ' A' ' 93' ' ' LYS . 10.1 tp -92.71 171.7 8.83 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.299 -1.741 . . . . 1.0 106.299 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.677 ' HB3' HG22 ' A' ' 22' ' ' ILE . 1.1 t70 78.41 23.0 0.7 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 103.987 -2.597 . . . . 1.0 103.987 -171.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.3 53.17 34.37 Favored Glycine 0 N--CA 1.503 3.138 0 CA-C-N 114.92 -1.036 . . . . 1.0 115.028 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.689 ' HD3' HG21 ' A' ' 22' ' ' ILE . 2.8 mptt -146.13 153.11 40.3 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 120.685 2.242 . . . . 1.0 112.557 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.5 117.25 16.02 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.622 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -146.94 164.53 32.63 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.463 -0.895 . . . . 1.0 111.905 -176.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.76 127.53 40.82 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 105.018 -2.215 . . . . 1.0 105.018 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.644 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.49 140.24 14.94 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.892 -1.13 . . . . 1.0 111.871 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.3 ptm85 -100.11 139.07 36.31 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.462 0.648 . . . . 1.0 109.72 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.638 HG12 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -128.67 161.89 54.64 Favored Pre-proline 0 N--CA 1.495 1.786 0 N-CA-C 108.905 -0.776 . . . . 1.0 108.905 -179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.638 ' HD2' HG12 ' A' ' 49' ' ' ILE . 33.1 Cg_endo -74.57 -44.86 0.35 Allowed 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 122.444 2.096 . . . . 1.0 111.386 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.66 -9.1 2.59 Favored Glycine 0 N--CA 1.499 2.887 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.119 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' HB3' ' CH2' ' A' ' 82' ' ' TRP . 0.0 OUTLIER -59.39 -34.24 72.19 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.277 -1.131 . . . . 1.0 110.472 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.529 ' HG ' ' CD2' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -51.0 -39.93 56.96 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.629 -0.67 . . . . 1.0 110.662 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -61.78 -50.45 72.31 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.573 -0.704 . . . . 1.0 110.215 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -71.06 -21.83 62.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.617 -0.677 . . . . 1.0 110.734 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -65.47 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.318 -0.864 . . . . 1.0 110.165 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.37 150.74 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.378 -0.826 . . . . 1.0 110.159 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -156.54 33.49 0.32 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.644 -0.66 . . . . 1.0 109.902 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.0 m -132.7 -3.73 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.179 -0.951 . . . . 1.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.05 164.54 34.34 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.047 -1.033 . . . . 1.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.34 142.16 51.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 1.0 109.633 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.26 86.9 0.67 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.774 -1.331 . . . . 1.0 109.774 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' HD11 ' A' ' 26' ' ' ILE . 4.5 m-20 -127.7 162.19 27.15 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.749 -0.854 . . . . 1.0 109.28 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 83' ' ' ARG . 5.9 p -97.18 138.62 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.839 -1.163 . . . . 1.0 108.168 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 82' ' ' TRP . 0.5 OUTLIER -141.75 142.71 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.841 -0.744 . . . . 1.0 111.282 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.739 HG12 HD11 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -99.11 139.06 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 104.475 -2.417 . . . . 1.0 104.475 176.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.874 HG12 HG22 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -126.52 156.55 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.972 -1.491 . . . . 1.0 113.667 -175.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -107.14 153.03 41.28 Favored Pre-proline 0 N--CA 1.489 1.489 0 N-CA-C 106.747 -1.575 . . . . 1.0 106.747 177.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 38.5 Cg_endo -89.03 140.0 3.85 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.412 2.075 . . . . 1.0 113.06 -177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.575 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.0 m95 -123.8 119.02 28.5 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.21 134.2 47.82 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 119.064 0.847 . . . . 1.0 109.935 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 75' ' ' ASP . 2.1 p 177.02 104.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 121.51 0.671 . . . . 1.0 109.32 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -52.26 142.32 17.12 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 1.0 110.359 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.3 -46.41 1.17 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.616 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -165.93 177.58 7.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.63 -0.924 . . . . 1.0 108.844 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 -109.29 150.15 28.39 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.593 -1.317 . . . . 1.0 110.931 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 1.7 mttm -112.54 152.13 29.18 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.644 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 28.9 p -145.72 153.61 41.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 119.908 -1.745 . . . . 1.0 112.289 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HB2' ' HE2' ' A' ' 68' ' ' LYS . 3.1 t0 -98.91 124.37 43.81 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.72 -2.326 . . . . 1.0 104.72 176.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.874 HG22 HG12 ' A' ' 67' ' ' VAL . 3.7 pt -122.33 149.97 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 117.484 -1.686 . . . . 1.0 114.72 -175.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.739 HD11 HG12 ' A' ' 66' ' ' ILE . 2.5 pt -121.98 119.51 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.838 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.42 159.83 14.69 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.009 0.909 . . . . 1.0 112.187 -176.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER 179.26 -179.57 0.4 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 86' ' ' LYS . 52.0 m-85 31.3 78.29 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 120.553 0.216 . . . . 1.0 110.912 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.5 p -58.57 72.09 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.63 0.729 . . . . 1.0 110.394 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -167.03 -163.46 0.54 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 -179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 87' ' ' THR . 9.0 t -98.95 112.69 24.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.916 -1.115 . . . . 1.0 109.57 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.11 32.67 1.23 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.387 -0.82 . . . . 1.0 110.014 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 23' ' ' LEU . 44.4 t -65.24 -37.69 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.328 -0.858 . . . . 1.0 109.568 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -60.19 -41.85 93.81 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.696 -0.627 . . . . 1.0 109.648 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -60.01 -46.69 88.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.72 -0.613 . . . . 1.0 109.477 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.85 ' CD1' HD11 ' A' ' 23' ' ' LEU . 60.8 mt -63.68 -38.02 89.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.601 -0.687 . . . . 1.0 110.252 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.538 ' HE3' HD23 ' A' ' 40' ' ' LEU . 15.0 mmtt -61.94 -50.21 73.03 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.523 -0.736 . . . . 1.0 109.018 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.651 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -57.59 -35.46 70.44 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.675 ' HA ' HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -62.22 -34.76 77.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.859 -0.526 . . . . 1.0 109.94 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.69 -39.79 90.3 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.847 -1.301 . . . . 1.0 109.847 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.7 m-85 -65.99 -53.05 43.71 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 1.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.2 pp -60.78 -37.65 82.61 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.423 -0.798 . . . . 1.0 109.514 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB2' HG21 ' A' ' 14' ' ' ILE . 1.7 t70 -65.76 -42.76 90.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.668 -0.645 . . . . 1.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.36 -49.24 54.77 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.989 -0.444 . . . . 1.0 110.118 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 111.86 13.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.708 . . . . 1.0 109.401 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.469 ' HA ' HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.839 -1.076 . . . . 1.0 109.686 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 tpp . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 109.627 -0.509 . . . . 1.0 109.627 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.68 82.19 0.19 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.464 0.649 . . . . 1.0 109.557 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.5 83.06 2.38 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 1.0 109.531 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.22 84.35 1.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.534 -0.729 . . . . 1.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.27 131.14 46.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.547 -0.72 . . . . 1.0 109.608 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -84.29 105.53 15.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.641 -0.662 . . . . 1.0 109.487 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -93.88 -31.54 14.28 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.743 -0.598 . . . . 1.0 109.807 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -114.47 142.87 45.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.533 -0.73 . . . . 1.0 109.772 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -118.28 18.89 13.63 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.417 0.627 . . . . 1.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.5 tt -106.3 100.06 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.766 0.793 . . . . 1.0 109.7 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.34 -14.53 12.78 Favored 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.985 0.898 . . . . 1.0 111.079 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.672 HG22 ' H ' ' A' ' 13' ' ' ARG . 3.5 p -88.81 -149.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.221 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.672 ' H ' HG22 ' A' ' 12' ' ' VAL . 12.6 mmm180 79.82 12.6 1.09 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.39 -0.818 . . . . 1.0 110.59 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 tp -64.85 132.5 95.47 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.367 -0.833 . . . . 1.0 109.013 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.46 -82.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.568 2.179 . . . . 1.0 111.147 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.27 60.05 3.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.488 -0.758 . . . . 1.0 109.289 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -96.93 34.83 1.64 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.599 -0.688 . . . . 1.0 110.621 -179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -73.17 -141.96 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.057 -1.027 . . . . 1.0 109.434 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -139.74 33.6 2.0 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.806 -1.184 . . . . 1.0 110.388 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.08 -81.74 0.05 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.185 -0.947 . . . . 1.0 110.087 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.12 93.75 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.695 -0.628 . . . . 1.0 109.613 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -103.67 161.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.33 -0.857 . . . . 1.0 109.06 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.712 HD11 ' HB2' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -114.07 119.93 38.83 Favored 'General case' 0 N--CA 1.515 2.78 0 C-N-CA 117.636 -1.626 . . . . 1.0 109.215 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 67' ' ' VAL . . . -122.55 161.54 16.71 Favored Glycine 0 N--CA 1.497 2.703 0 C-N-CA 118.971 -1.585 . . . . 1.0 112.937 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 37' ' ' VAL . 1.1 pp -124.0 137.07 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.443 -1.688 . . . . 1.0 106.443 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -99.15 154.98 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 CA-C-O 122.591 1.186 . . . . 1.0 112.602 -177.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -141.11 127.68 20.12 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.455 -1.702 . . . . 1.0 108.154 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -98.76 150.99 21.26 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.511 -0.743 . . . . 1.0 109.97 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.2 ttm -95.22 -65.03 1.0 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.551 -0.718 . . . . 1.0 109.289 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -166.21 50.06 0.08 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.642 -0.662 . . . . 1.0 109.743 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 110.06 1.6 Allowed Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.688 -1.365 . . . . 1.0 109.688 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 154.96 6.87 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.853 -0.792 . . . . 1.0 109.805 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -68.08 -49.09 63.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.62 -0.675 . . . . 1.0 109.308 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.6 mtt85 -100.35 158.83 15.6 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.353 0.597 . . . . 1.0 109.642 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -124.85 169.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 122.057 0.932 . . . . 1.0 110.386 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -97.07 127.98 43.56 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 107.237 -1.394 . . . . 1.0 107.237 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.882 HG21 HD13 ' A' ' 80' ' ' ILE . 1.5 t -131.36 152.32 37.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.426 1.108 . . . . 1.0 111.838 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.8 149.34 48.69 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.697 -1.964 . . . . 1.0 105.697 175.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -143.43 158.17 43.86 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.451 -1.3 . . . . 1.0 113.134 -176.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.712 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -94.62 176.38 6.3 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 106.562 -1.644 . . . . 1.0 106.562 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.756 ' HB3' HG22 ' A' ' 22' ' ' ILE . 0.2 OUTLIER 78.43 22.35 0.74 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.178 -2.527 . . . . 1.0 104.178 -171.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.49 52.84 9.44 Favored Glycine 0 N--CA 1.507 3.386 0 N-CA-C 115.759 1.064 . . . . 1.0 115.759 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . 1.4 mptt -146.85 158.4 43.91 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 121.201 2.5 . . . . 1.0 113.514 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 44' ' ' THR . 0.7 OUTLIER -140.54 118.39 11.76 Favored 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 106.148 -1.797 . . . . 1.0 106.148 176.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.661 ' HG3' ' CB ' ' A' ' 76' ' ' GLN . 2.4 mpp_? -147.17 165.26 30.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.081 -1.012 . . . . 1.0 113.392 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.421 ' C ' ' HG ' ' A' ' 78' ' ' CYS . 4.8 mp -94.94 129.12 42.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 104.347 -2.464 . . . . 1.0 104.347 174.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.1 137.95 13.71 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 119.709 -1.234 . . . . 1.0 112.053 -175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.479 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -111.67 151.48 28.81 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.791 HG21 ' CZ3' ' A' ' 82' ' ' TRP . 1.2 pp -133.36 164.42 44.1 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.684 -0.635 . . . . 1.0 110.022 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 34.4 Cg_endo -76.0 -51.44 0.1 Allowed 'Trans proline' 0 C--N 1.319 -0.981 0 C-N-CA 122.745 2.297 . . . . 1.0 111.173 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.6 2.1 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.04 -41.96 84.39 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.723 -0.869 . . . . 1.0 109.874 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.06 -38.32 82.45 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.795 -0.566 . . . . 1.0 110.135 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -39.61 79.03 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.652 -0.655 . . . . 1.0 110.155 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.13 -23.03 38.62 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.539 -0.725 . . . . 1.0 110.415 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.5 24.84 11.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.336 -0.852 . . . . 1.0 110.634 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.463 ' CG1' HG22 ' A' ' 59' ' ' VAL . 9.2 tp -132.39 151.48 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 1.0 110.006 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -139.75 45.53 1.91 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 57' ' ' ILE . 29.2 m -112.97 170.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 1.0 110.278 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -113.39 -161.43 0.76 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.527 -0.546 . . . . 1.0 109.527 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 150.36 25.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.468 -0.77 . . . . 1.0 110.344 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.56 76.54 1.27 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.634 -1.386 . . . . 1.0 109.634 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.835 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -132.76 161.88 32.91 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.627 -0.925 . . . . 1.0 109.906 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.597 ' CG1' HG23 ' A' ' 89' ' ' VAL . 19.1 m -100.79 145.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.478 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' A' ' 82' ' ' TRP . 2.9 m -144.7 157.65 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.655 0.741 . . . . 1.0 111.798 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.852 HG12 HG22 ' A' ' 81' ' ' ILE . 1.2 pt -99.56 132.36 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 103.591 -2.744 . . . . 1.0 103.591 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.864 HG12 ' CG1' ' A' ' 80' ' ' ILE . 1.4 m -122.25 155.36 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 118.106 -1.438 . . . . 1.0 114.257 -175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.4 mtpp -112.87 150.06 42.22 Favored Pre-proline 0 N--CA 1.494 1.771 0 CA-C-N 113.334 -1.757 . . . . 1.0 107.592 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.8 Cg_endo -89.94 141.07 3.58 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 122.617 2.212 . . . . 1.0 112.516 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.611 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.3 m0 -124.93 119.91 30.11 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.76 134.23 49.47 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.646 1.112 . . . . 1.0 110.366 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.833 HG11 ' HD3' ' A' ' 77' ' ' LYS . 1.5 p 177.01 108.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-O 121.689 0.756 . . . . 1.0 109.579 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -55.02 142.18 31.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.399 -0.813 . . . . 1.0 110.693 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.79 -43.06 1.74 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.145 -1.182 . . . . 1.0 110.145 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.823 ' O ' HG13 ' A' ' 72' ' ' VAL . 4.5 p-10 -172.46 163.43 5.49 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.661 ' CB ' ' HG3' ' A' ' 45' ' ' ARG . 2.8 mt-30 -103.63 157.63 16.92 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.897 -1.521 . . . . 1.0 110.872 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.833 ' HD3' HG11 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -109.35 155.2 21.5 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.554 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 25.6 p -144.19 151.74 39.91 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.195 -1.566 . . . . 1.0 111.319 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -98.6 118.7 35.9 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 103.737 -2.69 . . . . 1.0 103.737 176.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.882 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -120.95 138.2 52.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.377 -1.329 . . . . 1.0 113.49 -174.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.852 HG22 HG12 ' A' ' 66' ' ' ILE . 5.7 tt -115.23 120.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 175.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.871 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.8 p90 -97.99 160.13 14.49 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.416 1.103 . . . . 1.0 113.108 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 2.1 tpt180 -173.13 163.53 4.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 114.765 -1.107 . . . . 1.0 108.734 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -171.73 108.97 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.856 -0.794 . . . . 1.0 108.856 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 86' ' ' LYS . 8.9 t -155.35 -41.7 0.08 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.604 -0.685 . . . . 1.0 110.413 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.418 ' N ' HG23 ' A' ' 85' ' ' THR . 4.0 ttpm? -152.55 -65.68 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 1.0 110.098 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -137.9 149.31 46.12 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.479 -0.763 . . . . 1.0 110.045 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.49 ' CB ' HG21 ' A' ' 64' ' ' VAL . 2.4 tp60 -163.83 -64.02 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.645 -0.66 . . . . 1.0 109.547 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.843 ' HA ' HD12 ' A' ' 92' ' ' LEU . 92.5 t -60.67 -34.06 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.69 -0.631 . . . . 1.0 109.665 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.29 -52.38 63.65 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.558 -0.714 . . . . 1.0 109.284 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -39.52 91.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.646 . . . . 1.0 109.419 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 89' ' ' VAL . 15.9 mt -58.35 -40.31 81.87 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.608 ' HG3' HD13 ' A' ' 23' ' ' LEU . 15.3 mttm -64.13 -53.24 52.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.811 -0.555 . . . . 1.0 109.653 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 6.3 mtt-85 -55.45 -35.9 65.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.772 -0.58 . . . . 1.0 109.584 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.691 ' HE2' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -64.43 -34.9 79.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.833 -0.542 . . . . 1.0 110.24 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.22 -40.5 92.33 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.3 m-85 -66.53 -53.1 38.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.826 -0.808 . . . . 1.0 111.043 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.691 HD11 ' HE2' ' A' ' 95' ' ' LYS . 3.3 pp -61.96 -40.14 94.56 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.429 -0.794 . . . . 1.0 109.841 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.2 t70 -65.88 -38.74 89.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.586 -0.696 . . . . 1.0 109.457 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -55.15 20.53 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 1.0 109.632 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.8 100.25 11.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.621 -0.674 . . . . 1.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.452 -0.785 . . . . 1.0 109.745 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptm . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.412 0.625 . . . . 1.0 109.676 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.69 35.54 4.75 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.435 -0.791 . . . . 1.0 109.817 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -117.07 110.38 18.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 1.0 109.275 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -167.49 -42.11 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.673 -0.642 . . . . 1.0 110.238 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.5 117.76 3.87 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.675 -0.64 . . . . 1.0 110.026 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.37 33.6 3.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.741 -0.6 . . . . 1.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -125.21 112.04 15.95 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.387 -0.821 . . . . 1.0 109.438 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.16 116.38 28.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.561 -0.712 . . . . 1.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.13 168.06 10.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.638 -0.664 . . . . 1.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -85.03 72.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-O 121.798 0.809 . . . . 1.0 109.185 179.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.09 145.96 37.53 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.382 -0.824 . . . . 1.0 109.854 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' HG2' ' A' ' 13' ' ' ARG . 16.2 m 40.21 -151.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 CA-C-O 120.886 0.374 . . . . 1.0 111.038 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 12' ' ' VAL . 12.9 mmt85 61.06 -174.89 0.12 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.442 -0.786 . . . . 1.0 110.256 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.49 HD12 HD13 ' A' ' 66' ' ' ILE . 2.8 tt -157.21 127.16 3.3 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.356 -0.84 . . . . 1.0 109.735 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HD2' HG13 ' A' ' 14' ' ' ILE . 35.5 Cg_endo -76.82 -25.41 9.15 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.732 2.288 . . . . 1.0 110.824 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.8 mmt85 -62.15 117.37 5.93 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.609 -0.682 . . . . 1.0 109.361 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -121.11 50.71 1.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.464 0.649 . . . . 1.0 109.362 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.59 -60.01 2.44 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.479 -0.763 . . . . 1.0 109.137 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -165.53 -56.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.13 132.4 3.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.797 -0.565 . . . . 1.0 109.637 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.27 167.41 9.84 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -114.63 161.77 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD11 HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -126.95 123.07 36.32 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 117.722 -1.591 . . . . 1.0 109.658 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.538 ' O ' HG12 ' A' ' 65' ' ' VAL . . . -140.55 163.63 26.45 Favored Glycine 0 N--CA 1.496 2.675 0 C-N-CA 119.215 -1.469 . . . . 1.0 112.232 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.6 pt -97.58 146.67 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.027 ' HA ' HG22 ' A' ' 37' ' ' VAL . 1.7 pt -98.65 148.43 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 CA-C-O 122.265 1.031 . . . . 1.0 111.595 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 35' ' ' VAL . 34.2 tt0 -140.87 130.19 23.7 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.001 -1.454 . . . . 1.0 108.259 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.596 ' HA ' HG22 ' A' ' 35' ' ' VAL . 12.9 pt20 -58.68 141.2 53.28 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.526 -0.734 . . . . 1.0 110.529 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.6 ttp -100.02 -138.6 0.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.37 -35.68 81.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.082 -1.011 . . . . 1.0 109.603 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.72 82.29 1.16 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.538 -1.425 . . . . 1.0 109.538 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.52 -65.18 0.32 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.789 -0.83 . . . . 1.0 109.793 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.47 -46.04 0.05 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.585 -0.697 . . . . 1.0 110.098 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -99.12 141.66 31.6 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.588 0.709 . . . . 1.0 110.09 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -99.96 162.44 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -98.18 131.17 44.77 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.662 -1.236 . . . . 1.0 107.662 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.027 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -134.85 153.09 34.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.986 0.898 . . . . 1.0 111.35 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.02 147.86 48.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.156 -1.794 . . . . 1.0 106.156 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -144.27 160.47 40.94 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 118.411 -1.316 . . . . 1.0 114.09 -176.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 40' ' ' LEU . 6.0 mt -93.93 177.47 5.98 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 175.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 22' ' ' ILE . 22.5 m-20 77.03 22.66 1.01 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 104.344 -2.465 . . . . 1.0 104.344 -172.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.43 52.25 13.71 Favored Glycine 0 N--CA 1.502 3.077 0 CA-C-O 118.708 -1.051 . . . . 1.0 115.234 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.714 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -146.76 151.5 37.27 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.094 2.447 . . . . 1.0 113.153 177.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 44' ' ' THR . 3.3 t -134.73 118.19 16.83 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 105.094 -2.188 . . . . 1.0 105.094 176.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.77 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -146.65 162.74 37.8 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.882 -1.127 . . . . 1.0 113.028 -175.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -98.27 123.04 42.16 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 103.685 -2.709 . . . . 1.0 103.685 174.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -95.77 143.55 16.73 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.469 -1.348 . . . . 1.0 112.237 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -99.43 140.76 33.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.74 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 3.1 pt -129.13 169.53 12.89 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.776 -0.578 . . . . 1.0 109.837 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.74 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 33.7 Cg_endo -75.11 -20.67 16.42 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.598 2.199 . . . . 1.0 111.535 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.34 -0.75 20.65 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.758 -0.937 . . . . 1.0 110.758 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -65.3 -33.85 76.95 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.325 -1.103 . . . . 1.0 110.33 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HB ' ' A' ' 57' ' ' ILE . 1.3 mt -53.58 -34.97 60.26 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.573 -0.704 . . . . 1.0 110.596 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -46.44 62.66 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.554 -0.716 . . . . 1.0 110.295 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -93.73 -33.53 13.58 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.58 -0.7 . . . . 1.0 110.334 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -64.18 0.97 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.591 -0.693 . . . . 1.0 110.227 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.718 HD11 ' HA ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -80.02 164.28 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.465 -0.772 . . . . 1.0 109.75 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -173.36 -44.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.564 -0.71 . . . . 1.0 111.214 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.91 -50.7 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.289 -0.882 . . . . 1.0 111.384 -178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.63 151.64 25.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.166 -0.959 . . . . 1.0 110.746 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.718 ' HA ' HD11 ' A' ' 57' ' ' ILE . 1.1 mp0 -123.18 -168.51 1.77 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.732 -0.605 . . . . 1.0 109.652 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.9 84.76 1.48 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.12 -1.592 . . . . 1.0 109.12 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' CB ' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -127.1 163.85 22.89 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.735 -0.862 . . . . 1.0 110.156 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.764 HG21 ' HB3' ' A' ' 88' ' ' GLN . 1.5 p -96.21 136.81 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.628 HG13 HG12 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -140.92 139.23 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.621 -0.832 . . . . 1.0 110.982 -178.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 81' ' ' ILE . 1.7 pp -99.21 143.44 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 105.043 -2.206 . . . . 1.0 105.043 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 80' ' ' ILE . 1.5 m -140.28 159.31 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.611 -1.636 . . . . 1.0 114.677 -175.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 0.8 OUTLIER -99.29 151.68 37.5 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 113.265 -1.789 . . . . 1.0 107.056 176.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 40.5 Cg_endo -90.04 141.25 3.56 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.409 2.073 . . . . 1.0 112.13 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m0 -121.93 118.35 28.66 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.02 133.31 50.53 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 118.767 0.712 . . . . 1.0 110.246 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' ' 75' ' ' ASP . 1.3 p 174.57 104.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 109.152 -0.684 . . . . 1.0 109.152 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.05 144.16 35.52 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.434 -0.791 . . . . 1.0 110.464 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.78 -40.11 2.53 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.102 -1.199 . . . . 1.0 110.102 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.776 ' O ' HG13 ' A' ' 72' ' ' VAL . 3.8 p-10 -169.93 151.16 4.01 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.546 -0.973 . . . . 1.0 108.458 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . 1.5 mp0 -97.97 155.74 16.95 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.62 -1.232 . . . . 1.0 110.773 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 4.0 mttm -112.98 154.74 25.98 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.596 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 11.3 p -145.1 153.57 41.55 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 119.961 -1.712 . . . . 1.0 111.776 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.574 ' HA ' ' HG3' ' A' ' 48' ' ' ARG . 1.3 t70 -99.45 119.43 37.98 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 103.88 -2.637 . . . . 1.0 103.88 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 HG12 ' A' ' 67' ' ' VAL . 2.7 pt -120.84 150.96 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.392 -174.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.673 HD11 HG12 ' A' ' 66' ' ' ILE . 5.0 pt -126.39 118.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.181 -2.155 . . . . 1.0 105.181 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.613 ' CA ' HG23 ' A' ' 65' ' ' VAL . 7.5 p-90 -105.51 160.44 15.16 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 122.099 0.952 . . . . 1.0 112.792 -175.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 ttt-85 179.39 -175.63 0.25 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.337 -0.847 . . . . 1.0 108.717 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 64' ' ' VAL . 9.8 m-85 44.11 84.36 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.351 0.596 . . . . 1.0 110.753 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.3 t -60.98 -22.52 64.56 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.372 -0.83 . . . . 1.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 87' ' ' THR . 3.9 tttt -80.36 -79.59 0.15 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.367 -0.833 . . . . 1.0 110.147 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 86' ' ' LYS . 1.3 p -156.27 166.28 33.89 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.388 -0.82 . . . . 1.0 110.774 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.764 ' HB3' HG21 ' A' ' 64' ' ' VAL . 12.2 tp60 178.14 -29.33 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.909 -0.495 . . . . 1.0 110.333 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.648 ' CG2' HG23 ' A' ' 64' ' ' VAL . 87.3 t -49.98 -38.4 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.512 -0.742 . . . . 1.0 110.004 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -44.06 86.27 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.636 -0.665 . . . . 1.0 109.75 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.411 ' CZ3' ' HB ' ' A' ' 12' ' ' VAL . 83.6 t90 -58.31 -46.47 86.1 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.617 -0.677 . . . . 1.0 109.357 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.565 HD13 HD11 ' A' ' 23' ' ' LEU . 1.6 mt -63.58 -35.18 79.66 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.703 -0.623 . . . . 1.0 109.607 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HD2' HG12 ' A' ' 89' ' ' VAL . 1.1 mptp? -64.83 -50.27 67.34 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.588 -0.695 . . . . 1.0 109.534 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.666 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 15.7 mtm180 -54.75 -40.26 69.14 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' A' ' 98' ' ' LEU . 17.2 ttpp -63.06 -33.44 75.45 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.008 -0.433 . . . . 1.0 110.092 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -66.25 -38.83 94.12 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.261 -1.135 . . . . 1.0 110.261 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.666 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 3.4 m-85 -66.13 -53.88 32.41 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.756 -0.849 . . . . 1.0 110.735 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 95' ' ' LYS . 2.2 pp -62.52 -38.63 90.72 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -0.783 . . . . 1.0 110.08 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.9 -45.3 82.51 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.567 -0.708 . . . . 1.0 109.761 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -65.18 -34.95 79.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.787 -0.571 . . . . 1.0 110.168 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.82 -58.24 9.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.527 -0.733 . . . . 1.0 109.865 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.7 tp . . . . . 0 N--CA 1.502 2.157 0 CA-C-O 117.661 -1.162 . . . . 1.0 110.276 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.78 37.66 4.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.693 -0.629 . . . . 1.0 109.702 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -134.87 39.71 2.96 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.413 -0.804 . . . . 1.0 109.526 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.57 145.11 17.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.415 -0.803 . . . . 1.0 109.863 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -82.48 166.56 19.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.682 -0.636 . . . . 1.0 109.906 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.17 118.4 6.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.571 -0.705 . . . . 1.0 109.725 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.44 -164.78 1.33 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.804 -0.56 . . . . 1.0 109.742 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 158.29 16.59 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.408 -0.807 . . . . 1.0 110.278 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -108.28 144.59 35.56 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.526 -0.734 . . . . 1.0 109.642 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -136.78 74.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.742 0.782 . . . . 1.0 109.303 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -107.87 17.32 22.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.438 -0.789 . . . . 1.0 110.289 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 13' ' ' ARG . 2.1 p -93.31 172.09 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.742 -0.599 . . . . 1.0 109.717 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.464 ' H ' HG22 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 70.33 96.08 0.07 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.368 0.604 . . . . 1.0 109.488 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 4.4 tp -118.6 134.9 23.46 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.607 -0.683 . . . . 1.0 109.659 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 35.5 Cg_endo -77.08 -163.75 0.23 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.679 2.252 . . . . 1.0 110.675 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 67.6 90.58 0.09 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.6 -0.688 . . . . 1.0 109.506 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.9 pttt -163.86 72.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.609 -0.682 . . . . 1.0 109.36 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -60.0 -58.74 7.24 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.539 -0.725 . . . . 1.0 109.58 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -69.63 0.85 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.606 -0.684 . . . . 1.0 109.25 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -156.73 117.51 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.71 -0.619 . . . . 1.0 109.681 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.97 156.87 37.14 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.605 -0.684 . . . . 1.0 109.275 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.826 HG22 ' HB3' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -113.63 161.24 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.32 -0.862 . . . . 1.0 109.255 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -118.49 126.21 51.54 Favored 'General case' 0 N--CA 1.513 2.721 0 C-N-CA 118.384 -1.326 . . . . 1.0 109.234 -178.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.607 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -140.28 161.92 26.46 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 118.586 -1.768 . . . . 1.0 112.79 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 pp -108.64 144.5 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.954 ' HA ' HG22 ' A' ' 37' ' ' VAL . 3.7 pt -98.83 152.02 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.344 1.069 . . . . 1.0 111.985 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -140.75 121.66 14.53 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.204 -1.362 . . . . 1.0 108.617 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.538 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -82.17 105.69 13.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.742 -0.599 . . . . 1.0 109.564 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.82 -33.11 71.88 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.646 -0.659 . . . . 1.0 109.913 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -162.7 -58.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 1.0 109.16 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.33 -119.93 0.74 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.706 -1.358 . . . . 1.0 109.706 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 62.13 -169.54 0.18 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.808 -0.819 . . . . 1.0 110.219 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.91 9.36 42.39 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.386 -0.821 . . . . 1.0 110.288 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.47 134.99 42.14 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.273 -0.892 . . . . 1.0 109.966 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -110.96 161.9 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 109.069 -0.715 . . . . 1.0 109.069 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -98.25 131.33 44.68 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.954 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.5 t -129.97 147.25 33.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 122.397 1.094 . . . . 1.0 111.701 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -117.99 139.29 51.38 Favored 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 105.461 -2.052 . . . . 1.0 105.461 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.607 ' HB2' ' CA ' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -141.28 160.38 40.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.883 -1.527 . . . . 1.0 114.195 -175.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD13 ' HD2' ' A' ' 93' ' ' LYS . 6.1 mt -94.36 176.64 6.23 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.092 -1.413 . . . . 1.0 107.436 176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.826 ' HB3' HG22 ' A' ' 22' ' ' ILE . 3.3 t70 76.74 23.09 1.07 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 103.961 -2.607 . . . . 1.0 103.961 -171.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.07 54.99 18.16 Favored Glycine 0 N--CA 1.502 3.096 0 CA-C-N 115.001 -1.0 . . . . 1.0 114.247 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.721 ' HB3' ' HD2' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -146.38 155.05 42.32 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 120.573 2.187 . . . . 1.0 112.752 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.7 m -140.36 116.39 10.44 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.803 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.46 164.95 30.87 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.21 -0.996 . . . . 1.0 112.408 -175.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -95.3 126.31 40.53 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 104.464 -2.421 . . . . 1.0 104.464 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -94.76 131.49 10.73 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.67 -1.253 . . . . 1.0 111.535 -175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -104.33 133.85 48.53 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.501 0.667 . . . . 1.0 109.888 179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -122.17 151.19 58.34 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.927 -0.768 . . . . 1.0 108.927 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' HG12 ' A' ' 49' ' ' ILE . 34.2 Cg_endo -76.02 -86.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 122.471 2.114 . . . . 1.0 110.115 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.68 7.93 3.63 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.585 -1.006 . . . . 1.0 110.585 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -66.19 -52.78 44.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -1.139 . . . . 1.0 109.768 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' HB2' HD13 ' A' ' 49' ' ' ILE . 2.9 tp -65.44 -41.95 92.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.738 -0.601 . . . . 1.0 110.441 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -26.2 68.52 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.437 -0.789 . . . . 1.0 111.09 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -99.74 -37.56 9.05 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.246 -0.909 . . . . 1.0 110.776 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.44 -9.77 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.443 -0.785 . . . . 1.0 111.323 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 53' ' ' LEU . 3.5 tp -48.39 135.05 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.44 -0.788 . . . . 1.0 110.451 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.44 -45.23 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.339 -0.615 . . . . 1.0 109.339 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.18 174.15 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.698 -0.626 . . . . 1.0 110.098 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.9 mtt-85 -71.82 -75.92 0.12 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.493 -0.754 . . . . 1.0 109.714 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -169.73 174.02 5.96 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 1.0 109.935 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.23 75.03 1.29 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.221 -1.552 . . . . 1.0 109.221 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.22 161.21 20.26 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.658 -0.907 . . . . 1.0 109.707 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.82 HG21 ' CB ' ' A' ' 88' ' ' GLN . 2.6 p -99.25 133.53 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.927 -1.108 . . . . 1.0 108.386 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.129 HG12 ' HA ' ' A' ' 82' ' ' TRP . 35.9 m -139.64 150.16 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.682 0.753 . . . . 1.0 111.249 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.804 HG12 HD11 ' A' ' 81' ' ' ILE . 1.6 pp -99.6 142.2 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.994 -2.224 . . . . 1.0 104.994 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.803 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 2.0 m -140.25 156.4 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 117.38 -1.728 . . . . 1.0 114.367 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 8.8 ptpt -101.1 153.73 37.59 Favored Pre-proline 0 N--CA 1.489 1.517 0 CA-C-N 113.941 -1.481 . . . . 1.0 108.168 176.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.449 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.0 Cg_endo -89.83 143.82 4.29 Favored 'Trans proline' 0 C--N 1.322 -0.86 0 C-N-CA 122.605 2.203 . . . . 1.0 112.168 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.54 ' CD2' ' HB3' ' A' ' 77' ' ' LYS . 11.1 m0 -123.82 119.14 28.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.834 -1.172 . . . . 1.0 107.834 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.12 131.41 44.24 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 119.43 1.014 . . . . 1.0 109.648 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 75' ' ' ASP . 1.9 p 178.84 103.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-O 121.507 0.67 . . . . 1.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -51.42 141.41 15.61 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.56 -0.712 . . . . 1.0 110.783 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.45 -47.06 1.08 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.634 -1.386 . . . . 1.0 109.634 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.797 ' O ' HG13 ' A' ' 72' ' ' VAL . 30.7 t70 -166.84 156.91 11.45 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' A' ' 45' ' ' ARG . 42.0 mm-40 -94.09 149.04 21.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.88 -1.137 . . . . 1.0 110.557 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.54 ' HB3' ' CD2' ' A' ' 70' ' ' TRP . 16.0 mttm -107.8 152.96 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 106.634 -1.617 . . . . 1.0 106.634 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.69 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 24.9 p -144.79 154.61 42.88 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.94 -1.725 . . . . 1.0 111.805 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 6.7 t70 -99.27 118.44 35.95 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 103.403 -2.814 . . . . 1.0 103.403 175.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.725 HD13 HG21 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -118.61 147.19 22.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 118.145 -1.422 . . . . 1.0 113.752 -174.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.804 HD11 HG12 ' A' ' 66' ' ' ILE . 2.0 pt -125.58 120.31 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 105.472 -2.047 . . . . 1.0 105.472 175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 1.129 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -98.16 158.25 15.67 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.151 0.977 . . . . 1.0 112.993 -175.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 tpt85 -176.26 163.4 2.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.218 -0.901 . . . . 1.0 109.228 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 48.21 -149.23 0.18 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.938 -0.476 . . . . 1.0 110.537 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 p -147.21 103.81 3.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.363 -0.836 . . . . 1.0 108.848 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.8 pttm 38.84 46.33 1.05 Allowed 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.339 0.59 . . . . 1.0 110.774 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.8 p -140.97 77.5 1.6 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.453 -0.779 . . . . 1.0 109.467 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.82 ' CB ' HG21 ' A' ' 64' ' ' VAL . 0.3 OUTLIER 177.41 -35.4 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.636 -0.665 . . . . 1.0 110.188 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.642 HG13 HG23 ' A' ' 64' ' ' VAL . 10.0 m -54.27 -34.79 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.538 -0.726 . . . . 1.0 110.254 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.53 -42.34 78.29 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.456 -0.777 . . . . 1.0 109.183 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.41 ' CH2' ' HD2' ' A' ' 95' ' ' LYS . 59.1 t90 -64.99 -42.5 94.45 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.6 ' HB3' HD22 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -60.15 -34.66 73.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.746 -0.596 . . . . 1.0 109.692 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.627 ' HD2' HD13 ' A' ' 40' ' ' LEU . 1.6 mttt -63.63 -56.0 19.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.597 -0.69 . . . . 1.0 109.508 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -59.73 -36.46 76.61 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HD2' ' CH2' ' A' ' 91' ' ' TRP . 12.4 tttp -64.72 -33.57 76.27 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.502 -0.555 . . . . 1.0 109.502 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.07 -44.25 94.54 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.061 -1.215 . . . . 1.0 110.061 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.604 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -66.23 -36.69 83.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.693 -0.886 . . . . 1.0 109.831 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.667 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.4 tm? -57.42 -56.52 20.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.901 -0.5 . . . . 1.0 109.913 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.44 -34.21 77.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.274 -0.891 . . . . 1.0 109.599 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.44 -37.05 74.62 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.742 -0.599 . . . . 1.0 109.925 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.531 ' C ' ' HG ' ' A' ' 102' ' ' LEU . 0.5 OUTLIER -69.89 -40.16 75.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 1.0 109.944 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.531 ' HG ' ' C ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.509 2.486 0 CA-C-O 119.159 -0.448 . . . . 1.0 110.884 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.12 -42.56 9.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.747 -0.595 . . . . 1.0 109.678 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 62.33 33.07 16.7 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.806 -0.559 . . . . 1.0 109.969 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -142.44 121.63 13.01 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.42 -0.8 . . . . 1.0 109.385 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.85 145.74 28.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.594 -0.691 . . . . 1.0 109.889 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -125.1 -57.29 1.51 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.667 -0.645 . . . . 1.0 109.429 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -140.64 -56.44 0.52 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.632 -0.667 . . . . 1.0 109.373 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -144.28 125.38 14.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.743 -0.598 . . . . 1.0 109.473 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -155.43 -160.37 1.03 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 1.0 109.774 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 pt -70.06 -163.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.413 -0.804 . . . . 1.0 109.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.36 176.81 0.27 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.478 -0.764 . . . . 1.0 109.486 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.65 152.33 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.184 -0.948 . . . . 1.0 110.128 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 14' ' ' ILE . 0.3 OUTLIER -132.85 -65.57 0.7 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.594 HG23 ' O ' ' A' ' 14' ' ' ILE . 5.8 tp 0.52 87.46 0.04 OUTLIER Pre-proline 0 N--CA 1.512 2.673 0 C-N-CA 123.554 0.742 . . . . 1.0 112.757 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.15 145.17 17.1 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.918 2.412 . . . . 1.0 110.395 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -112.6 141.27 46.57 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.512 -0.743 . . . . 1.0 109.688 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.57 22.05 16.47 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.605 -0.685 . . . . 1.0 110.197 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -112.97 125.98 54.99 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.361 -0.837 . . . . 1.0 109.621 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.5 -36.74 26.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.754 -0.591 . . . . 1.0 109.973 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.72 96.16 3.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.587 -0.696 . . . . 1.0 109.562 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -153.9 134.54 13.62 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.653 -0.654 . . . . 1.0 109.658 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.46 161.35 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.938 HD11 ' HB2' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -121.26 132.36 54.76 Favored 'General case' 0 N--CA 1.515 2.779 0 C-N-CA 118.195 -1.402 . . . . 1.0 109.153 -179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -141.79 155.62 25.48 Favored Glycine 0 N--CA 1.498 2.808 0 C-N-CA 118.18 -1.962 . . . . 1.0 113.086 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.465 HG22 ' HG3' ' A' ' 38' ' ' ARG . 9.8 tt -100.37 138.93 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 105.958 -1.867 . . . . 1.0 105.958 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.898 ' HA ' HG22 ' A' ' 37' ' ' VAL . 6.6 pt -98.36 149.7 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 122.589 1.185 . . . . 1.0 112.567 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -141.44 119.4 11.94 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 113.865 -1.516 . . . . 1.0 108.763 178.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.587 ' HA ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -99.33 66.75 1.51 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.478 0.656 . . . . 1.0 109.905 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.3 mtt -101.21 114.02 27.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.325 -0.859 . . . . 1.0 108.792 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.59 42.44 8.5 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.46 0.648 . . . . 1.0 109.488 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -128.36 167.5 20.55 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -134.04 -67.84 0.58 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.491 -1.005 . . . . 1.0 109.787 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -94.12 -51.09 4.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.539 -0.725 . . . . 1.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.581 ' HD3' ' CB ' ' A' ' 46' ' ' LEU . 21.8 ttm-85 -99.27 146.55 26.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.67 -0.644 . . . . 1.0 109.381 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -111.05 161.82 9.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.728 -0.842 . . . . 1.0 108.728 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.445 ' HG2' ' N ' ' A' ' 37' ' ' VAL . 10.1 ttp180 -100.0 141.04 33.36 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.381 -1.34 . . . . 1.0 107.381 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 26' ' ' ILE . 2.3 t -133.87 148.49 30.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 122.442 1.115 . . . . 1.0 112.018 -176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HG3' HG22 ' A' ' 25' ' ' ILE . 1.1 ptm180 -112.68 141.17 46.78 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 104.657 -2.349 . . . . 1.0 104.657 175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.723 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -141.25 158.47 43.85 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 117.17 -1.812 . . . . 1.0 115.015 -175.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 40' ' ' LEU . 6.5 tp -93.42 172.78 8.07 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.775 -1.557 . . . . 1.0 107.477 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.528 ' HB3' HG22 ' A' ' 22' ' ' ILE . 2.1 t70 77.44 22.8 0.91 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 104.134 -2.543 . . . . 1.0 104.134 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.69 56.08 16.73 Favored Glycine 0 N--CA 1.501 3.018 0 CA-C-N 114.975 -1.011 . . . . 1.0 114.276 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.723 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -145.62 151.12 37.57 Favored 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 120.452 2.126 . . . . 1.0 112.661 178.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.557 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -133.93 117.92 17.3 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 106.145 -1.798 . . . . 1.0 106.145 176.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.997 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -145.95 162.57 37.51 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.001 -1.08 . . . . 1.0 112.847 -176.033 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CB ' ' HD3' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -97.89 117.89 33.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.401 -2.814 . . . . 1.0 103.401 174.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 80' ' ' ILE . . . -101.57 153.93 18.87 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.785 -1.198 . . . . 1.0 112.753 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.75 156.86 22.09 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.702 0.763 . . . . 1.0 110.143 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.588 ' HB ' ' HD2' ' A' ' 50' ' ' PRO . 3.5 pt -140.64 163.43 43.2 Favored Pre-proline 0 N--CA 1.498 1.934 0 N-CA-C 109.592 -0.522 . . . . 1.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 49' ' ' ILE . 32.9 Cg_endo -74.79 -34.06 4.39 Favored 'Trans proline' 0 C--N 1.316 -1.145 0 C-N-CA 122.575 2.183 . . . . 1.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.34 10.39 80.12 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.652 -0.979 . . . . 1.0 110.652 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -65.49 -50.96 63.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.273 -1.133 . . . . 1.0 109.39 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HA ' HD13 ' A' ' 53' ' ' LEU . 3.3 mm? -65.49 -34.23 77.79 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.739 -0.6 . . . . 1.0 109.967 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -54.78 -43.82 73.14 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.53 -0.732 . . . . 1.0 109.991 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.05 -33.94 61.78 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.634 -0.666 . . . . 1.0 110.06 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -61.54 1.79 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.439 -0.788 . . . . 1.0 109.782 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -120.48 157.52 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.68 -0.637 . . . . 1.0 109.923 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -121.95 127.82 50.8 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.0 109.553 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.32 161.14 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.744 -0.598 . . . . 1.0 109.751 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.34 168.84 18.87 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.552 -0.717 . . . . 1.0 110.024 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.02 132.19 47.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.588 -0.695 . . . . 1.0 109.879 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.53 76.97 0.25 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.064 -1.214 . . . . 1.0 110.064 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' HB3' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -129.61 160.68 32.53 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.56 137.84 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 120.502 -1.374 . . . . 1.0 109.183 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 82' ' ' TRP . 3.1 m -141.58 158.62 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.889 -0.724 . . . . 1.0 111.306 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.786 HG22 ' CG1' ' A' ' 81' ' ' ILE . 14.4 tt -99.57 149.03 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 105.045 -2.205 . . . . 1.0 105.045 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 1.3 m -134.22 157.4 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 117.6 -1.64 . . . . 1.0 114.54 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 41.4 mtmt -103.94 152.82 39.1 Favored Pre-proline 0 N--CA 1.483 1.219 0 CA-C-N 113.332 -1.758 . . . . 1.0 106.928 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 68' ' ' LYS . 40.3 Cg_endo -89.16 141.39 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.684 2.256 . . . . 1.0 113.033 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.601 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 11.1 m95 -123.27 119.04 28.98 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 130.28 40.99 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 119.336 0.971 . . . . 1.0 110.187 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 75' ' ' ASP . 1.4 p -177.56 111.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 CA-C-O 121.462 0.649 . . . . 1.0 109.737 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.52 143.79 44.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.073 -1.017 . . . . 1.0 109.867 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.47 -42.05 1.99 Allowed Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.849 ' O ' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -172.73 169.76 4.86 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.754 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 5.9 tt0 -108.29 157.5 18.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.44 -1.412 . . . . 1.0 110.471 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.601 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 16.4 mttm -114.87 158.87 21.36 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 68' ' ' LYS . 21.6 p -146.25 155.86 42.97 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.144 -1.597 . . . . 1.0 111.944 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.81 117.54 34.13 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 104.337 -2.468 . . . . 1.0 104.337 175.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.589 HG22 ' CB ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -120.01 161.35 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 115.312 1.597 . . . . 1.0 115.312 -174.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.786 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.2 pp -118.94 120.28 63.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 175.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.961 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -97.54 156.3 16.56 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.188 0.994 . . . . 1.0 112.709 -176.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.5 -176.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.303 -0.862 . . . . 1.0 109.067 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 60.65 99.07 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.17 0.51 . . . . 1.0 110.381 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.8 t -63.49 -33.87 76.53 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.477 -0.764 . . . . 1.0 109.008 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.98 174.49 7.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.5 p -63.91 132.27 50.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.443 -0.786 . . . . 1.0 110.217 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 8.65 3.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.0 110.5 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 23' ' ' LEU . 48.9 t -62.15 -34.31 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.247 -0.908 . . . . 1.0 108.933 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -63.22 -48.86 76.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.706 -0.621 . . . . 1.0 110.086 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -54.27 -50.54 67.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 1.0 109.395 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.938 ' HB2' HD11 ' A' ' 23' ' ' LEU . 2.4 mt -61.57 -39.05 89.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.758 -0.589 . . . . 1.0 109.622 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE2' HD23 ' A' ' 40' ' ' LEU . 10.1 mmtm -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.767 -0.583 . . . . 1.0 109.847 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.823 ' HA ' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -55.32 -55.32 32.83 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.659 -0.867 . . . . 1.0 108.659 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -25.17 67.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.94 -59.03 10.83 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 120.498 -0.858 . . . . 1.0 111.487 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.823 ' CZ ' ' HA ' ' A' ' 94' ' ' ARG . 10.4 p90 -70.58 -39.11 74.05 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.429 1.114 . . . . 1.0 110.308 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.5 -52.88 62.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.873 -0.517 . . . . 1.0 110.268 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.57 -42.15 95.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.591 -0.693 . . . . 1.0 109.778 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -46.36 89.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.582 -0.699 . . . . 1.0 109.585 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.29 84.86 6.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.439 0.638 . . . . 1.0 109.292 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.82 -1.086 . . . . 1.0 109.697 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.83 55.56 6.13 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.482 0.658 . . . . 1.0 109.678 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -92.27 167.98 11.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.483 -0.761 . . . . 1.0 110.093 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 63.56 81.85 0.2 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.443 0.64 . . . . 1.0 109.732 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -124.3 -45.19 1.97 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.634 -0.666 . . . . 1.0 109.625 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.34 153.8 29.91 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.621 -0.674 . . . . 1.0 109.792 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.85 127.26 31.18 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.655 -0.653 . . . . 1.0 109.793 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -142.27 140.61 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.576 -0.702 . . . . 1.0 109.877 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -113.32 22.22 14.46 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.513 0.673 . . . . 1.0 110.294 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.533 HD13 ' N ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -51.72 -24.31 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.043 -0.41 . . . . 1.0 110.965 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mtt85 -71.58 -146.32 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.483 -0.761 . . . . 1.0 109.524 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.4 m -60.48 -178.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.123 -0.985 . . . . 1.0 110.633 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -46.24 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.665 -0.647 . . . . 1.0 110.162 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 pt -53.89 129.27 56.5 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.727 -0.608 . . . . 1.0 110.039 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.11 157.16 30.26 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.782 2.321 . . . . 1.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.3 ttp-105 -82.23 76.74 9.09 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.75 13.35 9.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.687 . . . . 1.0 110.259 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.25 67.23 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.549 -0.719 . . . . 1.0 109.245 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -72.34 -64.82 0.87 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.658 -0.651 . . . . 1.0 109.708 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -172.22 -47.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.645 -0.659 . . . . 1.0 110.038 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.52 148.84 38.62 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 1.0 110.741 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.711 HG23 ' SG ' ' A' ' 39' ' ' CYS . 1.2 mp -111.13 158.37 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.929 ' HB3' HD22 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -130.62 126.97 38.0 Favored 'General case' 0 N--CA 1.527 3.413 0 C-N-CA 118.185 -1.406 . . . . 1.0 108.886 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -142.5 161.68 27.35 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 117.566 -2.254 . . . . 1.0 114.21 -177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.691 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -98.04 135.07 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 106.74 -1.578 . . . . 1.0 106.74 177.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.034 ' CD1' HG23 ' A' ' 37' ' ' VAL . 9.4 tp -104.57 152.72 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 122.498 1.142 . . . . 1.0 112.629 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.7 142.82 33.33 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.21 -1.359 . . . . 1.0 108.15 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -130.65 105.99 8.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.607 -0.683 . . . . 1.0 109.549 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -47.6 6.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.609 -0.682 . . . . 1.0 109.719 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mt -88.05 -53.79 4.55 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.596 -0.69 . . . . 1.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.04 79.87 1.06 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -130.76 52.63 2.03 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.799 -0.824 . . . . 1.0 109.187 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.34 5.56 4.81 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.726 -0.609 . . . . 1.0 110.869 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.67 160.28 40.37 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.273 -0.892 . . . . 1.0 109.52 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 26' ' ' ILE . 6.5 m -137.38 168.51 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 121.742 0.782 . . . . 1.0 110.188 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.62 122.31 41.25 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.259 -0.577 . . . . 1.0 110.725 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 1.034 HG23 ' CD1' ' A' ' 26' ' ' ILE . 0.9 OUTLIER -120.9 148.61 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-O 122.868 1.318 . . . . 1.0 111.78 -179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -110.03 139.89 44.66 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 103.899 -2.63 . . . . 1.0 103.899 174.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.711 ' SG ' HG23 ' A' ' 22' ' ' ILE . 1.8 p -141.32 162.56 35.18 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.334 -1.746 . . . . 1.0 115.665 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 41' ' ' ASP . 38.2 tp -89.84 169.49 11.21 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 112.91 -1.95 . . . . 1.0 105.926 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.608 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 15.6 m-20 78.83 24.5 0.55 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 104.527 -2.397 . . . . 1.0 104.527 -171.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.44 58.57 13.69 Favored Glycine 0 N--CA 1.498 2.799 0 CA-C-N 114.738 -1.119 . . . . 1.0 113.434 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.659 ' CB ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -144.79 156.35 43.99 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 119.679 1.739 . . . . 1.0 112.994 178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.91 120.74 12.71 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 106.218 -1.771 . . . . 1.0 106.218 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.814 ' CZ ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.18 163.23 35.02 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 118.144 -1.422 . . . . 1.0 114.456 -176.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 124.75 43.33 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 103.468 -2.79 . . . . 1.0 103.468 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' NH2' ' A' ' 45' ' ' ARG . . . -105.62 159.84 15.2 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.545 -1.312 . . . . 1.0 113.48 -174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -124.09 144.0 50.13 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.863 HG12 HD12 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -130.81 149.54 73.94 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' HG2' ' HG ' ' A' ' 53' ' ' LEU . 33.2 Cg_endo -74.71 153.57 43.42 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 122.721 2.281 . . . . 1.0 110.896 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.42 -26.81 64.77 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -54.07 -41.68 68.45 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.916 . . . . 1.0 110.01 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.863 HD12 HG12 ' A' ' 49' ' ' ILE . 10.5 mt -65.07 -43.96 90.52 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.632 -0.668 . . . . 1.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -65.25 -35.65 81.69 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.746 -0.596 . . . . 1.0 109.649 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -61.19 -40.79 95.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.689 -0.632 . . . . 1.0 109.659 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -65.02 -65.0 0.73 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tt -168.35 151.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -119.69 132.86 55.77 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.626 -0.671 . . . . 1.0 110.028 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.18 158.08 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.651 -0.655 . . . . 1.0 109.331 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -76.54 -57.59 3.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.38 -0.825 . . . . 1.0 109.459 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.9 150.88 5.81 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.62 -0.675 . . . . 1.0 109.829 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.42 66.0 1.06 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.462 ' HB3' HG22 ' A' ' 26' ' ' ILE . 9.3 t70 -128.95 160.42 32.76 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.592 -0.946 . . . . 1.0 109.361 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -102.23 128.44 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.12 . . . . 1.0 108.205 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 82' ' ' TRP . 16.5 m -140.59 148.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.79 -0.764 . . . . 1.0 109.521 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 80' ' ' ILE . 1.4 tt -98.72 141.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.819 -2.289 . . . . 1.0 104.819 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG22 ' CG2' ' A' ' 22' ' ' ILE . 1.2 m -121.6 148.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.726 -1.234 . . . . 1.0 113.536 -175.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' CYS . 0.1 OUTLIER -102.39 141.33 22.3 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 106.568 -1.641 . . . . 1.0 106.568 176.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.557 ' HA ' ' OE1' ' A' ' 76' ' ' GLN . 39.9 Cg_endo -88.64 137.25 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.967 1.778 . . . . 1.0 113.253 -176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 11.7 m0 -117.73 117.35 29.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 106.757 -1.571 . . . . 1.0 106.757 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.6 OUTLIER 51.15 -161.85 0.07 Allowed 'General case' 0 N--CA 1.512 2.669 0 CA-C-N 120.822 1.646 . . . . 1.0 109.326 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 71' ' ' GLU . 91.2 t -156.77 -83.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.515 -1.366 . . . . 1.0 111.773 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -31.1 134.6 0.06 Allowed 'General case' 0 N--CA 1.513 2.718 0 CA-C-O 121.808 0.813 . . . . 1.0 113.179 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.15 -58.41 4.24 Favored Glycine 0 N--CA 1.499 2.894 0 N-CA-C 110.416 -1.074 . . . . 1.0 110.416 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 177.92 168.35 0.73 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.668 ' HG3' ' HB3' ' A' ' 45' ' ' ARG . 1.3 pt20 -131.93 159.75 37.76 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 116.875 -1.93 . . . . 1.0 113.208 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -100.8 160.11 14.63 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 106.347 -1.723 . . . . 1.0 106.347 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.954 ' SG ' HG23 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -146.98 160.22 42.63 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 119.764 -1.835 . . . . 1.0 111.618 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 1.2 p-10 -117.95 117.81 30.27 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 104.35 -2.463 . . . . 1.0 104.35 173.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.954 HG23 ' SG ' ' A' ' 78' ' ' CYS . 2.4 pt -115.16 160.58 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 115.391 1.626 . . . . 1.0 115.391 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.34 122.29 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 105.227 -2.138 . . . . 1.0 105.227 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 1.002 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -98.36 148.12 23.99 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.325 0.584 . . . . 1.0 111.293 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.696 ' O ' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER 176.02 172.13 0.37 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.393 0.616 . . . . 1.0 110.43 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.686 ' HB2' ' CG1' ' A' ' 64' ' ' VAL . 99.9 m-85 47.01 -175.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 CA-C-O 121.686 0.755 . . . . 1.0 112.483 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 84' ' ' TYR . 6.3 t 175.45 51.44 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -152.48 -68.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.013 -1.054 . . . . 1.0 110.589 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.7 m -137.05 109.83 7.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.362 -0.836 . . . . 1.0 110.365 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.592 ' HB3' HG21 ' A' ' 64' ' ' VAL . 0.4 OUTLIER 174.96 -77.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.042 HG22 HD11 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -66.52 -33.74 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.142 -1.059 . . . . 1.0 108.142 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 3.1 mt-10 -52.68 -37.86 59.57 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -66.2 -55.03 18.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.853 -0.529 . . . . 1.0 109.864 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.042 HD11 HG22 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -63.98 -51.3 64.96 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.459 -0.775 . . . . 1.0 111.076 -178.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.533 ' N ' HD12 ' A' ' 92' ' ' LEU . 1.2 pttt -59.02 -43.47 91.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.283 -0.886 . . . . 1.0 110.42 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.639 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -60.49 -39.1 86.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.411 -0.806 . . . . 1.0 108.988 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.637 ' HA ' HD21 ' A' ' 98' ' ' LEU . 5.5 mtpp -59.53 -33.82 71.86 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.51 ' N ' HD13 ' A' ' 40' ' ' LEU . . . -66.22 -42.43 94.24 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.939 -1.264 . . . . 1.0 109.939 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.639 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.3 m-85 -66.46 -55.11 17.23 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.716 -0.873 . . . . 1.0 110.661 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.9 pp -59.78 -33.91 72.33 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.528 -0.733 . . . . 1.0 110.445 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.76 -51.04 64.4 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.486 -0.759 . . . . 1.0 109.764 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.644 ' O ' HD22 ' A' ' 101' ' ' LEU . 0.6 OUTLIER -66.03 -56.29 12.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.636 -0.665 . . . . 1.0 110.194 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -137.86 -172.4 3.24 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.61 -0.681 . . . . 1.0 109.725 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 117.711 -1.138 . . . . 1.0 110.25 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG2' ' HB2' ' A' ' 8' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.02 99.18 2.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.609 -0.682 . . . . 1.0 109.584 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.07 119.42 21.47 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.609 -0.682 . . . . 1.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.56 87.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.728 . . . . 1.0 109.7 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 38.92 42.25 0.63 Allowed 'General case' 0 N--CA 1.507 2.39 0 CA-C-O 121.157 0.503 . . . . 1.0 111.1 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -168.3 -74.65 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.883 . . . . 1.0 109.554 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.36 172.98 2.18 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.73 -0.606 . . . . 1.0 109.68 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.452 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.1 pt20 -89.41 11.05 20.35 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.421 -0.8 . . . . 1.0 110.236 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -101.1 20.12 16.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 1.0 110.278 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 tp -54.42 142.67 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.228 0.537 . . . . 1.0 110.089 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -71.35 178.61 3.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.678 -0.639 . . . . 1.0 110.174 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -65.13 159.56 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.566 -0.709 . . . . 1.0 110.071 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.31 88.82 1.6 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -144.83 116.92 5.35 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.541 -0.724 . . . . 1.0 109.413 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.5 -178.4 4.56 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 122.758 2.306 . . . . 1.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 66.7 98.73 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.305 0.574 . . . . 1.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -154.88 -55.59 0.1 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.616 -0.678 . . . . 1.0 109.46 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -15.3 32.33 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.642 -0.661 . . . . 1.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.44 -22.36 18.33 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 1.0 111.196 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -147.29 -62.62 0.28 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.031 -1.043 . . . . 1.0 111.246 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.75 119.06 6.45 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.504 -0.747 . . . . 1.0 110.727 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -104.21 155.1 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 92' ' ' LEU . 1.6 pp -122.64 119.68 31.47 Favored 'General case' 0 N--CA 1.517 2.915 0 C-N-CA 118.045 -1.462 . . . . 1.0 109.172 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' CA ' ' HB2' ' A' ' 39' ' ' CYS . . . -139.39 160.75 26.02 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 117.7 -2.19 . . . . 1.0 113.705 -177.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.703 HG23 HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -99.09 130.9 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 106.485 -1.672 . . . . 1.0 106.485 177.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 HG12 HG21 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -99.56 154.55 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-O 122.255 1.026 . . . . 1.0 111.991 -177.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -140.04 128.75 23.12 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.931 -1.031 . . . . 1.0 108.697 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -117.68 83.79 2.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.728 -0.608 . . . . 1.0 109.569 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.6 -40.6 76.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.433 -0.792 . . . . 1.0 109.033 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.08 124.12 51.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.086 -0.709 . . . . 1.0 109.086 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.96 89.88 1.28 Allowed Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.426 -1.47 . . . . 1.0 109.426 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.2 -71.38 0.73 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.719 -0.871 . . . . 1.0 109.663 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.44 -54.22 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.609 -0.682 . . . . 1.0 109.709 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.61 160.71 14.13 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.661 -0.649 . . . . 1.0 109.86 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG21 HG12 ' A' ' 26' ' ' ILE . 10.7 m -129.38 168.68 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 122.201 1.0 . . . . 1.0 110.883 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -106.14 131.55 53.27 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 115.236 -0.893 . . . . 1.0 109.216 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -140.41 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.226 -0.921 . . . . 1.0 111.035 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.34 141.07 40.7 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.751 ' SG ' ' HB3' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -142.09 162.32 35.76 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.881 -1.528 . . . . 1.0 114.306 -176.01 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.646 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -92.13 178.88 5.73 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 176.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER 76.58 23.8 1.07 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 -171.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 43' ' ' LYS . . . 62.94 55.31 27.4 Favored Glycine 0 N--CA 1.5 2.919 0 CA-C-N 114.806 -1.088 . . . . 1.0 113.989 176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.751 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . 3.2 tptp -145.85 153.99 41.48 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 120.634 2.217 . . . . 1.0 113.474 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -135.39 117.49 15.41 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 104.682 -2.34 . . . . 1.0 104.682 175.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.733 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -146.17 160.83 41.42 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.764 -1.175 . . . . 1.0 112.977 -175.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.18 123.56 43.56 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.634 ' HA3' HD12 ' A' ' 80' ' ' ILE . . . -96.9 146.07 18.13 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.433 -1.365 . . . . 1.0 112.652 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -106.67 140.45 39.51 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.659 HG12 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -135.17 157.19 77.34 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' HD2' HG12 ' A' ' 49' ' ' ILE . 33.5 Cg_endo -75.9 -44.23 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.043 0 C-N-CA 122.444 2.096 . . . . 1.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.45 33.51 0.1 Allowed Glycine 0 N--CA 1.499 2.835 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -66.76 -43.47 83.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.383 -1.069 . . . . 1.0 109.767 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.93 -49.96 75.34 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.798 -0.564 . . . . 1.0 109.981 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -24.65 61.45 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.513 -0.742 . . . . 1.0 110.556 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.49 5.09 31.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.35 -0.844 . . . . 1.0 111.07 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -129.0 -70.64 0.66 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.008 -1.058 . . . . 1.0 110.36 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.84 149.97 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.416 -0.802 . . . . 1.0 110.593 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -109.87 68.16 0.66 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.041 -0.725 . . . . 1.0 109.041 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.32 144.99 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.591 -0.693 . . . . 1.0 109.222 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 mtm-85 -61.36 -63.43 1.29 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.638 -0.664 . . . . 1.0 109.439 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.47 121.17 0.5 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.714 -0.616 . . . . 1.0 109.595 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.14 73.16 0.01 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.43 160.55 38.4 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.646 -0.914 . . . . 1.0 108.945 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.73 HG13 HG23 ' A' ' 89' ' ' VAL . 3.8 t -109.33 139.43 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.93 -1.106 . . . . 1.0 108.535 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 82' ' ' TRP . 34.6 m -140.2 152.93 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-O 121.973 0.892 . . . . 1.0 111.894 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.581 HG13 ' HB ' ' A' ' 81' ' ' ILE . 10.9 pt -99.61 139.68 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 105.501 -2.037 . . . . 1.0 105.501 176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -139.49 158.74 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 117.312 -1.755 . . . . 1.0 114.272 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -100.68 154.88 36.92 Favored Pre-proline 0 N--CA 1.483 1.177 0 N-CA-C 107.504 -1.295 . . . . 1.0 107.504 176.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' C ' ' HD1' ' A' ' 70' ' ' TRP . 42.8 Cg_endo -89.35 141.89 4.19 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 122.664 2.243 . . . . 1.0 112.549 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.701 ' CB ' ' HB2' ' A' ' 77' ' ' LYS . 12.3 m0 -121.42 117.35 26.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.031 -1.47 . . . . 1.0 107.031 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 72' ' ' VAL . 37.1 mt-10 47.91 -158.27 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.496 0 CA-C-N 120.244 1.384 . . . . 1.0 109.525 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 71' ' ' GLU . 73.5 t -155.91 -81.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.821 -1.174 . . . . 1.0 110.793 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -42.32 143.61 0.6 Allowed 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.667 0.746 . . . . 1.0 112.002 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.79 -54.46 3.73 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.876 -1.29 . . . . 1.0 109.876 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 p30 174.1 160.51 0.17 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' A' ' 45' ' ' ARG . 4.5 tt0 -111.37 149.72 30.78 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.277 -1.369 . . . . 1.0 111.388 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.701 ' HB2' ' CB ' ' A' ' 70' ' ' TRP . 37.2 mmtm -112.5 154.76 25.41 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.618 ' HB2' ' CG2' ' A' ' 67' ' ' VAL . 14.4 p -144.56 156.16 44.01 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 119.776 -1.828 . . . . 1.0 111.634 -178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER -106.23 119.17 38.54 Favored 'General case' 0 N--CA 1.506 2.367 0 N-CA-C 104.53 -2.396 . . . . 1.0 104.53 175.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.997 HG22 HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -106.65 161.72 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 115.575 1.694 . . . . 1.0 115.575 -174.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -120.29 123.61 70.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 103.781 -2.674 . . . . 1.0 103.781 175.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.937 ' HA ' HG12 ' A' ' 65' ' ' VAL . 6.6 t90 -96.29 138.0 34.54 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.951 0.881 . . . . 1.0 111.908 -175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.98 -167.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.17 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 6.0 m-85 59.44 89.02 0.07 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.474 0.654 . . . . 1.0 110.288 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -74.26 -29.16 61.55 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.485 -0.759 . . . . 1.0 109.547 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -102.11 -159.74 0.75 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 1.0 109.777 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 p -62.33 148.57 44.73 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.379 -0.825 . . . . 1.0 110.234 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.568 ' HB3' HG11 ' A' ' 64' ' ' VAL . 8.7 tp60 -161.76 -40.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.695 -0.628 . . . . 1.0 110.044 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.741 HG13 ' CD1' ' A' ' 23' ' ' LEU . 3.4 t -53.96 -34.94 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.64 -0.662 . . . . 1.0 109.771 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.61 -44.24 80.95 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.495 -0.753 . . . . 1.0 109.51 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.461 ' CE3' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -65.09 -45.13 86.5 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.791 ' HB3' HD22 ' A' ' 23' ' ' LEU . 1.9 mt -57.69 -40.99 80.72 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.609 -0.682 . . . . 1.0 109.212 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CE ' HG12 ' A' ' 89' ' ' VAL . 6.5 mtmt -58.57 -50.09 75.07 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.609 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -56.38 -36.11 68.48 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' A' ' 98' ' ' LEU . 7.4 tptt -62.22 -35.4 78.78 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.917 -0.489 . . . . 1.0 109.854 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -67.45 -39.59 91.34 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 2.1 m-85 -66.18 -53.04 42.28 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.915 -0.756 . . . . 1.0 110.802 -178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 95' ' ' LYS . 3.6 pp -62.17 -34.86 77.21 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.321 -0.862 . . . . 1.0 109.918 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.432 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -62.66 -38.98 92.45 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.59 -0.693 . . . . 1.0 109.818 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -61.35 -53.54 55.37 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.632 -0.667 . . . . 1.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.438 ' HA ' HD13 ' A' ' 101' ' ' LEU . 2.5 mm? -96.92 97.98 9.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 1.0 109.358 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 118.455 -0.783 . . . . 1.0 109.907 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.641 -0.503 . . . . 1.0 109.641 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.15 146.83 31.62 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.636 -0.665 . . . . 1.0 109.696 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -123.58 108.15 12.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.564 -0.71 . . . . 1.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -113.03 -58.28 2.18 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -111.54 -54.74 2.58 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.0 109.72 1.6 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.728 -0.608 . . . . 1.0 109.457 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.61 -86.16 0.57 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.584 -0.698 . . . . 1.0 109.2 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -179.5 -50.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.501 -0.75 . . . . 1.0 109.52 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -70.1 167.95 16.63 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.696 -0.627 . . . . 1.0 110.128 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.6 OUTLIER -108.78 62.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.678 0.751 . . . . 1.0 109.2 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.0 -16.98 59.87 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.943 0.878 . . . . 1.0 110.982 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.61 HG21 ' NE1' ' A' ' 91' ' ' TRP . 5.4 p -162.93 160.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.716 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' C ' ' A' ' 14' ' ' ILE . 1.5 ttm-85 -154.53 -69.43 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 88' ' ' GLN . 1.6 pt 23.54 81.15 0.18 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 122.693 0.397 . . . . 1.0 111.862 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.41 85.72 1.66 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.645 2.23 . . . . 1.0 110.044 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.87 109.1 19.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.663 -0.648 . . . . 1.0 109.74 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.67 37.3 4.44 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -118.17 148.71 42.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.52 -0.738 . . . . 1.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -105.77 44.24 1.06 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.669 -0.644 . . . . 1.0 109.374 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -163.6 99.36 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.451 -0.781 . . . . 1.0 109.257 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.06 142.67 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.597 -0.689 . . . . 1.0 109.76 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -122.49 161.74 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.272 -1.01 . . . . 1.0 108.272 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -127.96 127.75 43.85 Favored 'General case' 0 N--CA 1.523 3.191 0 C-N-CA 117.947 -1.501 . . . . 1.0 109.038 -179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -142.11 161.74 27.19 Favored Glycine 0 N--CA 1.496 2.66 0 C-N-CA 118.248 -1.929 . . . . 1.0 112.776 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -98.26 130.99 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.74 HD13 HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -99.03 153.34 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 122.198 0.999 . . . . 1.0 111.398 -177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -142.73 119.71 11.33 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.729 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.998 ' HB2' HG12 ' A' ' 35' ' ' VAL . 6.6 tp-100 -134.95 130.52 35.94 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.36 -0.607 . . . . 1.0 109.36 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.467 ' HA ' ' HE3' ' A' ' 29' ' ' MET . 5.3 tpt -162.02 39.21 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.421 -0.799 . . . . 1.0 110.015 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.6 mt -136.86 15.58 3.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.851 . . . . 1.0 110.245 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.26 66.81 2.31 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.66 144.27 30.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.609 -0.936 . . . . 1.0 110.12 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 t -68.87 -20.53 64.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.81 -0.556 . . . . 1.0 109.931 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.88 161.07 13.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.998 HG12 ' HB2' ' A' ' 28' ' ' GLN . 16.9 m -137.45 167.6 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.91 0.862 . . . . 1.0 110.79 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.537 ' HA ' HD12 ' A' ' 46' ' ' LEU . 8.6 ptt-85 -109.54 130.64 55.49 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 26' ' ' ILE . 0.5 OUTLIER -141.03 144.35 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.899 -1.12 . . . . 1.0 111.018 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.641 ' HG3' HD12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -108.37 144.48 35.86 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 105.548 -2.019 . . . . 1.0 105.548 176.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 2.0 m -139.61 157.24 46.13 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 118.233 -1.387 . . . . 1.0 113.125 -176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.53 ' CB ' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -94.25 179.51 5.28 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 105.89 -1.893 . . . . 1.0 105.89 175.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.673 ' HB3' HG13 ' A' ' 22' ' ' ILE . 6.9 t70 76.44 23.41 1.15 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 103.561 -2.755 . . . . 1.0 103.561 -171.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.66 52.74 36.28 Favored Glycine 0 N--CA 1.5 2.903 0 CA-C-N 114.878 -1.056 . . . . 1.0 113.99 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -146.03 154.02 41.39 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 120.818 2.309 . . . . 1.0 112.796 178.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.71 118.03 13.68 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' NH2' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -147.65 164.4 33.62 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.049 -1.06 . . . . 1.0 112.808 -175.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' N ' HD22 ' A' ' 46' ' ' LEU . 2.8 mm? -97.42 132.63 42.95 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 105.084 -2.191 . . . . 1.0 105.084 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.719 ' HA2' ' SG ' ' A' ' 78' ' ' CYS . . . -96.21 150.62 19.67 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.745 -1.217 . . . . 1.0 111.909 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HD3' ' CZ2' ' A' ' 70' ' ' TRP . 8.1 ptm180 -123.66 141.89 51.58 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.481 0.658 . . . . 1.0 109.787 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.449 HG21 ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -100.24 158.93 31.09 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.6 -58.29 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.483 2.122 . . . . 1.0 111.089 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 171.37 -63.07 0.16 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.759 -1.336 . . . . 1.0 109.759 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -39.03 89.02 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.784 -0.833 . . . . 1.0 109.369 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.662 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.4 mp -65.08 -34.61 78.82 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.762 -0.587 . . . . 1.0 109.688 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' CB ' HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -49.71 -36.4 25.21 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.507 -0.746 . . . . 1.0 110.542 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -85.81 -34.9 20.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.409 -0.807 . . . . 1.0 110.147 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -35.97 58.62 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.51 -0.744 . . . . 1.0 110.728 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 53' ' ' LEU . 1.3 pp -59.84 142.28 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.429 -0.794 . . . . 1.0 110.46 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -144.06 51.58 1.31 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.461 0.648 . . . . 1.0 109.366 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.805 HG12 ' HB2' ' A' ' 63' ' ' ASP . 26.5 m -68.47 134.91 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.411 -0.806 . . . . 1.0 109.089 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -137.37 -54.04 0.68 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.406 -0.809 . . . . 1.0 110.408 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -105.97 -14.86 15.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.614 -0.679 . . . . 1.0 111.201 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.42 92.62 0.12 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.758 -1.337 . . . . 1.0 109.758 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.805 ' HB2' HG12 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -97.19 160.68 14.2 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.447 -0.946 . . . . 1.0 108.447 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -102.45 141.74 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 120.805 -1.184 . . . . 1.0 109.906 -179.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.959 HG12 ' HA ' ' A' ' 82' ' ' TRP . 17.8 m -142.0 159.29 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.612 0.72 . . . . 1.0 111.224 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 81' ' ' ILE . 1.1 tt -100.32 144.17 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.76 HG22 HG22 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -129.66 152.85 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 118.0 -1.48 . . . . 1.0 113.432 -176.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 19.9 mttt -104.75 148.26 35.77 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 45' ' ' ARG . 39.5 Cg_endo -88.49 135.52 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.255 1.97 . . . . 1.0 112.875 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.714 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.3 m0 -120.74 117.11 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.621 -1.252 . . . . 1.0 107.621 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 47.5 -147.18 0.21 Allowed 'General case' 0 N--CA 1.505 2.304 0 CA-C-N 119.131 0.878 . . . . 1.0 110.203 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG13 ' H ' ' A' ' 73' ' ' GLN . 1.3 p -155.82 -84.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.091 -1.005 . . . . 1.0 109.567 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.739 ' H ' HG13 ' A' ' 72' ' ' VAL . 5.1 mt-30 49.31 -152.54 0.13 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.159 -0.963 . . . . 1.0 110.168 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.57 18.14 57.07 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.886 -1.286 . . . . 1.0 109.886 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.01 135.5 1.75 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -113.54 154.76 26.57 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.583 -1.247 . . . . 1.0 112.139 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.714 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 24.1 tptt -102.34 150.68 23.09 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 106.125 -1.805 . . . . 1.0 106.125 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.719 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 17.4 p -143.15 151.44 40.69 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 119.97 -1.706 . . . . 1.0 111.466 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -99.67 120.33 39.53 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.745 HG22 HG12 ' A' ' 67' ' ' VAL . 1.8 pp -119.95 156.64 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 117.618 -1.633 . . . . 1.0 115.064 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 1.084 HG22 HG22 ' A' ' 66' ' ' ILE . 1.4 tp -118.47 128.91 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 105.487 -2.042 . . . . 1.0 105.487 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.959 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.89 147.58 24.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.748 0.785 . . . . 1.0 111.665 -176.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HG2' ' HG2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -178.23 162.81 1.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.485 0.659 . . . . 1.0 109.605 179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -101.75 -50.69 3.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.553 -0.717 . . . . 1.0 109.126 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.9 p -126.19 70.67 1.24 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.479 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 0.5 OUTLIER -87.75 161.8 17.39 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.441 -0.787 . . . . 1.0 109.793 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.591 ' HB ' HG23 ' A' ' 12' ' ' VAL . 5.6 p -79.99 -1.96 41.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.591 -0.693 . . . . 1.0 110.702 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.544 ' HA ' HD13 ' A' ' 14' ' ' ILE . 0.6 OUTLIER -104.35 -52.77 2.85 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.26 -0.9 . . . . 1.0 109.834 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.783 ' HA ' HD21 ' A' ' 92' ' ' LEU . 86.1 t -65.39 -34.65 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.45 -0.781 . . . . 1.0 109.843 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -63.18 -38.49 91.37 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.166 -0.959 . . . . 1.0 109.26 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.61 ' NE1' HG21 ' A' ' 12' ' ' VAL . 1.7 m0 -66.19 -55.57 15.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.775 -0.578 . . . . 1.0 110.251 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.93 HD13 ' HG ' ' A' ' 23' ' ' LEU . 1.4 pp -58.28 -33.88 69.91 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.655 -0.653 . . . . 1.0 109.848 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' N ' HD12 ' A' ' 92' ' ' LEU . 10.9 mtpp -58.49 -49.63 76.67 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.589 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -58.48 -35.47 72.24 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -64.02 -34.19 77.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.795 -0.566 . . . . 1.0 109.966 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.24 -44.81 93.18 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.055 -1.618 . . . . 1.0 109.055 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 0.7 OUTLIER -65.93 -37.46 86.1 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.8 -56.03 26.77 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.63 -34.68 73.09 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.872 -0.518 . . . . 1.0 109.943 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.566 ' CB ' HD13 ' A' ' 101' ' ' LEU . 10.9 mt-10 -59.28 -55.09 39.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 1.0 110.176 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.781 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -139.34 156.91 46.7 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.411 -0.806 . . . . 1.0 110.293 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.503 2.212 0 CA-C-O 117.719 -1.134 . . . . 1.0 110.013 -179.598 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptp . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.174 0.511 . . . . 1.0 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.34 -51.78 7.56 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.608 -0.682 . . . . 1.0 109.627 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.24 165.36 29.44 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.686 . . . . 1.0 110.093 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.66 0.02 24.04 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.679 -0.638 . . . . 1.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.26 179.12 4.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.26 -0.9 . . . . 1.0 110.033 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 69.06 106.78 0.06 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.262 0.554 . . . . 1.0 109.976 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.37 -72.68 0.71 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.443 -0.786 . . . . 1.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.95 29.72 0.08 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.536 -0.728 . . . . 1.0 110.232 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -131.1 167.8 18.5 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.226 -0.922 . . . . 1.0 110.129 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -98.13 154.8 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.621 -0.675 . . . . 1.0 109.329 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.9 ptt85 -177.88 -32.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.833 0.825 . . . . 1.0 111.684 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.8 -87.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-O 122.031 0.92 . . . . 1.0 110.456 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.06 135.47 50.86 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.315 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.582 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 24.4 pt -78.05 162.48 67.03 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.846 -0.534 . . . . 1.0 109.685 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HD2' ' HB ' ' A' ' 14' ' ' ILE . 34.3 Cg_endo -75.9 -49.98 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 122.687 2.258 . . . . 1.0 111.238 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -79.57 156.78 27.56 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.428 -0.795 . . . . 1.0 109.79 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.43 56.12 1.85 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -0.793 . . . . 1.0 109.527 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -147.82 176.19 10.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.36 -0.838 . . . . 1.0 110.248 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.14 -7.59 59.59 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.569 -0.707 . . . . 1.0 110.728 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' HB2' ' HG3' ' A' ' 18' ' ' GLU . 18.2 m120 -54.3 -38.03 65.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.395 -0.816 . . . . 1.0 109.887 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.17 121.26 17.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.691 -0.63 . . . . 1.0 109.773 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.836 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 mp -110.26 162.13 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.29 -1.004 . . . . 1.0 108.29 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.893 ' O ' HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.12 125.26 38.84 Favored 'General case' 0 N--CA 1.518 2.957 0 C-N-CA 117.891 -1.524 . . . . 1.0 109.43 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' SG ' ' A' ' 39' ' ' CYS . . . -141.65 161.9 27.01 Favored Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.11 -1.995 . . . . 1.0 113.051 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.553 HG22 HG13 ' A' ' 64' ' ' VAL . 7.7 pt -98.29 131.67 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 106.805 -1.554 . . . . 1.0 106.805 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -100.5 156.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 122.182 0.992 . . . . 1.0 111.751 -177.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.99 126.05 18.33 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 115.256 -0.884 . . . . 1.0 109.708 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.891 ' HG2' HG12 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -131.19 104.86 7.31 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.3 tpt -139.58 49.14 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.401 -0.812 . . . . 1.0 109.272 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 36.8 mt -140.45 -54.98 0.52 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.569 -0.707 . . . . 1.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.89 73.09 0.98 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.41 -77.64 0.34 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.692 -0.887 . . . . 1.0 109.937 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.61 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.577 -0.702 . . . . 1.0 109.956 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.32 160.66 14.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.627 -0.671 . . . . 1.0 109.822 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.891 HG12 ' HG2' ' A' ' 28' ' ' GLN . 7.0 m -124.1 168.24 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 CA-C-O 121.888 0.851 . . . . 1.0 110.384 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.778 ' HA ' HD13 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -108.15 132.01 54.05 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 178.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.453 ' CG2' ' SG ' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -140.91 145.38 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 118.939 -1.105 . . . . 1.0 111.274 -178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HD2' HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -111.09 141.36 44.7 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 105.654 -1.98 . . . . 1.0 105.654 176.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' SG ' ' HA3' ' A' ' 24' ' ' GLY . 2.2 m -137.88 157.43 46.42 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.253 -1.379 . . . . 1.0 113.176 -176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.82 ' HB3' HD11 ' A' ' 23' ' ' LEU . 3.7 tp -93.69 177.94 5.84 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.279 -1.748 . . . . 1.0 106.279 176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.593 ' HB3' HG13 ' A' ' 22' ' ' ILE . 2.8 t70 76.63 22.87 1.13 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 104.308 -2.479 . . . . 1.0 104.308 -172.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.61 18.03 Favored Glycine 0 N--CA 1.499 2.874 0 CA-C-N 115.079 -0.964 . . . . 1.0 113.998 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.646 ' HB2' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -145.18 153.46 41.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 120.465 2.133 . . . . 1.0 112.203 178.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.5 116.89 10.71 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 105.179 -2.156 . . . . 1.0 105.179 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 78' ' ' CYS . 0.0 OUTLIER -148.27 164.08 35.1 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.716 -1.193 . . . . 1.0 113.342 -175.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.778 HD13 ' HA ' ' A' ' 36' ' ' ARG . 4.1 mm? -97.31 130.23 44.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 104.753 -2.314 . . . . 1.0 104.753 175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.715 ' HA3' HG12 ' A' ' 80' ' ' ILE . . . -95.18 149.09 19.22 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 120.027 -1.082 . . . . 1.0 111.921 -176.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -126.06 143.86 50.95 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.443 0.64 . . . . 1.0 109.981 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -101.75 157.7 33.18 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.556 ' HD2' HG13 ' A' ' 49' ' ' ILE . 34.8 Cg_endo -76.28 -50.64 0.11 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 C-N-CA 122.546 2.164 . . . . 1.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 169.66 -64.23 0.18 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -36.0 80.41 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.657 -0.908 . . . . 1.0 109.796 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 57' ' ' ILE . 4.5 mp -65.02 -34.78 79.25 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.7 -0.625 . . . . 1.0 109.882 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' CB ' HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -56.62 -32.8 65.66 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.483 -0.76 . . . . 1.0 110.34 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -84.04 -28.66 27.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.479 -0.763 . . . . 1.0 110.355 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.59 -34.81 19.77 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.41 -0.806 . . . . 1.0 110.83 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.626 HG22 ' HB3' ' A' ' 82' ' ' TRP . 1.3 pp -54.2 132.51 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.473 -0.767 . . . . 1.0 110.454 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 23.1 t-105 -143.87 60.71 1.37 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.05 -0.722 . . . . 1.0 109.05 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG12 ' HB2' ' A' ' 63' ' ' ASP . 11.5 m -74.29 153.17 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.522 -0.736 . . . . 1.0 109.349 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -141.35 -49.72 0.41 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.391 -0.818 . . . . 1.0 110.649 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.78 18.2 5.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.375 -0.828 . . . . 1.0 111.251 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.45 92.33 0.72 Allowed Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.7 -1.238 . . . . 1.0 110.521 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.627 ' HB2' HG12 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -99.25 161.33 13.68 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 178.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.846 ' CG1' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -105.36 140.74 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.753 -1.217 . . . . 1.0 109.776 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 82' ' ' TRP . 19.4 m -142.5 158.12 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.514 0.673 . . . . 1.0 111.071 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.822 HG22 ' CG1' ' A' ' 81' ' ' ILE . 1.8 tp -100.87 146.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.836 HG22 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -131.36 154.7 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 C-N-CA 118.291 -1.364 . . . . 1.0 113.444 -177.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 78' ' ' CYS . 1.1 mmpp? -107.48 149.32 38.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 106.507 -1.664 . . . . 1.0 106.507 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.565 ' HA ' HH22 ' A' ' 45' ' ' ARG . 38.1 Cg_endo -88.48 136.34 3.27 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.417 2.078 . . . . 1.0 112.956 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.667 ' CB ' ' HB3' ' A' ' 77' ' ' LYS . 11.7 m0 -121.08 116.15 24.47 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 45.09 -154.43 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 CA-C-N 118.999 0.818 . . . . 1.0 110.964 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -142.61 -79.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.211 -0.931 . . . . 1.0 109.225 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.37 -152.29 0.11 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.456 -0.777 . . . . 1.0 110.508 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.9 13.12 66.9 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.113 -1.195 . . . . 1.0 110.113 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.77 145.56 1.96 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -113.37 151.76 30.86 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 118.724 -1.19 . . . . 1.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.667 ' HB3' ' CB ' ' A' ' 70' ' ' TRP . 4.8 tppt? -99.73 151.98 20.62 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 106.317 -1.735 . . . . 1.0 106.317 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.666 ' SG ' ' HA2' ' A' ' 47' ' ' GLY . 30.9 p -142.73 152.04 41.91 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.126 -1.609 . . . . 1.0 111.31 -178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.64 119.62 38.83 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 104.788 -2.301 . . . . 1.0 104.788 176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.995 HD13 HD13 ' A' ' 26' ' ' ILE . 1.3 pp -120.32 155.79 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 117.761 -1.576 . . . . 1.0 114.994 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.822 ' CG1' HG22 ' A' ' 66' ' ' ILE . 1.8 pp -117.21 132.35 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.72 -1.955 . . . . 1.0 105.72 175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.921 ' HA ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -97.86 146.29 25.57 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.879 0.847 . . . . 1.0 111.462 -176.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -173.49 154.42 2.56 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.409 179.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -97.42 -45.7 6.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.509 -0.745 . . . . 1.0 109.132 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.7 p -122.13 56.14 1.11 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 83' ' ' ARG . 2.2 tmtm? -73.74 144.24 45.76 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.52 -0.737 . . . . 1.0 109.79 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -73.62 -20.24 60.64 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.664 -0.647 . . . . 1.0 109.624 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.66 -47.93 14.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.423 -0.798 . . . . 1.0 109.675 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.846 HG11 ' CG1' ' A' ' 64' ' ' VAL . 59.5 t -65.26 -36.32 77.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.705 -0.622 . . . . 1.0 110.262 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 91' ' ' TRP . 10.2 pt-20 -65.19 -34.33 78.12 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.985 -1.072 . . . . 1.0 109.342 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.412 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.3 m95 -65.26 -55.65 17.17 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.598 -0.689 . . . . 1.0 109.47 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.798 HD13 ' CG ' ' A' ' 23' ' ' LEU . 1.6 pp -62.02 -34.53 76.38 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.784 -0.573 . . . . 1.0 109.935 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HD2' HG12 ' A' ' 89' ' ' VAL . 2.4 mtpp -61.24 -50.03 74.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.604 -0.685 . . . . 1.0 109.501 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.522 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 1.0 OUTLIER -56.82 -37.56 71.38 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.776 -0.578 . . . . 1.0 109.531 179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.907 -0.496 . . . . 1.0 110.091 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -64.96 -44.46 94.49 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.179 -1.568 . . . . 1.0 109.179 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -65.89 -37.61 86.58 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.896 -0.767 . . . . 1.0 109.647 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.599 HD13 ' C ' ' A' ' 98' ' ' LEU . 3.1 tm? -61.13 -46.62 89.82 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.3 -34.73 79.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.643 -0.66 . . . . 1.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.568 ' CB ' HD13 ' A' ' 101' ' ' LEU . 12.2 mt-10 -60.25 -55.2 36.67 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.588 -0.695 . . . . 1.0 110.154 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.775 ' N ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -140.13 162.72 34.56 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.522 -0.736 . . . . 1.0 110.247 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.164 0 CA-C-O 117.725 -1.131 . . . . 1.0 110.137 -179.812 . . . . . . . . 1 1 . 1 stop_ save_